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Abstract!
Trypanosoma brucei is a unicellular trypanosomatid protozoan parasite and the 
etiological agent of sleeping sickness in sub-Saharan Africa. The trypanosomatid order 
also includes the parasites Trypanosoma cruzi (Chagas disease) and Leishmania major 
(Leishmaniasis). Sleeping sickness is estimated to cause ~10,000 deaths per year and 
current treatments are expensive, difficult to administer and toxic. Although genomic 
sequencing of all three parasites has identified the coding sequences of these organisms, 
much is still unknown about protein function, with 64% of identified genes annotated as 
“hypothetical”, lacking obvious homology with proteins of known function. To further 
understand the unusual biology of this family of eukaryotes, this thesis aimed to provide 
evidence for protein function in Trypanosoma brucei in a high-throughput manner, 
utilising global proteomic analyses. This work has encompassed two main approaches: 
The global analysis of protein interactions and the analysis of proteome changes across 
the cell-cycle. 
To enable these approaches, I developed protocols for proteome wide analysis of 
protein complexes in Trypanosoma brucei, combining multiple forms of 
chromatography on ‘native’ lysates of cells to produce a proteome wide map of core, 
soluble protein complexes in this organism. I further performed preliminary studies to 
optimise in vivo formaldehyde crosslinking in T. brucei in order to characterise 
membrane bound protein complexes. 
I also developed methodologies to produce large populations of procyclic 
T. brucei cells highly enriched in different phases of the cell-cycle for proteomic 
analysis. In conjunction with the optimisation of methods for isobaric tag quantitation 
on Fusion mass spectrometers, I provide the first characterisation of protein regulation 
during cell division in T. brucei at an unparalleled proteomic depth. 
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! iv!
Together, these datasets provide a wealth of information about the interaction 
and cell cycle regulation of many thousands of proteins in T. brucei, and contributes 
greatly to the understanding of protein function in trypanosomatid organisms. I 
highlight the ability of these methods to predict novel protein complexes, predict 
interactions between “hypothetical” proteins with proteins of known function, and to 
identify “hypothetical” cell-cycle regulated proteins that are essential for growth of the 
parasite, that are a potentially interesting source for novel drug targets. Data 
visualisation tools to browse the data in a user-friendly format will further allow the 
trypanosmatid research community to mine these datasets to understand function of 
proteins of interest and continue to extract functional information from these datasets to 
extend our understanding of trypanosomatid biology.!
List of figures 
 
! v!
List of figures 
Figure 1.1: Distribution of gHAT and rHAT                        2 
Figure 1.2: Life-cycle of T. brucei                       6 
Figure 1.3: Phylogenetic tree of Eukarya                       7 
Figure 1.4: Overview of transcription in T. brucei                      9 
Figure 1.5: Methods for the characterisation of protein complexes                15 
Figure 1.6: Overview of the procyclic T. brucei cell-division-cycle                20 
Figure 3.1: Overview of workflow for protein complex prediction               46 
Figure 3.2: SEC300 chromatography              47 
Figure 3.3: SEC1000 chromatography                 47 
Figure 3.4: Linear regression model or Mw                48 
Figure 3.5: SAX chromatography                    48 
Figure 3.6: SyPro Ruby staining of SDS-PAGE gels                  50 
Figure 3.7: Western blotting for enolase and tryparedoxin peroxidase                50 
Figure 3.8: Peak picking analysis from SEC300 fractionation                 51 
Figure 3.9: Comparison of Uniprot predicted and SEC300 estimated Mw              51 
Figure 3.10: Gene ontology enrichment analysis of proteins detected in each category from peak picking 
analysis                     53 
Figure 3.11: Median Pearson correlation within fractions                54 
Figure 3.12: Reproducibility of replicates                55 
Figure 3.13: Pearson correlation of elution profiles                  55 
Figure 3.14: Hierarchical clustering of protein elution profiles                57 
Figure 3.15: Elution of components of known core protein complexes across multiple forms of 
chromatography                      59 
Figure 3.16: Overview of machine learning protein complex prediction pipeline              62 
Figure 3.17: Machine learning interaction prediction score distributions                63 
Figure 3.18: Receiver operator curves from both random forest predictors           63 
Figure 3.19: Feature importance output of random forest analysis                 64 
Figure 3.20: Comparative analysis of our data and published data             64 
Figure 3.21: Machine learning prediction of protein-protein interactions and protein complexes         65 
List of figures 
 
! vi!
Figure 3.22: In vivo crosslinking and de-crosslinking analysis of T. brucei                       68 
Figure 3.23: Western blotting for enolase and tubulin in lysates from DSP or formaldehyde crosslinked 
cells                       69 
Figure 3.24: Denaturing SEC1000 on crosslinked lysates            69 
Figure 3.25: Elution profiles of components of novel predicted complexes across multiple forms of 
chromatography                      83 
Figure 3.26: Elution profiles of components of predicted complexes with characterised functions across 
multiple forms of chromatography                   87 
Figure 3.27: Data visualisation tools – Complex Explorer            92 
Figure 3.28: Data visualisation tools – Profile Explorer               93 
Figure 3.29: Data visualisation tools – Cluster Explorer            94 
Figure 4.1: General principle of counterflow centrifugal elutriation            100 
Figure 4.2: Direct counterflow centrifugal elutriation of trypanosomes             100 
Figure 4.3: Single-cut elutriation method            101 
Figure 4.4: Double-cut elutriation method             102 
Figure 4.5: Workflow for TMT based quantitation of the cell-cycle regulated T. brucei proteome      104 
Figure 4.6: Optimisation of high-pH reverse phase fractionation of TMT labelled peptides      105 
Figure 4.7: Experimental design for assessing TMT quantitation accuracy and precision       106 
Figure 4.8: Effect of isolation width on TMT quantitation on a QExactive+           108 
Figure 4.9: The use of an intensity filter to exclude inaccurate ratios           110 
Figure 4.10: TMT quantitation on a Fusion MS using different methods           110 
Figure 4.11: Number of psms identified and quantified across different Fusion methods        111 
Figure 4.12: Scatter plot of maximum fold-change across the cell-cycle and ANOVA p-value       112 
Figure 4.13: Hierarchical clustering               114 
Figure 4.14: Radial visualisation plot of clusters and known cell-cycle regulated proteins       115 
Figure 4.15: Many proteins detected as cell-cycle regulated lack cell-cycle GO annotation       116 
Figure 4.16: Radial visualization plot of ‘hypothetical’ proteins with an essential phenotype      116 
Figure 4.17: Overlap of proteomic and transcriptomic cell-cycle datasets        118 
Figure 4.18: Gene ontology enrichment for the transcript/protein categories described in Figure 4.17   119 
Figure 4.19: Relative protein and mRNA abundance of predicted DRBD17, Tb927.8.710 over the cell 
cycle                132 
List of figures 
 
! vii!
Figure 4.20: Relative protein abundance of predicted WD40 repeat protein, Tb927.10.10990 over the cell 
cycle                133 
Figure 4.21: Relative protein abundance of putative S/T protein kinase, Tb927.6.5100 over the cell cycle 
     134 
Figure 4.22: Relative protein abundance of hypothetical protein, Tb927.8.7540 over the cell cycle      135 
Supplementary Figure 1: Effect on TMT quantitation of modifying the isolation window on a QExactive+ 
MS                232 
Supplementary Figure 2: Effect on TMT quantitation of modifying the isolation window on a Fusion MS
                232 
Supplementary Figure 3: Effect on psm identification and quantification of isolation window on a Fusion 
MS                  233 
Supplementary Figure 4: Effect on TMT quantitation of peptide load on a Fusion MS       234 
Supplementary Figure 5: Effect on psm identification and quantification of peptide load on as Fusion MS
                234 
Supplementary Figure 6: Contour plots of compressed (red) and uncompressed (blue) psms with an 
expected 10-fold ratio with a range of methods tested on QExactive, QExactive+ and Fusion with mouse 
and trypanosome TMT-peptide mix             236 
Supplementary Figure 7: Effect on TMT quantitation of modifying the MS3 scan maximum injection 
time on a Fusion MS with mouse and trypanosome TMT-peptide mix         237 
Supplementary Figure 8: Effect on TMT quantitation of decreasing the number of SPS-notches used on a 
Fusion MS with mouse and trypanosome TMT-peptide mix          238 
Supplementary Figure 9: Effect on TMT quantitation of decreasing the automatic gain control target 
using 10 SPS-notches on a Fusion MS with mouse and trypanosome TMT-peptide mix       240 
Supplementary Figure 10: Effect on TMT quantitation of decreasing the automatic gain control target 
using 2 SPS-notches on a Fusion MS with mouse and trypanosome TMT-peptide mix            241 
Supplementary Figure 11: Percentage of mouse and trypanosome peptide spectral matches identified in 
all 6 TMT reporter ions channels             242 
List of tables 
 
! viii!
List of tables 
Table 3.1: List of proteins identified in Complex 31 – proteasome core complex          75 
Table 3.2: List of proteins identified in Complex 130 – F0F1 ATP synthase          76 
Table 3.3: List of proteins identified in Complex 85 – F0F1 ATP synthase          77 
Table 3.4: List of proteins identified in Complex 4 – mitochondrial ribosome          77 
Table 3.5: List of proteins identified in Complex 92 – mitochondrial ribosome                78 
Table 3.6: List of proteins identified in Complex 134 – mitochondrial ribosome          78 
Table 3.7: List of proteins identified in Complex 3 – AMPK            79 
Table 3.8: List of proteins identified in Complex 72 – PUF10 complex           80 
Table 3.9: List of proteins identified in Complex 174 – CNOT10 and 11          81 
Table 3.10: List of proteins identified in Complex 108 – U3 ribonucleoprotein          81 
Table 3.11: List of proteins identified in Complex 76 – H/ACA ribonucleoprotein         82 
Table 3.12: List of proteins identified in Complex 12 – HSP70/90 complex          84 
Table 3.13: List of proteins identified in Complex 99 – MTR1 and eIFB complex         85 
Table 3.14: List of proteins identified in Complex 165 – nucleolar associated complex         85 
Table 3.15: List of proteins identified in Complex 164 – GPI associated complex         86 
Table 4.1: Maximum enrichments achieved for each cell-cycle population using either direct, single-cut 
or double-cut elutriation, as measured by flow cytometry               102 
Table 4.2: Contingency table of peak expression time-points for genes/proteins identified as cell-cycle 
regulated in both transcriptomic and proteomic datasets              118 
Table 4.3: Evidence of cell-cycle regulation of PSP1 C-terminal domain containing proteins in T. brucei
                    130 
Supplementary Table 1: List of gold standard protein complexes used for random forest machine learning 
prediction of protein interactions             161 
Supplementary Table 2: List of predicted protein complexes from machine learning analysis      162 
Supplementary Table 3: List of suggested names for machine learning predicted protein complexes     183 
Supplementary Table 4: Proteins classified in cell-cycle regulated clusters        197 
List of tables 
 
! ix!
Supplementary Table 5: List of proteins detected as cell-cycle regulated in both T. brucei proteomic and 
transcriptomic analysis                  209 
Supplementary Table 6: List of proteins identified in both transcriptomic and proteomic analysis of the 
cell-cycle, and only classified as regulated from proteomic data         211 
Supplementary Table 7: List of proteins identified in both transcriptomic and proteomic analysis of the 
cell-cycle, and only classified as regulated from transcriptomic data         218 
Supplementary Table 7: Proteins classified as cell-cycle regulated that are not identified in transcriptomic 
data                225 
Supplementary Table 8: Transcripts classified as cell-cycle regulated that are not identified in proteomic 
data                226 
Abbreviations 
 
! x!
Abbreviations 
AAT – Animal African Trypanosomiasis 
ABK – aurora B kinase 
AGC – automatic gain control 
ANOVA – analysis of variance 
AP-MS – affinity purification mass spectrometry 
BSA – bovine serum albumin 
BSF – bloodstream form 
CBQCA – 3-(4-carboxybenzoyl) quinoline-2-carboxalehyde assay 
CDK – cyclin dependent kinase 
CID – collision induced dissociation 
CPC – chromosomal passenger complex 
CRK – cdc2 related kinase 
DMSO –dimethyl sulfoxide 
DRBD – double RNA binding domain 
DSP – dithiobis(succinimidyl propionate) 
EDTA – ethylenediametetraacetic acid 
GD – gold standard dataset 
GG-mito – glycerol gradient of mitochondrial extract 
GG-WCL – glycerol gradient of whole cell lysate 
gHAT – T. b. gambiense Human African Trypanosomiasis 
GO – gene ontology 
HAT – Human African Trypanosomiasis 
HCD – higher energy collisional dissociation 
HPLC – high performance liquid chromatography 
iBAQ – intensity based absolute quantitation 
IEX – ion exchange chromatography 
IEX-cyto – ion exchange chromatography of cytosolic extract 
IEX-mito – ion exchange chromatography of mitochondrial extract 
KKT - kinetochore 
Abbreviations 
 
! xi!
LDS – lithium dodecyl sulphate 
LFQ – label free quantitation 
maxIT – maximum injection time 
MS – mass spectrometry 
NCC – normalised cross-correlation 
NEM – N-ethylmaleimide 
OMSSA – open mass spectrometry search algorithim 
PBS – phosphate buffered saline 
PCC – Pearson cross-correlation 
PCF – procyclic form 
PCP-MS – protein correlation profiling mass spectrometry 
PGC – polycistronic gene cluster 
PMSF – phenyl-methyl sulfonyl fluoride 
psms – peptide spectral matches 
PSP1 – polymerase suppressor 1 domain 
PTM – post translational modification 
PUF – pumilio protein domain 
rHAT – T. b. rhodisiense Human African Trypanosomiasis 
RITseq – RNA interference target sequencing 
ROC – receiver operator curve 
SAX – strong anion exchange chromatography 
SDS – sodium dodecyl sulphate 
SEC – size exclusion chromatography 
SPS – synchronous precursor selection 
SSR – strand swith regions 
TCEP – tris(2-carboxyethyl)phosphine 
TFA – trifluoroacetic acid 
TLCK – 1-5-chloro-3-tosylamido-7-amino-2-heptone 
TMT – tandem mass tag 
UTR – untranslated region 
VSG – variant surface glycoprotein 
Chapter 1: Introduction 
 
 
!
!
1 
Chapter 1: Introduction 
1.1!Trypanosoma brucei and sleeping sickness 
Trypanosoma brucei is a unicellular trypanosomatid protozoan parasite, causing African 
sleeping sickness, or Human African Trypanosomiasis (HAT), a disease endemic to 
sub-Saharan Africa. Two sub-species of T. brucei (T. b. gambiense and 
T. b. rhodisiense) cause HAT, though they produce distinct pathologies and disease in 
different regions of Africa (Figure 1.1). T. b. gambiense is responsible for 98% of the 
detected cases of sleeping sickness in the past 10 years, causing a long-term chronic 
disease (gHAT) found in western and central Africa. T. b. rhodisiense is found in 
eastern and southern Africa, causing an acute form of sleeping sickness (rHAT), and is 
considered a zoonosis infecting mainly wild animals and livestock, only occasionally 
infecting humans (Franco et al., 2014). Infected tsetse flies of the Glossina genus act as 
the main vectors for transmission, releasing mammalian infective parasites in saliva 
when taking a blood-meal (Kennedy, 2008). 
 The disease is characterised by two clinical phases. In the first haemo-lymphatic 
stage, the parasite is found in the blood-stream and lymphatic system of the mammalian 
host. Symptoms include headache, intermittent fever, weakness and anaemia and can be 
easily confused for other diseases in the region. If untreated the disease progresses into 
the second meningo-encephalitic stage where parasites cross the blood-brain-barrier, 
accessing the central nervous system. Symptoms at this stage encompass a wide range 
of neurological disorders, including dysregulated sleeping patterns that give the name to 
the disease (Brun et al., 2010). If left untreated the disease is fatal in almost 100% of 
cases (Stuart et al., 2008). The acute rHAT can result in death within a period of 
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months, whereas chronic gHAT may remain in the first stage for many years before the 
second stage is observed (Brun et al., 2010). 
 !
Figure 1.1: Distribution of gHAT and rHAT. Risk of T. b. gambiense infection in red, 
concentrated in Western Africa, and risk of T. b. rhodisiense infection in blue, 
concentrated in Eastern Africa. Yellow colour depicts distribution of the tsetse fly 
vectors. Reproduced from (Franco et al., 2014). 
HAT mainly affects a young working age population in poor and rural areas. 
Together with the chronic nature of gHAT this results in a dramatic economic impact on 
already impoverished communities, as added on to the cost of seeking diagnosis and 
medical treatment is the loss of income generators within families (Franco et al., 2014). 
Further economic damage results from Animal African Trypanosomiasis (AAT), more 
commonly known as nagana, which is caused by T. b. brucei, T. congolense and T. 
vivax (Fevre et al., 2006). AAT leads to a loss of productivity in livestock species and 
Chapter 1: Introduction 
 
 
!
!
3 
can make this kind of farming impossible in endemic regions (Kristjanson et al., 1999; 
Swallow, 2000). 
The World Health Organisation has led and co-ordinated joint efforts to reduce a 
growing HAT epidemic which peaked at an estimated 300,000 cases in the late 1990s 
(WHO, 1998), with the aim of eventually eliminating HAT transmission by 2030 
(Simarro et al., 2015). Measures that increased surveillance and control of HAT 
implemented since 2000 have been highly successful, resulting in a 76% drop in case 
prevalance. Only 7,000 cases were detected between 2010-13, though due to under-
reporting it is estimated there are about 20,000 cases per year (Franco et al., 2014).  
There are only a handful of drugs used for treatment of HAT. gHAT is treated 
with pentamidine in the first stage of disease and with either, eflornitihine, or 
melarsoprol in the second stage. rHAT is treated with suramin during the first stage of 
disease and melarsoprol in the second stage (Brun et al., 2010; Steverding, 2010). These 
drugs can be expensive, have toxic side effects and require lengthy and complicated 
treatments. Although the recent development of combination therapy with nifurtimox 
and eflornithine has resulted in shorter treatment times and reduced toxicity, it still 
requires invasive intravenous administration (Priotto et al., 2009). It is therefore 
necessary to develop new drugs that can be taken orally and target the second-stage of 
disease, with fewer toxic side effects (Barrett et al., 2007). 
Eflornithine is the only trypanocidal drug developed with a known mechanism 
of action, irreversibly inhibiting ornithine decarboxylase (Bacchi et al., 1980). The 
identification of dye-based compounds, arsenicals and the hypoglycaemic drug, 
synthalin, as trypanocides, led to the development of suramin, melarsoprol and 
pentamidine in the first half of the 20th century (Steverding, 2010). However, due to the 
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identification of these drugs through phenotypic screening, their mechanisms of action 
are poorly understood. Regulatory requirements now require a better understanding of 
drug efficacy and toxicity, which favours a target based approach to drug discovery. 
The identification of useful drug targets requires the understanding of the biological 
functions and roles of proteins in the parasite (Horn, 2014). 
1.2!The life-cycle of T. brucei 
Trypanosomes undergo a complicated life-cycle involving cellular differentiation, 
which is necessary for survival in the different environments of the insect vector and 
mammalian host (Figure 1.2). T. brucei survives in the bloodstream and lymphatic 
system of infected mammals as a long slender bloodstream form (BSF). This form of 
the parasite is proliferative, actively dividing within the mammalian host. The BSF of 
T. brucei is densely covered with a variant surface glycoprotein (VSG) coat (Cross, 
1975), which is recognised by the immune system. A single VSG is expressed at any 
one time, and there is a large number of genes that can encode for them. Within an 
infecting population a subset of cells will switch their VSG encoding gene, allowing 
escape from the host immune response and expansion of a trypanosome population 
encoding a different VSG (Cross, 1979; Horn and Cross, 1997; Pays and Nolan, 1998). 
This process of antigen switching leads to the characteristic intermittent waves of 
parasitaemia observed in sleeping sickness (Doyle et al., 1980; MacGregor et al., 2012). 
 As the BSF population increases, a quorum sensing mechanism causes the long 
slender BSF parasites to differentiate into a short stumpy form that is cell-cycle arrested 
(Mony et al., 2014; Reuner et al., 1997; Vassella et al., 1997). This differentiation is 
thought to limit cell numbers, prolonging host survival, and prepare cells for the 
environment of the insect vector (MacGregor et al., 2012). Following a blood-meal, 
stumpy form cells further differentiate into replicative procyclic form (PCF) cells in the 
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tsetse fly midgut (Dyer et al., 2013). The mitochondrion of PCF cells is elaborated with 
the formation of cristae as proline becomes their major energy source instead of the 
glucose that is plentiful in mammalian blood (Milne et al., 1998; Vickerman, 1965; 
Vickerman et al., 1988). 
 PCF cells then migrate through to the proventriculus, differentiating into an 
epimastigote form. The epimastigote form divides asymmetrically into a long slender 
motile cell, like the parent cell, and a short cell with a short flagellum that attaches to 
the salivary gland (Van Den Abbeele et al., 1999). While attached to the salivary gland, 
the short epimastigote form cells differentiate into mammalian infective metacyclic 
cells, which are released from the endothelial wall into the salivary gland, ready to be 
transmitted in the next blood-meal (Vickerman et al., 1988). Metacyclic cells express 
one of around twenty-seven metacyclic specific VSGs as protection against the host 
immune system (Barry et al., 1998; Tetley et al., 1987). 
 Upon release into the dermal connective tissue of the host, the parasites migrate 
into the bloodstream via the lymphatic system and differentiate into BSF cells, 
completing the T. brucei life-cycle (Vickerman, 1985). 
 The parasite can also undergo the process of sexual recombination between 
different strains of T. brucei, a non-essential component of the parasite life-cycle that 
occurs in the salivary gland of the tse-tse fly. Prior to sexual recombination, parasites 
divide by meiosis to produce haploid gametes, which have a distinct morphology with a 
long free flagellum and pear-shaped body. Haploid gametes interact through 
intertwining their flagella prior to fusion of the two cells, though the mechanics of DNA 
exchange are currently unknown (Gibson, 2015). 
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Figure 1.2: Life-cycle of T. brucei. Right-hand side depicts mammalian blood-stream 
stages of the parasite. Left-hand side depicts insect stages of the parasite. (1) Metacyclic 
cells differentiate into long-slender BSF as they are released into the mammalian blood-
stream. (2) Long-slender BSF cells differentiate to cell-cycle arrested short stumpy form 
cells. (3) Following a tsetse fly blood-meal, short stumpy cells differentiate to PCF 
cells. (4-7) PCF cells migrate through the proventriculus to the salivary glands, 
eventually differentiating into epimastigote form cells, which upon release from the 
salivary glands differentiate into metacyclic form cells. Reproduced from 
www.richardwheeler.net. 
1.3!Evolutionary divergence of kinetoplastids 
Trypanosome species belong to the class of kinetoplastid organisms, which are 
found in the Excavata super-group, one of five which divide the eukaryotic domain of 
life (Figure 1.3)(Adl et al., 2012; Lukeš et al., 2014). Kinetoplastids are defined through 
the presence of an organelle known as the kinetoplast – the dense DNA compartment of 
the single mitochondrion of the cell. This class of organism is thought to have diverged 
very early during eukaryotic evolution (Dacks et al., 2008; Lukeš et al., 2014) and 
demonstrates unusual biological processes in comparison to more commonly studied 
organisms such as yeast, mice and humans. For example, mitochondrial RNA 
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transcripts go through a complex process of RNA editing, glycolysis is 
compartmentalised into unique organelles and apart from two protein-coding genes, 
lack intronic DNA sequences (Simpson et al., 2006). 
!
Figure 1.3: Phylogenetic tree of Eukarya. Eukaryotic species are divided into five 
super-groups, depicted as different colours of tree branches. SAR represents 
Stramenopliles, Alvolates and Rhizaria. Species in grey are not currently placed in any 
of the major super-groups. T. brucei is found in the Excavata super-group, within the 
Kinetoplastea class. Reproduced from (Lukeš et al., 2014). 
The genome organisation and mechanism of transcription in T. brucei further 
demonstrates the unusual biology of these parasites. The nuclear genome is composed 
of 11 diploid megabase-sized chromosomes (0.9-6Mbp), ~5 aneuploid intermediate-
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sized chromosomes (150-900 Kbp) and ~100 mini-chromosomes (50-150 
Kbp)(Berriman et al., 2005). The sub-telomeric region of megabase-sized chromosomes 
contain arrays of VSG genes and pseudogenes, though only one VSG is transcribed at 
any one time in the BSF of the parasite (Cross et al., 2014; Marcello and Barry, 2007). 
RNA polymerase I transcribes a single VSG gene, in conjunction with expression site 
associated genes, from a single bloodstream expression site that can be found on either 
megabase, or intermediate-sized chromosomes (Gunzl et al., 2003; Günzl et al., 2015). 
The intermediate-sized and minichromosomes also encode VSG genes that can be 
activated and expressed upon antigenic variation. VSG pseudogenes can also be 
involved in recombination events to produce new functional VSGs, providing a 
mechanism to create an endless repertoire of proteins crucial for immune evasion 
(Glover et al., 2013).  
Most protein-coding genes in trypanosomatids are transcribed as long polycistronic 
units, with tens to hundreds of protein coding sequences produced in a single transcript 
(Imboden et al., 1987; Johnson et al., 1987). Genes within a polycistronic unit are 
arranged in a head to tail orientation, and distinct units are separated by strand switch 
regions, which can be oriented in a head to tail, convergent or divergent manner. 
Individual mRNAs are produced by co-transcriptional trans-splicing of a 39-nucleotide 
spliced leader mini-exon to the 5’ untranslated region (UTR) of a gene, in combination 
with cleavage and polyadenylation of the 3’ UTR (Figure 1.4)(Huang and Van der 
Ploeg, 1991; Ullu et al., 1993). Genes within a polycistronic unit do not necessarily 
share functional relationships and regulation of gene expression is thought to occur 
mainly at the post-transcriptional level. RNA binding proteins compose a major part of 
the trypanosomatid genome, and are known to play key roles in regulating the 
expression of mRNAs (Clayton, 2013; 2002). For example, a 3’ UTR in VSG 
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transcripts promotes mRNA stability in BSF cells, while the same mRNA is rapidly 
degraded in PCF cells, ensuring VSGs are only expressed in the mammalian host 
(Berberof et al., 1995). 
!
Figure 1.4: Overview of transcription in T. brucei. Diagrammatic representation of 
genes in T. brucei, transcribed from polycistronic gene clusters (PGCs). Strand switch 
regions (SSRs), characterized by long stretches of guanine (G) nucleotides, separate 
PGCs. Co-transcriptional trans-splicing, of a spliced leader sequence, and poly-
adenylation resolves polycistronic mRNA transcripts into individual mRNA transcripts. 
Reproduced from (Martínez-Calvillo et al., 2010). 
Although a major cause of global disease, the large evolutionary divergence from 
intensively studied eukaryotic model organisms, means much of the unusual biology of 
trypanosomatids remains poorly characterised. In 2005 the genomic sequence of 
T. brucei was reported, identifying ~9,100 genes, providing a highly useful resource for 
the trypansomatid research community (Berriman et al., 2005). However, many of the 
identified genes lack classifiable homology to known proteins, hampering their 
functional classification. It has been previously estimated that 4,900 T. brucei genes 
have no reliable homologs in other organisms, and of the remaining 4,200 genes, 35% 
were annotated as “hypothetical”, lacking functional evidence in other organisms too 
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(Salavati and Najafabadi, 2010). In 2011 it was estimated that 64% of ~7,500 non-
redundant genes were annotated as “hypothetical” (Alsford et al., 2011). 
1.4!Global strategies to annotate gene function 
To overcome the lack of functional annotation from genomic sequence, it is necessary 
to provide evidence for protein or gene function through a variety of high-throughput 
methods (Field et al., 2012). 
It has been demonstrated that computational analysis of protein and gene 
sequences can allow for the prediction of function (Gazestani et al., 2014; Salavati and 
Najafabadi, 2010). For example, gene expression in T. brucei is heavily regulated at the 
post-transcriptional level through RNA binding proteins. The stability of mRNA is 
dependent on the sequence motifs to which these proteins bind, and genes of a 
functional class may share these regulatory sequences. It is possible to predict these 
regulatory elements within groups of proteins that are known to share a particular 
function, are involved in similar metabolic pathways, or display similar patterns of 
expression. Analysis of trypanosmatid genes within the same KEGG pathway predicted 
15 and 21 function-specific motifs in 5’ and 3’ UTRs respectively (Mao et al., 2009). 
Together with analysis of gene codon-usage it was possible to predict components of 
metabolic pathways such as inositol phosphate metabolism, with a reasonable 
sensitivity (50%) and precision (>60%)(Salavati and Najafabadi, 2010). However, these 
methods are dependent on prior knowledge of function or co-regulation of a set of 
genes. 
The availability of genomic data has also opened the door to transcriptomic and 
proteomic approaches to provide direct experimental evidence for the functional 
properties of trypanosomatid genes and proteins on a genome-wide scale. Omics 
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technologies are particularly useful in this scenario, as data is produced for many of the 
trypanosomatid specific “hypothetical” genes and proteins, which may begin to 
highlight their potential biological role, and direct hypothesis driven research to test 
potential functions. 
Transcriptomic studies have been utilised to determine changes in mRNA 
abundance between life-cycle stages of the parasite  and during time-courses of 
differentiation or cell-division (Archer et al., 2011; Brems et al., 2005; Jensen et al., 
2009; Kabani et al., 2009; Koumandou et al., 2008; Siegel et al., 2010). These studies 
have led to the discovery of groups of transcripts which are up-regulated in different 
phases of the T. brucei life or cell cycle, together with the identification of RNA 
sequence motifs responsible for regulation of gene expression across cell-division 
(Archer et al., 2011). Transcriptomic datasets can produce very high coverage, with 
quantitative data from 70-90% of all annotated T. brucei genes in some experiments. 
However, the data are limited to information on mRNA abundance, whereas many other 
factors also account for gene function. Furthermore, as transcript regulation occurs 
mainly post-transcriptionally, and with the translation efficiency between individual 
transcripts varying by 100-fold, it is clear that mRNA abundance may not be 
representative of the final protein abundance in a cell (Jensen et al., 2014; Vasquez et 
al., 2014). 
Proteomic analyses tend to have much lower coverage than transcriptomic 
studies, with the deepest data-sets reaching just over 4,000 proteins identified. However, 
a wider range of experimental methodologies can be employed to extract different 
functional information. Proteomic studies have also been used to perform comparisons 
of relative protein abundance between distinct life-cycle stages, or during a time-course 
of differentiation (Butter et al., 2013; Dejung et al., 2016; Gunasekera et al., 2012; 
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Urbaniak et al., 2012a), identifying novel factors such as a DEAD/H RNA helicase, and 
DOT1B, a histone deacetylase, necessary for cell division in BSF cells or differentiating 
BSF cells, respectively (Butter et al., 2013; Dejung et al., 2016). 
In addition to quantifying the total abundance of proteins, proteomic methods 
can also identify and quantify post-translational modifications on proteins that further 
informs on function. Post-translational modifications (PTM) regulate protein function in 
a variety of ways that may either inhibit, or activate protein activity. PTMs are also 
crucial for signal transduction pathways that allow cells to respond and react to 
environmental conditions, without modifying total protein abundance. The simple 
identification of where a protein is post-translationally modified can define amino acids 
that may be critical for the regulation of protein function (Cohen, 2000; Nett et al., 
2009). Comparative analysis of BSF and PCF parasites has identified phosphorylation 
sites that differ between the two biological states, and may be indicative of mechanisms 
that may establish and maintain these biological differences (Urbaniak et al., 2013). 
Sub-cellular localisation is yet another factor that points towards the biological 
role of a protein. A large number of proteomic studies in T. brucei have focused on 
mapping proteins which localise to different organelles and structures within the cell, 
including the glycosome (Colasante et al., 2006; Güther et al., 2014; Parsons and 
Nielsen, 1990; Vertommen et al., 2008), flagellum (Broadhead et al., 2006; Hart et al., 
2009; Lacomble et al., 2009; Oberholzer et al., 2011; Pullen et al., 2004; Subota et al., 
2014), bi-lobed structure (Gheiratmand et al., 2013; Zhou et al., 2010), acidocalcisome 
(Huang et al., 2014), nucleus (DeGrasse et al., 2008; Rout and Field, 2001), 
mitochondrion (Panigrahi et al., 2009), and a range of lipid membranes (Acestor et al., 
2009; Bridges et al., 2008; Niemann et al., 2012; Shimogawa et al., 2015). 
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Proteomics can also be utilised: to determine protein-protein interactions within 
complexes (section 1.5); in combination with genetic approaches to determine proteome 
effects after knock-down or knock-out of a protein (Zoltner et al., 2015); or in artificial 
assays, identifying the mRNA (Lueong et al., 2016) or drug binding proteome 
(Urbaniak et al., 2012b) for example. The information produced for a protein from the 
wide range of proteomic experiments described here can be used to classify protein 
behaviour and group together proteins with similar behaviours and hence similar 
functions (Ohta et al., 2010). 
Finally, the development of RNA interference target sequencing (RITseq) has 
produced a powerful genetic screening technology in T. brucei that can identify genes 
that are lethal, or promote survival under a particular treatment condition after knock-
down (Alsford et al., 2011). Current publications have identified groups of genes which 
are essential for survival of T. brucei in culture (Alsford et al., 2011); have identified 
the targets of trypanocidal drugs (Alsford et al., 2012); or have identified components of 
the quorum sensing pathway in BSF T. brucei (Mony et al., 2014). The RIT-seq 
approach requires no a priori knowledge of proteins or genes that may be involved in a 
process of interest, so is another powerful tool to begin to annotate gene function on a 
genome wide scale. 
With this in mind, the project plan for this thesis aimed to contribute to the unbiased 
genome wide annotation of gene function in T. brucei. I achieved this by providing 
experimental evidence for protein function using proteomic technologies to determine 
regulation of protein abundance across the cell-division cycle and to globally 
characterise protein-protein interactions. 
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1.5!Protein interactions 
Many intracellular biological processes are dependent on the stable physical association 
between two or more proteins (Alberts, 1998). Indeed, many proteins require to form 
part of a complex to carry out their function, including many well characterised 
complexes such as the proteasome, ribosome and spliceosome. Thus, identifying which 
proteins are interacting can inform us of their likely function and associated biological 
process. The global characterisation of model organism interactomes has led to greater 
understanding of the proteome organisation and improved the functional annotation of 
uncharacterised proteins via guilt by association (Gavin et al., 2006; 2002; Ho et al., 
2002; Hu et al., 2009; Krogan et al., 2006). 
 A number of proteomic methods have been developed to experimentally identify 
and characterise protein interactions in a large-scale, high throughput manner 
(Figure 1.5)(Gingras et al., 2007; Köcher and Superti-Furga, 2007; Mehta and Trinkle-
Mulcahy, 2016; Smits and Vermeulen, 2016). Affinity purification in combination with 
mass spectrometry (AP-MS) is one of the most common methods for protein interaction 
mapping, at either a low or high-throughput scale. This method relies on high-quality 
antibodies to the endogenous protein being purified, or on genetic modification, to 
produce tagged proteins, that can be purified with a generic set of antibodies, or other 
probes, against the tag. A major strength of AP-MS is the ability to enrich for a protein 
of interest, allowing the characterisation of low abundance proteins and complexes. 
Furthermore, in genetically tractable systems it is possible to query the interactome in a 
high-throughput manner. Through the genetic tagging of thousands of proteins, studies  
Chapter 1: Introduction 
 
 
!
!
15 
!
Figure 1.5: Methods for the characterisation of protein complexes. AP-MS can be used 
to purify endogenous or epitope tagged proteins using antibodies to identify components 
of protein complexes. Proximity labelling covalently modifies proteins within a 10-20 
nm radius of a genetically tagged protein with biotin. Modified proteins can then be 
purified through streptavidin to identify interactors. Co-perturbation approaches rely on 
similar behaviour of proteins within a complex in proteomic experiments. Biochemical 
fractionation separates protein complexes based on properties such as charge and 
size/shape and attempts to predict protein interaction through co-fractionation of 
component proteins. Figure adapted from (Smits and Vermeulen, 2016). 
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in yeast and human cell lines have been able to identify tens of thousands of protein 
interactions (Gavin et al., 2006; Hein et al., 2015; Huttlin et al., 2015; Krogan et al., 
2006). 
  The lack of a library of high-quality antibodies against endogenous T. brucei 
proteins, and the high costs required to produce one, has meant that AP-MS studies 
have mainly utilised systems of genetic tagging to purify proteins and their associated 
binding partners. These methods have been a key tool for trypanosome biologists to 
identify and characterise individual protein complexes, including the spliceosome (Luz 
Ambrósio et al., 2009; Palfi et al., 2005), ATP synthase (Zikova et al., 2009) and 
mitochondrial ribosomes (Zikova et al., 2008), to name but a few. 
 Another method which has been used successfully in T. brucei is proximity 
labelling, which allowed the identification of proteins associated with the unique bi-lobe 
structure (Morriswood et al., 2013). This method genetically tags a protein with an 
enzyme that biotinylates neighbouring proteins within a 10 to 20 nm radius (Rhee et al., 
2013; Roux et al., 2012). Biotinylated proteins can then be enriched using streptavidin. 
The in vivo labelling method may allow for the identification of transient or weak 
interacting proteins that may be disrupted upon cellular lysis. Proximity labelling also 
avoids the necessity of low-stringency purification strategies to minimise disruption of 
protein interactions required in AP-MS. 
 Alternatively, a number of studies have been able to identify proteins interacting 
within a complex through their co-behaviour across multiple experiments. This effect 
depends on the principle that if one member of a protein complex is disrupted or 
depleted, the other members of the complex will demonstrate a similar effect. 
Therefore, across multiple experiments the similar behaviour of a set of proteins 
Chapter 1: Introduction 
 
 
!
!
17 
indicates a functional linkage between these proteins, and has been demonstrated to 
detect known protein complexes (Ohta et al., 2010). 
 Interactomes are highly dynamic and individual proteins may have completely 
different interaction partners in different biological conditions. Affinity purification 
based interactomes require the culturing of thousands of independent cell lines to profile 
protein interactions in one biological state, which is already costly and labour intensive. 
Furthermore, usually only one buffer condition is utilised, which is unlikely to be 
compatible with all protein-protein interactions. Affinity tagging can also lead to 
artefacts from either overexpression, or disruption of the endogenous function of the 
tagged protein (Banks et al., 2015; Boulon et al., 2010). AP-MS methods are therefore 
not amenable to the comparison of protein-protein interactions between different 
biological conditions on a proteome-wide scale. 
 The co-fractionation of assayable proteins (i.e. enzymes and proteins to which 
there are antibodies or other selective probes) by liquid chromatography and/or 
sedimentation methods has long been used to provide compositional data on sub-
cellular organelles and protein complexes. Conventionally these methods have been 
used to isolate individual protein complexes or biological structures. For example, to 
define components of the proteasome (Wang et al., 2003) or sub-nuclear compartments 
(Rout and Field, 2001) in trypanosomes. 
Applying modern shot-gun proteomics to such a chromatographic and/or density 
sedimentation fractions from cell lysates provides a more general protein detection and 
quantification mechanism. This, in turn, allows the simultaneous recording of the 
separation profiles of several thousands of proteins (independent of specific assays) and 
these data can be used to suggest physical associations between them. This method has 
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come to be termed PCP-MS (protein correlation profiling-MS) and was initially utilised 
to analyse sub-cellular organelles (Andersen et al., 2003; Dunkley et al., 2004; Foster et 
al., 2006). More recently PCP-MS has been used to analyse soluble protein complexes 
through fractionation of whole cell lysates by size-exclusion chromatography 
(SEC)(Kirkwood et al., 2013; Kristensen et al., 2012; Li and Giometti, 2007; Olinares et 
al., 2010) and ion-exchange chromatography (IEX)(Havugimana et al., 2012), 
identifying hundreds of protein complexes in single experiments. 
One of the major benefits of PCP-MS methods is the applicability to any 
cultivatable biological system, without genetic manipulation, and the ability to compare 
different biological conditions in a simple manner. This makes PCP-MS an ideal 
method to take forward to carry out global protein interaction analysis in understudied 
organisms such as T. brucei, with the potential to produce a wealth of useful functional 
information on hundreds of uncharacterised proteins. Indeed, during the course of this 
thesis, work from Gazestani and colleagues was published, using glycerol gradient 
centrifugation and ion-exchange chromatography, to identify protein complexes in PCF 
T.brucei mitochondrial and cytoplasmic lysates (Gazestani et al., 2016). 
1.6!Cell cycle 
The eukaryotic cell cycle is an evolutionarily conserved process in which a cell 
duplicates and segregates newly synthesised cellular components to produce two 
daughter cells from a single mother cell. The activation and inactivation of key 
regulatory proteins plays an important role in controlling the temporal order of events 
that must occur for cell division to proceed correctly. The key events of cell division 
include DNA replication (S-phase) and segregation of replicated DNA (mitosis/M-
phase), preceded and interceded by two ‘gap’ phases (G1 and G2-phases) where cells 
sense environmental conditions prior to commitment to cell division, or assess 
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completion of DNA replication prior to entry into mitosis, respectively. These events 
must occur in order and must occur only once per cell cycle (Elledge, 1996). 
Although T. brucei shares this basic eukaryotic cell cycle regulatory scheme, it is 
clear there are some trypanosome-specific mechanisms of regulation. Trypanosomes 
contain a number of unique single copy organelles such as the basal body, the flagella, 
the mitochondrion and the kinetoplast (mitochondrial DNA network) that must be 
duplicated and segregated equally to produce viable daughter cells. In the initial stages 
of G1, trypanosomes contain a single kinetoplast and nucleus (a 1K1N cell). 
Duplication of the basal body is the first morphological event that can be observed 
during the cell cycle and begins the nucleation of a new flagellum. The basal body is 
closely associated with the kinetoplast and its segregation drives duplication and 
segregation of kinetoplast DNA, producing a 2K1N cell. Following completion of 
nuclear DNA replication, cells enter M-phase, segregating replicated chromosomes to 
daughter nuclei (2K2N), followed by cleavage furrow ingression longitudinally down 
the axis of the cell to produce two daughters (Figure 1.6)(Hammarton, 2007; Li, 2012; 
McKean, 2003). 
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Figure 1.6: Overview of the procyclic T. brucei cell-division-cycle. (a) Cells begin with 
1 kinetoplast and 1 nucleus (1K1N). Initial stages of division include basal body 
duplication, initiation of flagellar duplication and Golgi duplication. Segregation of the 
basal body is closely followed by replication and segregation of kinetoplast DNA, 
producing 2K1N cells. Following nuclear DNA replication and segregation in mitosis 
(2K2N) cells separate duplicated organelles and divide into two daughter cells. Images 
adapated from (Akiyoshi and Gull, 2013). (b) Relative timing of the distinct but co-ordinated 
replication and segregation of the nuclear and kinetoplast DNA compartments. D stands 
for division of kinetoplast DNA and A for apportioning, where basal bodies continue to 
move apart. Reproduced from (McKean, 2003). 
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The transition between distinct phases of the cell-cycle is controlled by regulatory 
proteins, several of which have been studied intensively in eukaryotic model organisms. 
Many of these regulatory proteins and their functions are highly conserved within 
eukaryotic species, including trypanosomes. Cyclin-dependent kinases (CDKs) play a 
major role in committing cells to entry into S-phase from a G1 state, and entry into M-
phase from a G2-state. CDK activity is controlled through interaction with partner 
cyclin proteins, expressed in a cyclical manner during different phases of cell division, 
and through post-translational modification, such as phosphorylation. These 
mechanisms allow strict temporal control of cell division processes and allow for the 
input of signal transduction pathways to promote or inhibit progression of the cell cycle, 
depending on the internal and external cellular environment (Murray, 2004). The T. 
brucei genome contains 10 cyclins and 11 Cdc2-related kinases (CRKs) and 
experimental evidence indicates different pairs of cyclins and CRKs are necessary for 
transition between G1/S and G2/M-phases in trypanosomes, as found in other 
eukaryotes (Hammarton et al., 2004; Li and Wang, 2003; Tu and Wang, 2004; 2005). 
Although some proteins are conserved, they may have trypanosome specific 
functions. Aurora B kinase (ABK) forms interactions with three evolutionarily 
conserved proteins (INCENP, Borealin and Survivin) to form the Chromosomal 
Passenger Complex (CPC) in yeast and metazoa (Carmena et al., 2012). The ABK 
interaction partners are involved in the dynamic localisation of the CPC during mitosis 
where it relocates from chromatin, to the mitotic spindle and mid-body of dividing cells. 
T. brucei contains a conserved ABK orthologue, though none of the partner CPC 
proteins have been identified. Instead, trypanosome ABK interacts with trypanosome 
specific proteins (CPC1 and CPC2) that show similar dynamic patterns of localisation 
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as seen in other eukaryotes from chromatin, to the mitotic spindle and the flagellar basal 
body (Li et al., 2008a). 
Some of the major components of the cell division machinery in trypanosomes have 
only been discovered recently, or have yet to be discovered. The kinetochore is a 
macromolecular structure composed of hundreds of proteins that forms on the 
centromeres of chromosomes during mitosis, ensuring correct chromosome segregation 
to daughter cells (Akiyoshi and Gull, 2013; Santaguida and Musacchio, 2009; Wittmann 
et al., 2001). Core kinetochore proteins were expected to be conserved across all 
eukaryotes, although none had been identified in kinetoplastid species until work by 
Akiyoshi and Gull (Akiyoshi and Gull, 2014). Through fluorescent tagging of 
uncharacterised proteins in T. brucei that were upregulated in G2&M-phase in 
transcriptomic studies (Archer et al., 2011), a single protein was identified with 
localisation patterns indicative of a kinetochore component. Iterative immuno-
precipitation experiments eventually identified nineteen novel trypanosome kinetochore 
proteins, conserved among kinetoplastids, but with insufficient homology to have been 
identified from BLAST searches to kinetochore proteins found in other organisms. 
The use of cell cycle regulated transcriptomic data in the identification of a 
completely novel kinetochore complex demonstrates the power of large-scale datasets to 
provide information on the function of uncharacterised proteins. Previous 
transcriptomic analysis has comprehensively determined the cell cycle regulated 
patterns of mRNA abundance in trypanosomes. However, it is not necessarily the case 
that RNA abundance directly correlates to protein abundance. Discrepancies in this 
equation can occur due to differences in rates of translation of mRNA, or rates of 
degradation of protein. Furthermore, in an organism that controls gene expression 
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through RNA binding proteins, the transcriptome may not be an accurate representation 
of the proteome (Clayton, 2013; 2002; Jensen et al., 2014; Vasquez et al., 2014). 
I therefore decided to carry out a proteomic analysis of cell division in PCF 
trypanosomes. Our aim was to identify cell-cycle regulated proteins, characterise the 
temporal regulation of thousands of uncharacterised proteins and to identify key 
proteins which may be useful drug targets involved in key aspects of trypanosome 
biology. The data produced in this thesis will provide a strong platform to further 
understand the biology of cell-division in this unusual eukaryotic parasite. 
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Chapter 2: Materials and methods 
2.1!SDM-79 media preparation 
Powdered SDM-79 media was hydrated with 5 L of Milli-Q water, and supplemented 
with haemin to 7.5 mg/L (from a 10 mg/mL stock in 0.1 M NaOH) and 2 g/L of sodium 
bicarbonate. The pH was adjusted to 7.3 with NaOH, and sterile filtered using Stericups 
500. Under sterile conditions, heat inactivated and non-dialysed fetal bovine serum 
(PAA) was added to final 15% (v/v) and Glutamax I to 2 mM final concentration. The 
antibiotics, G418 and hygromycin, were added to 15 µg/mL and 50 µg/mL respectively. 
2.2!Cell culture 
Procyclic trypanosomes (clone 29.13.6) were cultured in SDM-79 media at 28°C, 
without CO2, in fully capped culture flasks. 
2.3!Size-exclusion chromatography (SEC) 
Procyclic trypanosomes (3x109 cells/replicate) were washed three times in 50 mL of 
phosphate-buffered saline (PBS) and lysed using a Bioruptor Pico (Diagenode) water 
bath sonicator for 10 cycles of 30 seconds on/off, in 0.75 mL of PBS containing 0.1 µM 
1-5-chloro-3-tosylamido-7-amino-2-heptone (TLCK), 1 mM phenyl-methyl sulfonyl 
fluoride (PMSF), 1 µg/mL leupeptin, 1 µg/mL pepstatin and 5 mM 
ethylenediametetraacetic acid (EDTA). Lysates were spun at 17,000 g for 10 min, and 
the supernatant filtered through a 0.45 µm filter unit, all at 4°C. Bradford assays were 
performed on the filtrates for protein quantitation. 
Filtered lysates (~1.2 mg in 200 µL, ~8x108 cell equivalents) were injected onto a 
BioBasic SEC 300 or a BioBasic SEC 1000 column (30 nm or 100 nm pore size 
respectively), using a Dionex Ultimate 3000 high-performance liquid chromatography 
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(HPLC) system, and collected into 48 fractions of 120 µL. Columns were equilibrated 
with PBS and run at 0.3 mL/min at 4°C. Protein concentrations of collected fractions 
were determined using Bradford assays. 
Each fraction was made up to 0.1 M Tris-HCl (pH 8.0), 1 M urea and 5 mM 
dithiothreitol and incubated for 2 h at 37°C, followed by addition of iodoacetamide at a 
final concentration of 25 mM at room temperature for 1 h. Trypsin and LysC were 
added, each at a ratio of 1:100 to total average protein per fraction and incubated 
overnight at 37°C. Each fraction was made up to 1% (v/v) trifluoroacetic acid (TFA) 
and desalted using Sep-Pak tC18 plates, with peptides eluted in 50% acetonitrile, 0.1% 
TFA. Peptides were dried using a GeneVac evaporator and resuspended in 5% formic 
acid and quantified using a 3-(4-carboxybenzoyl) quinoline-2-carboxaldehyde assay 
(CBQCA). Five biological replicates were performed in total for each chromatography 
column. 
For a highly denaturing lysis, cells were lysed in 4% sodium dodecyl sulphate 
(SDS), 10 mM sodium phosphate (pH 6.0) and 100 mM NaCl, sonicated and filtered as 
above, followed by separation in a running buffer containing 0.2% SDS on a BioBasic 
SEC300 column. 
2.4!Strong anion exchange (SAX) 
Procyclic trypanosome cells were prepared in a similar manner as described for SEC 
analysis, with lysis in 1mL 20 mM ethanolamine (pH 9.0) containing 0.1 µM TLCK, 1 
mM PMSF, 1 µg/mL leupeptin, 1 µg/mL pepstatin and 5 mM EDTA. Lysates were spun 
and filtered as described previously. 
Filtered lysate was injected onto a Protein-Pak Hi Res Q, 5 µm, 4.6 x 100 mm, 
column (Waters), equilibrated in 20 mM ethanolamine (pH 9.0). Proteins were resolved 
Chapter 2: Materials and methods 
 
 
!
!
26 
over a gradient of 0 to 100 % 0.5 M NaCl in 20 mM ethanolamine (pH9.0) over the 
course of 26 min, at a flow rate of 0.3 mL/min at 5°C. 96 fractions, of 105 µL, were 
collected from 1.5 to 35 min. 
Collected fractions were made up to 4% SDS and 25 mM tris(2-
carboxyethyl)phosphine (TCEP), then heated to 65°C for 30 min. Once samples had 
cooled to room temperature, N-ethylmaleimide (NEM) was added to a final 
concentration of 50 mM, and incubated for 1 h. 
The denatured, reduced and alkylated proteins in each fraction were prepared for 
digestion utilising a Kingfisher Flex Purification System (ThermoFisher Scientific) in 
combination with magnetic SP3 beads. 20 µL of a 1:1 mixture of hydrophobic and 
hydrophilic, carboxylate modified, Sera-Mag SpeedBead magnetic particles (20 mg/mL 
in H2O, GE) was added to each fraction, followed by the addition of 500 µL of 
acetonitrile and 15 µL of 10% formic acid. In a 96-well plate format, the Kingfisher 
Flex System, was then utilised to wash the magnetic beads (protein bound) for each 
collected fraction, twice in 1 mL 70% ethanol, once in 1 mL 100% acetonitrile, and then 
released into a pre-cooled plate, containing 50 µL 0.1 M Tris-HCl (pH 8.0), 0.1% SDS, 
1 mM CaCl2 and trypsin and LysC at a 1:100 ratio of protease to estimated protein per 
fraction. The plate was incubated overnight at 37°C at 500 rpm in a ThermoMixer 
(Eppendorf). Following overnight digestion, the 96-well plate was thoroughly vortexed 
to ensure resuspension of SeraMag beads, and 950 µL of acetonitrile added. Peptides 
bound to the magnetic beads were washed in 1 mL of acetonitrile, eluted in 40 µL of 2% 
dimethylsulfoxide (DMSO) and beads removed from the sample again on the 
Kingfisher System. Formic acid was added to each sample to a final concentration of 
5%. 
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2.5!SDS-PAGE and Western blotting 
Aliquots of fractions from SEC runs were pooled into groups of three, made up to 1x 
Lithium Dodecyl Sulfate (LDS) Sample Loading Buffer and 25 mM TCEP, heated to 
95°C for 10 min, and resolved on 4-12% SDS-PAGE. Gels were run in MES buffer for 
45 min at 200 V, and were either stained for total protein using SYPRO Ruby, as per 
manufacturers protocol, or transferred onto nitrocellulose membranes at 35 V for 90 
min. 
Membranes were blocked in 3% skimmed milk and 0.1% Tween20 in PBS for 1 
h at room temperature and subsequently probed with primary antibody overnight at 4°C 
in Stericup filtered 5% bovine serum albumin (BSA), 0.1% Tween20 and 0.02% sodum 
azide in PBS. The primary antibodies were utilised at the following dilutions: rabbit 
anti-enolase, 1:3000; rat anti-tryparedoxin peroxidase, 1:500; mouse anti-beta-tubulin, 
1:2000. Membranes were then washed three times in 0.1% Tween20 in PBS at room 
temperature. Secondary anti-rat, rabbit and mouse antibodies, conjutgated to 800 and/or 
680 IRDyes, were used at 1: 15,000 dilutions in 3% skimmed milk and 0.1% Tween20 
in PBS and incubated with membranes for 1 h at room temperature. Membranes were 
washed five times in 0.1% Tween20 in PBS and three times in PBS prior to imaging on 
a LiCOR Odyssey CLx imager. 
2.6!LC-MS/MS and analysis of spectra 
For each biological replicate of 48 SEC or 96 SAX fractions, 1µg of peptide was 
injected from the most concentrated fraction, and the equivalent volume injected for the 
remaining fractions. Peptides in 5% formic acid were injected onto a C18 nano-trap 
column using a Thermo Scientific Ultimate 3000 nanoHPLC system. Peptides were 
washed with 2% acetonitrile, 0.1% formic acid and resolved on a 150 mm x 75 µm C18 
reverse phase analytical column over a gradient from 2% to 28% acetonitrile over 120 
Chapter 2: Materials and methods 
 
 
!
!
28 
min at a flow rate of 200 nL/min. Peptides were ionised by nano-electrospray ionisation 
at 2.5 kV. Tandem mass spectrometry analysis was carried out on a QExactive+ mass 
spectrometer, using HCD fragmentation of precursor peptides. A data-dependent 
method was utilised, acquiring MS/MS spectra for the top 15 most abundant precursor 
ions. 
SEC RAW data files were analysed using MaxQuant version 1.5.1.3, supplied with 
the T. brucei brucei 927 annotated protein database from TriTrypsDB release 8.1, 
containing 11,567 entries. The mass tolerance was set to 4.5 ppm for precursor ions and 
MS/MS mass tolerance was set at 20 ppm. The enzyme was set to trypsin and 
endopeptidase LysC, allowing up to 2 missed cleavages. Carbamidomethyl on cysteine 
was set as a fixed modification. Acetylation of protein N-termini, deamidation of 
asparagine and glutamine, pyro-glutamate (with N-terminal glutamine), oxidation of 
methionine and phosphorylation of serine, threonine and tyrosine were set as variable 
modifications. Match between runs was enabled, allowing transfer of peptide 
identifications of sequenced peptides from one LC-MS run to non-sequenced ions, with 
the same mass and retention time, in another run. A 20-min time window was set for 
alignment of separate LC-MS runs and a 30-second time window for matching of 
identifications. The false-discovery rate for protein and peptide level identifications was 
set at 1%, using a target-decoy based strategy. Each individual SEC fraction was set as 
an individual experiment in MaxQuant parameters, to output IBAQ data for protein 
groups in every fraction, and only unique peptides were utilised for quantitation. 
SAX RAW data files were analysed using MaxQuant version 1.5.3.30, supplied 
with the T. brucei brucei 927 annotated protein database from TriTrypDB release 26.0, 
also containing 11,567 entries. All other settings were identical, apart from the fixed 
modification on cysteine, which was set to NEM. 
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2.7!Data analysis of protein elution profiles 
Data analysis was performed using custom scripts in Python language using numpy, 
scikit-learn, pandas and matplotlib libraries. Elution profiles for individual proteins 
were created using the following MaxQuant abundance metrics: label free quantitation 
(LFQ) intensity, intensity based absolute quantitation (IBAQ), MS/MS count and 
unique peptide count. Profiles produced from each metric were normalised by the 
maximum value detected, and used to determine the Pearson correlation of proteins 
between biological replicates. All further data analysis utilised maximum normalised 
LFQ intensities, using the mean of four or three biological replicates from SEC300 and 
SEC1000 experiments. From SEC experiments, proteins were required to be detected 
with at least one unique peptide found in two biological replicates and with Pearson 
correlation coefficients between elution profiles >0.6. 
2.8!Hierarchical clustering 
The mean LFQ profiles for each protein were hierarchically clustered, separately for 
each experiment type (SEC300, SEC1000 and SAX), using the Euclidean distance 
measurement and Ward’s agglomeration method. The Gene Ontology (GO) term 
enrichment was computed for each cluster obtained by cutting the dendrogram tree at 
predetermined distances. Cutting distances from 0 to n were evaluated, where n was the 
cutting distance producing only two clusters. GO term enrichment p-values were 
computed with a Fisher test. The Bonferroni correction was applied and only the GO-
terms with a p-value <0.05 were accepted. The cutting distance producing the highest 
number of enriched GO terms was taken to produce the final clusters for each 
experiment type. 
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2.9!Peak picking 
For the analysis of the observed against the expected molecular weight, the LFQ elution 
profiles of each protein detected in the SEC300 experiment were split into individual 
peaks by adapting a Ricker wavelet encompassing 2 to 4 fractions. The two minimum 
points of the wavelet were used to define the peak range, and any other LFQ values 
outside this range were set to 0. Several filters were applied before considering peaks 
further. Firstly, individual peaks where the maximum intensity was below 20% of the 
most intense peak across the entire protein profile were filtered. Secondly, peaks lying 
in a region of the fractionation profile corresponding to, or less than, the protein dimer 
molecular weight (as annotated in TriTrypDB) or present in the void (fractions 1 to 6) 
were discarded. Observed molecular weights were calculated from a linear regression 
analysis of the elution of molecular weight standards. GO term enrichment analysis was 
performed for each category as described in section 2.8, and plots were produced using 
ReviGO (Supek et al., 2011).  
2.10! Machine learning 
A pipeline similar to that applied previously for PCP analysis was utilised 
(Havugimana et al., 2012) to predict protein complexes using data from all three 
experiment types. The protein elution profiles were used to train a random forest 
predictor implemented with the scikit-learn python package. Protein pairs were scored 
according to four features, namely: the co-apex score, Normalized Cross Correlation 
(NCC), Pearson Correlation Coefficient (PCC) and STRING scores. The first three 
features are based purely from the protein elution profiles. 
The co-apex score was used by Havugimana and colleagues (Havugimana et al., 
2012), and is based on the number of biological replicates in which the protein pairs 
showed maximum abundance in the same fraction. The co-apex score  was derived for 
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the SEC300 and SEC1000 experiments with four and three biological replicates 
respectively by using the scipy package.  For the SEC1000, with three biological 
replicates, the possible co-apex scores were: 1 (3 of 3 replicates), 0.6 (2 of 3 replicates), 
0.3 (1 of 3 replicates) and 0 (none of the replicates). Similarly, For the SEC300, with 
four biological replicates, the possible co-apex scores were 1, 0.75, 0.5, 0.25 and 0. 
The NCC was derived in two steps. First, the maximum cross correlation between 
the two protein profile pairs P1-2CC was computed. Then the maximum self-cross-
correlation of the first protein profile (P1CC) and the maximum self-cross-correlation of 
the second protein profile (P2CC) was determined. The NCC was finally derived as P1-
2CC / max(P1CC, P2CC). 
The PCC was computed as the Pearson correlation score between the two elution 
profiles. 
The PCC and NCC was calculated for the SEC300, SEC1000 and SAX experiments 
described here, and for experiments produced in (Gazestani et al., 2016). This includes 
ion exchange of mitochondrial extracts (IEX-mito) and cytoplasmic extracts (IEX-cyto) 
and glycerol gradient fractionation of whole cell lysates (GG-WCL) and mitochondrial 
extracts (GG-mito). The STRING features (Neighborhood, Fusion, Cooccurence, 
Coexpression, Experimental, Database, Text Mining) are derived from version 10 of the 
STRING database (Szklarczyk et al., 2015). The STRING IDs were mapped to the 
TriTrypDB IDs, and the values were normalized from 0 to 1. The aforementioned 
scoring features were calculated for all the possible permutations of protein pairs that 
showed a NCC value greater than 0.15 in at least one of the SEC300, SEC1000 or SAX 
experiments, creating a matrix of 609,100 protein pairs with 23 features.  
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For the machine learning, a dataset of ‘gold standard’ true positive peak pairs (GD) 
was manually assembled. Thirty-one theoretical protein complexes were derived from 
data deposited in CORUM (Ruepp et al., 2007), together with manual addition of 
protein complexes derived from literature information, producing 293 unique true 
positive pairs of interacting proteins. A negative dataset was extracted by random 
sampling of the 293 proteins annotated in different complexes. As it would be possible 
to introduce false negative interactions in this step, the random sampling was repeated 
100 times. Finally, using these true positive and true negative test pairs 100 Random 
Forest classifiers were assembled based on the same true positive pairs, but with each 
using a different negative set. Two predictor sets were developed, one set of 100 
predictors based on the features derived only from experiments performed in this thesis 
(SEC300, SEC1000 and SAX) and a second set of predictors that implemented all the 
available features (including STRING, IEX-mito, IEX-cyto, GG-mito and GG-WCL). 
All the classifiers were inspected to determine the area under the curve values of the 
receiver operator curves in ten-fold cross validation. The median values of the 
probability score outputs of the two 100 classifier sets were used as the final interaction 
prediction score for the protein pairs.   
An interaction prediction score cut-off of 0.75 was selected, and separately fed the 
protein pairs from the two predictor sets to the ClusterONE algorithm. A search matrix 
was created for the ClusterONE program with the parameters ‘d’ (0.1 to 1, step 0.1), 
‘haircut’ (0.1 to 1, step 0.1) and ‘s’ fixed to 2. The outputs were parsed to derive the 
parameters that were optimal to obtain the maximum number of GD true positive pairs 
grouped together. The complexes predicted by ClusterONE using the outputs of the two 
different predictor sets were merged together, joining predicted complexes that shared 
two or more proteins. 
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2.11! In vivo chemical crosslinking 
Procyclic T. brucei cells were used (6x107 cells/condition) to assess the optimal 
conditions for in vivo chemical crosslinking with either formaldehyde or 
dithiobis(succinimidyl propionate) (DSP). Cells were washed twice in 15 mL of PBS 
prior to resuspension in PBS containing the appropriate crosslinker concentration. 
DSP was prepared as a 20 mM stock in DMSO and diluted in PBS to working 
concentrations between 0.125-2 mM. Samples were crosslinked for 30 min at room 
temperature with gentle agitation on a roller. Crosslinking was quenched by the addition 
of Tris-HCl (pH 7.5) to 20 mM at room temperature for 15 min Cells were pelleted, 
washed with PBS and lysed in 4% SDS, 10 mM sodium phosphate (pH 6.0) and 
100 mM NaCl. Lysates were heated to 95°C for 10 min and sonicated for 10 cycles of 
30 seconds on/off in a Bioruptor Pico (Diagenode) water bath sonicator. Lysates were 
split into two samples each, and mixed with 4x LDS sample buffer, one with the 
addition of 5 mM TCEP, and heated to 95°C for ten min prior to SDS-PAGE and/or 
Western blotting as described previously. 
Methanol-free aliquots of 16% (w/v) formaldehyde solution were used to prepare 
PBS ranging from 0.2-6% formaldehyde. Samples were crosslinked as above, and 
quenched by pelleting cells and resuspending in 250 mM L-glycine for 15 min at room 
temperature. Cells were washed and lysed as above, though only heated to 37°C for 30 
min prior to sonication. Samples were mixed with 4x LDS sample buffer and split in 
half and either heated to 65°C or 95°C for ten min prior to SDS-PAGE and/or Western 
blotting. 
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Sonicated lysates were filtered through a 0.45 µm filter unit before loading onto a 
BioBasic SEC 1000 column under denaturing conditions already described. Fractions 
were not collected. 
2.12! Direct elutriation 
Procyclic cells (2.7x109) were harvested from 100 mL of a log-phase culture by 
centrifugation and resuspended in 10 mL of elutriation buffer (a 1:4 dilution of SDM-
79). Cells were passed two times through a 20-gauge needle and injected into a 
Sanderson loading chamber of an Avanti J-26 XP elutriation centrifuge equipped with 
JE5.0 rotor at a temperature of 28°C. Cells were loaded at a flow rate of 10 mL/min. 
The rotor was kept at a constant speed of 5,000 rpm. Fractions of 50 mL were collected 
at each flow rate of 10, 15, 18, 20, 23, 25, 27, 28, 29, 31, 32, 33 and 35 mL/min. The 
final fraction was collected at 35 mL/min with the rotor turned off. Aliquots were taken 
from each collected fraction for flow cytometry analysis, and the remaining cell pellets 
were snap frozen. 
2.13! Single and double-cut elutriation 
Cells were prepared in a similar manner as described in section 2.12. Instead of 
collecting multiple fractions over a range of flow rates, cells were collected at two flow 
rates – 15 mL/min (small cells) and 32 mL/min (large cells). Both collected cell 
populations were pelleted by centrifugation and resuspended in SDM-79 at a 
concentration of 3x107 cells/mL and recultured. 
The small cell population was used for the single-cut time-course and aliquots were 
taken for flow cytometry at 0.5, 3, 4, 5, 6, 7, 8, 9, 10 and 11 h after elutriation. 
The large cell population was cultured for 1 h and elutriated again, splitting the cells 
into the newly divided small cells, that were recultured in SDM-79, and large cell that 
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were discarded. This second small cell population was used for the double-cut time-
course and aliquots were taken at the same intervals as the single-cut samples. 
2.14! Flow cytometry 
Cells were washed three times in 5 mL of PBS, fixed in 1 mL 70% ice-cold ethanol and 
stored at -20°C until ready for DNA staining for flow cytometry. Fixed cells were 
washed with 1 mL of PBS and resuspended in staining solution composed of 50 µg/mL 
propidium iodide, 100 µg/mL ribonuclease A, 0.5% (w/v) Triton-X100 and 0.5% 
bovine serum albumin in PBS. Cells were incubated in the dark at room temperature for 
a minimum of 20 min. Propidium iodide fluorescence was detected from 10,000 cells 
per sample on an LSR Fortessa. 
2.15! Tandem Mass Tag (TMT) Labelling 
For TMT labelling, ~100 µg of peptide was solubilised in 100 µL of 50 mM HEPES 
(pH 8.5) and mixed with the appropriate TMT labelling reagent. Aliquots (0.8 mg) of 
each reagent were solubilised in 41 µL of anhydrous acetonitrile. Peptide and label were 
incubated together for 2 h at room temperature. The reaction was quenched through the 
addition of 8 µL of 5% hydroxylamine for 15 min at room temperature. This reaction 
was scaled up or down dependent on the amount of peptide being labelled. 
TMT 6-plex and 10-plex labelled peptides were mixed at this stage. Samples were 
acidified through the addition of TFA to a concentration of 1% and loaded onto 200 mg 
SepPak cartridges (Waters) that had been wetted with 100% acetonitrile and 
equilibrated with 0.1% TFA. Labelled peptides were washed with 0.1% TFA, eluted in 
1 mL of 80% acetonitrile and 0.1% TFA and dried using a GeneVac evaporator. 
Peptides were solubilised in 5% formic acid for injection onto a mass spectrometer or in 
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2% acetonitrile in 10 mM ammonium formate (pH 9.0) for high-pH reverse phase 
chromatography. 
2.16! High-pH reverse phase chromatography 
Tryptic procyclic T. brucei peptides (2 mg) were labelled with TMT-zero labelling 
reagent and solubilised in 1 mL of 2% acetonitrile in 10 mM ammonium formate (pH 
9.0). TMT labelled or non-TMT labelled peptides (200 µg) were injected onto an 
Xbridge BEH C18 column (130 Å, 3.5 µm, 4.6 x 150 mm), using a Dionex Ultimate 
3000 HPLC system. Buffer A was composed of 2% acetonitrile in 10 mM ammonium 
formate (pH 9.0) and buffer B of 80% acetonitrile in 10 mM ammonium formate (pH 
9.0). Columns were run at 1 mL/min at 30°C and equilibrated with ten column volumes 
to the composition of buffer A and B from the start of each respective run. A number of 
different gradients were used, starting at either 0, 10, 25 or 35% buffer B, rising to 60% 
B over the course of a linear gradient from 0 to 11 min. There was a spike to 100% 
buffer B from 11 to 12 min followed by a drop back to the starting percentage B from 
12 to 13 min until the end of the run at 20 min. 
2.17! Optimisation of TMT quantitation 
Peptides from human HEK293 cells and procyclic T. brucei cells were labelled with 6-
plex TMT reagents. Human peptides were labelled with all six reagents (126-131) and 
mixed in a ratio of 50:20:5:5:20:50 µg for the respective TMT labels. Trypanosome 
peptides were only labelled with the 126, 127 and 128 reagents and mixed with the 
human peptides in a ratio of 50:50:50 µg. After desalting and dehydrating the mixed 
sample, peptides were resuspended in 5% formic acid. 
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Unless otherwise specified, 1 µg of human-trypanosome peptide mix was injected 
onto QExative+ or Fusion mass spectrometers for each run. The chromatography 
methods employed were identical to those described in section 2.6. 
The QExactive+ survey scan was performed across the range from 300-1400 m/z at 
a resolution of 70,000. An Automatic Gain Control (AGC) target of 1x106 and a 
maximum injection time (maxIT) of 20 ms was set for MS1 survey scans. The top 10 
most intense ions with an isotopic envelope and a charge state between 2-7 were 
selected for fragmentation using Higher-Energy Collisional Dissociation (HCD) using a 
stepped normalised collision energy of 28, 35 and 42%. MS2 scans were acquired from 
120-1050 m/z at a resolution of 70,000. The AGC target was set to 2x105, with a maxIT 
of 250 ms. The isolation width for selection of precursor ions for fragmentation was 
varied between 0.4 – 4.0 m/z. Ions selected for fragmentation were excluded from 
further selection for 40 s. 
Survey scans carried out on the Fusion mass spectrometer were carried out on the 
Orbitrap at a resolution of 120,000 over a range of 350-1400 m/z with an AGC target of 
2x105 and a maxIT of 50 ms. Monoisotopic ion precursor selection was turned on, and 
only ions with a charge state between 2-7 and a minimum intensity of 5x103 were 
selected for fragmentation. Ions selected were excluded from further selection for 40 s. 
The default starting method (‘Thermo’) utilised a 0.8 m/z isolation width to select ions 
from the MS1 survey scan for Collision Induced Dissociation (CID) fragmentation at a 
normalised collision energy of 30%. Scans of fragment ions were acquired on the ion 
trap in Rapid Scan mode with an AGC target of 1x104 and a 70 ms maxIT. Fragment 
ions were selected for further fragmentation using Synchronous Precursor Selection. 
Fragment ions were selected from 400-1,200 m/z and excluded ions 20 m/z below or 5 
m/z above the precursor ion mass, and m/z ratios correlating to the loss of TMT from the 
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precursor ion. The top 10 most intense fragment ions, unless otherwise specified, were 
selected for HCD fragmentation with a 55% normalised collision energy and an 
isolation width of 2 m/z. The default method (‘Thermo’) MS3 scans were acquired on 
the Orbitrap at a resolution of 60,000 from 100-500 m/z, an AGC target of 1x105 and a 
maxIT of 150 ms. A cycle time between MS1 survey scans was set to 2 seconds and a 
Top Speed method to select precursor ions for MS2 and MS3 analysis was used, 
allowing software to determine the optimal number of ions to fragment in this period. 
The ‘Thermo’ method was sequentially modified to increase the maxIT to 300 ms 
(‘300 ms scan’), then increasing the isolation width for precursor ions for fragmentation 
for the MS2 scan to 1.6 m/z (‘1.6 m/z’). 
A second batch of peptides, using mouse and trypanosome samples, was prepared as 
described above, with mouse peptides labelled using all six TMT reporter labels and 
trypanosome in three. This was utilised to determine the effects of: modifying the 
number of ‘notches’ (number of fragment precursor ions) in the SPS method for the 
MS3 scan; titrating the maxIT for the MS3 scan; changing the isolation width for the 
MS1 to MS2 scan leading to the MS3 scan; and titrating the AGC target at either 10 or 
2 notches. The output from these experiments is detailed in the Appendix. 
RAW data files were analysed using COMPASS version 1.4.5295.18481, supplied 
with a concatenated database of Homo sapiens or Mus musculus from UniProt and T. 
brucei brucei proteins from TriTrypDB. The COMPASS Database Maker was used to 
create a peptide database containing concatenated target and reversed decoy peptides. 
DTA files were produced from RAW files using the DTA Generator and peptides 
matched using the Open Mass Spectrometry Search Algorithm (OMSSA). The mass 
tolerance was set to 20 ppm for precursor ions and MS/MS tolerance was set to 0.35 Da. 
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The enzyme was set to trypsin, allowing for up to 3 missed cleavages. NEM on cysteine 
was set as a fixed modification. Acetylation of protein N-termini, deamidation of 
asparagine and glutamine, pyro-glutamate (with N-terminal glutamine), oxidation of 
methionine and TMT 6-plex on lysine and N-termini of peptides were set as variable 
modifications. A maximum e-value of 100 was set and peptide matches required at least 
one match to the top ten most intense fragment peaks. Peptide spectral matches were 
then filtered using a maximum false discovery rate of 1% and a maximum error of 20 
ppm. Resulting files of filtered peptide spectral matches (psms) were then quantified 
using the Tag Quant application in COMPASS. MS3 quantitation was turned on for 
quantitation of data acquired on the Fusion. 
Quantified psms were filtered to ensure they matched human peptides, were 
identified with a TMT modification, were identified in all six TMT channels and the 
sum of the reporter intensities were above 100,000. Ratios were calculated between 
TMT reporter channels 126:128, 126:127, 127:128, 131:129, 131:130 and 130:129. 
2.18! TMT labelling of samples from single-cut elutriation 
Three biological replicates of single-cut elutriation were performed as described in 
section 2.13, with time-points collected at 0.5, 3, 5, 6, 7, 8, 9, 10 and 11 h. For each 
biological replicate cells were harvested during log-phase growth at a density ~3x107 
cells/mL. Between 4.6-5.7x109 cells were harvested in each experiment, producing 
between 1.35-1.65x109 small cells. At each time-point cells were washed once in 15 mL 
of PBS and three times in 2 mL PBS at 4°C prior to lysis in 200 µL of 4% SDS, 10 mM 
sodium phosphate (pH 6), 100 mM NaCl, 25 mM TCEP and 50 mM NEM. Lysates 
were sonicated in a Bioruptor Pico (Diagenode) water bath sonicator for 10 min and 
heated to 65°C for 10 min prior to chloroform-methanol precipitation. 
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For chloroform-methanol precipitation one volume of lysate (200 µL) was mixed 
with four volumes of methanol, one volume of chloroform and three volumes of Milli-Q 
H2O and vortexed for 1 min. Samples were spun at 9,000 g for 5 min at room 
temperature in a bench-top centrifuge. The upper phase was removed, carefully 
avoiding the inter-phase of precipitated protein. Three volumes of methanol were added 
and the sample centrifuged again, followed by removal of all remaining supernatant. 
Protein pellets were air-dried and resuspended in one volume of 8 M urea, 1 mM CaCl2 
in 0.1 M Tris-HCl (pH 8). 
Protein concentrations were determined by Bradford assay for each time-point and 
LysC added at a 1:100 ratio of protein to protease and digested overnight at 37°C. 
Samples were diluted to 1 M urea with 0.1 M Tris-HCl (pH 8) and 1 mM CaCl2 and 
trypsin added at the same ratio. Digestion proceeded for 6 h prior to acidification of 
samples with TFA to 1%.  Each time-point was loaded onto a 500 mg SepPak cartridge 
to desalt the samples as described in section 2.13, although peptides were eluted using 
50% acetonitrile and 0.1% TFA. Peptides were dried using a GeneVac evaporator and 
resuspended in 50 mM HEPES (pH 8.5) with 123 µg from each sample used for TMT 
labelling. 
TMT ten-plex reagents were used to label one biological replicate each. The labels 
from 127N-131 were used to label the nine time-points collected in each biological 
replicate, and the first reagent (126) was used to label a peptide mix derived from only 
one biological replicate. This mix was produced by equally mixing aliquots of peptide 
from each time-point, and following TMT labelling, this was equally added to each set 
of biological replicates.  
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Each biological replicate was fractionated using high-pH reverse phase 
chromatography. The concentration of buffer B at the start of the chromatography run 
was 35%, and proceeded as described in section 2.12. Fractions were collected from 2 
to 16 min with 8.75 seconds per fraction, producing 96 fractions. Fractions were 
collected into 24 samples, for example the 1st, 25th, 49th and 73rd fractions were 
collected in the same well of a 96-well plate. The 24 samples per biological replicate 
were dried again using a GeneVac evaporator and solubilised in 5% formic acid. 
2.19! LC-MultiNotch-MS3 and analysis of spectra 
Data was acquired for each sample in triplicate producing 216 RAW files (3 runs of 24 
samples from 3 biological replicates). Chromatography was performed as described in 
section 2.6 and data was acquired on a Fusion mass spectrometer as described in 
section 2.17, with a 300 ms maxIT and a 1.6 m/z isolation width. 
RAW data files were analysed using MaxQuant version 1.5.3.8, supplied with the 
T. brucei brucei 927 annotated protein database from TriTrypDB release 9.0. The mass 
tolerance was set to 4.5 ppm for precursor ions and MS/MS mass tolerance was set at 20 
ppm. The enzyme was set to trypsin and endopeptidase LysC, allowing up to 2 missed 
cleavages. NEM on cysteine was set as a fixed modification. Acetylation of protein N-
termini, deamidation of asparagine and glutamine, pyro-glutamate (with N-terminal 
glutamine), oxidation of methionine and phosphorylation of serine, threonine and 
tyrosine were set as variable modifications. The false-discovery rate for protein and 
peptide level identifications was set at 1%, using a target-decoy based strategy. Only 
unique peptides were utilised for quantitation. 
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2.20! Data analysis of cell cycle 
Each TMT reporter channel was normalised by dividing by the median value of the 
intensity distribution. The cell-cycle time-course was then scaled for each individual 
protein quantified in each technical replicate by dividing all values by the maximum 
detected value. Mean values for the biological replicates were calculated from the 
technical triplicates, and maximum fold-changes were calculated by dividing the 
maximum detected value by the minimum. Proteins detected in all three biological 
replicates were tested by an analysis of variance (ANOVA) to determine if there was 
more variance between time-points or among the same time-points between biological 
replicates. Maximum normalised proteins with a p-value <0.05 from the ANOVA, were 
hierarchically clustered based on Euclidean distance measurement and a ‘complete’ 
agglomeration method. GO enrichment analysis of each cluster was performed using the 
GO enrichment tool for sets of genes on TriTrypDB. 
Gene classifier information was obtained from multiple sources and mapped to 
proteins in this study using assigned TriTrypDB gene IDs. TriTrypDB was used to filter 
for proteins annotated with GO terms associated with the cell-cycle; genes specified in 
(Alsford et al., 2011) were classified as ‘essential’; and genes identified as upregulated 
in different cell cycle phases in (Archer et al., 2011) were classified with the appropriate 
phase (early or late G1, S or G2&M phase). TriTrypDB was used to determine the 
overlap in identified proteins/genes, and those classified as cell-cycle regulated, 
between proteomic and transcriptomic data.!
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Chapter 3: Mapping core protein 
complexes of Trypanosoma brucei!
3.1 Introduction 
In this chapter, I present the application of protein-correlation-profiling mass 
spectrometry (PCP-MS) methodologies to map protein complexes in T. brucei. Our aim 
was to produce information that, through ‘guilt-by-association’, would provide 
functional suggestions for many uncharacterised proteins, aiding the annotation of the T. 
brucei proteome. PCP-MS methods are particularly useful for the study of protein 
complexes in trypanosomes, because they obviate the need for genetic tagging of 
thousands of individual proteins, along with the associated financial and labour costs of 
maintaining cell lines and performing thousands of immunoprecipitations. Rather, 
PCP-MS methods allow us to study protein complexes in a ‘native’ state, directly from 
cellular lysates, and provide a platform that can be easily adapted for future comparative 
studies of T. brucei interactomes in different biological conditions. 
To achieve this, I fractionated ‘native’ lysates from procyclic form (PCF) 
T. brucei, followed by mass spectrometry to identify and quantify elution profiles of 
5,854 protein groups. I have utilised three different chromatography columns, 
encompassing two biochemically orthogonal modes of separation, size exclusion 
chromatography (SEC) and strong anion exchange (SAX), and distinct molecular 
weight separation ranges for SEC. We demonstrate that detected protein elution profiles 
are highly reproducible across biological replicates, and that proteins in the same 
complex consistently co-elute. We utilise this large dataset to assess co-elution patterns 
between all proteins detected by hierarchical clustering and, further, use machine 
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learning to produce a high-confidence global interaction network, which identifies 805 
protein groups in 234 complexes. These predicted protein complexes encompass many 
known and novel protein complexes and protein-protein interactions. This is the largest 
and most comprehensive analysis of soluble cytoplasmic complexes in PCF T. brucei to 
date. 
3.2 Aims and hypotheses 
Our hypotheses were that: 
•! We could separate physiologically relevant protein complexes from PCF 
Trypanosoma brucei. 
•! Orthogonal modes of chromatography could provide complementary and 
reinforcing evidence for protein co-elution and interaction. 
•! Through the identification of co-eluting proteins, we could propose the functions 
of many ‘hypothetical’ proteins. 
Our aims were to: 
•! Optimise methods to separate physiologically relevant protein complexes from 
cellular lysates. 
•! Advance methods of data analysis to reconstitute protein complexes in silico, 
from chromatographic elution profiles of individual proteins. 
•! Identify novel interactions in T. brucei from our predictions to improve genome 
and proteome annotation. 
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3.3 Results 
3.3.1 SEC and SAX of Trypanosoma brucei lysates 
PCF Trypanosoma brucei brucei, strain 427, were prepared for native protein complex 
analysis by resuspension in either ice-cold PBS (for SEC), or 20 mM ethanolamine (for 
SAX), containing protease inhibitors, followed by sonication lysis. The resulting lysates 
were centrifuged, filtered, and fractionated either using BioBasic SEC300 or SEC1000 
columns, separating protein complexes based on their size and shape; or a Protein-Pak 
HiRes SAX column, separating protein complexes based on their charge. The proteins 
in the fractions from each type of chromatography were reduced, S-alkylated and 
digested to peptides with trypsin and endopeptidase LysC. After desalting, the resulting 
peptides were analysed by LC-MS/MS (Figure 3.1). 
Protein molecular weight standards were utilised to characterise the separation 
ranges of the BioBasic SEC300 (Figure 3.2) and SEC1000 (Figure 3.3) columns, 
indicating that the SEC300 column has an effective separation range from 8 kDa to 1.2 
MDa, while the SEC1000 column separates material above 1.2 MDa. The retention 
times of each standard were used to generate a linear regression model, allowing us to 
calculate apparent molecular weights for the proteins and protein complexes found in 
our dataset (Figure 3.4). A separate set of protein standards were used to characterise 
the resolution and separation of the SAX column (Figure 3.5). 
To assess the monomeric molecular weights of proteins eluting across the 
SEC300 fractionation range, fractions were pooled in groups of three, run on SDS-
PAGE under reducing conditions, and stained for total protein. Most proteins eluted at a 
higher apparent molecular weight by native SEC than expected from their monomeric, 
denatured and reduced molecular weights (indicated by SDS-PAGE). This is consistent 
Chapter 3: Mapping core protein complexes of Trypanosoma brucei 
 
 
!
!
46 
!
Figure 3.1: Overview of workflow for protein complex prediction. Lysates are 
produced containing a mixture of protein complexes, which are separated by either size-
exclusion (300 and 1000 Å pore size) or strong anion exchange chromatography. The 
proteins in each fraction are digested and identified by LC-MS/MS from which protein 
elution profiles can be deduced. Putative protein-protein interactions are predicted via 
both hierarchical clustering of similar elution profiles and through machine learning 
analysis. Figure adapted from (Kirkwood et al., 2013). 
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Figure 3.2: SEC300 chromatography. Chromatogram of absorbance (mAU) at 280 nm 
of a PBS based T. brucei lysate (black) and multiple molecular weight markers (colour) 
injected onto an SEC300 column. 
!
Figure 3.3: SEC1000 chromatography. Chromatogram of absorbance (mAU) at 280 nm 
of a PBS based T. brucei lysate (black) and multiple molecular weight markers (colour) 
injected onto an SEC1000 column. 
Chapter 3: Mapping core protein complexes of Trypanosoma brucei 
 
 
!
!
48 
!
Figure 3.4: Linear regression model for Mw. Approximate molecular weight of 
complexes/proteins in each fraction as determined from elution of molecular weight 
markers on SEC300 column (blue) and SEC1000 column (red). 
!
Figure 3.5: SAX chromatography Chromatogram of absorbance (mAU) at 280 nm of a 
T. brucei lysate, in black, and multiple molecular weight markers, in colour, injected 
onto a SAX column. 
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with many of the individual proteins participating as components of larger complexes. 
By contrast, when cells were lysed in a highly denaturing buffer, containing 4% SDS, 
and the SEC was carried out in the presence 0.2% SDS, I could see a direct correlation 
between SEC and SDS-PAGE apparent molecular weights (Figure 3.6). 
I found by Western blotting that enolase, thought to be a monomeric protein, 
eluted mostly at the correct predicted molecular weight by SEC, whereas tryparedoxin 
peroxidase, known to form 50 kDa dimers and 250 kDa decamers in its recombinant 
form (Alphey et al., 2000; Piñeyro et al., 2005), eluted at the void volume (> 1 MDa) by 
SEC300 (Figure 3.7). The latter result may suggest that tryparedoxin peroxidase forms 
higher order oligomers in vivo than in vitro. 
In addition, a peak-picking analysis of the SEC300 dataset was performed, 
where individual protein elution profiles were broken up into their constituent peaks, 
extracting multiple ‘peak’ profiles from a single ‘protein’ profile (Figure 3.8). Peaks 
were then classified based on their retention time from SEC. Proteins eluting in the first 
ten fractions were classified as ‘void volume’ proteins, i.e., present in material that is 
larger than the 30 nm pores of the SEC column, hence eluting first without any 
separation. The second classification was based on the expected molecular weight of the 
protein; if an individual protein eluted at the expected molecular weight, or two times 
the expected molecular weight, the protein was classified as a monomer or a dimer. 
Above this range, the protein was classified as being in a protein complex (Figure 3.9). 
Of 3,326 detected protein elution peaks, 1,480 (44%) are classified in the monomer or 
dimer range, 658 (20%) in the protein complex range, and 1,188 (36%) in the void 
volume of the SEC300 column.  
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Figure 3.6: SyPro Ruby staining of SDS-PAGE gels. Staining of consecutive fractions 
collected from SEC300 fractionation of PBS based lysate (top) and SDS based lysate 
with denaturing chromatography (bottom). 
!
Figure 3.7: Western blotting for enolase and tryparedoxin peroxidase. Western blotting 
of consecutive fractions collected from SEC300 fractionation of PBS based lysate. 
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Figure 3.8: Peak picking analysis from SEC300 fractionation. If a protein contains a 
peak in the first ten fractions it is classified as ‘void’ material. Proteins with peaks in 
their expected monomeric or dimer molecular weight are classified as ‘dimer/monomer 
or degradation product’. Remaining peaks are in the optimal molecular weight range for 
an SEC300 column. 
!
Figure 3.9: Comparison of Uniprot predicted and SEC300 estimated molecular weight. 
Different colours depict the different categories classified from the peak picking 
analysis, and n shows number of protein peaks detected in each category. 
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Gene ontology analysis of these three different categories highlights the 
enrichment of integral membrane and organellar proteins in the void volume, a number 
of distinct protein complexes (ARP2/3, chaperonin, proteasome) in the complex range 
category and more general cytosolic terms in the monomer and dimer category (Figure 
3.10). 
From five biological replicates of SEC300 fractionation experiments, 65,967 
peptides were identifed, corresponding to 5,929 protein groups, detected by at least one 
unique peptide. From five biological replicates of SEC1000 chromatography, 58,069 
peptides were identified, corresponding to 5,628 protein groups, and from a single SAX 
fractionation experiment, 38,804 peptides were identified, corresponding to 3,213 
protein groups.
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Figure 3.10: Gene ontology enrichment analysis of proteins detected in each category from peak picking analysis. The left hand side panel shows the 
GO enrichment of void fractions; the middle panels shows the protein complex range; and the right hand side panel shows the 
dimer/monomer/degradation range. The circle size represents the frequency of the GO term in the underlying GO annotation database.  
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3.3.2 Reproducibility of mass spectrometry based elution profiles 
The reproducibility of individual biological replicates was assessed for both the SEC300 
and SEC1000 experiments. Figure 3.11 shows the median Pearson correlation 
coefficient in each fraction from each biological replicate compared to the four other 
replicates, for both SEC300 and SEC1000 fractionation experiments. Most biological 
replicates within SEC300 or SEC1000 data showed high reproducibility, with median 
Pearson correlation coefficients of each fraction typically >0.75. However, for one 
experiment on SEC300 (E3025) and two experiments on SEC1000 (E3022 and E3026) 
the datasets deviated from the other replicates. Comparison of the elution profiles of 
individual proteins between replicates demonstrated that reproducible protein elution 
patterns were lost in E3025, E3022 and E3026 due to compromised chromatographic 
resolution (Figure 3.12), and these replicates were therefore excluded from further 
analyses. 
!
Figure 3.11: Median Pearson correlation within fractions. Median Pearson correlation 
coefficient of each fraction in each biological replicate from SEC300 (left) and 
SEC1000 (right). E3025 (SEC300) and E3022 and E3026 (SEC1000) deviate from 
correlation pattern seen for other biological replicates. 
Pearson correlation coefficients of elution profiles were also calculated for each 
protein detected across remaining biological replicates, using unique and total peptide 
counts (MS), Intensity Based Absolute Quantitation (IBAQ) and Label Free 
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Quantitation (LFQ) as metrics of protein abundance (Figure 3.13). These data are 
described on density plots, demonstrating the high reproducibility of elution profiles 
across biological replicates for all metrics, with LFQ values showing the highest 
reproducibility. LFQ values were therefore for further data analysis. 
!
Figure 3.12: Reproducibility of replicates. Elution profiles for three proteins in either 
SEC300 (left) and SEC1000 (right) in each biological replicate displaying LFQ 
intensity over time. Reproducible elution patterns are seen in four of five SEC300 
experiments and three of five SEC1000 experiments. 
!
Figure 3.13: Pearson correlation of elution profiles. Density plot of the median Pearson 
correlation for elution profiles of each protein detected across biological replicates in 
SEC300 (left) and SEC1000 (right). The reproducibility of four different quantitative 
metrics of protein abundance are compared: iBAQ, LFQ, MS counts and unique peptide 
counts. 
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3.3.3 Hierarchical clustering of protein elution profiles 
Hierarchical clustering of all detected protein elution profiles was performed for each 
dataset separately (Figure 3.14). By cutting the resulting dendrograms of hierarchically 
clustered proteins, we can define groups of proteins that have similar elution profiles, 
and hence that potentially interact. We simulated a range of cutting distances and 
observed the within-cluster Gene Ontology (GO) term enrichment and the mean 
Pearson correlation coefficients of elution profiles (Figure 3.14). As we reduced the 
number of clusters, a sharp increase in the number of enriched GO terms was observed 
in all datasets, as functionally associated proteins were grouped together within a 
cluster. As clusters became larger and unrelated proteins were grouped together, the 
number of enriched GO terms decreased. We therefore chose the cutting distance 
producing the highest GO term enrichment within clusters across the dataset for each 
form of fractionation. Thus, for the SEC300, SEC1000 and SAX experiments, cutting 
distances of 1.53, 1.28 and 1.92 were chosen, producing 440, 365 and 529 clusters of 
proteins, respectively. These data suggest that we are grouping together proteins with 
similar annotated functions, indicative of proteins interacting in a complex, and 
supporting the idea that hierarchical clustering of elution profiles can predict 
protein-protein interactions. As a control, we randomly shuffled the order of proteins 
within the dendrograms of each dataset and then performed the same analyses; under 
these conditions we did not see a similar increase in GO term enrichment across cutting 
distance (Figure 3.14).
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Figure 3.14: Hierarchical clustering of protein elution profiles. Heat-maps of hierarchically clustered protein elution profiles from lysates separated 
using either SEC, with either (a) 300 or (b) 1000 Å pore size, and (c) SAX chromatography. Plots below heat-maps demonstrate the effect of varying 
the dendrogram cutting distance on the mean Pearson correlation coefficient of proteins (green line), and the total number of gene ontology terms 
enriched (blue line) within clusters in (d) SEC300, (e) SEC1000 and (f) SAX. The red line depicts the number of GO terms enriched within clusters 
with a random ordering of proteins each dataset. Proteins within clusters can be viewed in the Cluster Explorer web-tool described later in the text.   
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3.3.4 Characterisation of known complexes 
To benchmark how well each form of chromatography performed in maintaining and 
separating protein complexes, we inspected the elution profiles of proteins expected to 
be present as stable complexes, either from information from the T. brucei literature, or 
by analogy with complexes known to be highly conserved in other organisms. The 
elution profiles of proteins thought to form the chaperonin T-complex, the core 
proteasome subunit, the proteasome regulatory cap, ATP synthase, the chaperone 
prefoldin complex and the ARP2/3 complex across SEC300, SEC1000 and SAX 
chromatography are shown in (Figure 3.15). 
The proteasome core and regulatory subunits have quite distinct elution profiles 
on the SEC300 column, with the regulatory cap eluting at ~770 kDa and the core 
complex at ~660 kDa. This is consistent with previous reports showing that the 
proteasome core and cap dissociate in PBS based T. brucei lysates (Li et al., 2002). The 
elution profiles of the proteasome core and regulatory cap components by an orthogonal 
chromatographic method, ion exchange on a SAX column, further demonstrates the 
stability of these complexes, although the core subunit appears more stable to SAX 
chromatography than the regulatory subunit. 
Unlike the trypanosome proteasome, the prefoldin complex has not previously 
been characterised in T. brucei. Here, I show the co-elution of many predicted prefoldin 
subunits in SEC and SAX chromatography, providing the first supporting evidence that 
these proteins come together as a functional prefoldin chaperone complex in T. brucei. 
Together with the elution profiles of other known or suggested T. brucei protein 
complexes, we can see that high-resolution chromatography, fractionation, mass 
spectrometric identification and quantification can produce distinct and consistent 
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co-chromatographic elution profiles for the protein subunits belonging to unique 
complexes. 
!
Figure 3.15: Elution of components of known core protein complexes across multiple 
forms of chromatography. LFQ intensity for each protein plotted across the 
fractionation range collected for mass spectrometry analysis. Molecular weight marker 
retention times on SEC300 and SEC1000 columns marked below the plot. 
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3.3.5 Machine learning analysis to predict protein complexes 
To predict the likelihood of binary interactions between all pairs of co-eluting proteins 
detected in our datasets, a scoring methodology was designed to quantify the similarity 
of elution patterns. Two random forest predictors were implemented. The first predictor 
was trained with features extracted from data produced in this project. The second 
predictor was trained by combining the first set of features with features extracted from 
a recently published interactome study in T. brucei (Gazestani et al., 2016). Features 
retrieved from the version 10 of the STRING interaction database were also added to 
the second predictor (Szklarczyk et al., 2015) with the intention of promoting 
interacting protein pairs with orthogonal literature evidence for interaction 
(Figure 3.16). 
Both predictors were trained using 31 protein complexes, comprising 293 true 
positive interaction pairs (Supplementary Table 1). True positive pairs had an average 
interaction prediction score >0.75 (Figure 3.17), hence this was used as the threshold for 
positive interaction across the whole dataset. Receiver Operator Curves (ROC) also 
demonstrate the high precision and recall of the machine learning method (Figure 3.18) 
Analysis of how often the random forest predictors utilised each feature to 
classify positive and negative interactions showed that SEC300 co-apex score, cross-
correlation and Pearson correlation and SEC1000 co-apex features had the highest 
predictive power (Figure 3.19). 
We performed an analysis of the Pearson correlation coefficient distribution of 
all pairwise combinations of elution profiles detected within our SAX and SEC300 and 
compared them to IEX fractionation of mitochondrial extracts and glycerol gradient 
fractionation of whole cell lysates (Gazestani et al., 2016), respectively. 
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The outputs of the two random forest predictors were fed to ClusterOne to 
derive two sets of predicted protein complexes. These two complex predictions were 
merged to assemble 234 predicted protein complexes encompassing 805 proteins, with 
complexes ranging from 2-18 proteins. I have ascribed a putative function, or name, to 
the complexes when they contain proteins of known or suggested biological function in 
the TriTrypDB genome database (Figure 3.21, Supplementary Tables 2 and 3)(Aslett et 
al., 2010).  
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Figure 3.16: Overview of machine learning protein complex prediction pipeline. Data produced either solely in this project, or including data from 
STRING and a recent T. brucei interactome paper (Gazestani et al., 2016), were used to train two sets of random forest predictors to score binary protein-
protein interactions. The resulting scores were used to predict protein complexes separately for each set, then merged to join redundant complexes. 
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!
Figure 3.17: Machine learning interaction prediction score distributions. Interaction 
prediction score distributions of 293 gold standard protein-protein interaction pairs 
using random forest predictor 1 and 2. Vertical green line highlights the 0.75 interaction 
prediction score threshold. 
!
Figure 3.18: Receiver operator curves from both random forest predictors. Each random 
forest analysis was performed 100 times with a random selection of true negative 
interactors. 
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Figure 3.19: Feature importance output of random forest analyses. Feature importance 
reveals how often a scoring feature is used by random forest analysis to predict the gold 
standard protein complexes dataset. It therefore informs us on which are the most useful 
features for predicting protein interactions. 
!
Figure 3.20: Comparative analysis of our data and published data. Distribution of  
Pearson correlation coefficients between all pairwise combinations of proteins in each 
dataset. Distributions of cytosolic IEX (Gazestani et al., 2016) and SAX fractionation (left) 
and glycerol gradient fractionation of whole cell lysate (Gazestani et al., 2016) and SEC300 
(right). n = the number of pairwise protein correlations calculated within each dataset.        
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Figure 3.21: Machine learning prediction of protein-protein interactions and protein complexes. ClusterOne output of merged predictions from 
machine learning with both sets of predictors. Known protein complexes, or complexes with proteins of similar function have been manually 
annotated.
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3.3.6 Prediction of novel protein complexes and interactions 
Although many of the complexes we predict are highly abundant core protein 
complexes conserved across eukaryotic evolution, we also detect a number of novel 
complexes and protein-protein interactions not previously described in T. brucei. Some 
of these predicted interactions will shed light on the functions of some of the many 
‘hypothetical’ proteins in the trypanosome genome. Some examples of previously 
uncharacterised associations are described in section 3.4.4. 
3.3.7 Formaldehyde and DSP cross-linking and protein fractionation 
 To increase the coverage of membrane protein complexes in our dataset I 
initiated work to optimise in vivo crosslinking of protein complexes with formaldehyde 
or dithiobis(succinimidyl propionate) (DSP), followed by lysis in denaturing SDS based 
buffers. A range of concentrations of either DSP (0-2 mM), or formaldehyde (0-6%) 
were tested and analysed before and after de-crosslinking by addition of reducing agent 
or heat, respectively. 
 SyPro stained SDS-PAGE gels were utilised to visualise the degree of protein 
cross-linking (Figure 3.22). The lowest concentration of DSP tested (0.125 mM) leads 
to the formation of large protein aggregates that could not enter the SDS-PAGE gel, 
indicating effective protein cross-linking. Formaldehyde only begins to show an 
obvious effect of crosslinking at concentrations >1%, with very few distinctive bands of 
monomeric proteins below 250 kDa observed at a concentration of 3%. De-crosslinking 
was highly effective for both methods as demonstrated by the loss of the high-molecular 
weight protein in the well of the gel, and the similarity in the banding pattern of proteins 
in each sample (Figure 3.22). 
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 Western blotting of DSP crosslinked samples for enolase and tubulin (Figure 
3.23), again shows the effective crosslinking of samples at the lowest concentrations of 
DSP tested. From 0.125-1 mM DSP a higher molecular weight band of ~100 kDa is 
detected for enolase, indicating formation of a dimer. At 2 mM this band disappeared, 
with a concomitant increase in the staining of material in the well of the lane. Tubulin is 
seen as a monomer at 49 kDa with no crosslinking, and a faint monomer and dimer can 
be seen upon addition of DSP, though most of the tubulin signal is lost upon cross-
linking. This may be indicative of cross-linking large chunks of microtubules that may 
be lost from the sample upon centrifugation. 
 In formaldehyde cross-linked samples, enolase is detected as a monomer across 
the tested concentration range from 0-6%. A faint dimer band can be observed from 
0.4%, and at 2% high-molecular weight material not entering the gel can be observed. A 
similar pattern is observed for tubulin, with the presence of a monomer and dimer band 
from 0.2-2% formaldehyde. Above this concentration, the monomeric band is lost and 
most tubulin stained material is found in the high molecular weight material 
(Figure 3.23). 
 Formaldehyde crosslinked and de-crosslinked samples were run on an SEC1000 
column in an SDS based buffer. Comparison of the 215 nm chromatograms of these 
lysates clearly shows increasing material at high molecular weight at higher 
formaldehyde concentrations (Figure 3.24). Following de-crosslinking with heat, all 
samples looked identical. 
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Figure 3.22: In vivo crosslinking and de-crosslinking analysis of T. brucei. SyPro 
staining of SDS-PAGE analysis of lysates from T. brucei cells treated with varying 
concentrations of DSP (top) or formaldehyde (bottom). Lysates from DSP treated cells 
were de-crosslinked through the addition of the reducing agent, TCEP (top, right five 
lanes). Lysates from formaldehyde treated cells were de-crosslinked by heating samples 
to 95˚C (bottom right gel). 
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Figure 3.23: Western blotting for enolase and tubulin in lysates from DSP (top) or 
formaldehyde (bottom) crosslinked cells. 
!
Figure 3.24: Denaturing SEC1000 on crosslinked lysates. Chromatograms of 215 nm 
absorbance of lysates from formaldehyde crosslinked T. brucei, fractionated using 
SEC1000 column in a denaturing buffer. 
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3.4 Discussion 
In this study, I have produced information on the elution profiles across SEC and SAX 
chromatograms for 5,845 protein groups, providing a rich data source that predicts 
protein interactions. Computational analysis of these elution profiles allows us to 
predict 234 protein complexes, containing groups from two to eighteen proteins that we 
predicted to interact. This includes a number of well-characterised complexes in T. 
brucei, confirms some predictions from electronic annotations based on homology to 
known complexes from other organisms and provides evidence for the existence of 
previously uncharacterised complexes. We hope that these data will be a useful resource 
for trypanosome biologists working across a number of areas of trypanosome molecular 
cell biology. 
Our data show that we can reliably characterise the interactions of thousands of 
untagged and natively expressed proteins directly from cellular lysates. Analysis of five 
individual biological replicates demonstrates the reproducibility of these methods to 
characterise protein elution profiles on a proteome wide scale. Through the pair-wise 
analysis of five replicates for each of the SEC columns tested, we could also detect 
outliers where deterioration of chromatography and/or some error in sample preparation 
occurred, and we could discount them from further analysis (Figures 3.11, 3.12).  We 
would, therefore, advocate that researchers perform such pair-wise quality control 
analysis of datasets prior to counting data. 
3.4.1 Utility of orthogonal modes of chromatography 
I utilised two orthogonal modes of separation to fractionate T. brucei lysates, 
i.e., by charge (SAX), or size/shape (SEC). For the latter I used two columns with 
different size/shape separation ranges (SEC300 and SEC1000). Through combining 
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evidence of co-elution of individual proteins from multiple forms of fractionation, we 
can have higher confidence in our protein-protein interaction predictions. 
Each of the methods of chromatography used in this study have their own 
strengths and weaknesses with respect to their contributions to our protein complex 
predictions. One of the main benefits of SEC is that almost any buffer can be utilised for 
lysis and fractionation, and that the chemical properties of the buffer can be kept 
constant throughout chromatography. It is possible, therefore, lyse cells and fractionate 
lysates in a buffer such as PBS, which is similar in pH and ionic strength to the 
intracellular milieu, and thus limit the disruption of the protein-protein interactions we 
are trying to capture. Another benefit of SEC columns, is the ability to calibrate them 
with molecular weight markers (Figures 3.2, 3.3), which allows an estimation of the 
molecular weight of eluting proteins through regression analysis (Figure 3.4). The 
elution of a protein during SEC therefore informs us of the molecular weight of that 
proteoform (Figure 3.8). I have used this estimated molecular weight information in our 
SEC300 dataset to classify proteins into monomers and dimers, protein complexes and 
void material (i.e. too large to be separated by SEC300), providing a global overview of 
the protein interaction state in PBS based lysates of procyclic T. brucei (Figure 3.9). 
The weaknesses of SEC include its relatively low resolution, its relatively high elution 
volumes (requiring sample concentration post-chromatography) and its ultimate 
limitation in fractionation range. The latter can be ameliorated by using more than one 
fractionation range SEC column, as in this study with SEC300 and SEC1000 columns. 
Although I did not use density-gradient centrifugation in our study, this technique has 
many of the same strengths and weaknesses as SEC, with the added complication of the 
presence of the density-gradient forming solute in all fractions. 
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The advantages of ion-exchange chromatography (in our case SAX) include its 
relatively high resolution and relatively low elution volumes. The high-resolution of 
SAX chromatography can be seen in the elution profiles of the protein standards used to 
characterise the columns (Figures 3.2, 3.3, 3.5) and the heat-maps of elution profiles 
from all proteins detected by mass spectrometry (Figure 3.14). The proteasome core 
complex, for example, co-elutes consistently across SEC and SAX chromatography. 
However, in SEC the elution peak is very broad spanning six fractions whereas it spans 
only three in SAX (Figure 3.15). Its key weaknesses are that fractionation pH (in our 
case pH 9.0) and ionic strength (which varies from low to very high across the NaCl 
elution gradient) are non-physiological and can promote dissociation of part of or all 
protein complexes in the absence of chemical cross-linking. For example, although 
components of the proteasome regulatory subunit co-elute together in SEC, when 
separated by SAX a more complex elution pattern is observed at later stages of the 
gradient where there are high salt concentrations, indicating breaking apart of the 
complex (Figure 3.15). 
The elution profiles of the proteasome core and regulatory subunits, 
demonstrates the advantage of using multiple forms of chromatography and lysis 
conditions, when as in this case, both forms of fractionation provide reinforcing 
evidence for protein interactions. However, individual protein complexes have a diverse 
range of required conditions necessary for their stability, and by using orthogonal lysis 
conditions and methods of chromatography, a wider range of cellular complexes that 
may only be stable under certain conditions are captured. Other forms of 
chromatography that could be considered for future studies include hydrophobic 
interaction chromatography, heparin affinity columns and a wide variety of anion and 
cation exchange columns. 
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3.4.2 Global analysis of protein interaction state 
We estimate that 44% of the 3,326 proteoforms detected in our SEC300 dataset are 
present in monomeric or dimeric states, a large proportion of the proteome. This may be 
a true indication of how many proteins are present in the monomer/dimer pool within 
the cell, however, it cannot be discounted that some protein complexes may fall apart 
during cell lysis and sample chromatography, or that there may be some proteolysis 
when cells are lysed in PBS, even with the addition of protease inhibitors. 
The optimal fractionation range (between the void and the monomer and dimer 
regions) of the SEC300 column contains 20% of detected proteoforms. GO enrichment 
analysis of the proteins eluting in these fractions highlights the detection of many 
annotated large macro-molecular complexes, validating that we can capture protein 
complexes using this method (Figure 3.10). 
The remaining 36% of proteoforms are in material too large to be separated by 
SEC300. Proteins eluting in higher molecular weight fractions are enriched in GO terms 
associated with integral membrane and organellar proteins. This effect is likely due to 
presence of membranous vesicles, which have a large hydrodynamic radius, and hence 
elute in the void together with membrane proteins. We would therefore recommend that 
future PCP-MS studies, utilising SEC fractionation, incorporate ultracentrifugation of 
lysates prior to chromatography to remove vesicles and organelle fragments. 
It would be interesting to compare the values reported here with future studies 
incorporating in vivo chemical crosslinking prior to lysis and fractionation. The physical 
crosslinking of proteins may prevent complexes dissociating into sub-complexes or 
monomeric subunits, providing a more realistic picture of how many proteins are truly 
monomeric in the cellular environment. The covalent association of proteins in 
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complexes would further allow lysis in detergent based buffers, solubilising vesicles, 
organelles and membrane protein complexes, increasing their coverage in the dataset 
and reducing the complexity of the void material (Larance et al., 2016). 
3.4.3 Comprehensive characterisation of known complexes 
Using machine-learning techniques, we have assessed the likelihood of all proteins 
within the dataset to interact in an exhaustive pairwise manner and predicted the 
formation of 234 protein complexes, comprising 805 proteins (Figure 3.21, 
Supplemenatry Tables 2 and 3). We have demonstrated the ability of this method to 
predict interaction between most, if not all, components of a number of highly abundant 
and well characterised protein complexes. For example, all fourteen proteins of the core 
20S proteasome subunit are grouped together using this method, as all components co-
elute in all three fractionation experiments. Other predicted complexes capture AMPK 
(complex 3), vacuolar ATP synthase (complex 20), the exosome (complex 28), 
prefoldin (complex 29), sub-components of the spliceosome (complexes 86 and 180), 
the nucleosome (complex 87), ARP2/3 (complex 112), T-complex (complex 129) and 
F1F0 ATP synthase (complex 130), among others detailed in Supplementary Tables 2 
and 3. This validates the concept that by scoring how well proteins co-elute, we can 
predict genuine protein-protein interactions. This dataset of predicted interactions 
produced here is a powerful tool as a hypothesis generator; predicting interactions in a 
pairwise fashion across the dataset, which can then be directly tested or confirmed by 
orthogonal techniques such as immunoprecipitation or yeast-2-hybrid experiments. 
This dataset can also be used to increase confidence in the annotation of the 
trypanosomatid proteome. For example, although most of the proteins detected in the 
proteasome complex (complex 31, Table 3.1) are annotated as proteasome alpha and 
beta subunits, one is annotated as ‘unspecified product’ (Tb927.9.11310). A bespoke 
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BLASTp search with this gene product reveals that it has homology to a proteasome 
beta subunit. Thus, the co-chromatograph of Tb927.9.11310 with the proteasome core 
complex has led to a re-evaluation of its likely identity. 
Table 3.1: List of proteins identified in Complex 31 – proteasome core complex 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$
Tb11.v5.0196$ Proteasome!subunit!A!N0terminal!
signature/Proteasome!subunit,!
putative!
20S!proteasome!subunit!
alpha06!(2.5e0141)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!1.3e013);!
Proteasome!subunit!(IPR001353,!1.4e0
53)!
Tb927.10.230$ proteasome!subunit!alpha!type05,!
putative!
20S!proteasome!subunit!
alpha05!(3.6e0126)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!2e013);!
Proteasome!subunit!(IPR001353,!6.7e0
57)!
Tb927.10.290$ proteasome!alpha!2!subunit,!
putative!
20S!proteasome!subunit!
alpha02!(3.5e0121)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!1.5e09);!
Proteasome!subunit!(IPR001353,!2.7e0
63)!
Tb927.10.4710$ 20S!proteasome!subunit,!
proteasome!subunit!beta!type02,!
putative!(PSB4)!
20S!proteasome!subunit!
beta04!(6.8e0109)!
Proteasome!subunit!(IPR001353,!1e0
27)!
Tb927.10.6080$ proteasome!subunit!beta!type05,!
putative,!proteasome!subunit!
beta!type05,!putative!
Proteasome!subunit!beta!
type05!(2.8e071)!
Proteasome!subunit!(IPR001353,!2.2e0
50)!
Tb927.11.7020$ proteasome!alpha!7!subunit,!
putative!(PSA4)!
20S!proteasome!subunit!
alpha04!(5.1e0127)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!1.3e014);!
Proteasome!subunit!(IPR001353,!4.8e0
58)!
Tb927.11.7270$ proteasome!beta!3!subunit,!
putative!(PSB3)!
20S!proteasome!subunit!
beta03!(5.5e0107)!
Proteasome!subunit!(IPR001353,!1e0
39)!
Tb927.3.780$ proteasome!alpha!7!subunit!
(TbPSA7)!
20S!proteasome!subunit!
alpha07!(1.6e059)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!5.7e011);!
Proteasome!subunit!(IPR001353,!5.6e0
44)!
Tb927.4.430$ proteasome!beta!7!subunit! Proteasome!subunit!beta!
type04!(1.2e040)!
Proteasome!subunit!(IPR001353,!7.2e0
36)!
Tb927.6.1260$ proteasome!beta01!subunit,!
putative!(PSB1)!
Proteasome!subunit!beta!
type06!(8.6e054)!
Proteasome!subunit!(IPR001353,!1e0
42)!
Tb927.7.4420$ proteasome!alpha!3!subunit,!
putative!
20S!proteasome!subunit!
alpha03!(4.5e064)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!1.3e012);!
Proteasome!subunit!(IPR001353,!6.4e0
48)!
Tb927.7.4790$ proteasome!beta!6!subunit,!20S!
proteasome!beta!6!subunit,!
putative!(BETA6)!
20S!proteasome!subunit!
beta06!(2.6e0139)!
Proteasome!subunit!(IPR001353,!2.2e0
32)!
Tb927.9.11310$ unspecified!product! Proteasome!subunit!beta!
type02!(2.7e073)!
Proteasome!subunit!(IPR001353,!8.9e0
47)!
Tb927.9.9670$ proteasome!alpha!1!subunit,!
putative,!20S!proteasome!subunit!
alpha06,!(putative)!(TbPSA6)!
Proteasome!subunit!alpha!
type01!(4e0120)!
Proteasome!subunit!A!N0terminal!
signature!(IPR000426,!1.2e011);!
Proteasome!subunit!(IPR001353,!1.7e0
38)!
 
Likewise, complex 130 (Table 3.2) contains all characterised subunits (!, ", #, $ and %) 
of the F1 domain of the F0F1-ATP synthase complex (Zikova et al., 2009). 
Riboonucleoprotein p18 is also observed in this predicted complex, a protein also 
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demonstrated to be the b subunit of the Fo domain (Zikova et al., 2009). Complex 130 
contains two other proteins (Tb927.11.13070 and Tb927.3.3410) with no prior evidence 
to indicate functional interaction with the ATP synthase complex. Additionally, 
complex 85 comprises three hypothetical proteins, two of which are also detected in the 
T. brucei ATP synthase (Table 3.3). Tb927.10.8030 is thought to be the homolog of the 
oligomycin sensitivity conferring protein of the Fo domain, and Tb927.11.6250 is a 
trypanosome specific ATP synthase associated protein (Zikova et al., 2009). The third 
and final protein, Tb927.5.1780, has no other functional information and may be a novel 
component of ATP synthase. 
Table 3.2: List of proteins identified in Complex 130 – F0F1-ATP synthase complex 
Gene$ID$ GeneDB$Annotation$ Homology$
search$
BLAST$search$ Interpro$domain$
search$
Tb927.10.180$ ATP!synthase!F1!
subunit!gamma!
protein,!putative!
ATP!synthase!
gamma!chain!
(2.1e020)!
ATP!synthase!(IPR000131,!4.7e0
33);!ATP!synthase!(F10ATPase),!
gamma!subunit!(IPR023633,!4.5e0
49)!
Classed!as!gamma!
subunit!of!F0F1!ATP!
synthase!in!(Zikova!et!
al.,!2009)!
Tb927.10.5050$ Mitochondrial!ATP!
synthase!epsilon!chain,!
putative!
0! Epsilon!subunit!of!mitochondrial!
F1F00ATP!synthase!(IPR006721,!
9.7e013)!
Classed!as!epsilon!
subunit!of!F0F1!ATP!
synthase!in!(Zikova!et!
al.,!2009)!
Tb927.11.13070$ O0phosphoseryl0
tRNA(Sec)!selenium!
transferase,!putative!
Selenocysteinyl0
tRNA(Sec)!
synthase!(9.4e0
100)!
Soluble!liver!antigen/liver!
pancreas!antigen!(IPR008829,!
9.2e059)!
0!
Tb927.3.1380$ ATP!synthase!subunit!
beta,!mitochondrial,!
ATP!synthase!F1,!beta!
subunit!(ATPB)!
ATP!synthase!
subunit!beta!
(1.3e0171)!
ATP!synthase!alpha/beta!family,!
nucleotide0binding!domain!
(IPR000194,!5.7e064)!
Classed!as!beta!subunit!
of!F0F1!ATP!synthase!in!
(Zikova!et!al.,!2009)!
Tb927.3.3410$ aspartyl!
aminopeptidase,!
putative,!metallo0
peptidase,!Clan!MH,!
Family!M20!
Aspartyl!
aminopeptidase!
(3.3e0111)!
0! 0!
Tb927.5.1710$ ribonucleoprotein!p18,!
mitochondrial!
precursor,!putative!
Protein!P18!
(1.4e076)!
0! Classed!as!b!subunit!of!
F0F1!ATP!synthase!in!
(Zikova!et!al.,!2009)!
Tb927.6.4990$ ATP!synthase,!epsilon!
chain,!putative!
ATP!synthase!
subunit!delta!
(6.7e015)!
ATP!synthase,!Delta/Epsilon!
chain,!beta0sandwich!domain!
(IPR020546,!3.1e017)!
Classed!as!delta!
subunit!of!F0F1!ATP!
synthase!in!(Zikova!et!
al.,!2009)!
Tb927.7.7430$ ATP!synthase!alpha!
chain,!mitochondrial!
precursor,!ATP!
synthase!F1,!alpha!
subunit!
ATP!synthase!
subunit!alpha!
(1.3e0107)!
ATP!synthase!alpha/beta!family,!
nucleotide0binding!domain!
(IPR000194,!4.8e069)!
Classed!as!alpha!
subunit!of!F0F1!ATP!
synthase!in!(Zikova!et!
al.,!2009)!
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Table 3.3: List of proteins identified in Complex 85 – F0F1-ATP synthase complex 
Gene$ID$ GeneDB$
Annotation$
BLAST$
search$
Interpro$domain$search$ Comments$
Tb927.10.8030$ hypothetical!
protein,!conserved!
0! ATP!synthase!delta!(OSCP)!
subunit!(IPR000711,!2.6e05)!
Classed!as!OSCP!subunit!of!F0F1!ATP!
synthase!in!!(Zikova!et!al.,!2009)!
Tb927.11.6250$ hypothetical!
protein,!conserved!
0! 0! Classed!as!trypanosome!specific!subunit!
of!F0F1!ATP!synthase!in!(Zikova!et!al.,!
2009)!
Tb927.5.1780$ hypothetical!
protein,!conserved!
0! 0! 0!
 Previous AP-MS analysis of the mitochondrial ribosome of T. brucei identified 
133 proteins, 77 of which were classed as large-subunit and 56 as small-subunit 
associated proteins (Zikova et al., 2008). From our data analysis we predict three groups 
of complexes (complex 4, 92 and 134, Tables 3.4-3.6) which are composed solely of 
proteins identified from this previous publication, apart from one hypothetical protein 
(Tb927.7.3030) in complex 134. Within these three complexes 26 mitochondrial 
ribosomal proteins are identified, and one potentially novel component. Of these, 15 are 
identified as hypothetical proteins, which with prior evidence from AP-MS studies and 
this work may warrant re-classification as mitochondrial ribosome subunits. 
Table 3.4: List of proteins identified in Complex 4 – mitochondrial ribosome 
Gene$ID$ GeneDB$
Annotation$
BLAST$search$ Interpro$domain$search$ Comments$
Tb927.11.12930$ DEAD0box!helicase,!
putative!
ATP0dependent!rRNA!
helicase!RRP3!(2e030)!
DEAD/DEAH!box!
helicase!(IPR011545,!
3.8e026)!
0!
Tb927.11.5990$ hypothetical!
protein,!conserved!
Pseudouridylate!synthase!7!
homolog0like!protein!(6.9e0
9)!
Pseudouridine!synthase!
(IPR020103,!8.8e035)!
mitochondrial!LSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.4.1070$ 50S!ribosomal!
protein!L13,!
putative!
50S!ribosomal!protein!L13!
(6.5e017)!
Ribosomal!protein!L13!
(IPR023564,!2e030)!
MRPL13!(Zikova!et!al.,!
2008)!
Tb927.6.4080$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!SSU!or!
LSU!protein!(Zikova!et!
al.,!2008)!
Tb927.7.1640$ ras0like!small!
GTPase,!putative!
(TbEAR)!
GTPase!Der!(1.5e056)! 50S!ribosome0binding!
GTPase!(IPR006073,!
1.8e015)!
mitochondrial!LSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.7.3460$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!LSU!
protein,!KRIT2!(Zikova!et!
al.,!2008)!
  
Chapter 3: Mapping core protein complexes of Trypanosoma brucei 
 
 
!
!
78 
Table 3.5: List of proteins identified in Complex 92 – mitochondrial ribosome 
Gene$ID$ GeneDB$Annotation$ BLAST$
search$
Interpro$domain$
search$
Comments$
Tb927.10.3580$ hypothetical!protein,!conserved! 0! 0! mitochondrial!SSU!protein!(Zikova!
et!al.,!2008)!
Tb927.11.2530$ Mitochondrial!SSU!ribosomal!
protein,!putative!
0! 0! mitochondrial!SSU!protein!(Zikova!
et!al.,!2008)!
Tb927.7.3050$ hypothetical!protein,!conserved! 0! 0! mitochondrial!SSU!protein!(Zikova!
et!al.,!2008)!
Table 3.6: List of proteins identified in Complex 134 – mitochondrial ribosome 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$ Comments$
Tb927.1.1200$ SSU!ribosomal!
protein,!
mitochondrial!
(MRPS15)!
0! S15/NS1!RNA0binding!
domain!(IPR009068,!1.9e07)!
MRPS15!(Zikova!et!al.,!
2008)!
Tb927.10.7380$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!LSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.11.11630$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!LSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.11.1250$ Mitochondrial!SSU!
ribosomal!protein,!
putative!
0! 0! mitochondrial!SSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.11.6000$ ribosomal!protein!
L4/L1!family,!
putative!
50S!ribosomal!protein!L4!
(1.3e06)!
Ribosomal!protein!L4!
(IPR023574,!4.6e040)!
MRPL4!(Zikova!et!al.,!
2008)!
Tb927.11.870$ hypothetical!
protein,!conserved!
0! Ribosomal!proteins!S24e,!
L23!and!L15e!(IPR012678,!
7.6e09)!
MRPL23!(Zikova!et!al.,!
2008)!
Tb927.2.4890$ ribosomal!protein!
L11,!putative!
54S!ribosomal!protein!
L19,!mitochondrial!(1.3e0
13)!
Ribosomal!protein!L11/L12!
(IPR000911,!1.2e09)!
MRPL11!(Zikova!et!al.,!
2008)!
Tb927.3.5610$ ribosomal!protein!
L3!mitochondrial,!
putative!
39S!ribosomal!protein!
L3,!mitochondrial!(2e0
27)!
Ribosomal!protein!L3!
(IPR000597,!1.2e011)!
MRPL3!(Zikova!et!al.,!
2008)!
Tb927.5.3980$ hypothetical!
protein,!conserved!
54S!ribosomal!protein!
L10,!mitochondrial!(1.9e0
8)!
Ribosomal!proteins!L15p!
and!L18e!(IPR021131,!3.1e0
9)!
MRPL15!(Zikova!et!al.,!
2008)!
Tb927.5.4120$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!LSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.6.2080$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!SSU!
protein!(Zikova!2008)!
Tb927.6.4560$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!SSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.7.2760$ ribosomal!protein!
L22p/L17e,!putative!
50S!ribosomal!protein!
L22!(7.6e09)!
Ribosomal!protein!L22!
(IPR001063,!6.4e020)!
MRPL22!(Zikova!et!al.,!
2008)!
Tb927.7.3030$ hypothetical!
protein,!conserved!
0! 0! !
Tb927.7.4140$ ribosomal!protein!
L21,!putative!
Probable!39S!ribosomal!
protein!L21,!
mitochondrial!(9.8e014)!
Ribosomal!prokaryotic!L21!
protein!(IPR001787,!7e020)!
MRPL21!(Zikova!et!al.,!
2008)!
Tb927.8.5200$ hypothetical!
protein,!conserved!
0! 0! mitochondrial!SSU!
protein!(Zikova!et!al.,!
2008)!
Tb927.9.7170$ Mitochondrial!390S!
ribosomal!protein!
L47!(MRP0L47),!
putative!
39S!ribosomal!protein!
L47,!mitochondrial!(1.2e0
13)!
Mitochondrial!390S!
ribosomal!protein!L47!
(IPR010729,!2.3e025)!
MRPL47!(Zikova!et!al.,!
2008)!
Tb927.9.8290$ hypothetical!
protein,!conserved!
0! Ribosomal!protein!L30p/L7e!
(IPR016082,!9.9e012)!
MRPL30!(Zikova!et!al.,!
2008)!
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Complex 3 contains both experimentally verified members (Tb927.8.2450 and 
Tb927.10.3700, β and γ subunits respectively) of the AMPK complex (Table 3.7) 
(Clemmens et al., 2009). The three other proteins include Tb927.3.4560, annotated as 
the AMPKα subunit; Tb927.10.5310, an SNF1 related protein kinase, also with 
homology to AMPKα; and Tb927.9.9270, a hypothetical protein with little extra 
functional information. AMPK is thought to be a heterotrimeric complex, therefore it is 
possible that the two putative AMPKα subunits are isoforms, forming part of two 
independent protein complexes which co-elute. Whether the hypothetical protein is a 
novel component of the trypanosome AMPK complex, is a subunit isoform, or is simply 
a contaminating co-eluted protein warrants further investigation. 
Table 3.7: List of proteins identified in Complex 3 - AMPK 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$ Comments$
Tb927.10.3700$ AMP0activated!protein!kinase,!
gamma!regulatory!subunit,!SNF10
related!protein!kinase!regulatory!
subunit!gamma,!AMPK!subunit!
gamma!(AMPKG)!
AMPK!subunit!
gamma03!(2.2e014)!
0! identified!in!
(Clemmens!et!
al.,!2009)!
Tb927.10.5310$ SNF10related!protein!kinases,!
putative!
AMPK!subunit!
alpha01!(3.1e077)!
0! 0!
Tb927.3.4560$ 5'0AMP0activated!protein!kinase!
catalytic!subunit!alpha,!putative,!
AMPK!subunit!alpha,!putative,!SNF10
related!protein!kinase!catalytic!
subunit!alpha,!putative!
AMPK!subunit!
alpha02!(4.2e090)!
0! 0!
Tb927.8.2450$ SNF10related!protein!kinase!
regulatory!subunit!beta,!5'0AMP0
activated!protein!kinase!subunit!
beta,!AMPK!subunit!beta!(AMPKB)!
AMPK!subunit!beta0
1!(1.1e010)!
5'0AMP0activated!
protein!kinase!beta!
subunit,!interation!
domain!(IPR006828,!
9.6e041)!
identified!in!
(Clemmens!et!
al.,!2009)!
Tb927.9.9270$ hypothetical!protein,!conserved! Ankyrin!repeat!and!
zinc!finger!domain0
containing!protein!1!
(1.6e012)!
0! 0!
3.4.4 Discovery of novel interactions and functional information 
Our machine learning based interactome dataset predicts a number of complexes and 
interactions that have not previously been observed in T. brucei (Figures 3.25 and 3.26, 
Tables 3.8-3.15). These data have: (a) revealed putative functional information for 
‘hypothetical’ proteins that are partnered with proteins of known function; (b) identified 
evolutionary conserved complexes characterised in other eukaryotes; (c) predicted novel 
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interactions between proteins of known function. Some examples of each are given 
below. 
(a)!We demonstrate the consistent co-elution of the RNA binding protein 
PUF10 with a hypothetical protein (Tb927.7.2170) across SEC300, 
SEC1000 and SAX fractionation in complex 72 (Table 3.8, Figure 3.25a). 
PUF proteins are known to bind to mRNA, and the hypothetical protein has 
also been predicted to bind mRNA through capture on oligo(dT) beads 
(Lueong et al., 2016). Taken together, these data indicate that Tb927.7.2170 
interacts with PUF10 and may play a role in mRNA regulation. This 
outcome displays the power of PCP-MS, as there are now multiple lines of 
evidence for this interaction and it provides insights into the role of this 
‘hypothetical’ protein as a mRNA binder, working in conjunction with 
PUF10. 
Table 3.8: List of proteins identified in Complex 72 – PUF10 complex 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$
search$
Comments$
Tb927.11.6740$ pumilio/PUF!RNA!
binding!protein!10,!
putative!
0! ARM!repeat!
(IPR016024,!2.4e0
19)!
mRNA!binding!
(Lueong!et!al.,!
2016)!
Tb927.7.2170$ hypothetical!protein,!
conserved!
ANP32/acidic!nuclear!phosphoprotein0
like!protein!2!(3.3e010)!
0! mRNA!binding!
(Lueong!et!al.,!
2016)!
In complex 174 two proteins are detected, a hypothetical protein 
(Tb927.8.1960) together with subunit 10 of the CCR4-NOT complex 
(Tb927.10.8720)(Table 3.9, Figure 3.25b) (Schwede et al., 2008). The 
hypothetical protein has recently been co-purified with CAF1, a core 
component of the CAF1-NOT deadenylase complex (Färber et al., 2013). It is 
also the homologue of a human protein (C2ORF29) recently classified as 
subunit 11 of the CCR4-NOT complex that interacts with subunit 10 
(Mauxion et al., 2013). The co-chromatography with CCR4-NOT subunit 10 
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provides further evidence for this functional classification of the hypothetical 
protein. 
Table 3.9: List of proteins identified in Complex 174 – CNOT10 and 11 complex 
Gene$ID$ GeneDB$Annotation$ BLAST$
search$
Interpro$
domain$
search$
Comments$
Tb927.10.8720$ CCR40NOT!transcription!
complex!subunit!10,!putative!
0! 0! Identified!in!Caf1!pulldown!(Schwede!et!al.,!
2008)!
Tb927.8.1960$ hypothetical!protein,!conserved! 0! 0! Copurified!with!Caf1!protein!of!CNOT!
complex,!and!Tb927.10.8720!and!is!human!
homolog!of!CNOT11!(Färber!et!al.,!2013;!
Mauxion!et!al.,!2013;!Schwede!et!al.,!2008)!
Out of the 234 complexes predicted from machine-learning, 77 contain at 
least one protein annotated as ‘hypothetical’ and 19 are composed solely of 
‘hypothetical’ proteins with no other orthogonal information on protein 
function. 
(b)!The trypanosome orthologue of Pwp2 (Tb927.10.13270) co-elutes with 
Tb927.11.10480, Tb927.11.460 and Tb927.7.4220, predicted to contain C-
terminal Utp21, Utp13 and Utp12 domains respectively, in complex 108 
(Table 3.10, Figure 3.25c). Work in yeast has shown that Pwp2 is known to 
associate with four other proteins (containing the same C-terminal Utp 
domains) in the U3 ribonucleoprotein assembly machinery, forming a 
complex necessary for pre-18S rRNA processing (Dosil and Bustelo, 2004). 
We therefore postulate that complex 108 performs a similar pre-18S rRNA 
processing function in T. brucei. 
Table 3.10: List of proteins identified in Complex 108 – U3 ribonucleoprotein 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$
Tb927.10.13270$ Periodic!tryptophan!protein!2!homolog,!
putative!
Periodic!tryptophan!
protein!2!homolog!(2.2e0
116)!
WD40!repeat0like!(IPR017986,!
2.9e052)!
Tb927.11.10480$ PQQ0like!domain/WD!domain,!G0beta!
repeat/Utp21!specific!WD40!associated!
putative!domain!containing!protein,!
putative!
U3!snoRNA0associated!
protein!21!(2.9e021)!
Utp21!specific!WD40!associated!
putative!domain!(IPR007319,!
4e019)!
Tb927.11.460$ predicted!WD40!repeat!protein! U3!snoRNA0associated!
protein!13!(2.2e051)!
Utp13!specific!WD40!associated!
domain!(IPR013934,!2.3e042)!
Tb927.7.4220$ WD!domain,!G0beta!repeat/Dip2/Utp12!
Family,!putative!
U3!snoRNA0associated!
protein!12!(1.6e054)!
Dip2/Utp12!Family!(IPR007148,!
2.6e06)!
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Additionally, in complex 76 three proteins are detected: Tb927.10.170 
(pseudouridine synthase, Cbf5p), Tb927.4.470 (snoRNP protein, GAR1 
putative) and Tb927.4.750 (50S ribosomal protein L7Ae, putative) 
(Table 3.11, Figure 3.25d). Cbf5 is the enzymatic component of the H/ACA 
ribonucleoprotein complex which pseudouridylates target RNAs. There are 
over 100 H/ACA ribonucleoprotein complexes, formed through interaction 
of different RNAs with the same four core proteins (Cbf5, Gar1, Nhp2 and 
Nop10)(Meier, 2006). The co-elution of these three proteins provides 
evidence for the existence of this complex in trypanosomatids and confirms 
the putative identity of Tb927.4.470 as a Gar1 homolog. A BLAST-p search 
of the putative ribosomal subunit, Tb927.4.750 also indicates homology to 
Nhp2, further confirming the identity of this complex. A search of 
TriTrypDB indicates that there is one annotated Nop10 homolog 
(Tb927.10.4740) in T. brucei. Although this protein is not detected in our 
high-confidence protein complex prediction, using the “Profile Explorer” 
data visualisation tool (described in section 3.4.7), we can see this protein is 
detected in our SAX fractionation experiment, and perfectly co-elutes with 
the three other components of complex 76. 
Table 3.11: List of proteins identified in Complex 76 – H/ACA ribonucleoprotein 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$
Tb927.10.170$ pseudouridine!
synthase,!Cbf5p!
H/ACA!ribonucleoprotein!
complex!subunit!4!(9.6e0142)!
0!
Tb927.4.470$ snoRNP!protein!GAR1,!
putative!
snoRNP!protein!GAR1!(8.6e054)! Gar1/Naf1!RNA!binding!region!(IPR007504,!
1.4e038)!
Tb927.4.750$ 50S!ribosomal!protein!
L7Ae,!putative!
snoRNP!protein!NHP2!(4e024)! Ribosomal!protein!L7Ae/L30e/S12e/Gadd45!
family!(IPR004038,!2.1e017)!
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Figure 3.25: Elution profiles of components of novel predicted complexes across 
multiple forms of chromatography. LFQ intensity for each protein plotted across the 
fractionation range collected for mass spectrometry analysis. Molecular weight marker 
retention times on SEC300 and SEC1000 columns marked below the plot. 
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(c)!Previous published studies have demonstrated the constitutive interaction of 
a heat-shock protein (HSP) 90 with protein phosphatase 5 (PP5) in T. brucei 
(Jones et al., 2008). Complex 12 contains five proteins, including an HSP90 
(Tb927.3.3580), and the PP5 previously demonstrated to interact with 
HSP90 (Tb927.1013670) (Table 3.12, Figure 3.26a). The association of 
these proteins with a putative HSP70 protein (Tb927.9.9860) can also be 
observed. HSP90 chaperones function through the association with HSP70 
proteins, which recruit and transfer substrate proteins to HSP90 (Folgueira 
and Requena, 2007). This novel association therefore matches our 
understanding of HSP90 function, and identifies a putative function for a 
previously uncharacterised HSP70. 
Table 3.12: List of proteins identified in Complex 12 – HSP70/90 Complex 
Gene$ID$ GeneDB$Annotation$ Homology$search$ BLAST$search$ Interpro$
domain$search$
Tb927.10.13670$ serine/threonine!
protein!phosphatase!
5!
Serine/threonine0protein!
phosphatase!5!(3.2e0
132)!
0! interacts!with!
HSP90!(Jones!
et!al.,!2008)!
Tb927.10.14030$ hypothetical!protein,!
conserved!
0! 0! 0!
!
Tb927.3.3580$ heat!shock!protein!
90,!putative!(LPG3)!
HSP90.2!(7.8e0132)! ATPase!domain!of!HSP90!
chaperone/DNA!topoisomerase!
II/histidine!kinase!(IPR003594,!
8.6e061)!
0!
Tb927.5.3260$ WD!domain,!G0beta!
repeat,!putative!
WD!repeat0containing!
protein!17!(4.7e058)!
WD40!repeat0like!(IPR017986,!
2.6e046)!
0!
Tb927.9.9860$ Hsp70!protein,!
putative!
Hsp70017!(8.6e068)! Hsp70!protein!(IPR013126,!1.6e0
67)!
0!
In complex 99 the association of proteins from two distinct protein 
complexes are seen (Table 3.13, Figure 3.26b). Two proteins have been 
experimentally verified as members of the spliced leader RNA cap 
methyltransferase (Zamudio et al., 2009), including the enzymatic MTR1 
subunit and a hypothetical protein (Tb927.10.7940 and Tb927.11.16490). 
The three other proteins in this predicted complex are identified as 
translation elongation factors (Tb927.10.5840, Tb927.11.13190 and 
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Tb927.4.3590) indicating an association between the methyltransferase 
capping enzymes of spliced leader RNA and the mRNA translation 
machinery. 
Table 3.13: List of proteins identified in Complex 99 – MTR1 and eIFB Complex 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$ Comments$
Tb927.10.5840$ translation!elongation!
factor!10beta,!putative!
EF010beta!(1.8e062)! eEF01beta0like!(IPR014038,!
7.7e030)!
0!
Tb927.10.7940$ methyltransferase,!
putative!
MTr1!(4.8e0202)! FtsJ0like!methyltransferase!
(IPR002877,!1.3e030)!
0!
Tb927.11.13190$ elongation!factor!1!
gamma,!putative!
eEF01B!gamma!
(8.3e0175)!
eEF10gamma!domain!
(IPR001662,!8.4e063)!
0!
Tb927.11.16490$ hypothetical!protein,!
conserved!
Telomerase!Cajal!
body!protein!1!
(2.4e09)!
WD40!repeat0like!
(IPR017986,!1.6e014)!
Identified!interacting!
with!Mtr1!in!(Zamudio!
et!al.,!2009)!
Tb927.4.3590$ translation!elongation!
factor!10beta,!putative!
EF010beta!(3.3e084)! eEF01beta0like!(IPR014038,!
1.3e029)!
0!
Personal communication with Laurie Read also confirms predictions 
identified in complex 165(Table 3.14, Figure 3.26c), a complex dominated 
by nucleolar associated proteins. Within this complex two arginine-N-
methyltransferases (Tb927.1.4690 and Tb927.10.3560) are seen, that are 
confirmed to form a protein complex, through directed studies in the Read 
lab. 
Table 3.14: List of proteins identified in Complex 165 – nucleolar complex 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$
Tb927.10.11310$ intraflagellar!transport!protein!
57/55!(IFT57/55)!
Intraflagellar!transport!protein!57!
homolog!(7.7e053)!
Intra0flagellar!transport!
protein!57!(IPR019530,!8.3e0
125)!
Tb927.10.13860$ GPI0anchor!transamidase!subunit!8!
(GPI8)!
GPI!transamidase!(1.8e051)! Peptidase!C13!family!
(IPR001096,!1.1e031)!
Tb927.10.4040$ 30keto0dihydrosphingosine!
reductase!
30ketodihydrosphingosine!
reductase!(1.9e033)!
short!chain!dehydrogenase!
(IPR002198,!6.7e035)!
Tb927.10.4610$ dolicholphosphate0mannose!
synthase,!putative!(DPMS)!
Dolichol0phosphate!
mannosyltransferase!(2e061)!
Glycosyl!transferase!family!2!
(IPR001173,!4.3e033)!
Tb927.11.13820$ hypothetical!protein,!conserved! 0! 0!
Tb927.11.15760$ GPI!transamidase!subunit!Tta1!
(TTA1)!
0! 0!
Tb927.2.1810$ transcription!silencer!(ISWI)! ISW20like!(1.4e0168)! SNF2!family!N0terminal!
domain!(IPR000330,!1.2e082)!
Tb927.5.1930$ signal!peptidase!subunit,!putative! 0! Signal!peptidase!subunit!
(IPR007653,!5.9e013)!
Tb927.8.5760$ Ankyrin!repeats!(many!
copies)/Alpha/beta!hydrolase!
family,!putative!
0! 0!
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Complex 164 (Table 3.15, Figure 3.26d) further demonstrates how the 
methods described in this work can produce novel information on proteins 
with characterised functions, enhancing our knowledge of their biology. An 
association of the GPI transamidase with signal peptidase, suggests 
association of the GPI transamidase with the translocon complex in the 
endoplasmic reticulum (ER) (Johnson and van Waes, 1999). The suggested 
colocation of these components is novel, but consistent with the known co-
translational addition of GPI anchors to nascent proteins in T. brucei 
(Ferguson et al., 1985). 
Table 3.15: List of proteins identified in Complex 164 – GPI associated complex 
Gene$ID$ GeneDB$Annotation$ BLAST$search$ Interpro$domain$search$
Tb927.1.4690$ arginine!N0methyltransferase!
(PRMT1)!
Histone0arginine!N0
methyltransferase!PRMT1!(7.7e085)!
0!
Tb927.10.12980$ Multisite0specific!tRNA:(cytosine0
C(5))0methyltransferase,!putative!
tRNA!(cytosine050)0
methyltransferase!NCL1!(1.5e038)!
NOL1/NOP2/sun!family!
(IPR001678,!9.2e021)!
Tb927.10.14750$ fibrillarin,!putative! rRNA!20X0methyltransferase!
fibrillarin!(2e0102)!
Fibrillarin!(IPR000692,!
6.7e0103)!
Tb927.10.1960$ hypothetical!protein,!conserved! 0! ARM!repeat!(IPR016024,!
1.5e013)!
Tb927.10.3560$ arginine!N0methyltransferase,!
putative!
Probable!protein!arginine!N0
methyltransferase!1!(4.8e037)!
0!
Tb927.10.7500$ fibrillarin!(NOP1)! rRNA!20X0methyltransferase!
fibrillarin!(4.2e0132)!
Fibrillarin!(IPR000692,!
2.2e0106)!
Tb927.8.3750$ Nucleolar!protein!56,!putative!
(NOP56)!
Nucleolar!protein!56!(2.1e0107)! Putative!snoRNA!binding!
domain!(IPR002687,!4.1e0
56)!
Tb927.8.900$ splicing!factor!TSR1!(TSR1)! Splicing!factor,!arginine/serine0rich!2!
(1.7e018)!
0!
Tb927.9.5320$ nucleolar!RNA!binding!protein,!
putative!
Nucleolar!protein!5802!(6.5e0100)! Putative!snoRNA!binding!
domain!(IPR002687,!1.6e0
52)!
Tb927.9.6870$ RNA0binding!protein,!putative!
(RBSR1)!
Probable!splicing!factor,!
arginine/serine0rich!6!(7.2e018)!
0!
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Figure 3.26: Elution profiles of components of predicted protein complexes with 
characterised functions across multiple forms of chromatography. LFQ intensity for 
each protein plotted across the fractionation range collected for mass spectrometry 
analysis. Molecular weight marker retention times on SEC300 and SEC1000 columns 
marked below the plot. 
 
 
 
Chapter 3: Mapping core protein complexes of Trypanosoma brucei 
 
 
!
!
88 
3.4.5 Co-chromatography complicates protein interaction prediction 
The last of these examples also illustrates the limitations of our methodology, which is 
ultimately dependent on co-chromatography of the component parts of protein 
complexes. This means that ambiguities are bound to arise when two or more 
complexes co-chromatograph. It would be expected from our knowledge of the function 
of the genes described above that complex 164 is found in the ER. However, we also 
detect proteins with similar elution profiles that are not expected to be resident ER 
proteins; an intraflagellar transport protein, an ISWI protein and an Ankyrin repeat 
protein with alpha/beta hydrolase activity. As we are fractionating whole cell lysates, 
that contain a very complicated mixture of protein complexes that originate from 
various sub-cellular compartments, such ambiguities are not surprising. Furthermore, 
the mixing of different subcellular compartments during whole cell lysis might also lead 
to non-native interactions between proteins and complexes that do not usually see each 
other. To reduce these complexities, it would be interesting to utilise subcellular 
fractionation techniques prior to fractionation of proteins in future studies. This would 
physically separate components that are in different compartments during 
chromatography and allow for better predictions of protein-protein interactions. Another 
beneficial side effect would be to increase the coverage of lower abundance proteins in 
different sub-cellular compartments. 
3.4.6 Comparison to other datasets 
Figure 3.19 reveals that scoring features derived from data produced from SEC300 and 
SEC1000 elution profiles, are more highly used than features derived from STRING, or 
a recently published T. brucei interactome, by the random forest predictors trained in 
this study. A number of factors account for this result. For example, some of the 
components of the proteasome that co-elute in our datasets are not annotated as 
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interacting partners in the STRING database (Tb927.11.8310 and Tb927.10.9740). 
Hence, only in our dataset could information be produced to confirm the association of 
these component parts of the proteasome, which are backed up by BLASTp homology 
to subunits in other organisms. Furthermore, the glycerol gradient experiments 
performed in (Gazestani et al., 2016), have a low number of protein groups identified 
(1,300 and 593 for whole cell and mitochondrial extracts, respectively).  A lower 
number of identified proteins means a lower number of potential gold standard positive 
interactors used to train the random forest algorithm, leading to a reduced use of these 
features to score interactions. 
This effect is also seen in the ion-exchange chromatography (IEX) experiments 
from the same publication. In this case, only 19 (cytosol extract) or 20 (mitochondrial 
extract) fractions are collected across the chromatographic run. A smaller number of 
fractions limits the ability to resolve separate protein elution peaks, increasing the 
chance of detecting co-eluting profiles and predicting false positive interactions. The 
distribution of Pearson correlation coefficients between all detected proteins in each 
datasets confirms this result. Comparison of the glycerol gradient and SEC experiments, 
where 48 to 50 fractions were collected, shows most proteins within each experiment 
have no correlation between elution profiles, with a small proportion showing high 
correlation. This is what would be expected, as most proteins do not interact with each 
other. Focusing on the cytosolic IEX experiment, we see that a lower proportion of 
elution profiles have no correlation, with a distinct peak of proteins showing very high 
correlation >0.8. This highlights the need for extensive, high resolution fractionation to 
be able to distinguish closely co-eluting protein complexes in PCP-MS studies. 
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3.4.7 Data visualisation 
We have made all of the processed data and predictions available to browse on a web 
server with a user friendly interface developed by Dr Michele Tinti 
(http://134.36.66.166:8083/complex_explorer), which will allow other researchers to 
explore and interrogate our predicted complexes and elution profiles. There are three 
distinct applications with which to browse the data: 
 The “Complex Explorer” (Figure 3.27) is a dynamic browser of the high-
confidence predictions of protein complexes derived from machine learning of 
exhaustive pairwise comparisons of all protein elution profiles, matching the data 
presented in Figure 3.21 and Supplementary Table 2. Each cluster is displayed as a 
network of interconnected nodes (protein groups) with the lines between the nodes 
indicating evidence of pairwise associations. The stringency (cutting threshold) for the 
associations can be varied with a slider below the browser and the cluster browser can 
be queried to highlight individual protein groups and cluster numbers. Mousing over the 
nodes brings up their GO-terms within a word cloud of the GO-terms for the other 
nodes in the complex, which can give a general impression of possible cluster function. 
The dynamic browser can be adjusted through ‘settings’ to highlight any or all of those: 
Nodes with human homologues. Nodes identified as essential in cell culture (Alsford et 
al., 2011). Nodes that were used as ‘gold-standards’ for the machine-learning. Clusters 
which agree with homologous associations in the STRING database (using a relatively 
high combined STRING score threshold value of >950). Clusters that are inter-related 
by the same STRING associations. Clusters predicted by those STRING associations 
alone. Nodes which appear in more than one cluster. Clicking on any node in a cluster 
brings up a table of the protein group components, alongside the SEC300, SEC1000 and 
SAX chromatograms for those protein groups. The chromatograms are dynamic and can 
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be expanded in the x- (time) axis and display either raw LFQ or normalised LFQ 
intensity data on the y-axis. Further, the colour-coded elution profiles of individual 
protein groups can be switched on or off by double-clicking on the gene IDs below the 
chromatograms. Below the dynamic cluster browser is a table of all the nodes in the 
browser, which can be searched in various ways and downloaded by the user for other 
applications.   
The second application, “Profile Explorer” (Figure 3.28) allows exploration of 
protein-protein associations based on the machine learning predictions. The application 
allows the input of a list of up to twenty TriTrypDB geneIDs, and outputs the predicted 
interactions between them and the associated fractionation data in any of the SEC300, 
SEC1000 and SAX datasets, as well as in the density gradient and ion exchange 
fractionations recently published in (Gazestani et al., 2016).  
 The “Cluster Explorer” (Figure 3.29) application allows exploration of putative 
protein-protein associations based purely on hierarchical clustering of the protein 
elution profiles from SEC300, SEC1000 and SAX chromatography (Figure 3.14). These 
are lower confidence predictions of protein-protein associations than those based on 
machine learning but they allow the user to ask whether there is any evidence for the 
possible association of two or more proteins by co-chromatography. Thus, the 
application allows the input of a list of up to twenty TriTrypDB geneIDs, and outputs 
graphs showing which hierarchical clusters they belong to. From there, selecting the 
cluster number will display the relevant chromatogram. 
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Figure 3.27: Data visualisation tools - Complex Explorer. As described in Section 3.4.7, allows browsing of our predictions of protein complexes from 
machine learning analysis detailed in Supplementary Table 2.
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Figure 3.28: Data visualisation tools - Profile Explorer. As described in Section 3.4.7. 
allows users to search all data produced to compare elution profiles for any protein 
detected to assess their potential interaction. 
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Figure 3.29: Data visualisation tools - Cluster Explorer. As described in Section 3.4.7, 
allows browsing for any protein detected in SEC300, SEC100 or SAX experiments and 
identify proteins with similar elution patterns, as identified by hierarchical clustering 
(Figure 3.14). 
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3.4.8 Initial development of cross-linking methodologies 
Initial studies optimising in vivo crosslinking with formaldehyde and 
dithiobis(succinimidyl propionate) (DSP) indicate that different cross-linkers have 
differing effects in crosslinking distinct protein complexes. Even at the lowest 
concentration of DSP tested (0.125 mM), a lot of high-molecular weight protein at the 
top of the gel is observed, potentially indicating over-crosslinking. Formaldehyde shows 
a similar effect above concentrations of 2%, under the conditions utilised. 
Western blotting for enolase shows that DSP stabilises a putative dimeric form 
of the protein up to concentrations of 1 mM, followed by an increase in high-molecular 
weight material. In contrast, under all formaldehyde concentrations utilised, the 
monomeric 47 kDa is the predominant form of enolase, with a faint dimeric band and 
high molecular weight forms above concentrations of 2%. In contrast, tubulin is almost 
undetectable when cross-linked with DSP, and a clear dimeric band is seen when 
utilising formaldehyde. Differing effects of cross-linking between individual proteins is 
likely due to the chemistries and structure of the cross-linkers. DSP is able to cross-link 
primary amines of different proteins across a distance of 12 Å, while the reactivity of 
formaldehyde is more complex. Formaldehyde can cross-link over a range of distances 
through the formation of polymeric para-formaldehyde, and reacts with a range of 
protein moieties. It is therefore likely that different complexes will require different 
cross-linkers at different concentrations to optimally stabilise physiologically relevant 
forms of the protein. Analysis of the 215 nm chromatograms from SEC of 
formaldehyde cross-linked lysates shows that high molecular weight proteins are 
stabilised at concentrations of formaldehyde above 3%. 
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3.4.9 Summary 
To summarise, a major benefit of utilising a PCP-MS approach for proteomic analysis is 
that we produce information not just on protein abundance, but on protein interaction 
too, in a high-throughput and unbiased manner. This adds an extra dimension to the data 
we can extract on individual protein behaviour from a single proteomic experiment. It 
will be exciting to apply this approach to compare different biological samples, such as 
the comparison of different life-cycle stages or the effect of different drug-treatments. 
With the increasing ability for automation in sample preparation for chromatography (as 
demonstrated for SAX methodology reported here), and mass spectrometry, future 
studies should allow the quick production of more data looking at such effects on core 
protein complexes. 
3.5 Distribution of work 
The experimental design for the work in the chapter was devised with discussion and 
the advice of Dr Mark Larance. I performed all of the wet lab experiments, from cell 
culture to mass spectrometry data processing. The development of the machine learning 
pipeline for the prediction of protein complexes, all data analysis and development of 
data visualisation tools in this chapter was performed by Dr Michele Tinti, in discussion 
with myself and Professor Michael Ferguson. 
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Chapter 4: Proteomic analysis of the 
cell-division-cycle of Trypanosoma brucei 
4.1 Introduction 
In this chapter I will describe methods for producing populations of synchronous 
G1-phase procyclic form (PCF) T. brucei at a scale amenable for proteomic analysis, 
without the use of chemical agents to synchronise the cells, and the optimisation of 
mass spectrometry for protein quantitation employing 10-plex Tandem Mass Tag 
(TMT) technology. Our aim was to use these methods to characterise the cell-cycle 
regulated proteome of T. brucei, in a drug-free system, to produce data that might 
provide functional evidence for many uncharacterised proteins. 
Previous transcriptomic analysis of the cell-cycle in T. brucei uncovered novel 
biological components of cell-division, unique to trypanosomatids, hence identifying 
highly attractive drug targets (Akiyoshi and Gull, 2014; Archer et al., 2011). The 
proteomic analysis carried out in this chapter should complement these transcriptomic 
data and further contribute to our understanding of cell-cycle control in trypanosomes. I 
have quantified the relative abundance of 5,034 proteins in PCF T. brucei across nine 
time-points of cell division, in all three biological replicates. From the results, I 
identified known cell-cycle regulators and describe cell-cycle regulated patterns of 
expression for 218 ‘hypothetical’ proteins, 57 of which are thought to be essential for 
parasite survival in culture, and may be interesting future candidates as drug targets. 
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4.2 Aims and hypothesis 
Our hypotheses were that: 
•! We could identify key proteins involved in the regulation of cell division of 
T. brucei through the identification of proteins with high fold-changes across the 
cell-cycle. 
•! The identification of cell-cycle regulated patterns of protein expression could 
help to elucidate the biological function of ‘hypothetical’ proteins. 
•! We might identify novel drug targets through the identification of cell-cycle 
regulated ‘hypothetical’ proteins that have been classified as essential for growth 
in culture from RNA interference target sequencing (RITseq) studies. 
Our aims were to: 
•! Adapt published methods for elutriation of PCF trypanosomes to a scale 
appropriate for proteomic analysis. 
•! Optimise methods for isobaric mass tag based proteomic quantitation, to carry 
out quantitative analysis across nine time-points of the T. brucei cell-cycle. 
•! Identify novel and essential proteins involved in the cell-cycle of 
trypanosomatids by cross-comparing our data to RITseq studies. 
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4.3 Results 
4.3.1 Counterflow centrifugal elutriation  
 ‘Direct’ counterflow centrifugal elutriation (Figure 4.1) was used to attempt to enrich 
for cells in G1, S, or G2&M phases of the cell-cycle. Fractions were collected by 
gradually increasing flow rates, and were analysed by flow cytometry to determine the 
cell"cycle distribution of collected populations (Figure 4.2). The maximum enrichment 
in any fraction collected for G1, S or G2&M"phase cells was 93%, 34% and 52% 
respectively (Table 4.1). Since the enrichment of S and G2&M-phase cells were 
relatively low, I chose instead to start from a G1-phase enriched (synchronised) 
population of cells and follow these in time to obtain S and G2&M-phase cells. Two 
methods were compared to produce a synchronised cell population. Single"cut 
elutriation splits an asynchronous culture into ‘large’ and ‘small’ cells. The small cells, 
enriched in G1"phase, are taken as the synchronous population (Figure 4.3). Double"cut 
elutriation (Archer et al., 2011) involves taking the large cell population, and culturing 
for 1"2 h before a second round of elutriation, where small, newly divided cells, are 
taken as the synchronous population (Figure 4.4). In both cases, aliquots were taken 
over an 11!h time"course for flow cytometry analysis. The maximum enrichment for G1, 
S and G2&M"phase cells was 88%, 53% and 61% using the single"cut method and 83%, 
63% and 68% using the double"cut method (Table 4.1). Since the G1 cell enrichment 
was similar and since, single-cut elutriation returns 20% of the original culture while 
double"cut elutriation reduces this to about 5%, single-cut enrichment was utilised for 
all further studies. 
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Figure 4.1: General principle of counterflow centrifugal elutriation. (A) An 
asynchronous culture of cells is loaded into an elutriation chamber. (B) At a constant 
centrifugal force and counter-flow of buffer a size gradient of cells forms, with small 
cells at the front of the chamber and large cells at the back of the chamber. (C) By 
gradually increasing the counter-flow rate of buffer smaller cells elute first followed by 
larger cells. Figure reproduced from (Banfalvi, 2008). 
!
Figure 4.2: Direct counterflow centrifugal elutriation of trypanosomes. Fractions of 
PCF trypanosomes (small to large) were collected by gradually increasing the flow rate. 
Thirteen fractions were collected, and flow cytometry profiles of DNA content 
(propidium iodide fluorescence) were used to analyse the proportions of G1, S and 
G2&M-phase cells (bottom left panel). The distributions of cells in G1, S and G2&M-
phase, in an asynchronous population of cells (Async) and the collected fractions are 
shown in the bottom right panel. 
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Figure 4.3: Single-cut elutriation method. Very small (G1-phase) cells were enriched 
from asynchronous cultures by elutriation (top panel) and these were used to seed 
synchronised cultures that were sampled at the times indicated for flow cytometry 
analysis (lower panels). Maximum enrichment for G1, S and G2&M-phase cells were 
obtained at t = 0, 7 and 11 h, respectively. 
!
!
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Figure 4.4: Double-cut elutriation method. Very small (G1-phase) cells were depleted 
from asynchronous cultures by elutriation (top panel) then cultured for 2-3 h and 
subjected to a second round of elutriation (middle panel) to obtain only newly divided 
small (G1-phase) cells to seed synchronized cultures. Maximum enrichment of G1, S 
and G2&M-phase cells were obtained at t = 0, 6 and 10 h respectively. 
Cell"cycle!phase! Direct! Single"cut! Double"cut!
G1# 93%! 88%! 83%!
S# 34%! 53%! 63%!
G2&M# 52%! 61%! 68%!
Table 4.1: Maximum enrichments achieved for each cell-cycle population using either 
direct, single-cut or double-cut elutriation, as measured by flow cytometry. 
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4.3.2 Experimental design and chromatography of TMT labeled peptides 
Three biological replicates of single-cut elutriation were performed, collecting nine 
time-points across 11 h in each case. TMT 10-plex technology was used to measure the 
relative abundance of proteins across the time-course (Figure 4.5). The chemical 
labelling of peptides with TMT increases the hydrophobicity of the peptides in question. 
I therefore adapted and optimised the gradients between aqueous and organic buffer 
across the off-line reverse-phase HPLC chromatographic run to produce an even elution 
of TMT labeled peptides (Figure 4.6). A shallow gradient of 35-60% acetonitrile 
containing buffer, followed by a sharp increase to 100% produced the most even elution 
pattern, based on the 215 nm absorbance profile. 
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Figure 4.5: Workflow for Tandem Mass Tag (TMT) based quantitation of the cell-cycle regulated T. brucei proteome. Nine time-points were collected 
and prepared as indicated following the seeding of a synchronised culture with G1-phase enriched parasites from single-cut elutriation. The peptides 
from all time-points were mixed together after TMT labelling, fractionated into twenty-four fractions using high-pH reverse phase chromatography and 
analysed by LC-MS. A Fusion mass spectrometer using the MultiNotch SPS MS3 method (McAlister et al., 2014) was utilised for quantitation. 
Chapter 4: Proteomic analysis of the cell-division-cycle of Trypanosoma brucei 
 
 
 
!
105 
!
Figure 4.6: Optimisation of high-pH reverse phase fractionation of TMT labelled 
peptides. The 215 nm chromatogram of unlabeled and TMT-labelled peptides run on the 
same gradient are shown in black and blue, respectively. The chromatograms of the 
TMT labelled peptides with varying starting concentrations of acetonitrile are shown in 
pink, brown and green.  
4.3.3 Optimising TMT quantitation 
To develop a system to be able to analyse the precision and accuracy of TMT 
quantitation, and to determine the associated effects of ratio compression, I took 
advantage of a previously published experimental design (McAlister et al., 2014). 
Human peptides were labelled with six-plex TMT reagents that generate reporter ions at 
m/z 126, 127, 128, 129, 130 and 131, and mixed these in a ratio of 50:20:5:5:20:50 µg, 
respectively.  Trypanosome peptides were labelled with TMT reagents 126, 127 and 
128 and mixed at a ratio of 50:50:50 µg, and added to the human peptide mix. With this 
design, the quantification of human peptide ratios using the 129, 130 and 131 TMT  
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Figure 4.7: Experimental design for assessing TMT quantitation accuracy and 
precision. Human peptides and trypanosome peptides were labelled with the TMT 
reporters and mixed in the proportions indicated on the left. In the ideal situation, with 
no co-isolation and interference, the ratios between 126, 127 and 128 m/z should equal 
the 129, 130 and 131 m/z ratios (top right). However, if trypanosome peptides are 
co-isolated they will compress the ratios between 126, 127 and 128 m/z, but have no 
effect on the 129, 130 and 131 m/z ratios (bottom right). Figure adapted from (Ting et al., 
2011). 
reporter ions will be uncompressed, whereas the 126, 127 and 128 TMT reporter ions 
will demonstrate effects of interference if trypanosome peptides are co-isolated with 
human peptides, leading to compression of the ratios measured (Figure 4.7). For the two 
sets of compressed and uncompressed reporter ions there are three expected ratio 
measurements: 126/128 or 131/129 as a ratio of 10-fold; 127/128 and 130/129 as a ratio 
of 4-fold; and 126/127 or 131/130 as ratio of 2.5-fold. This set-up was utilised to test 
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the effects on compression of a variety of parameters on QExactive+ and Fusion mass 
spectrometers. 
Decreasing the isolation width used to select target precursor ions for 
fragmentation on a QExactive+ instrument from 4.0 to 1.5 and 0.4 m/z resulted in more 
accurate quantification of peptide spectral matches (psms) from compressed reporter 
channels, with an expected 10:1 ratio quantified as 2.8±0.9, 3.4±1.1 and 4.1±1.4, 
respectively. This equates to a 3.5-fold, 2.9-fold and a 2.4-fold compression, 
respectively. An increased number of psms is also detected, from 2,754 at 4.0 m/z, to 
3,327 at 1.5 m/z and 3,422 at 0.4 m/z (Figure 4.8). It was not possible to detect a 
measurable difference between the compressed 4-fold and 2.5-fold ratios at any of the 
isolation widths tested. All uncompressed ratios were calculated within one unit of their 
expected values. An expanded set of isolation widths (0.4, 0.7, 1.0, 1.5, 2.0, 3.0 and 4.0 
m/z) tested on a QExactive+ instrument is displayed in Supplementary Figure 1 in the 
Appendix. 
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Figure 4.8: Effect of isolation width on TMT quantitation on a QExactive+. Dashed 
lines indicate the expected ratio in each facet. The key shows the isolation width used in 
each method together with N, the number of peptide spectral matches (psms) quantified 
in each method, and the percentage of psms identified that are modified with TMT, 
identified in all six TMT reporter channels and pass the intensity threshold of 100,000. 
Data obtained on a Fusion mass spectrometer indicated high levels of inaccuracy 
in quantitation of ratios at lower total TMT reporter ion intensities (Figure 4.9). Many 
psms quantified with an expected 10-fold ratio, were detected as >20-fold ratios. To 
exclude these imprecise ratios an intensity threshold of 100,000 units was implemented 
for all data acquired in this set of samples. Following filtering of the psms by intensity, 
most methods on the Fusion produced similar distributions of compressed ratios, 
ranging from 7.5±2.2 to 6.8±2.1 for an expected ratio of 10:1, equating to 1.3 and 1.5-
fold compression. 
Using an initial default method provided from the mass spectrometer 
manufacturer (‘Thermo’) I tested the effects of: increasing the maximum injection time 
(maxIT) for MS3 ion accumulation from 105 ms to 300 ms (‘300 ms scan’); modifying 
the isolation width for target ion selection from 0.8 to 1.6 m/z (‘1.6 m/z’); and increased 
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the amount of peptide loaded from 1 to 2 µg (‘2 µg’) per run (Figure 4.10). To 
demonstrate the sequential effects of modifying the default ‘Thermo’ method in the 
parameters described above, a sub-set of experiments carried out are shown, 
highlighting the key effect from modifying each parameter. More extensive results are 
described in the Appendix and Supplementary Figures 2-5, showing a wider range of 
settings tested for isolation width and peptide load. 
Only 30.7% of psms identified using the original default method passed the 
intensity threshold of 100,000. Increasing the maxIT for the MS3 scan to 300 ms led to 
a decrease in the number of identified psms, but an increase in identified and quantified 
psms, as 61.8% now passed the intensity filter. Further sequential modification of the 
300 ms method by increasing the isolation window of the MS1 to MS2 scan from 0.8 to 
1.6 m/z also increases the number of psms passing the intensity filter to >80%, as did 
increasing peptide load to 2 µg (Figure 4.11). I therefore utilised a 300 ms maxIT and 
1.6 m/z mass spectrometry method with ~2 µg peptide load for analysis of the T. brucei 
cell-cycle regulated proteome. 
In a second set of experiments with a mixture of mouse and trypanosome 
peptides a number of other parameters on quantitation were tested, including the 
number of SPS notches used to select fragment ions for quantitation; a titration of the 
Automatic Gain Control target; a titration of maxIT; and tested software allowing for 
separate isolation widths for MS2 and MS3 scans. The results of these variations are 
described in the Appendix and Supplementary Figures 6-11. 
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Figure 4.9: The use of an intensity filter to exclude inaccurate ratios. Scatter plots of the 
total TMT reporter intensity for a psm and the calculated compressed ratio 
(126/128 m/z) and uncompressed ratio (131:129 m/z) on a QExactive+ (left) and Fusion 
(right). Dashed green line shows the expected 10:1 ratio and the full green line shows 
the intensity filter of 100,000 implemented to remove inaccurate ratios calculated at low 
reporter intensities. 
!
Figure 4.10: TMT quantitation on a Fusion mass spectrometer using different methods. 
The key shows method used together with N, the number of peptide spectral matches 
(psms) quantified in each method and the percentage of psms identified that are 
modified with TMT, identified in all six TMT reporter channels and pass the intensity 
threshold of 100,000.  
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Figure 4.11: Number of psms identified and quantified across different Fusion methods. 
Transparent bar shows the number of psms identified in each method, and filled bar 
shows the number of identified psms that are TMT modified, quantified in all six TMT 
channels and pass the intensity filter of 100,000. The key shows the number of peptides 
quantified (N) and the percentage of psms identified that are quantified. 
4.3.3 Cell-cycle regulated proteome 
Following digestion of proteins to peptides, TMT labelling and mixing of time-points, 
each of the three biological replicates were separated by high-pH reverse phase 
fractionation into twenty-four fractions. Each fraction was run on a Fusion mass 
spectrometer using a 300 ms maxIT and 1.6 m/z isolation width in triplicate. A total of 
45,777 peptide sequences were identified corresponding to 6,356 protein groups, with 
5,034 detected and quantified across all nine time-points in all three biological 
replicates with ≥1 unique peptide. Protein levels were normalised by setting the 
maximum reporter intensity for a particular protein to 1.  
 To determine if there is more variation across a time-course than between 
biological replicates an Analysis of Variance (ANOVA) was performed on protein 
groups detected across all three biological replicates. Of the 5,034 protein groups 
quantified, 2,215 had p-values <0.05, indicating a statistically significant difference in 
Chapter 4: Proteomic analysis of the cell-division-cycle of Trypanosoma brucei 
 
 
 
!
112 
their measurement across the time-course, compared to within time-points across 
biological replicates; 166 of these proteins have a maximum fold-change >1.5, and 396 
are >1.3 fold (Figure 4.12). 
!
Figure 4.12: Scatter plot of maximum fold-change across the cell-cycle and ANOVA 
p-value. Dashed lines show a p-value of 0.05 and a maximum fold change of 1.3. Of 
5,034 proteins detected, 396 (blue dots) can be classified as cell-cycle regulated with a 
fold change ≥1.3 and p-value ≤0.05. 
  The 2,215 protein groups were hierarchically clustered into ten groups 
classifying distinct patterns of cell-cycle regulation (Figure 4.13). Clusters were named 
based on the temporal expression patterns of proteins and cross-referencing to the flow 
cytometry profiles of collected samples (Figure 4.3). 1,787 proteins were classified as 
“Unchanging”, 210 as “G2&M”, 110 as “G1/early S”, 52 as “early G1”, 20 as “high 
G2&M”, 16 as “high S”, 13 as “high early G1”, 2 as “high G1”, 4 as “high early S” and 
1 as “early G1/late G2&M”, with “high” indicating clusters of proteins with larger 
fold-changes (Supplementary Table 4). Selected gene ontology (GO) terms enriched 
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within each cluster are displayed in the appropriate panels in Figure 4.13. 
 To display the data, I have produced radial visualisation plots where time-points 
are hours on the clock-face and proteins are plotted towards the time-point they are most 
abundantly detected in. A number of known regulators of the cell-cycle in T. brucei are 
upregulated at time-points that correlate well with their biological function (Figure 
4.14). Thirty-eight proteins annotated with GO terms associated with the cell-cycle are 
detected; 24 in the “Unchanging” cluster and 14 in the remaining 9 clusters with 
patterns of cell-cycle regulation (Figure 4.15). By cross-comparison to RNA interfering 
target sequencing (RITseq) datasets it was determined that 287 of the 428 proteins in 
cell-cycle regulated clusters are essential for growth in one or more lifecycle stage of 
T. brucei in culture (Alsford et al., 2011). Of these, 57 are annotated as ‘hypothetical’ 
proteins (Figure 4.16). These data are also available to browse on an interactive html 
file (https://uod.box.com/v/cellcycle). 
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Figure 4.13: Hierarchical clustering. 2,215 proteins with a p-value ≤0.05 were hierarchically clustered into ten clusters. Heat-map of clustered 
normalised elution profiles on left panel. Right panel shows line-plots of proteins within each cluster. GO terms enriched in each cluster are annotated 
in line-plots. The colours of dendrogram branches match colours of the respective line-plots. 
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Figure 4.14: Radial visualisation plot of clusters and known cell-cycle regulated 
proteins. Each time-point is depicted as an hour on a clock-face. Coloured arrows are 
representative of the cell-cycle phase at each time-point. Proteins are pulled towards the 
time-point they are most abundantly expressed in. Dot colour refers to the cluster the 
protein is detected in (Figure 4.13). Proteins known to be involved in cell-cycle 
regulation are annotated. 
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Figure 4.15: Many proteins detected as cell-cycle regulated lack cell-cycle GO 
annotation. Proteins in blue are annotated with a GO term associated with the cell-cycle, 
red proteins have no detectable cell-cycle GO term association. 
!
Figure 4.16: Radial visualization plot of ‘hypothetical’ proteins with an essential 
phenotype. Proteins displayed are annotated as ‘hypothetical’ and are essential for 
growth of one or more life-cycle stages in RITseq studies. Proteins at further edges of 
the plot are highly cell-cycle regulated, and their essentiality may be due to a cell-cycle 
function. 
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4.3.4 Comparison to transcriptomic dataset 
We determined the overlap of proteins detected in our dataset to transcripts detected in a 
previously published transcriptome analysis of the cell-cycle of PCF trypanosomes 
(Figure 4.17)(Archer et al., 2011). Of the 5,034 proteins quantified in this work, 93% 
are detected in the transcriptomic dataset. Conversely 67% of the 6,948 transcripts 
identified are identified in the proteomic dataset. Proteomic and transcriptomic analyses 
classify 428 or 544 proteins/transcripts as regulated across the cell-cycle, respectively, a 
total of 887 unique transcripts/proteins. Of these, only 85 are classified as regulated in 
both datasets (Supplementary Table 5), while 302 (proteome, Supplementary Table 6) 
and 374 (transcriptome, Supplementary Table 7) are identified in both datasets, though 
only changing in one, and 41 (proteome, Supplementary Table 8) and 185 
(transcriptome, Supplementary Table 9) are only identified in one dataset. GO 
enrichment analysis of each of these classes of transcripts/proteins was performed 
(Figure 4.18). From the 85 transcripts/proteins identified as changing in both 
transcriptomic and proteomic analyses, I produced a contingency table to assess how 
well the classification of cell-cycle phases associated with each transcript/protein 
matched between each dataset (Table 4.2). Early and late G1-phase classified transcripts 
from (Archer et al., 2011) were grouped to produce the G1-phase set of genes from 
transcriptomic data. 
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Figure 4.17: Overlap of proteomic and transcriptomic cell-cycle datasets. Large, lighter 
coloured circles depict transcript/protein IDs identified in either proteomic (red) or 
transcriptomic (green) datasets (Archer et al., 2011). Small, darker coloured circles depict 
those transcripts/proteins classed as cell-cycle regulated. (a) Regulated 
transcripts/proteins in common. (b) Identified in both datasets but only regulated in 
proteomic dataset. (c) Changing proteins uniquely identified by proteomics. (d) 
Identified in both datasets but only regulated in transcriptomic dataset. (e) Changing 
transcripts uniquely identified by transcriptomics 
! G1!$!proteome!
S!$!
proteome!
G2&M!$!
proteome!
total!
transcripts!
G1!$!transcriptome! 29! 12! 11! 52!
S!$!transcriptome! 3! 2! 18! 23!
G2&M!$!
transcriptome! 2! 0! 8! 10!
total!proteins! 34! 14! 37! 85!
Table 4.2: Contingency table of peak expression time-points for genes/proteins 
identified as cell-cycle regulated in both transcriptomic and proteomic datasets. 
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Figure 4.18: Gene ontology enrichment for the transcript/protein categories described in 
Figure 4.17. Dot sizes representative of the –log(p-value) associated with each GO term. 
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4.4 Discussion 
I have optimised methods for centrifugal elutriation to produce synchronous G1-phase 
PCF trypanosome cell populations, without the aid of chemical agents, and methods for 
quantitation of TMT reporter ions on a Fusion mass spectrometer. Together, this has 
allowed us to quantify the relative abundance of 5,034 proteins in PCF trypanosomes 
across the cell-cycle, a useful resource that will contribute to our understanding of cell 
division in this parasite. Hierarchical clustering was used to classify patterns of 
temporal regulation, which allowed the identification of uncharacterised proteins 
upregulated in different phases of cell division, highlighting their potential functions. A 
number of known cell-cycle regulators in trypanosomes were detected, and a number of 
novel, essential, cell-cycle regulated proteins which are promising future drug targets 
were identified. 
4.4.1 Comparison of elutriation methods 
Using elutriation to directly enrich for different cell-cycle phases works well for G16
cells, (93% enrichment) however there does not appear to be enough of a size difference 
to fully separate S6phase and G2&M6phase cells (34 and 52% maximum enrichment, 
Table 4.1). Better results were obtained by seeding synchronised cultures with G1-phase 
cells. Of these, double-cut elutriation provides an extremely effective method to 
produce synchronous G1 cells as previously described (Archer et al., 2011). However, 
the single6cut method described here produced very similar results while providing a 
higher yield of G1-phase cells, which is beneficial for high proteomic coverage to 
capture low abundant proteins. 
 Single-cut elutriation compares well to other methods to produce populations 
enriched in different cell-cycle phases. It is possible to sort cells by flow cytometry 
based on DNA content either on live or fixed cells for proteomic analysis (Kabani et al., 
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2010). However, to produce ~200-400 µg of protein per sample requires ~1 x 108 
trypanosome cells, which would require very long sorting times using flow cytometry, 
especially for S-phase cells that constitute ~15% of asynchronous cultures. Other 
methods include drug treatments to synchronise cells, such as hydroxyurea treatment 
(Chowdhury et al., 2008; Forsythe et al., 2009), or starvation through removal of serum 
from culture (Gale et al., 1994). Although these are much simpler methods than 
elutriation, it has been shown to lead to the proteomic analysis of cell-cycle arrest rather 
than physiological cell-cycle regulation (Ly et al., 2015). 
4.4.2 Comparison of methods for protein quantitation 
To quantify cell-cycle regulated changes of the T. brucei proteome across nine time-
points over 11 h I decided to use ten-plex TMT technology (Figure 4.5). For this study, 
the ability to quantify ten samples in a single mass spectrometry run dramatically 
reduced the amount of continuous instrument time required from ~5 months to just over 
two weeks in comparison to an equivalent label free experiment. This technique also 
eliminates the “missing value problem” that affects label free quantitation, as 
quantitative data from all nine time-points are detected in a single mass spectrometry 
scan as opposed to from multiple separate scan events from different samples in a label 
free set-up. 
 However, one of the major drawbacks of using isobaric tagging technology such 
as TMT for quantitative proteomics is the effect of interference. Interference occurs 
when peptides with a similar retention time and a similar m/z are co-isolated when 
selecting a target ion for quantitation. Quantitative information is therefore produced 
from btoh the target ion and the co-isolated contaminant ions, which distorts the 
quantitation of the target. As most peptides do not differ in abundance across most 
biological conditions, the global effect of this is to compress the measured ratios of 
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peptides which are changing. To lessen the effect of interference I tested the use of very 
narrow isolation widths on QExactive+ mass spectrometers and determined optimal 
parameters on a Fusion mass spectrometer, which can perform a function known as 
synchronous precursor selection (SPS). SPS is used to select up to ten fragment ions 
from the initial target ion for a third MS scan for quantitation, reducing the likelihood of 
co-isolating contaminant ions. 
 Narrowing the isolation width on a QExactive+ instrument from 4.0 to 1.5 and 
0.4 m/z reduced the effect of ratio compression (Figure 4.8). It may be expected that 
narrowing isolation widths too much would lead to a reduced number of peptides being 
identified due to lower signal intensity, and hence poorer quality MS2 identification 
scans. However, an increasing number of psms is observed by decreasing the isolation 
width from 1.5 m/z (3,327) to 0.4 m/z (3,422). These results indicate that if samples are 
being quantified on a QExactive+ mass spectrometer then lower isolation widths reduce 
the effects of compression without a hit on numbers of psms identified. Unfortunately, 
even using a very narrow isolation width of 0.4 m/z, interference still causes dramatic 
effects of ratio compression, with a 2.4-fold compression for a 10:1 ratio, 2-fold for a 
4:1 ratio and 1.25-fold for a 2.5:1 ratio. 
  The use of the SPS-MS3 method using a Fusion mass spectrometer reduces ratio 
compression significantly (Figure 4.10). A caveat for this method is that at low reporter 
ion intensities, inaccurate ratios are calculated (Figure 4.9). Implementing an intensity 
filter on identified psms improves the accuracy of quantification, though leads to a large 
drop in the number of psms utilised in quantification – 1,119 in the case of the original 
manufacturer method (30.7% of psms identified), 3-fold lower than detected on the 
QExactive+. Increasing the amount of material available for the quantitation scan 
improved the proportion of psms quantified. This was achieved by: increasing the 
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maxIT for the quantitative MS3 scan to 300 ms, allowing a longer period of time for 
lower abundance ions to accumulate; increasing the isolation width for target ion 
selection to 1.5 m/z from 0.8 m/z; and simply by injecting >2 µg of peptide per run 
(Figure 4.11). Together these measures boosted the number of quantified psms to 2,434, 
90.6% of those identified and only 1.3 fold lower than the number detected on the 
QExactive+ system. 
4.4.3 Identification of known cell-cycle regulated proteins 
Of the 5,034 protein groups identified and quantified across the cell-cycle of PCF 
T. brucei, 2,155 have an ANOVA p-value <0.05 indicating a statistically significant 
change in abundance across the time-course. We classify 396 of these as being 
cell-cycle regulated, with a fold change >1.3. Proteins with a fold-change >3 across the 
cell-cycle include a mixture of hypothetical proteins of unknown function, proteins with 
a putative gene annotation and several proteins known to be cell-cycle regulated 
(Figure 4.12).  
Of the proteins with prior evidence of cell-cycle regulation, increases in 
expression are detected at the expected time-points (Figures 4.12 and 4.14). Upregulated 
at the 5 h time-point, between G1 and S-phase, CRK2 is detected (a cdc2 related 
kinase), depletion of which results in a G1-phase block in T. brucei (Tu and Wang, 
2004; 2005). PIF1, a DNA helicase necessary for kinetoplast DNA replication in early 
S-phase (Liu et al., 2009), is detected between the 5 and 6 h time-points, and thymidine 
kinase upregulated between 6 and 7 h, necessary for genomic DNA replication (Valente 
et al., 2016). Many of the proteins upregulated between 8 and 9 h are well annotated 
with ascribed G2&M-phase functions and include components of the chromosomal 
passenger complex (AUK1, CPC1 and KIN-A)(Li et al., 2008a; 2008b; Tu et al., 2006), 
another cdc2-related kinase (CRK3)(Tu and Wang, 2004), motor proteins involved in 
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spindle assembly (Mlp2 and KIF13)(Chan and Ersfeld, 2010; Holden et al., 2014; 
Morelle et al., 2015; Wickstead et al., 2010) and multiple kinetochore proteins 
(KKTs)(Akiyoshi and Gull, 2014). Finally, DOT1B is upregulated late in G2&M-phase 
and into G1-phase, a histone methyltransferase known to modify chromatin as cells exit 
mitosis, and necessary for cell division during differentiation from BSF to PCF (Dejung 
et al., 2016; Janzen et al., 2006). 
4.4.4 Classification of temporal patterns of protein abundance 
We have grouped the protein abundance profiles detected in this dataset into ten clusters 
with distinct patterns of regulation across the collected time-course (Figure 4.13). As 
expected, 80% of proteins (1,787) with an ANOVA p-value <0.05 do not have a strong 
pattern of regulation across the cell-cycle. Of the remaining nine clusters we see two 
clusters for proteins peaking in G2&M phase of the cell-cycle; three clusters each for 
proteins peaking in S-phase or G1; and a single cluster with one protein (DRBD17) 
downregulated in S-phase and upregulated in G1 and late G2&M. In total, this classifies 
428 genes in clusters with patterns of cell-cycle regulated expression (Supplementary 
Table 4). We observe GO terms enriched in cell-cycle phases where we would expect 
them to be associated with. For example, both G2&M-phase clusters are associated with 
GO terms such as ‘M-phase’, ‘spindle assembly’, ‘chromosome segregation’ and 
‘mitotic cell-cycle’. This result provides strength to the idea that we can begin to 
associate proteins of unknown function with roles in particular cell-cycle phases based 
on their clustering. To this end, 23 ‘hypothetical’ proteins are observed within G1-phase 
clusters, 71 in S-phase clusters and 124 in G2&M-phase clusters, indicating potential 
roles for these proteins in these distinct stages of cell division. Moreover, due to the 
‘high-resolution’ temporal profile it is possible to distinguish between regulation of 
proteins involved in kinetoplast DNA replication (high early S) and nuclear genomic 
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DNA replication (high S), for example, identifying the mitochondrial helicase PIF1 
upregulated in early S phase. 
Surprisingly, the majority of proteins with a described cell-cycle GO term are 
found in our “Unchanging” cluster (Figure 4.15). If a protein performs a role during the 
cell-cycle we would expect a cell-cycle specific pattern of regulation, though this does 
not necessarily have to occur at the level of protein abundance. The unchanging, cell-
cycle GO associated proteins, may therefore be regulated at the level of post-
translational modification, or through modification of interaction partners or sub-
cellular localisation, where protein abundance would remain relatively constant. 
Another explanation could be that the peptides used to quantify these proteins may be 
suffering effects of interference, leading to ratio compression, masking real changes in 
quantified protein abundance. 
4.4.5 Comparative analysis of the cell-cycle regulated transcriptome and proteome 
A comparison of a previously published transcriptomic cell-cycle study in PCF 
T. brucei (Archer et al., 2011) to our proteomic dataset highlights that transcriptomic 
analysis reached a much greater depth, identifying 93% of the proteins identified here, 
whereas we identified 67% of the transcripts identified. Both studies classify a similar 
number of genes as cell-cycle regulated, with 544 identified from transcriptomics and 
428 identified in this study. However, there is surprisingly little overlap between these 
sets of transcripts/proteins, with only 85 in common (Figure 4.17a, Supplementary 
Table 5). Therefore, we now have evidence for the cell-cycle regulation of up to 887 
individual transcripts/proteins from transcriptomic and/or proteomic studies. 
As expected, the 85 proteins identified in common between both datasets 
contains many known cell-cycle regulated proteins, including CPC1, AUK1, CRK3 and 
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multiple kinetochore proteins (KKT1, 7 and 2). The classification of this group of 
proteins in two independent studies, increases our confidence that they are genuinely 
cell-cycle regulated. There are 343 proteins identified as regulated which are not 
corroborated by transcriptomic data; 302 (Figure 4.17b, Supplementary Table 6) of 
which are identified by transcriptomics and 41 (Figure 4.17c, Supplementary Table 8) 
which are not. In this class of proteins regulated at the protein level, and identified, but 
not regulated at the transcript level, an enrichment for GO terms associated with the 
cell-cycle is still observed (Figure 4.18b). Additionally, this protein set contains 
DOT1B, KIN-A, CYC4, CRK2 and multiple kinetochore proteins (KKT10, 17 and 5), 
demonstrating the identification of cell-cycle regulated proteins that do not appear to be 
regulated at the transcript level. Furthermore, an enrichment for the organelle fission 
GO term in this group is also observed, through the inclusion of glycosomal biogenesis 
proteins such as GIM5A and GIM5B, which are highly upregulated in early G1-phase 
time-points. Of the 41 proteins not identified by transcriptomics there is no enrichment 
for cell-cycle related GO terms (Figure 4.18c), and no known cell-cycle regulated 
proteins. Therefore, there is less confidence that these proteins are genuinely cell-cycle 
regulated. 
From transcriptomic evidence, 459 mRNAs are classified as regulated which are 
not supported by the proteomic data produced here; 274 which are also identified at the 
protein level (Figure 4.17d, Supplementary Table 7), and 185 only identified by 
transcriptomics (Figure 4.17e, Supplementary Table 9). The former set of 274 
transcripts is enriched for proteins associated with microtubule based movement (the 
flagellum) and DNA replication (Figure 4.18e). In this group many components of the 
trypanosome flagellum and various subunits of nuclear and kinetoplastid DNA 
polymerases are detected. The latter set of 185 transcripts, not detected in our dataset, is 
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also enriched for cell-cycle associated genes (Figure 4.18e), including CDC45, MCM5, 
CRK10, CYC8, KIN-B, DOT1A, PLK and multiple kinetochore components (KKT8, 
11, 13 and 9). 
These results demonstrate the complementarity of both datasets, as although 
there is little overlap in the transcripts/proteins classified as cell-cycle regulated, both 
are successful in identifying known regulated transcripts/proteins which the other 
dataset does not identify. There are a number of reasons why both experiments identify 
different sets of transcripts/proteins. For example, utilising proteomic techniques, it is a 
challenge to reliably identify and quantify low abundance proteins, as evidenced by our 
ability to identify only 67% of the transcripts identified. Many cell-cycle regulated 
proteins are low abundance, hence it is no surprise that, particularly in the class of 
transcripts not identified in our dataset (Figure 4.17e), there are many canonical cell-
cycle proteins only identified by transcriptomics. Moreover, it is not surprising that 
some transcripts/proteins are only identified as regulated from proteomic evidence, as 
protein abundance can be regulated by factors independent of mRNA abundance, such 
as the rate of translation and protein degradation. 
Using the remaining 85 transcripts/proteins found in common to be cell-cycle 
regulated between both datasets, we compared the classification of the cell-cycle phases 
that the transcript/protein peaks in. There appears to be broad agreement in the 
classification of G1-phase upregulated transcripts and proteins, with 29 out of 34 
proteins or 52 transcripts both classed as G1. For S-phase and G2&M-phase 
classifications there appears to be more variation. From 23 S-phase classified 
transcripts, 18 are identified in G2&M-phase clusters in our proteomic data. Similarly, 
of 14 proteins classified as S-phase, 12 are classed as G1-phase in transcriptomic data. 
Of the 37 proteins classed as G2&M-phase, only 8 are similarly annotated in the 
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transcriptomic data. These results may indicate a lag between an increase in mRNA 
abundance translating into an increase in protein abundance, as we see the that S-phase 
and G2&M-phase proteome classified proteins are mainly identified as G1 and S-phase 
transcripts, respectively in transcriptomic data. Alternatively, the experimental design in 
our proteomic study may allow for more accurate classification of peak expression, due 
to a higher temporal resolution, using nine time-points, compared to four in the 
transcriptome study. 
4.4.6 Cell-cycle regulatory role of PSP1 domain proteins 
We would also like to note the enrichment of polymerase suppressor 1 (PSP1) domain 
containing proteins within the group of 887 transcripts/proteins with evidence for cell-
cycle regulation. The PSP1 protein was first discovered in yeast, where it was found to 
suppress mutations in temperature sensitive DNA polymerases (Formosa and Nittis, 
1998). The C-terminus of PSP1 contains a domain that is found in up to 13 proteins in 
T. brucei (Table 4.3). Two of these proteins have homologs in Crithidia fasciculata 
(RBP33 and RBP45) that are subunits of the cycling sequence binding protein 
(CSBP II), which bind directly to mRNAs that periodically accumulate across the 
cell-cycle. RBP33 and RBP45 are also known to be differentially phosphorylated across 
the cell-cycle, which may regulate their interaction with mRNA (Mittra and Ray, 2004). 
Of the remaining 11 PSP domain containing proteins in T. brucei, 4 are classified as 
cell-cycle regulated in both transcriptomic and proteomic datasets, and one more in the 
transcriptomic data alone. All four proteins detected are in the top-22 most significantly 
changing proteins in the proteomic data with maximum fold-changes across the 
cell-cycle >3.3 (Table 4.3). As there is now evidence for cell-cycle regulation of 7 out 
of 13 PSP1 domain containing proteins in T. brucei, either through changes in 
abundance or phosphorylation, we propose that this domain may be a conserved domain 
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intimately involved in cell-cycle associated processes in kinetoplastids. 
4.4.7 Identification of novel cell-cycle regulated proteins 
From the 428 proteins in the nine clusters with patterns of cell-cycle regulation, only 14 
are associated with a cell-cycle GO term (Figure 4.15). We are therefore potentially 
describing novel cell-cycle associated functions for hundreds of proteins in T. brucei. 
However, within this group we find a few proteins such as PIF1, thymidine kinase and 
PUF9, all known to have key functions during cell division, but lacking GO annotation. 
This result highlights the need for better curation of trypanosomatid database resources, 
and studies such as this can contribute evidence through the data produced. It is also 
obvious from Figure 4.16 that proteins upregulated in G2&M-phase of the cell-cycle are 
more likely to be annotated, showing the bias of the field towards the study of mitosis. 
To further identify novel proteins essential for the cell-cycle in trypanosomatids, 
our dataset was filtered to only display ‘hypothetical’ proteins that are essential for the 
growth of the parasites in culture (Figure 4.16)(Alsford et al., 2011). Of the 287 
essential proteins in cell-cycle regulated clusters, 57 are classed as ‘hypothetical’ with 
fold-changes up to 4.13 across the time-course. That these proteins are changing in 
abundance across the cell-cycle, and are essential for growth in culture, points to the 
idea that their essentiality may be due to their role in cell-division of the organism. As 
these proteins are classed as ‘hypothetical’, and they lack obvious sequence homology 
to proteins characterised in other eukaryotes, they could be useful candidates for drug 
targets which would specifically interfere with trypanosomatid cell division. 
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Gene!ID! Gene!description! Evidence!for!cell$cycle!regulation!
Tb927.3.5080! PSP1!C6terminal!conserved!region,!putative! ID!in!transcriptome!–!not!changing!
Tb927.8.3850! PSP1!C6terminal!conserved!region,!putative! ID!in!transcriptome!–!late!G1!
Tb927.9.9370! PSP1!C6terminal!conserved!region,!putative! ID!in!transcriptome!–!not!changing!
Tb927.10.8330! S.!cerevisiae!PSP1!homologue,!putative!
ID!in!transcriptome!–!late!G1;!
ID!in!proteome!–!S6phase!
3.5!MaxFC!
Tb927.10.9910! PSP1!C6terminal!conserved!region,!putative! ID!in!transcriptome!and!proteome!–!not!changing!
Tb927.10.11630! PSP1!C6terminal!conserved!region,!putative! ID!in!transcriptome!and!proteome!–!not!changing!
Tb927.11.4180! PSP1!C6terminal!conserved!region,!putative!
ID!in!transcriptome!–!late!G1;!
ID!in!proteome!–!S6phase!!
3.3!MaxFC!
Tb927.11.14750! PSP1!C6terminal!conserved!region,!putative!
ID!in!transcriptome!–!late!G1;!
ID!in!proteome!–!S6phase!
4.1!MaxFC!
Tb927.5.760! cell6cycle!sequence!binding!phosphoprotein!(RBP33),!putative!
ID!in!transcriptome!–!early!G1!
ID!in!proteome!–!not!changing!
Cell6cycle!phosphorylation!
(Mittra!and!Ray,!2004)!
Tb927.6.2000! spliceosome!associated!protein,!putative! ID!in!transcriptome!and!proteome!–!not!changing!
Tb927.6.2850! ESAG!associated!protein,!putative!(PIE8)!
D!in!transcriptome!–!S;!
ID!in!proteome!–!S!
4.3!MaxFC!
Tb927.10.9330! hypothetical!protein,!conserved! ID!in!transcriptome!and!proteome!–!not!changing!
Tb927.11.7140! cell6cycle!sequence!binding!phosphoprotein!(RBP45),!putative!
ID!in!transcriptome!and!proteome!–!not!changing!
Cell6cycle!phosphorylation!
(Mittra!and!Ray,!2004)!
Table 4.3:  Evidence of cell-cycle regulation of PSP1 C-terminal domain containing 
proteins in T. brucei. Genes identified as containing PSP1 domains through Interpro 
annotation. MaxFC stands for maximum fold-change detected in the proteomic dataset. 
Transcript/protein evidence annotation is based on the classification into cell-cycle 
phase in (Archer et al., 2011), or into cell-cycle regulated clusters (Figure 4.13) in proteomic 
analysis. 
We highlight here a number of proteins we think are interesting for follow-up 
studies based on their pattern of expression and/or their predicted domain structure and 
function. For example, Tb927.8.710 (DRBD17) is predicted to contain two RNA 
binding domains and in our proteomic dataset is strongly downregulated between the 5 
and 6 h time-points, in S-phase of the cell-cycle. Transcriptomic data from elutriated 
trypanosomes shows an anti-correlated pattern between the protein and mRNA data, 
with mRNA abundance peaking at a 5.5 h time-point in S-phase (Figure 4.19)(Archer et 
al., 2011). The functional relevance of this anti-correlation between RNA and protein is 
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unknown, though potentially indicates a crucial role in cell-cycle regulated expression 
of mRNA transcripts, a mechanism already described for other RNA binding proteins 
such as PUF9 (Archer et al., 2009). 
A ‘predicted WD40 repeat protein’ (Tb927.10.10990) is seen peaking in 
expression at the 9 h time-point in the “high G2&M” cluster (Figure 4.20). BLAST-P 
searches indicate homology to cell-division-cycle protein 20 (cdc20), an activator of the 
Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligase, recruiting 
substrates for ubiquitin mediated degradation once cells are ready to segregate 
replicated chromosomes during mitosis (Barford, 2011). However, as it lacks a KEN 
amino acid motif, and another gene in T. brucei is already annotated as a cdc20 
orthologue (Tb927.8.6500), we propose that this gene is a cdh1 orthologue. Cdh1 is 
highly structurally homologous to cdc20 and also recruits substrates to the APC/C, 
including cdc20 itself, acting slightly later as cells exit mitosis, ensuring the mitotic 
apparatus is degraded prior to re-entry into G1 (Barford, 2011). 
In a similar manner a putative ‘serine-threonine protein kinase’ (Tb927.6.5100) 
and a ‘hypothetical’ protein (Tb927.8.7540), are both upregulated in G1-phase, that 
have BLAST-P hits to polo-like kinase (PLK) and cyclin dependent kinase (CDK) 
domains (Figures 4.21 and 4.22). Proteins with these types of domain are known to play 
key regulatory roles during the cell-cycle of other organismsm and we propose these 
genes should be annotated as a likely PLK and CDK, respectively. 
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Figure 4.19: Relative protein and mRNA abundance of predicted DRBD17, 
Tb927.8.710 over the cell cycle. Red line shows mean of three biological replicates and 
red ribbon represents the standard deviation of measurements of TMT reporter ion 
intensity. Green line shows mRNA abundance (maximum normalized RPKM) as 
quantified in (Archer et al., 2011).
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Figure 4.20: Relative protein abundance of predicted WD40 repeat protein, 
Tb927.10.10990 over the cell cycle. Black line shows mean of three biological 
replicates and red ribbon represents the standard deviation of measurements. Diagram 
below shows BLAST-P hits of Tb927.10.10990 displayed on TriTrypDB (Aslett et al., 
2010), with multiple hits to cdc20 related proteins. 
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Figure 4.21: Relative protein abundance of putative S/T protein kinase, Tb927.6.5100 
over the cell cycle. Black line shows mean of three biological replicates and red ribbon 
represents the standard deviation of measurements. Diagram below shows BLAST-P 
hits of Tb927.6.5100 displayed on TriTrypDB (Aslett et al., 2010), with multiple hits to 
polo-like kinases. 
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Figure 4.22: Relative protein abundance of hypothetical protein, Tb927.8.7540 over the 
cell cycle. Black line shows mean of three biological replicates and red ribbon 
represents the standard deviation of measurements. Diagram below shows BLAST-P 
hits of Tb927.8.7540 displayed on TriTrypDB (Aslett et al., 2010), with a single hit to a 
cyclin-dependent kinase protein.  
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4.4.8 Summary 
In summary, I present here the development of drug-free methodologies to study 
cell-cycle regulation of the T. brucei proteome through centrifugal elutriation. I have 
advanced mass spectrometry methods to enhance the accurate quantitation of isobaric 
tagging technology. Using 10-plex TMT and extensive fractionation of samples I have 
produced a comprehensive dataset, which quantifies 5,034 proteins in PCF T. brucei 
with a high temporal resolution across nine time-points of the cell-cycle. Through this 
analysis I have identified ~400 cell-cycle regulated proteins and classified these into 
different patterns of regulation, elucidating the biological role of many proteins with 
previously little or no evidence for function. Crucially, I identify 285 cell-cycle 
regulated proteins which are essential for growth of the parasite in culture, 57 of which 
are ‘hypothetical’ proteins, providing a comprehensive list of putative drug-targets with 
a role in cell-division of the parasite. 
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Chapter 5: Future directions and 
perspectives 
5.1 Developments in understanding protein function in Trypanosoma brucei 
One of the major challenges for the kinetoplastid research community is to understand 
the biological function of thousands of uncharacterised gene products identified from 
genome sequencing (Field et al., 2012). An understanding of protein function is 
important to further appreciate fundamental cell biological mechanisms of 
trypanosomes, and for the development of trypanocidal drugs with a clearer idea of 
putative mechanisms of action. In Chapter 1, I outlined a number of strategies which are 
being utilised to provide evidence for protein or gene function, ranging from 
computational, transcriptomic, proteomic and genetic techniques. In this thesis I have 
tried to contribute to this effort by applying unbiased proteomic methods, to understand 
protein-protein interactions, and cell cycle regulation of protein abundance in PCF T. 
brucei. 
 I have developed techniques to study soluble core protein complexes in T. 
brucei. Through the use of conventional chromatographic techniques, to separate 
complexes in whole cell lysates, in combination with quantitative mass spectrometry, I 
have produced information on elution profiles for 5,854 proteins. From this data we 
predicted 805 proteins in 234 protein complexes, including 135 proteins annotated as 
“hypothetical” and 488 proteins annotated with “putative” in their gene name. 
Protein-protein interactions are highly informative about the biological function of 
proteins, and I have highlighted key examples in Chapter 3 which demonstrate the 
power of our predictions to improve the annotation of the trypanosomatid proteome. 
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 My analysis of the cell-cycle regulated proteome of PCF T. brucei identified and 
quantified the relative abundance of 5,034 proteins, across nine time-points over the 
course of 11 hours of cell-division. Of these, 428 were hierarchically clustered into 
groups with patterns of cell-cycle regulation; 219 were annotated as “hypothetical” and 
139 had gene names annotated as “putative”. The association of “hypothetical” or 
“putative” proteins with proteins of known function, and particular biological processes, 
such as DNA synthesis or mitosis, begins to provide evidence for function in a “guilt by 
co-regulation” approach, and leads to testable hypotheses of these functions. The 
identification of a cell-cycle regulated pattern of expression also throws new light onto 
putative predicted functions of proteins. For example, proteins with RNA binding 
domains may be playing key roles in translational control of proteins necessary for cell-
cycle control, or proteins with kinase domains may be important players in signalling 
events necessary for cell-cycle progression. 
 I have highlighted, and can only work on, a handful of the proteins for which 
there may be novel evidence for protein function. A crucial component of large omics 
datasets is ensuring that the wider research community can access and work with the 
data produced in a fun and easy format. We have produced data visualisation 
applications for each of the datasets described in this work, which will allow the 
research community to explore this data and begin to identify other crucial proteins 
which they themselves may interested in characterising further. 
5.2 Furthering analysis of protein complexes 
I have taken a fairly straight-forward approach to my study of protein complexes, by 
simply lysing cells in PBS or ethanolamine, and loading the resulting lysates onto SEC 
or SAX columns. The use of orthogonal modes of chromatography increased the 
confidence in the predictions of complexes co-eluting across two conditions, and 
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allowed for the detection of complexes only stable under one condition. In future, the 
use of alternative chromatographic methods, such as hydrophobic interaction 
chromatography, may further increase the coverage of protein complexes and increase 
the confidence of predictions made so far. 
 Improvements in the global mapping of core protein complexes could also be 
made through subcellular fractionation of trypanosomes, prior to chromatographic 
fractionation. This would prevent complexes of similar size/shape or charge from co-
eluting in SEC or SAX, allow for the reliable detection of lower abundance proteins that 
may have been excluded in this study and reduce the complexity of data analysis. 
 Moreover, under the ‘native’ lysis conditions used in these studies it is unlikely I 
would have solubilised membrane protein complexes. It would be interesting to test the 
effects of adding mild detergents, commonly used in immunoprecipitation studies, such 
as NP-40, digitonin, n-octyl glucoside or CHAPS, to lysis and fractionation buffers on 
the extraction and separation of membrane protein complexes. It is likely that buffers 
would have to be optimised for different subsets of complexes, and may result in 
conditions that disrupt other soluble cytoplasmic complexes. 
 Alternatively, it is possible to physically cross-link proteins in vivo, covalently 
capturing protein interactions in a physiological state. In the final stages of the work 
presented here I started the optimisation of formaldehyde and DSP cross-linking 
protocols for PCF T. brucei, followed by lysis in harsh SDS containing buffers. This 
methodology has previously been used to extract and fractionate membrane protein 
complexes in PCP-MS studies of human cancer cell lines (Larance et al., 2016). 
 Protein crosslinking mass spectrometry is commonly associated with the 
structural analysis of highly purified protein complexes. The heterogeneity and low 
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abundance of cross-linked peptides, in combination with complicated data analysis, has 
limited the use of these techniques in large-scale proteomic approaches. Many strategies 
have been implemented to counter these associated caveats, making global detection of 
cross-linked peptides more feasible. This has been made possible through: Affinity 
enrichable crosslinking reagents, to directly enrich for crosslinked peptides. Isotope 
labelled cross-linkers, allowing the detection of low abundance ions through the 
identification of specific mass shifts. MS-cleavable cross-linkers, allowing for simpler 
identification of cross-linked peptides (Tang and Bruce, 2010). The identification of 
directly cross-linked peptides would provide strong evidence to support the predictions 
of protein complexes made in this study, which are based on co-fractionation rather than 
any direct physical interaction. 
 Finally, we have demonstrated that elution profiles of individual proteins are 
highly reproducible between biological replicates. It is therefore possible to compare the 
elution profiles of the same protein between different biological conditions to determine 
if proteins have changed interaction state, possibly informing on biological function. 
Future studies could therefore compare BSF and PCF T. brucei, allowing for the 
detection of global changes in not just protein abundance, but protein interaction states 
between these distinct life-cycle stages. Furthermore, the formation of protein 
complexes at different stages of the cell-cycle is important for cell-cycle progression. 
The combination of elutriation with PCP-MS could provide key insights into the 
remodelling of the interactome over the cell-cycle in PCF trypanosomes. 
5.3 Furthering analysis of the cell-division-cycle 
I have comprehensively characterised the cell-cycle regulated proteome of PCF 
trypanosomes, using 10-plex TMT technology to produce a high resolution temporal 
map of relative protein abundance. However, there are a number of questions still to be 
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answered about cell-cycle control in these unusual eukaryotes. It is clear that different 
mechanisms control the cell-cycle in different life-stages of the parasite. Differences 
have been observed at the morphological level, with different positioning of nuclei and 
kinetoplasts prior to cytokinesis (Wheeler et al., 2013), and at the molecular level, as 
depletion of cell-cycle regulators by RNAi, or inhibition by small molecules, leads to 
different phenotypes. For example, the inhibition of DNA synthesis or the depletion of a 
mitotic cyclin, or the partner cyclin dependent kinase, results in a block in cytokinesis in 
BSF, yet PCF progress through cytokinesis (Hammarton, 2007; Li, 2012). Previous 
publications have indicated that BSF parasites are not amenable to elutriation as they 
are too small, however the parameters used for elutriation in this work were poorly 
reported (Archer et al., 2011). It is therefore worthwhile revisiting the elutriation of BSF 
trypanosomes in an attempt to carry out a comparative proteomic analysis to PCF cells, 
potentially revealing life-cycle specific factors controlling and regulating cell-division. 
 In this work, I utilised 10-plex TMT technology for a number of reasons. It 
reduced the amount of mass spectrometry acquisition time required by a factor of ten-
fold. I could quantitate up to ten samples across a time-course in an individual mass 
spectrometry run, allowing for a high temporal resolution of our analysis of cell 
division. The nature of TMT quantitation, where all ten samples are quantified in a 
single mass spectrometry scan also reduced the number of missing values, a major 
caveat in label-free analysis when comparing many samples. Unfortunately, there is a 
well-documented effect of ratio compression when quantifying peptides using isobaric 
tags (Christoforou and Lilley, 2012), even when using SPS-MS3 methods on a Fusion 
MS. Although, this effect is unlikely to prevent the detection of proteins with high 
abundance changes between time-points, it may obscure proteins that have small 
changes in abundance, or proteins which are identified with low numbers of peptides. 
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Alternative methods of quantitation may reveal some of those proteins missed in this 
work, for example it would be possible to carry out a similar analysis using label-free 
quantitation either using Data Dependent Acquisition (DDA) or Data Independent 
Acquisition (DIA), as these methods have larger dynamic ranges and more robust 
quantitation. Conventional DDA analysis may require a reduction in the number of 
time-points collected, especially as extensive fractionation of peptides would be 
required for deep proteomic coverage using this method, leading to a large number of 
samples for analysis. Otherwise, publications utilising DIA-MS methods have 
demonstrated deep proteomic coverage for single-shot runs of complex lysates, without 
the difficulties of ‘missing values’ observed when using DDA methods (Bruderer et al., 
2015). DIA-MS may therefore allow for a similar proteomic coverage seen in this 
dataset, without the need for a large number of samples that a DDA method would 
require. 
 Although protein abundance is a crucial factor for the regulation of biological 
processes such as the cell-cycle, it is not the only factor involved in such regulation. 
Post-translational modifications of proteins can change the function of a protein by 
affecting enzyme activity or modifying protein interaction partners, without a change in 
the abundance of a protein. It is also known that post-translational modifications such as 
phosphorylation play important regulatory roles across the cell-cycle (Fisher et al., 
2012; Mocciaro and Rape, 2012). It would therefore be of interest to identify how 
phosphorylation varies across the cell-cycle on a proteome wide scale, potentially 
identifying regulated phospho-sites on proteins important for cell-division in 
trypanosomes. Identifying co-regulated phospho-sites may also allow for the 
identification of particular amino acid motifs that are the target of specific kinases. 
Furthermore, a number of kinases which are involved in cell-cycle regulation are 
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already known in T. brucei; for example, aurora-B kinase or cyclin-dependent kinases. 
However, the substrates of these kinases are unknown. It may be possible to identify the 
direct targets of these kinases through phospho-proteomic analysis of cells depleted of 
these enzymes, or through treatment of cells with specific inhibitors of these enzymes. 
 Finally, for the identification of putative drug candidates it is important to select 
proteins that are essential for the survival of the parasite. However, it is not necessarily 
the case that because a protein is regulated in terms of abundance or post-translational 
modification that it plays an essential role in cell-division. Therefore, in this work I 
performed a cross-comparison of our data to previously published RITseq screens that 
identified proteins essential for survival of T. brucei in cell culture (Alsford et al., 
2011). If proteins are cell-cycle regulated and essential, it is likely that these proteins 
will be critical for cell-cycle progression. By understanding that these essential proteins 
are cell-cycle regulated we can also begin to further understand the mechanism of why 
these proteins are critical for parasite survival. Further evidence through RITseq studies 
with assays specifically designed to identify genes important for cell-division would 
provide another valuable data-set, with direct evidence for gene function. A theoretical 
example of such an assay is through the use of carboxyfluorescein succinimdyl ester 
(CFSE), which is used to stain cells in a pulse, followed by a chase where the number of 
cell-divisions can be counted through the cellular fluorescence of CFSE (Claes et al., 
2009).  It would therefore be possible to identify genes which are enriched in 
populations that arrest after one, two, three or four divisions following depletion by 
tetracycline induced RNAi in comparison to a non-induced sample. 
 
 
 
Chapter 5: Future directions and perspectives 
 
 
 
!
144 
5.4 Prediction of gene function 
Together with other large-scale datasets produced from transcriptomic, proteomic or 
genetic techniques, the data produced here will contribute to our understanding of gene 
and protein function in this understudied eukaryote. These experiments by themselves 
can provide important information on individual biological questions, such as which 
proteins are cell-cycle regulated; which proteins form the flagella; or what proteins are 
depleted upon knock-out of another. However, they can also be highly useful when 
combined together to ask questions globally about protein function. Proteins involved in 
similar biological pathways, processes or complexes may demonstrate co-behaviours in 
these experiments, and the future computational analysis of such data may therefore 
identify groups of co-behaving proteins, and further our functional understanding of the 
T. brucei proteome. This kind of analysis has already been performed successfully on 
transcriptomic data from trypanosomes to annotate ‘hypothetical’ genes with unknown 
function, and therefore holds great promise for future analysis with the ever increasing 
output of large-scale data from many studies across the T. brucei field. 
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Supplementary Tables 
Supplementary Table 1: List of gold standard protein complexes used for random forest 
machine learning prediction of protein interactions. A representative protein complex 
name is shown along with the gene IDs of component proteins. 
Protein Complex Gene IDs 
Acidic Ribosomal Tb927.10.3380; Tb927.9.5690 
ALBA Tb927.4.2040; Tb927.11.4460; Tb927.4.2030; Tb927.11.4450 
Arginine N-
methyltransferase 
Tb927.1.4690; Tb927.10.3560 
ARP2/3 Tb927.10.4540; Tb927.9.5350; Tb927.10.15800; Tb927.2.2900; 
Tb927.8.4410 
ATP synthase Tb927.3.1380; Tb927.10.180; Tb927.5.1710; Tb927.6.4990; 
Tb927.10.5050; Tb927.7.7430 
Dihydrolipoamide 
dehydrogenase 
Tb927.8.7380; Tb927.3.4390; Tb927.4.5040; Tb927.5.3800 
DNA polymerase Tb927.11.8890; Tb11.v5.0480 
Exosome Tb927.10.7450; Tb927.11.11030; Tb927.11.16600; Tb927.4.1630; 
Tb927.5.1200; Tb927.6.670; Tb927.9.7070 
Fibrillarin Tb927.10.14750; Tb927.10.7500 
Nucleosome Tb927.10.10590; Tb927.5.4260; Tb927.7.2940 
Mitochondrial 
peptidase 
Tb927.11.3980; Tb927.5.1060 
Mitochondrial RNABP Tb927.11.13280; Tb927.11.1710 
Mitochondrial SSU Tb927.11.2530; Tb927.10.3580; Tb927.7.3050 
MRB1 complex Tb927.2.3800; Tb927.7.2570 
MVP Tb927.5.4460; Tb927.10.1990; Tb927.10.6310 
N-acetyltransferase Tb927.10.5670; Tb927.11.4530; Tb927.10.3150 
Nucleosome assembly Tb927.10.15180; Tb927.9.5730 
Oxoglutarate 
dehydrogenase 
Tb927.11.1450; Tb927.11.9980; Tb927.11.11680 
Oxoisovalerate 
dehydrogenase 
Tb927.10.4330; Tb927.10.660 
Phosphoribosylpyropho
sphate synthetase 
Tb927.5.2960; Tb927.11.3030; Tb927.10.9430; Tb927.5.3170 
Prefoldin Tb927.7.570; Tb927.7.2590; Tb927.11.12680; Tb927.5.580; 
Tb927.6.2280; Tb927.11.800; Tb927.11.16040; Tb927.11.12910 
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Proteasome core Tb927.10.290; Tb927.7.4790; Tb927.9.11310; Tb927.4.430; 
Tb927.6.1260; Tb927.7.4420; Tb927.9.9670; Tb927.11.7020; 
Tb927.3.780; Tb927.10.4710; Tb927.10.230; Tb11.v5.0196; 
Tb927.10.6080; Tb927.11.7270 
Proteasome regulatory Tb927.11.9220; Tb927.10.3520; Tb927.10.15720; Tb927.10.9740; 
Tb927.11.14430; Tb927.10.1550; Tb927.11.16030; Tb927.7.2550; 
Tb927.6.1090 
Pyruvate 
dehydrogenase 
Tb927.10.12700; Tb927.3.1790; Tb927.10.7570 
Ribosome 60S Tb927.9.3990; Tb927.8.1340; Tb927.3.3320; Tb927.7.1730 
ruvB-like DNA helicase Tb927.4.1270; Tb927.4.200 
SMD Tb927.2.4540; Tb927.2.5850; Tb927.4.890 
Spliceosome Tb927.5.2290; Tb927.11.15430; Tb927.9.11110 
Succinyl-CoA Tb927.3.2230; Tb927.10.2560 
T-Complex Tb927.10.1060; Tb927.10.8190; Tb927.11.16760; Tb927.11.3240; 
Tb927.11.14250; Tb927.11.1900; Tb927.9.11270; Tb927.8.3150 
Translation elongation Tb927.10.5840; Tb927.4.3590; Tb927.11.13190 
tRNA processing 
complex 
Tb927.9.5210; Tb927.8.5330; Tb927.10.1250; Tb927.10.10030 
Supplementary Table 2: List of predicted protein complexes from machine learning 
analysis. Protein complex numbers match those displayed on ‘Complex Explorer’ web 
application described in Chapter 3. 
Predicted 
Protein 
Complex 
Protein Id Protein Description 
1 
 
Tb927.10.2290 chaperone protein DNAj, putative 
Tb927.11.7380 glycerol-3-phosphate dehydrogenase (FAD-dependent), 
mitochondrial 
Tb927.8.6080 Glycerophosphoryl diester phosphodiesterase family, putative 
(POMP42) 
Tb927.9.15000 proteasome complex subunit Rpn13 ubiquitin receptor, putative 
2 Tb927.4.1330 DNA topoisomerase IB, large subunit 
Tb927.9.10530 hypothetical protein, conserved 
3 
 
Tb927.10.3700 AMP-activated protein kinase, gamma regulatory subunit, SNF1-
related protein kinase regulatory subunit gamma, AMPK subunit 
gamma (AMPKG) 
Tb927.10.5310 SNF1-related protein kinases, putative 
Tb927.3.4560 5'-AMP-activated protein kinase catalytic subunit alpha, putative, 
AMPK subunit alpha, putative, SNF1-related protein kinase 
catalytic subunit alpha, putative 
Tb927.8.2450 SNF1-related protein kinase regulatory subunit beta, 5'-AMP-
activated protein kinase subunit beta, AMPK subunit beta 
(AMPKB) 
Tb927.9.9270 hypothetical protein, conserved 
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4 
 
Tb927.11.12930 DEAD-box helicase, putative 
Tb927.11.5990 hypothetical protein, conserved 
Tb927.4.1070 50S ribosomal protein L13, putative 
Tb927.6.4080 hypothetical protein, conserved 
Tb927.7.1640 ras-like small GTPase, putative (TbEAR) 
Tb927.7.3460 hypothetical protein, conserved 
5 
 
Tb927.11.11290 heat shock protein 70, putative 
Tb927.11.7150 NGG1 interacting factor 3-like 
Tb927.5.3520 queuine tRNA-ribosyltransferase, putative 
Tb927.6.4920 S-adenosylmethionine synthetase, putative (METK1) 
Tb927.9.5190 proliferative cell nuclear antigen (PCNA), putative 
Tb927.9.9820 glyceraldehyde-3-phosphate dehydrogenase, putative 
6 
 
Tb11.1390 hypothetical protein, conserved 
Tb927.1.4050 protein phosphatase with EF-Hand domains (PPEF), ser/thr protein 
phosphatase, putative 
Tb927.10.12500 P-type H+-ATPase, putative 
Tb927.10.12510 P-type H+-ATPase, putative 
Tb927.10.7700 ABC transporter, putative 
Tb927.10.8530 glucose transporter 2A (THT2A) 
Tb927.10.9080 pteridine transporter, putative 
Tb927.11.540 ABC transporter, mitochondrial, putative, multidrug resistance 
protein, mitochondrial, putative (ABCT) 
Tb927.11.5970 phosphoinositide-specific phospholipase C, putative 
Tb927.11.6040 Nodulin-like, putative 
Tb927.4.4360 monoglyceride lipase, putative 
Tb927.4.4490 multidrug resistance protein E, p-glycoprotein (MRPE) 
Tb927.8.2160 multidrug resistance protein A, p-glycoprotein (PGPA) 
Tb927.9.15460 calcium motive p-type ATPase, putative 
Tb927.9.6310 ABC transporter, putative 
7 
 
Tb11.v5.0807 ribonuclease, putative 
Tb927.10.5620 fructose-bisphosphate aldolase, glycosomal (ALD) 
Tb927.11.6830 Domain of unknown function(DUF2779), putative 
Tb927.11.7310 RNA binding protein, putative 
Tb927.2.820 retrotransposon hot spot protein (RHS, pseudogene), putative, 
retrotransposon hot spot protein 1 (RHS1), interrupted 
Tb927.9.9580 tubulin tyrosine ligase protein, putative 
8 
 
Tb927.10.11530 hypothetical protein, conserved 
Tb927.11.10300 hypothetical protein, conserved 
Tb927.11.5510 dynein light chain p28, axonemal, putative 
Tb927.3.5580 tryptophanyl-tRNA synthetase 
Tb927.7.4570 inosine-guanine nucleoside hydrolase (IG-NH) 
Tb927.9.12290 Peroxin 19 
9 
 
Tb927.1.870 deoxyhypusine synthase, putative 
Tb927.10.2750 deoxyhypusine synthase, putative 
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10 
 
Tb927.11.10240 hslVU complex proteolytic subunit, threonine peptidase, Clan T(1), 
family T1B, ATP-dependent protease subunit HslV (HsIV) 
Tb927.11.2230 carnitine O-acetyltransferase, putative (CAT) 
Tb927.4.1270 ruvB-like DNA helicase, putative 
Tb927.4.2000 ruvB-like DNA helicase, putative (RUVBL) 
Tb927.6.3610 SET domain containing protein, putative 
Tb927.6.950 cysteinyl-tRNA synthetase, putative 
Tb927.7.5890 hypothetical protein, conserved 
Tb927.9.5900 glutamate dehydrogenase (GDH) 
11 
 
Tb927.1.1670 ARM-like helical domain-containing protein 
Tb927.4.1890 hypothetical protein, conserved 
Tb927.5.1090 threonyl-tRNA synthetase, putative 
Tb927.7.760 hypothetical protein, conserved 
12 
 
Tb927.10.13670 serine/threonine protein phosphatase 5 
Tb927.10.14030 hypothetical protein, conserved 
Tb927.3.3580 heat shock protein 90, putative (LPG3) 
Tb927.5.3260 WD domain, G-beta repeat, putative 
Tb927.9.9860 Hsp70 protein, putative 
13 
 
Tb927.5.2250 META domain/Domain of unknown function (DUF1935), putative 
Tb927.6.4950 mago nashi-like protein, putative 
Tb927.7.1170 RNA-binding protein, putative (Y14) 
14 
 
Tb927.11.15370 hypothetical protein, conserved (TbKap123) 
Tb927.3.1670 hypothetical protein, conserved 
Tb927.3.4250 hypothetical protein, conserved 
15 
 
Tb927.10.10030 hypothetical protein, conserved 
Tb927.10.1250 Aminoacyl-tRNA editing domain containing protein, putative 
Tb927.5.4450 hypothetical protein, conserved 
Tb927.8.5330 tyrosyl/methionyl-tRNA synthetase, putative 
Tb927.9.5210 glutaminyl-tRNA synthetase, putative 
16 
 
Tb927.10.12700 pyruvate dehydrogenase E1 alpha subunit, putative 
Tb927.10.7570 dihydrolipoamide acetyltransferase E2 subunit, putative 
Tb927.3.1790 pyruvate dehydrogenase E1 beta subunit, putative 
Tb927.5.1090 threonyl-tRNA synthetase, putative 
17 
 
Tb927.1.1670 ARM-like helical domain-containing protein 
Tb927.10.15180 nucleosome assembly protein, putative 
Tb927.11.6370 leucine-rich repeat protein (LRRP), putative 
Tb927.9.5730 nucleosome assembly protein-like protein 
18 
 
Tb927.10.2620 CS domain containing protein, putative 
Tb927.2.1890 E2-like ubiquitin-conjugation enzyme (ATG3) 
19 
 
Tb927.10.15170 hypothetical protein, conserved 
Tb927.10.1990 major vault protein, putative (MVP) 
Tb927.10.6310 major vault protein, putative (MVP) 
Tb927.5.4460 major vault protein, putative (MVP) 
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20 
 
Tb927.8.5900 Sedlin, N-terminal conserved region, putative 
Tb927.9.12150 transport protein particle (TRAPP) subunit, putative 
21 
 
Tb927.10.3710 proteasome activator protein PA26 (pa26) 
Tb927.3.4040 Ankyrin repeats (3 copies), putative 
22 
 
Tb927.10.11390 60S ribosomal protein L6, putative 
Tb927.3.3320 60S ribosomal protein L13, putative 
Tb927.4.2180 60S ribosomal protein L35a, putative 
Tb927.6.720 40S ribosomal protein L14, putative 
Tb927.7.1730 60S ribosomal protein L7, putative 
Tb927.8.1340 60S ribosomal protein L7a, putative 
Tb927.9.3990 ribosomal protein S7, putative 
23 
 
Tb927.11.9710 60S ribosomal protein L10a, putative (RPL10A) 
Tb927.5.2770 SET domain containing protein, putative 
24 
 
Tb927.10.10960 heat shock protein, putative 
Tb927.8.3100 coronin, putative (CRN12) 
25 
 
Tb927.10.1100 60S ribosomal protein L9, putative 
Tb927.11.14130 ribosomal protein L18, putative 
Tb927.11.3600 40S ribosomal protein S4, putative 
Tb927.11.9730 60S ribosomal protein L34, putative 
Tb927.4.1100 ribosomal protein L21E (60S), putative 
Tb927.4.1860 ribosomal protein S19, putative 
Tb927.5.1610 60S ribosomal protein L13a, putative 
Tb927.7.1050 40S ribosomal protein S16, putative 
Tb927.7.5020 60S ribosomal protein L19, putative 
Tb927.8.6160 40S ribosomal protein S8, putative 
Tb927.9.11410 60S ribosomal protein L23, putative 
Tb927.9.11490 60S ribosomal protein L27a, 60S ribosomal protein L28, 60S 
ribosomal protein L29 (RPL27A) 
Tb927.9.8420 60S ribosomal protein L10, putative, QM-like protein 
26 
 
Tb927.10.3760 vacuolar ATP synthase subunit d, putative 
Tb927.10.730 ATP synthase, putative 
Tb927.11.11690 Vacuolar proton pump subunit B, putative, V-type proton ATPase 
subunit B, putative 
Tb927.11.9420 ATP synthase, putative 
27 
 
Tb927.10.9020 Gcd10p family, putative 
Tb927.11.11660 conserved protein 
Tb927.11.9210 NOL1/NOP2/sun family, putative 
Tb927.2.380 retrotransposon hot spot protein 2 (RHS2), putative 
Tb927.2.830 retrotransposon hot spot protein (RHS, pseudogene), putative, 
retrotransposon hot spot protein 1 (RHS1), interrupted 
28 
 
Tb927.1.2580 RNasePH-like protein, exosome-associated protein 1 (EAP1) 
Tb927.10.5840 translation elongation factor 1-beta, putative 
Tb927.10.7450 exosome complex exonuclease RRP41A, Ribosomal RNA 
processing protein 41A (RRP41A) 
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Tb927.11.16600 exosome-associated protein 2 (EAP2) 
Tb927.11.630 RNA polymerase I second largest subunit (RPA135) 
Tb927.3.1150 Conserved hypothetical ATP binding protein, putative 
Tb927.3.1300 hypothetical protein, conserved 
Tb927.5.1200 exosome component CSL4 (CSL4) 
Tb927.6.670 ribosomal RNA processing protein 45, exosome complex 
exonuclease (RRP45) 
Tb927.7.4670 ribosomal RNA processing protein 4, exosome complex 
exonuclease (RRP4) 
Tb927.7.710 heat shock 70 kDa protein, putative (HSP70) 
Tb927.9.7070 exosome complex exonuclease RRP40 (RRP40) 
29 
 
Tb927.11.12680 prefoldin subunit 2, putative 
Tb927.5.580 prefoldin subunit, putative 
Tb927.7.2590 prefoldin, putative 
Tb927.7.570 prefoldin, putative 
30 
 
Tb927.10.1550 proteasome regulatory non-ATP-ase subunit 5 (RPN5) 
Tb927.10.15720 proteasome regulatory non-ATP-ase subunit 9 (RPN9) 
Tb927.10.3030 proteasome regulatory non-ATPase subunit 11 (RPN11) 
Tb927.10.3520 protease regulatory ATPase subunit 4 (RPT4) 
Tb927.10.9740 Regulatory particle triple-A ATPase subunit 6, 19S proteasome 
regulatory subunit (RPT6) 
Tb927.11.14430 proteasome regulatory non-ATP-ase subunit 
Tb927.11.16030 proteasome regulatory non-ATP-ase subunit 7 (RPN7) 
Tb927.11.3740 proteasome regulatory ATPase subunit 2 (RPT2) 
Tb927.11.8310 class I transcription factor A, subunit 4 (CITFA-4) 
Tb927.2.2440 proteasome regulatory non-ATPase subunit 6 (RPN6) 
Tb927.6.1090 proteasome regulatory ATPase subunit 3 (RPT3) 
Tb927.7.2500 proteasome regulatory ATPase subunit 1 
Tb927.7.2550 proteasome regulatory ATPase subunit 5 (RPT5) 
Tb927.8.570 proteasome regulatory non-ATP-ase subunit 10 
31 
 
Tb11.v5.0196 Proteasome subunit A N-terminal signature/Proteasome subunit, 
putative 
Tb927.10.230 proteasome subunit alpha type-5, putative 
Tb927.10.290 proteasome alpha 2 subunit, putative 
Tb927.10.4710 20S proteasome subunit, proteasome subunit beta type-2, putative 
(PSB4) 
Tb927.10.6080 proteasome subunit beta type-5, putative, proteasome subunit beta 
type-5, putative 
Tb927.11.7020 proteasome alpha 7 subunit, putative (PSA4) 
Tb927.11.7270 proteasome beta 3 subunit, putative (PSB3) 
Tb927.3.780 proteasome alpha 7 subunit (TbPSA7) 
Tb927.4.430 proteasome beta 7 subunit 
Tb927.6.1260 proteasome beta-1 subunit, putative (PSB1) 
Tb927.7.4420 proteasome alpha 3 subunit, putative 
Tb927.7.4790 proteasome beta 6 subunit, 20S proteasome beta 6 subunit, putative 
(BETA6) 
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Tb927.9.11310 unspecified product 
Tb927.9.9670 proteasome alpha 1 subunit, putative, 20S proteasome subunit 
alpha-6, (putative) (TbPSA6) 
32 
 
Tb927.10.3280 60S ribosomal proteins L38, putative 
Tb927.2.6090 60S ribosomal protein L44 (RPL44) 
33 
 
Tb927.10.3380 60S acidic ribosomal protein P2, putative 
Tb927.9.5690 60S acidic ribosomal protein, putative 
34 
 
Tb927.10.2200 hypothetical protein, conserved 
Tb927.10.4220 hypothetical protein, conserved 
35 
 
Tb11.02.5380b exosome complex exonuclease RRP44p homologue, putative 
Tb927.10.7630 transportin2- like protein 
36 
 
Tb927.10.9250 adenylyl cyclase-associated protein, putative 
Tb927.7.880 RNA-binding protein, putative (RPB25) 
37 
 
Tb927.11.14190 Staphylococcal nuclease homologue/Tudor domain containing 
protein, putative 
Tb927.11.2650 heat shock protein 84, putative 
38 
 
Tb927.11.11680 2-oxoglutarate dehydrogenase E2 component, putative 
Tb927.11.1450 2-oxoglutarate dehydrogenase E1 component, putative 
Tb927.11.9980 2-oxoglutarate dehydrogenase E1 component, putative 
39 
 
Tb927.11.3660 Dynein light chain Tctex-type, putative 
Tb927.7.4820 Trm112p-like protein, putative 
40 
 
Tb927.11.3980 mitochondrial processing peptidase alpha subunit, putative, 
metallo-peptidase, Clan ME, Family M16 
Tb927.5.1060 mitochondrial processing peptidase, beta subunit, putative, metallo-
peptidase, Clan ME, Family M16 
41 
 
Tb927.11.4360 Protein of unknown function (DUF1014), putative 
Tb927.3.1920 NOT5 protein (NOT5) 
42 
 
Tb927.11.4480 radial spoke protein RSP4/6, putative 
Tb927.3.2890 radial spoke protein RSP10, putative 
43 
 
Tb927.11.4920 hypothetical protein, conserved 
Tb927.5.1900 hypothetical protein, conserved 
44 
 
Tb927.11.9610 eukaryotic translation initiation factor 3 subunit 2, putative (eIF-3 
beta) 
Tb927.5.2570 translation initiation factor, putative (EIF3B) 
45 
 
Tb927.2.2230 hypothetical protein, conserved 
Tb927.2.2390 hypothetical protein, conserved 
46 
 
Tb927.10.1890 cysteine peptidase, Clan CA, family C2, putative 
Tb927.2.5810 Holliday-junction resolvase-like of SPT6/SH2 domain containing 
protein, putative 
47 
 
Tb927.3.1210 protein transport protein Sec24 (SEC24.1) 
Tb927.3.3890 hypothetical protein, conserved 
48 
 
Tb927.3.2660 TatD related DNase, putative 
Tb927.9.8200 Pescadillo N-terminus/BRCA1 C Terminus (BRCT) domain 
containing protein, putative 
49 
 
Tb927.3.3630 Elongation factor Ts, mitochondrial, putative (EF-Ts) 
Tb927.7.1340 10 kDa heat shock protein, putative (HSP10) 
Supplementary Tables 
 
 
 
!
168 
50 
 
Tb927.3.5310 paraflagellar rod protein 
Tb927.5.940 NADH-dependent fumarate reductase, putative 
51 
 
Tb927.3.5370 hypothetical protein, conserved 
Tb927.6.1870 eukaryotic translation initiation factor 4e, putative 
52 
 
Tb927.11.3850 AMP deaminase, putative 
Tb927.4.1680 ZFP family member, putative (ZC3H10) 
53 
 
Tb927.4.2630 ATP-dependent DEAD/H RNA helicase, putative 
Tb927.4.4160 mitochondrial RNA binding protein (MRB4160) 
54 
 
Tb927.6.1200 hypothetical protein, conserved 
Tb927.7.930 zinc finger CCCH domain containing protein 17 (ZC3H17) 
55 
 
Tb927.5.3900 Galactose oxidase, central domain/Domain of unknown function 
(DUF4110), putative 
Tb927.6.1990 hypothetical protein, conserved 
56 
 
Tb927.11.4160 predicted C2 domain protein 
Tb927.6.3310 calpain-like cysteine peptidase, putative, cysteine peptidase, Clan 
CA, family C2, putative 
57 
 
Tb927.6.2170 co-chaperone GrpE, putative 
Tb927.6.4000 small glutamine-rich tetratricopeptide repeat protein, putative, 
(SGT) 
58 
 
Tb927.10.600 hypothetical protein, conserved 
Tb927.6.4200 hypothetical protein, conserved 
59 
 
Tb927.11.2640 ras-like small GTPase, putative (TbNST) 
Tb927.6.4750 hypothetical protein, conserved 
60 
 
Tb927.7.1360 hypothetical protein, conserved 
Tb927.7.7140 Vta1 like, putative 
61 
 
Tb927.11.10330 Regulator of chromosome condensation (RCC1) repeat, putative 
Tb927.7.970 NMD3 family, putative 
62 
 
Tb927.8.1420 acyl-CoA dehydrogenase, mitochondrial precursor, putative 
Tb927.8.1740 hypothetical protein, conserved 
63 
 
Tb927.11.10760 kinesin-like protein, putative 
Tb927.8.2630 kinesin, putative 
64 
 
Tb927.8.4400 hypothetical protein, conserved 
Tb927.9.8820 hypothetical protein, conserved 
65 
 
Tb927.8.1090 NPAPL (NPAPL) 
Tb927.8.4870 DIGIT 
66 
 
Tb927.10.15410 glycosomal malate dehydrogenase (gMDH) 
Tb927.9.11940 replication factor A protein 3, putative 
67 
 
Tb927.7.4500 PX domain containing protein, putative 
Tb927.9.13380 phosphoinositide-binding protein, putative 
68 
 
Tb927.9.5040 cAMP-specific phosphodiesterase (PDEB1) 
Tb927.9.5100 cAMP-specific phosphodiesterase (PDEB2) 
69 
 
Tb927.11.1840 hypothetical protein, conserved 
Tb927.6.5070 hypothetical protein, conserved 
70 Tb927.10.8940 flagellum targeting protein kharon1, putative (KH1) 
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 Tb927.3.3750 paraflagellar rod component, putative (PFC7) 
71 
 
Tb927.10.4330 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial 
precursor, putative 
Tb927.10.660 2-oxoisovalerate dehydrogenase alpha subunit, putative 
72 
 
Tb927.11.6740 pumilio/PUF RNA binding protein 10, putative 
Tb927.7.2170 hypothetical protein, conserved 
73 
 
Tb927.1.1000 developmentally regulated phosphoprotein 
Tb927.11.4780 pyruvate dehydrogenase (lipoamide) kinase, putative 
74 
 
Tb927.10.15520 signal recognition particle protein, putative 
Tb927.4.1850 hypothetical protein, conserved 
Tb927.5.3800 glutamine hydrolysing (not ammonia-dependent) carbomoyl 
phosphate synthase, putative 
75 
 
Tb927.10.14150 nuclear segregation protein, putative 
Tb927.11.6440 hypothetical protein, conserved 
Tb927.6.4770 protein mkt1, putative (MKT1) 
76 
 
Tb927.10.170 pseudouridine synthase, Cbf5p 
Tb927.4.470 snoRNP protein GAR1, putative 
Tb927.4.750 50S ribosomal protein L7Ae, putative 
77 
 
Tb927.10.2720 hypothetical protein, conserved 
Tb927.10.6680 member of the NOL1/NOP2/sun family of proteins 
Tb927.10.9050 pseudouridine synthase TruD, putative, tRNA pseudouridine 
synthase TruD, putative (pus7) 
78 
 
Tb927.11.13740 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.11.17040 expression site-associated gene 4 (ESAG4) protein, putative, 
receptor-type adenylate cyclase, putative 
Tb927.7.7470 receptor-type adenylate cyclase GRESAG 4, putative 
79 
 
Tb927.10.3150 N-acetyltransferase, putative 
Tb927.10.5670 N-acetyltransferase subunit Nat1, putative (NAT1) 
Tb927.11.4530 N-acetyltransferase subunit ARD1 (ARD1) 
80 
 
Tb927.11.11330 heat shock protein 70 
Tb927.11.7510 glucose-regulated protein 78, putative, luminal binding protein 1 
(BiP), putative (BiP) 
Tb927.6.3800 heat shock 70 kDa protein, mitochondrial precursor, putative 
81 
 
Tb927.2.4540 Small nuclear ribonucleoprotein-associated protein B (snRNP-B) 
(Sm protein B) (Sm-B) (SmB), putative (TbSmB) 
Tb927.2.5850 small nuclear ribonucleoprotein SmD2 (Sm-D2) 
Tb927.4.890 small nuclear ribonucleoprotein SmD3, putative (SmD3) 
82 
 
Tb927.3.2280 vacuolar sorting protein 33 , putative 
Tb927.8.3370 Ran-binding protein, putative 
Tb927.8.6270 hypothetical protein, conserved 
83 
 
Tb927.11.5840 Protein translation factor SUI1 homolog, putative 
Tb927.3.3300 hypothetical protein, conserved 
Tb927.8.6240 STOP axonemal protein 
84 
 
Tb927.11.4460 ALBA-Domain Protein (ALBA1) 
Tb927.4.2030 ALBA-Domain Protein (ALBA4) 
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Tb927.4.2040 ALBA-Domain Protein (ALBA3) 
85 
 
Tb927.10.8030 hypothetical protein, conserved 
Tb927.11.6250 hypothetical protein, conserved 
Tb927.5.1780 hypothetical protein, conserved 
86 
 
Tb927.11.13960 U6 snRNA-associated Sm-like protein LSm4p (TbLSm4) 
Tb927.5.4030 U6 snRNA-associated Sm-like protein LSm7p (TbLSm7) 
Tb927.8.2850 Poly(A)-specific ribonuclease PARN-1 
87 
 
Tb927.10.10590 histone H2B, putative 
Tb927.5.4260 histone H4, putative 
Tb927.7.2940 histone H2A, putative 
88 
 
Tb927.10.10010 60S acidic ribosomal protein, putative 
Tb927.10.1900 DNA topoisomerase IA, putative 
Tb927.5.4420 nucleolar RNA helicase II, putative, nucleolar RNA helicase Gu, 
putative 
89 
 
Tb927.7.6280 Domain of unknown function (DUF3508), putative 
Tb927.8.1560 hypothetical protein, conserved 
90 
 
Tb11.v5.0394 hypothetical protein, conserved 
Tb927.6.2010 AMP-binding enzyme, putative 
Tb927.6.740 ATP-dependent DEAH-box RNA helicase, putative 
91 
 
Tb927.3.1010 hypothetical protein, conserved 
Tb927.7.2640 hypothetical protein, conserved 
Tb927.9.10400 hypothetical protein, conserved 
92 
 
Tb927.10.3580 hypothetical protein, conserved 
Tb927.11.2530 Mitochondrial SSU ribosomal protein, putative, mitochondrial 
RNA binding complex 1 subunit 
Tb927.7.3050 hypothetical protein, conserved 
93 
 
Tb927.11.1680 vesicular-fusion protein SEC18, putative 
Tb927.7.1100 hypothetical protein, conserved 
Tb927.7.3810 'Cold-shock' DNA-binding domain containing protein, putative 
94 
 
Tb927.2.4230 NUP-1 protein, putative 
Tb927.7.3330 hypothetical protein, conserved 
Tb927.8.3870 SRP40, C-terminal domain containing protein, putative 
95 
 
Tb927.11.3830 hypothetical protein, conserved 
Tb927.8.5090 DNA-directed RNA polymerase I largest subunit (RPA190) 
Tb927.9.2120 hypothetical protein, conserved 
96 
 
Tb927.10.7230 hypothetical protein, conserved 
Tb927.3.3520 hypothetical protein, conserved (POMP25) 
Tb927.9.3400 endo-beta-N-acetylglucosaminidase, putative 
97 
 
Tb927.11.16200 cytoskeleton-associated protein 17, corset-associated protein 17 
(CAP17) 
Tb927.8.6440 RNA-binding protein, putative (RPB20) 
Tb927.9.9060 Lsm12 protein, putative 
98 
 
Tb927.3.1600 Tim10/DDP family zinc finger, putative 
Tb927.9.1350 hypothetical protein, conserved 
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99 
 
Tb927.10.5840 translation elongation factor 1-beta, putative 
Tb927.10.7940 methyltransferase, putative 
Tb927.11.13190 elongation factor 1 gamma, putative 
Tb927.11.16490 hypothetical protein, conserved 
Tb927.4.3590 translation elongation factor 1-beta, putative 
100 
 
Tb927.11.12670 Methyltransferase TYW3, putative 
Tb927.11.7080 acidocalcisomal pyrophosphatase 
Tb927.8.2050 GDP-mannose pyrophosphorylase 
Tb927.9.1880 WD domain, G-beta repeat, putative 
101 
 
Tb927.1.1030 leucine-rich repeat protein (LRRP), putative 
Tb927.10.2570 lysosomal alpha-mannosidase precursor, putative 
Tb927.11.6670 hypothetical protein, conserved 
Tb927.4.1520 Pestivirus Npro endopeptidase C53, putative 
102 
 
Tb927.11.1050 Ribosome production factor 1, putative 
Tb927.11.3120 nucleolar GTP-binding protein 1 (NOG1) 
Tb927.11.6790 predicted WD40 repeat protein 
Tb927.6.3790 valosin-containing protein homolog, putative, AAA ATPase 
103 
 
Tb927.10.11170 hypothetical protein, conserved 
Tb927.11.10840 hypothetical protein, conserved 
Tb927.11.7770 oxidoreductase-like protein 
Tb927.9.12780 Leucine carboxyl methyltransferase/Cupin-like domain containing 
protein, putative 
104 
 
Tb927.5.1840 hypothetical protein, conserved 
Tb927.8.6900 transport protein particle (TRAPP) component, putative 
105 
 
Tb927.10.6120 Peptidase M76 family, putative 
Tb927.3.2300 DNL zinc finger, putative 
Tb927.6.2990 Putative papain-like cysteine peptidase (DUF1796), putative 
106 
 
Tb927.4.360 1,2-Dihydroxy-3-keto-5-methylthiopentene dioxygenase, putative 
Tb927.6.3600 hypothetical protein, conserved 
107 
 
Tb927.6.4530 RNA-binding protein, putative (RBP17) 
Tb927.7.5760 nuclear transport factor 2 protein, putative, mRNA transport 
regulator MTR2, putative, nuclear transport factor, nuclear 
transport factor 2 protein, putative (MTR2) 
Tb927.9.9450 zinc finger protein family member, putative (ZC3H28) 
108 
 
Tb927.10.13270 Periodic tryptophan protein 2 homolog, putative 
Tb927.11.10480 PQQ-like domain/WD domain, G-beta repeat/Utp21 specific 
WD40 associated putative domain containing protein, putative 
Tb927.11.460 predicted WD40 repeat protein 
Tb927.7.4220 WD domain, G-beta repeat/Dip2/Utp12 Family, putative 
109 
 
Tb927.10.13720 RNA-binding protein 29, putative (RBP29) 
Tb927.11.10540 hypothetical protein, conserved 
110 
 
Tb927.3.2490 hypothetical protein, conserved 
Tb927.6.1770 kinesin, putative 
Tb927.9.15470 kinesin, putative 
Supplementary Tables 
 
 
 
!
172 
Tb927.9.9730 hypothetical protein, conserved 
111 
 
Tb927.6.4300 glyceraldehyde 3-phosphate dehydrogenase, glycosomal (GAPDH) 
Tb927.8.2000 cyclophilin, putative (NCP1) 
Tb927.8.3530 glycerol-3-phosphate dehydrogenase [NAD+], glycosomal 
Tb927.9.8720 fructose-1,6-bisphosphatase (FBPase) 
112 
 
Tb927.10.15800 actin related protein 2, putative 
Tb927.10.4540 ARP2/3 complex subunit, putative 
Tb927.2.2900 ARP2/3 complex subunit, putative 
Tb927.8.4410 ARP2/3 complex subunit, putative 
Tb927.9.5350 actin related protein 3, putative 
113 
 
Tb927.11.6630 3-methylcrotonoyl-CoA carboxylase beta subunit, putative 
Tb927.3.4390 dihydrolipoamide dehydrogenase, putative (GCVL-1) 
Tb927.4.5040 dihydrolipoamide dehydrogenase, putative 
Tb927.8.6970 3-methylcrotonyl-CoA carboxylase alpha subunit, putative 
Tb927.8.7380 dihydrolipoamide dehydrogenase, point mutation, acetoin 
dehydrogenase e3 component, putative 
114 
 
Tb927.1.3180 40S ribosomal protein S11, putative 
Tb927.10.14930 Zinc finger CCCH domain-containing protein 39 (ZC3H39) 
Tb927.11.6300 40S ribosomal protein S5, putative 
Tb927.7.4910 hypothetical protein, conserved 
115 
 
Tb927.11.8030 hypothetical protein, conserved 
Tb927.3.3030 START domain containing protein, putative 
Tb927.5.780 hypothetical protein, conserved 
Tb927.7.3370 hypothetical protein, conserved 
116 
 
Tb927.5.2320 Mak10 subunit, NatC N(alpha)-terminal acetyltransferase, putative 
Tb927.7.2080 methyltransferase, putative, mRNA cap methyltransferase-like 
protein 
Tb927.7.2360 N-acetyltransferase, putative 
Tb927.8.960 hypothetical protein, conserved 
Tb927.9.4500 heat shock protein, putative, HSP70-like protein 
117 
 
Tb927.11.11080 Nucleoporin (TbNup149) 
Tb927.11.6170 protein transport protein SEC31, putative 
Tb927.11.7900 mitochondrial RNA binding protein 16 (RBP16) 
Tb927.7.320 hypothetical protein, conserved (TbRBP8) 
Tb927.9.3760 poly(A) export protein, putative (TbGLE2) 
118 
 
Tb927.11.8270 hypothetical protein, conserved 
Tb927.5.2530 Domain of unknown function (DUF1726)/Helicase/GNAT 
acetyltransferase 2/Possible tRNA binding domain containing 
protein, putative 
Tb927.8.1980 UTP15 C terminal, putative 
119 
 
Tb927.5.4270 ATP-dependent DEAD/H RNA helicase, putative 
Tb927.8.4820 eukaryotic translation initation factor 4 gamma, putative (eIF4G3) 
120 
 
Tb927.10.2770 eukaryotic translation initiation factor 5, putative 
Tb927.11.11010 hypothetical protein, conserved 
Supplementary Tables 
 
 
 
!
173 
121 
 
Tb927.10.11210 hypothetical protein, conserved 
Tb927.11.12230 ATP-dependent protease ATPase subunit HslU2 (HslU2) 
Tb927.2.3800 MRB1-associated protein, guide RNA associated protein 1 (GAP1) 
Tb927.3.2900 eukaryotic initiation factor 2a, putative 
Tb927.7.2570 guide RNA associated protein, GAP2, mitochondrial RNA binding 
protein 1 
122 
 
Tb927.10.14700 hypothetical protein, conserved 
Tb927.3.3610 peroxisomal targeting signal 2 receptor, putative, Peroxin-7, 
putative, PTS2 receptor, putative (PEX7) 
Tb927.8.5780 phosphatase of regenerating liver-type phosphatase, putative 
123 
 
Tb927.10.5860 hypothetical protein, conserved 
Tb927.11.16220 hypothetical protein, conserved 
Tb927.4.1080 V-type ATPase, A subunit, putative 
124 
 
Tb927.11.8100 Ankyrin repeats (3 copies), putative 
Tb927.5.1280 alanine racemase, putative 
125 
 
Tb927.11.14490 RNA polymerase subunit, putative (RPB7) 
Tb927.8.6580 succinate dehydrogenase flavoprotein, putative 
Tb927.8.6920 hypothetical protein, conserved 
126 
 
Tb927.1.3050 tRNA (Uracil-5-)-methyltransferase, putative 
Tb927.10.3630 hypothetical protein, conserved 
Tb927.11.13280 mitochondrial RNA binding protein 2 (GBP25) 
Tb927.11.1550 XRN 5'-3' exonuclease N-terminus, putative 
Tb927.11.1710 mitochondrial RNA binding protein 1, guide RNA-binding protein 
of 21 kDa (gBP21) 
Tb927.3.1590 mitochondrial RNA binding complex 1 subunit (MRB1590) 
Tb927.3.3230 NOL1/NOP2/sun family, putative 
127 
 
Tb927.10.6220 5'-3' exoribonuclease D (XRND) 
Tb927.3.1040 unspecified product 
Tb927.5.2790 mitochondrial DNA polymerase beta-PAK (Pol beta-PAK) 
Tb927.5.4040 hypothetical protein, conserved 
Tb927.7.6800 Alpha/beta hydrolase family, putative 
Tb927.9.5590 DNA topoisomerase ii (TOP2) 
128 
 
Tb927.10.5770 Transitional endoplasmic reticulum ATPase, putative, Valosin-
containing protein, Cell division control protein 48 (VCP) 
Tb927.10.9430 phosphoribosylpyrophosphate synthetase, putative (PRS) 
Tb927.11.3030 phosphoribosylpyrophosphate synthetase, putative (PRS) 
Tb927.5.2960 phosphoribosylpyrophosphate synthetase, putative (PRS) 
Tb927.5.3170 ribose-phosphate pyrophosphokinase, putative (PRPS5) 
Tb927.7.6910 Phosphatidylinositol 4-phosphate 5-kinase, putative, MORN 
repeat-containing protein 
Tb927.8.7100 acetyl-CoA carboxylase 
129 
 
Tb927.10.1060 T-complex protein 1, delta subunit, putative (TCP-1-delta) 
Tb927.10.8190 T-complex protein 1, theta subunit, putative, CCT-theta, putative 
Tb927.11.14250 T-complex protein 1, epsilon subunit, putative (TCP-1-epsilon) 
Tb927.11.16760 T-complex protein 1, alpha subunit, putative (TCP-1-alpha) 
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Tb927.11.1900 T-complex protein 1, beta subunit, putative 
Tb927.11.3240 T-complex protein 1, zeta subunit, putative (TCP-1-zeta) 
Tb927.8.3150 T-complex protein 1, gamma subunit, putative (TCP-1-gamma) 
Tb927.9.11270 T-complex protein 1, eta subunit, putative, t- complex protein 1 
(eta subunit), putative (TCP-1-eta) 
130 
 
Tb927.10.180 ATP synthase F1 subunit gamma protein, putative 
Tb927.10.5050 Mitochondrial ATP synthase epsilon chain, putative 
Tb927.11.13070 O-phosphoseryl-tRNA(Sec) selenium transferase, putative 
Tb927.3.1380 ATP synthase subunit beta, mitochondrial, ATP synthase F1, beta 
subunit (ATPB) 
Tb927.3.3410 aspartyl aminopeptidase, putative, metallo-peptidase, Clan MH, 
Family M20 
Tb927.5.1710 ribonucleoprotein p18, mitochondrial precursor, putative 
Tb927.6.4990 ATP synthase, epsilon chain, putative 
Tb927.7.7430 ATP synthase alpha chain, mitochondrial precursor, ATP synthase 
F1, alpha subunit 
131 
 
Tb927.3.1680 hypothetical protein, conserved 
Tb927.3.5470 hypothetical protein, conserved 
Tb927.4.3560 protein phoshatase 1, putative 
Tb927.8.4220 hypothetical protein, conserved 
132 
 
Tb927.10.5860 hypothetical protein, conserved 
Tb927.5.3970 adenylate kinase, putative (ADKE) 
Tb927.6.2790 L-threonine 3-dehydrogenase, putative 
Tb927.7.5160 deoxyuridine triphosphatase, putative, dUTP diphosphatase 
133 
 
Tb927.10.13950 tubulin-specific chaperone, putative 
Tb927.11.8770 ATP-dependent RNA helicase FAL1, putative 
Tb927.8.1990 peroxidoxin (TRYP2) 
134 
 
Tb927.1.1200 SSU ribosomal protein, mitochondrial (MRPS15) 
Tb927.10.7380 hypothetical protein, conserved 
Tb927.11.11630 hypothetical protein, conserved 
Tb927.11.1250 Mitochondrial SSU ribosomal protein, putative 
Tb927.11.6000 ribosomal protein L4/L1 family, putative 
Tb927.11.870 hypothetical protein, conserved 
Tb927.2.4890 ribosomal protein L11, putative 
Tb927.3.5610 ribosomal protein L3 mitochondrial, putative 
Tb927.5.3980 hypothetical protein, conserved 
Tb927.5.4120 hypothetical protein, conserved 
Tb927.6.2080 hypothetical protein, conserved 
Tb927.6.4560 hypothetical protein, conserved 
Tb927.7.2760 ribosomal protein L22p/L17e, putative 
Tb927.7.3030 hypothetical protein, conserved 
Tb927.7.4140 ribosomal protein L21, putative 
Tb927.8.5200 hypothetical protein, conserved 
Tb927.9.7170 Mitochondrial 39-S ribosomal protein L47 (MRP-L47), putative 
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Tb927.9.8290 hypothetical protein, conserved 
135 
 
Tb927.11.7170 seryl-tRNA synthetase 
Tb927.5.4560 guanine deaminase, putative, guanase, putative, guanine aminase, 
putative, guanine aminohydrolase, putative 
Tb927.8.1020 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 
Tb927.9.7550 adenylosuccinate lyase, putative (ADSL) 
136 
 
Tb927.10.8880 hypothetical protein 
Tb927.9.12910 unspecified product 
137 
 
Tb927.10.2350 pyruvate dehydrogenase complex E3 binding protein, putative 
Tb927.9.7550 adenylosuccinate lyase, putative (ADSL) 
138 
 
Tb927.10.10140 paraflagellar rod component, putative (PFC19) 
Tb927.10.3710 proteasome activator protein PA26 (pa26) 
Tb927.10.8060 SET domain containing protein, putative 
Tb927.10.8360 Poly(A)-specific ribonuclease PARN-2 
Tb927.11.2630 diphthamide biosynthesis enzyme Dph1/Dph2 domain containing 
protein, putative 
139 
 
Tb927.10.1930 hypothetical protein, conserved 
Tb927.6.1830 WD domain, G-beta repeat, putative 
Tb927.6.2380 hypothetical protein, conserved 
Tb927.7.2450 hypothetical protein, conserved 
Tb927.7.2520 Uncharacterised protein family UPF0066, putative 
Tb927.7.4970 glutamine synthetase, putative (GS) 
140 
 
Tb927.10.7550 hypothetical protein, conserved 
Tb927.11.7520 hypothetical protein, conserved 
Tb927.3.3330 heat shock protein 20, putative 
Tb927.8.2020 agmatinase, putative 
141 
 
Tb927.2.1890 E2-like ubiquitin-conjugation enzyme (ATG3) 
Tb927.6.4950 mago nashi-like protein, putative 
142 
 
Tb927.11.14120 phenylalanyl-tRNA synthetase alpha chain, putative 
Tb927.4.1270 ruvB-like DNA helicase, putative 
Tb927.4.2000 ruvB-like DNA helicase, putative (RUVBL) 
Tb927.6.4670 MORN repeat-containing protein 1 (MORN1) 
Tb927.7.5290 hypothetical protein, conserved 
Tb927.9.5900 glutamate dehydrogenase (GDH) 
143 
 
Tb927.1.3000 amidohydrolase, putative 
Tb927.10.14140 pyruvate kinase 1 (PYK1) 
Tb927.11.6590 aminopeptidase, putative, metallo-peptidase, Clan MF, Family M17 
Tb927.6.2970 pseudouridine synthase A-like protein, putative 
Tb927.7.3770 YjeF family N-terminal domain/YjeF family C-terminal domain 
containing protein, putative 
Tb927.9.7540 calpain-like cysteine peptidase, putative, cysteine peptidase, Clan 
CA, family C2, putative 
144 
 
Tb927.10.14680 ribosome biogenesis protein, putative 
Tb927.10.8200 Ribosomal protein L1p/L10e family, putative 
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Tb927.11.1390 class I transcription factor A, subunit 1 (CITFA-1) 
Tb927.11.14020 RNA-binding protein (NRBD2) 
Tb927.11.1410 class I transcription factor A, subunit 3 (CITFA-3) 
Tb927.11.14960 pumilio/PUF RNA binding protein 7, putative (PUF7) 
Tb927.11.1670 cysteine desulfurase 
Tb927.3.1350 hypothetical protein, conserved 
Tb927.3.2830 brix domain containing protein, putative 
Tb927.5.2080 guanosine monophosphate reductase, putative 
Tb927.5.840 KRI1-like family/KRI1-like family C-terminal, putative 
Tb927.5.970 class I transcription factor A, subunit 6 (CITFA-6) 
Tb927.6.2050 ribosome biogenesis regulatory protein (RRS1), putative 
Tb927.7.270 ribosome biogenesis protein, putative 
Tb927.8.5040 EMG1/NEP1 methyltransferase, putative 
Tb927.9.15060 rRNA processing protein, putative 
145 
 
Tb927.10.11130 SET domain containing protein, putative 
Tb927.10.12710 heat shock protein 110, putative 
Tb927.11.6370 leucine-rich repeat protein (LRRP), putative 
146 
 
Tb927.11.16020 RNA-binding protein, putative (DRBD10) 
Tb927.11.16400 kinetoplast-associated protein 3, putative (KAP3) 
Tb927.11.4690 mitochondrial DNA polymerase I protein B (POLIB) 
147 
 
Tb927.10.1930 hypothetical protein, conserved 
Tb927.10.2490 glucose-6-phosphate 1-dehydrogenase (G6PD) 
Tb927.10.7420 bromodomain factor 2 protein, putative 
148 
 
Tb11.v5.0325 retrotransposon hot spot (RHS) protein, putative 
Tb11.v5.0713 retrotransposon hot spot (RHS) protein, putative 
Tb927.11.2630 diphthamide biosynthesis enzyme Dph1/Dph2 domain containing 
protein, putative 
Tb927.3.4040 Ankyrin repeats (3 copies), putative 
149 
 
Tb927.11.15280 tRNA-sepcific adenosine deaminase (ADAT3) 
Tb927.8.4180 tRNA-specific adenosine deaminase (ADAT2) 
150 
 
Tb927.5.1270 hypothetical protein, conserved 
Tb927.9.10200 hypothetical protein, conserved 
Tb927.9.10880 hypothetical protein, conserved 
151 
 
Tb927.10.7140 membrane-bound acid phosphatase 2 (MBAP2) 
Tb927.8.5720 Met-10+ like-protein, putative 
152 
 
Tb927.1.1220 RWD domain-containing protein 
Tb927.10.13650 ARF-like 2-binding protein, putative 
Tb927.11.13690.1 unspecified product 
Tb927.6.2860 WD domain, G-beta repeat, putative 
Tb927.6.4420 tRNA (Guanine-1)-methyltransferase, putative 
Tb927.9.9020 ribosome-interacting GTPase 2, putative (RBG2) 
153 
 
Tb927.11.1300 UBA/TS-N domain containing protein, putative 
Tb927.3.4340 diphthamide synthesis protein, putative 
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Tb927.6.2940 phosphopantothenoylcysteine decarboxylase, putative (PPCDC) 
Tb927.9.12830 hypothetical protein, conserved 
154 
 
Tb927.10.2990 nuclear cap binding complex subunit CBP110 (CBP110) 
Tb927.7.6270 peptidase t, putative, aminotripeptidase, putative 
155 
 
Tb927.10.8060 SET domain containing protein, putative 
Tb927.11.11290 heat shock protein 70, putative 
Tb927.7.6620 Probable N6-adenine methyltransferase, putative 
156 
 
Tb927.10.3950 hypothetical protein, conserved 
Tb927.5.1460 Possible lysine decarboxylase, putative 
Tb927.5.3520 queuine tRNA-ribosyltransferase, putative 
Tb927.6.3130 queuine tRNA-ribosyltransferase, putative 
Tb927.9.5190 proliferative cell nuclear antigen (PCNA), putative 
157 
 
Tb927.11.16510 hypothetical protein, conserved 
Tb927.6.4210 aldehyde dehydrogenase, putative (ALDH) 
Tb927.9.9710 Histidine phosphatase superfamily (branch 1), putative 
158 
 
Tb927.10.8290 eukaryotic translation initiation factor 3 subunit 8, putative 
Tb927.7.6090 hypothetical protein, conserved 
159 
 
Tb927.6.4920 S-adenosylmethionine synthetase, putative (METK1) 
Tb927.7.6450 tRNA-dihydrouridine synthase 3, putative 
160 
 
Tb927.10.12710 heat shock protein 110, putative 
Tb927.6.670 ribosomal RNA processing protein 45, exosome complex 
exonuclease (RRP45) 
Tb927.7.710 heat shock 70 kDa protein, putative (HSP70) 
161 
 
Tb927.11.10240 hslVU complex proteolytic subunit, threonine peptidase, Clan T(1), 
family T1B, ATP-dependent protease subunit HslV (HsIV) 
Tb927.11.14120 phenylalanyl-tRNA synthetase alpha chain, putative 
Tb927.11.2360 phenylalanyl-tRNA synthetase (beta subunit), putative 
162 
 
Tb927.10.7110 inositol-3-phosphate synthase, putative 
Tb927.11.16770 glucosamine-6-phosphate isomerase, putative 
163 
 
Tb927.11.7060 acidocalcisomal pyrophosphatase 
Tb927.2.450 retrotransposon hot spot protein 4 (RHS4), putative 
Tb927.3.1550 Rab3 GTPase-activating protein catalytic subunit, putative 
Tb927.5.3430 ubiquitin-activating enzyme E1, putative 
Tb927.9.7540 calpain-like cysteine peptidase, putative, cysteine peptidase, Clan 
CA, family C2, putative 
164 
 
Tb927.10.11310 intraflagellar transport protein 57/55 (IFT57/55) 
Tb927.10.13860 GPI-anchor transamidase subunit 8 (GPI8) 
Tb927.10.4040 3-keto-dihydrosphingosine reductase 
Tb927.10.4610 dolicholphosphate-mannose synthase, putative (DPMS) 
Tb927.11.13820 hypothetical protein, conserved 
Tb927.11.15760 GPI transamidase subunit Tta1 (TTA1) 
Tb927.2.1810 transcription silencer (ISWI) 
Tb927.5.1930 signal peptidase subunit, putative 
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Tb927.8.5760 Ankyrin repeats (many copies)/Alpha/beta hydrolase family, 
putative 
165 
 
Tb927.1.4690 arginine N-methyltransferase (PRMT1) 
Tb927.10.12980 Multisite-specific tRNA:(cytosine-C(5))-methyltransferase, 
putative 
Tb927.10.14750 fibrillarin, putative 
Tb927.10.1960 hypothetical protein, conserved 
Tb927.10.3560 arginine N-methyltransferase, putative 
Tb927.10.7500 fibrillarin (NOP1) 
Tb927.8.3750 Nucleolar protein 56, putative (NOP56) 
Tb927.8.900 splicing factor TSR1 (TSR1) 
Tb927.9.5320 nucleolar RNA binding protein, putative 
Tb927.9.6870 RNA-binding protein, putative (RBSR1) 
166 
 
Tb927.3.640 hypothetical protein, conserved 
Tb927.5.1020 disulfide isomerase, putative 
Tb927.6.1140 dolichyl-P-Man:GDP-Man5GlcNAc2-PP-dolichyl alpha-1,2-
mannosyltransferase, putative (ALG9) 
Tb927.6.1810 Alpha/beta hydrolase family, putative 
Tb927.9.3770 hypothetical protein, conserved 
167 
 
Tb927.10.2940 Soluble NSF attachment protein, SNAP, putative 
Tb927.7.2260 SEP domain containing protein, putative 
168 
 
Tb927.10.390 DUF2407 ubiquitin-like domain containing protein, putative 
Tb927.7.6850 trans-sialidase (TS) 
169 
 
Tb927.11.10960 2OG-Fe(II) oxygenase superfamily, putative 
Tb927.8.4100 hypothetical protein, conserved 
170 
 
Tb927.5.930 NADH-dependent fumarate reductase (FRDg) 
Tb927.7.2440 pyrroline-5-carboxylate reductase, putative (P5CR) 
171 
 
Tb927.11.11380 hypothetical protein, conserved 
Tb927.6.650 hypothetical protein, conserved 
172 
 
Tb927.11.9700 nascent polypeptide associated complex alpha subunit, putative 
Tb927.7.5490 arginine N-methyltransferase, type III (PRMT7) 
173 
 
Tb927.1.2750 hypothetical protein, conserved 
Tb927.7.5680 deoxyribose-phosphate aldolase, putative 
174 
 
Tb927.10.8720 CCR4-NOT transcription complex subunit 10, putative 
Tb927.8.1960 hypothetical protein, conserved 
175 
 
Tb927.8.1590 ubiquitin-protein ligase, putative (upl3) 
Tb927.9.13610 helicase, putative 
176 
 
Tb927.1.120 retrotransposon hot spot protein 4 (RHS4), putative 
Tb927.9.13990 RNA-binding protein, putative (DRBD2) 
177 
 
Tb927.9.15150 unspecified product 
Tb927.9.4200 fatty acyl CoA synthetase 2 (ACS2) 
178 
 
Tb927.4.1250 peroxisome biogenesis factor 1, putative 
Tb927.5.3920 peroxisome assembly protein, putative 
179 Tb11.v5.0746 tatD related deoxyribonuclease, putative 
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 Tb927.10.4640 eukaryotic translation initiation factor 3 subunit L, putative 
(EIF3L) 
Tb927.11.15420 COP9 signalosome, subunit CSN8, putative 
180 
 
Tb927.11.15430 U5 small nuclear ribonucleoprotein component, putative, U5 snrnp-
specific protein, putative 
Tb927.5.2290 ATP-dependent RNA helicase, putative 
Tb927.9.11110 PRP8 protein homologue, U5 snRNA-associated splicing factor 
181 
 
Tb927.11.14200 ubiquitin-conjugating enzyme E2, putative 
Tb927.7.1020 hypothetical protein, conserved 
Tb927.8.5880 eukaryotic translation initiation factor 1A, putative 
182 
 
Tb927.11.2340 hypothetical protein, conserved 
Tb927.11.2370 mRNA export factor MEX67, Nuclear RNA export factor 
(MEX67) 
Tb927.5.4380 kinetoplastid-specific phospho-protein phosphatase, putative 
Tb927.8.1840 Sec7 domain containing protein, putative 
183 
 
Tb927.3.4850 enoyl-CoA hydratase, mitochondrial precursor, putative 
Tb927.6.4540 3-hydroxy-3-methylglutaryl-CoA reductase, putative 
Tb927.7.1080 hypothetical protein, conserved 
Tb927.8.5510 apurinic/apyrimidinic endonuclease, putative 
184 
 
Tb927.10.14180 protein transport protein SEC13, putative 
Tb927.11.3770 Dpy-30 motif containing protein, putative 
Tb927.8.4790 Putative snoRNA binding domain containing protein, putative 
Tb927.9.5410 hypothetical protein, conserved 
185 
 
Tb927.10.1490 Temperature dependent protein affecting M2 dsRNA replication, 
putative 
Tb927.6.2640 importin alpha subunit, putative (TbKap60) 
186 
 
Tb927.11.230 cleavage and polyadenylation specificity factor, putative 
Tb927.4.1340 cleavage and polyadenylation specificity factor subunit, putative 
(CPSF3) 
187 
 
Tb927.10.11300 paraflagellar rod component, putative (PFC16) 
Tb927.6.4140 paraflagellar rod component, putative (PFC4) 
188 
 
Tb927.11.9880 Protein of unknown function (DUF2009), putative 
Tb927.9.10690 Protein of unknown function (DUF2009), putative 
189 
 
Tb927.1.2570 coatomer beta subunit (beta-coP) 
Tb927.10.7060 nucleoporin interacting component (NUP93), putative 
Tb927.11.11900 Coatomer subunit gamma (COPG) 
Tb927.11.14970 hypothetical protein, conserved 
Tb927.11.5400 signal recognition particle 54 kDa (SRP54) 
Tb927.7.1920 paraflagellar rod component, putative (PFC5) 
190 
 
Tb927.1.3830 glucose-6-phosphate isomerase, glycosomal (PGI) 
Tb927.10.13430 citrate synthase, putative 
Tb927.9.12110 6-phosphogluconate dehydrogenase, decarboxylating (gnD) 
191 
 
Tb927.4.3950 cytoskeleton-associated protein CAP5.5, putative, cysteine 
peptidase, Clan CA, family C2, putative, Calpain-like protein 1 
(CAP5.5) 
Tb927.9.2470 nucleolar protein (NOP86) 
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192 
 
Tb927.4.2670 Cysteine peptidase, Clan CF, family C15, pyroglutamyl-peptidase 
I, putative (PPI) 
Tb927.5.950 monothiol glutaredoxin, putative 
Tb927.7.6890 methyltransferase domain containing protein, putative 
Tb927.8.4930 hypothetical protein, conserved 
Tb927.9.7000 methyltransferase domain containing protein, putative 
193 
 
Tb927.3.860 Acyl carrier protein, mitochondrial, NADH-ubiquinone 
oxidoreductase complex I subunit, putative (ACP) 
Tb927.9.9840 lipoic acid containing carrier protein, putative (GCVH) 
194 
 
Tb927.11.180 electron transfer flavoprotein, putative 
Tb927.11.7540 electron-transfer-flavoprotein, alpha polypeptide, putative 
195 
 
Tb927.11.14870 NAD+ synthase, putative 
Tb927.4.2700 Hydroxymethylglutaryl-CoA lyase, mitochondrial, putative 
196 
 
Tb927.4.3350 N2227-like protein, putative 
Tb927.9.1510 D-ala D-ala ligase C-terminus/SET domain containing protein, 
putative 
197 
 
Tb927.5.2690 inositol-1(or 4)-monophosphatase 1, putative (IMPase 1) 
Tb927.9.6350 inositol-1(or 4)-monophosphatase, putative (IMPase) 
198 
 
Tb927.5.1000 ubiquitin-conjugating enzyme E2, putative, ubiquitin carrier 
protein, putative, ubiquitin-protein ligase, putative 
Tb927.9.1520 hypothetical protein, conserved 
199 
 
Tb927.7.4360 hypothetical protein, conserved 
Tb927.8.6930 serine/threonine-protein kinase NrkA (NRKB) 
200 
 
Tb927.6.2330 RGG protein (RGG1) 
Tb927.7.1790 Adenine phosphoribosyltransferase, putative 
201 
 
Tb927.6.2200 DJ-1 family protein, putative 
Tb927.8.1440 maoC-like dehydratase, putative 
202 
 
Tb927.10.8920 ras-like small GTPase, putative (TbGRP) 
Tb927.11.3320 ras-like small GTPase, putative (TbGTR) 
203 
 
Tb927.11.3310 ubiquitin-conjugating enzyme, putative 
Tb927.9.8000 ubiquitin-conjugating enzyme E2, putative, ubiquitin carrier 
protein, putative, ubiquitin-protein ligase, putative 
204 
 
Tb927.3.3450 ADP-ribosylation factor-like protein 3, putative (arl3) 
Tb927.3.3780 tryparedoxin 1a, putative (TXN1a) 
205 
 
Tb927.10.8360 Poly(A)-specific ribonuclease PARN-2 
Tb927.3.4490 protein farnesyltransferase alpha subunit, putative 
Tb927.7.460 protein farnesyltransferase beta subunit (TbPFT) 
206 
 
Tb927.3.4040 Ankyrin repeats (3 copies), putative 
Tb927.7.4000 glutathione synthetase, putative 
207 
 
Tb927.10.7060 nucleoporin interacting component (NUP93), putative 
Tb927.10.8170 nuclear pore complex protein (NUP155), putative, nucleoporin, 
putative 
Tb927.9.2320 methyltransferase domain containing protein, putative (POMP1) 
208 
 
Tb927.11.7840 ribonucleoside-diphosphate reductase large chain (RNR1) 
Tb927.3.610 N-acetyltransferase complex ARD1 subunit, putative 
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Tb927.6.1950 N-acetyltransferase B complex (NatB) non catalytic subunit, 
putative 
209 
 
Tb927.7.1120 trypanothione/tryparedoxin dependent peroxidase 1, cytosolic, 
glutathione peroxidase-like protein 1 (TDPX1) 
Tb927.7.1130 trypanothione/tryparedoxin dependent peroxidase 2, glutathione 
peroxidase-like 2 (TDPX2) 
210 
 
Tb927.11.7100 cytoplasmic translation machinery associated protein, putative 
Tb927.8.4330 small GTP-binding protein Rab11 (RAB11) 
211 
 
Tb927.11.2090 choline kinase (EK1) 
Tb927.6.1530 Glutamine amidotransferase class-I, putative 
212 
 
Tb927.10.3260 Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Long-chain 
acyl-CoA synthetase 5) (LACS 5), putative 
Tb927.2.4130 enoyl-CoA hydratase/Enoyl-CoA isomerase/3-hydroxyacyl-CoA 
dehydrogenase, putative 
213 
 
Tb927.1.1270 homocysteine S-methyltransferase, putative 
Tb927.11.13730 ornithine decarboxylase (ODC) 
Tb927.4.1740 hypothetical protein, conserved 
Tb927.6.1780 mitogen-activated protein kinase, putative, protein kinase, putative 
Tb927.8.2690 SET domain containing protein, putative 
214 
 
Tb927.11.5440 malic enzyme 
Tb927.11.5450 malic enzyme 
215 
 
Tb927.10.7930 2,3-bisphosphoglycerate-independent phosphoglycerate mutase 
(PGAM) 
Tb927.11.8970 ribose 5-phosphate isomerase, putative 
Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.9.7770 spermidine synthase (SpSyn) 
216 
 
Tb927.6.4480 valyl-tRNA synthetase, putative (ValRS) 
Tb927.6.4920 S-adenosylmethionine synthetase, putative (METK1) 
217 
 
Tb927.10.6970 dipeptidyl-peptidase 8-like serine peptidase, serine peptidase, Clan 
SC, Family S9B 
Tb927.10.8060 SET domain containing protein, putative 
Tb927.11.7150 NGG1 interacting factor 3-like 
Tb927.7.1910 pyridoxal phosphate containing glycine decarboxylase, putative 
(GCVP) 
Tb927.9.9820 glyceraldehyde-3-phosphate dehydrogenase, putative 
218 
 
Tb927.11.6210 sterol 14-alpha-demethylase (CYP51) 
Tb927.7.210 proline dehydrogenase 
Tb927.9.4190 fatty acyl CoA syntetase 1 (ACS1) 
219 
 
Tb927.2.4110 metallo-peptidase, Clan ME, Family M16, Mitochondrial-
processing peptidase subunit alpha (MPPA) 
Tb927.4.600 Alpha/beta hydrolase family, putative 
Tb927.9.4520 metallo-peptidase, Clan ME, Family M16, Mitochondrial-
processing peptidase subunit beta (MPPB) 
220 
 
Tb927.3.2090 aminopeptidase P1, putative, metallo-peptidase, Clan MG, Family 
M24, Xaa-Pro aminopeptidase, putative 
Tb927.8.2640 ubiquitin-activating enzyme E1, putative (UBA1) 
221 
 
Tb927.1.1380 serine/threonine protein phosphatase 2A regulatory subunit, 
putative 
Tb927.6.4760 T-complex protein 11, putative 
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222 
 
Tb927.1.3950 alanine aminotransferase (ALAT) 
Tb927.11.3570 aminopeptidase, putative, metallo-peptidase, Clan MA(E) Family 
M1 
Tb927.11.5090 aspartate aminotransferase, mitochondrial 
223 
 
Tb927.11.11250 cytosolic malate dehydrogenase (cMDH) 
Tb927.8.4430 uridine phosphorylase 
224 
 
Tb927.10.4000 methylglutaconyl-CoA hydratase, mitochondrial precursor, putative 
Tb927.2.4590 branched-chain amino acid aminotransferase, putative 
Tb927.7.2100 GMP synthase, putative, glutamine amidotransferase, putative 
Tb927.8.980 phosphoacetylglucosamine mutase, putative, 
acetylglucosaminephosphomutase, putative, N-acetylglucosamine-
phosphate mutase, putative 
225 
 
Tb927.10.13130 UTP-glucose-1-phosphate uridylyltransferase 
Tb927.10.14780 mitogen-activated protein kinase kinase kinase, putative (CBPK1) 
Tb927.9.1960 nitrilase, putative 
226 
 
Tb927.11.16480 enoyl-CoA hydratase/isomerase family protein, putative 
Tb927.6.2360 adenosine kinase, putative 
Tb927.8.5600 transaldolase, putative 
227 
 
Tb927.11.1560 1,2-Dihydroxy-3-keto-5-methylthiopentene dioxygenase, putative 
Tb927.11.15910 iron superoxide dismutase 
Tb927.7.1780 Adenine phosphoribosyltransferase, putative 
228 
 
Tb927.9.13490 aminopeptidase P, putative, metallo-peptidase, Clan MG, Family 
M24 
Tb927.9.2010 kynureninase, putative 
229 
 
Tb927.7.5210 Putative Phosphatase/Protein of unknown function DUF89, 
putative 
Tb927.8.1860 pitrilysin-like metalloprotease, metallo-peptidase, Clan ME, Family 
M16C 
230 
 
Tb927.10.10390 trypanothione reductase 
Tb927.10.11970 glutamine aminotransferase (GlnAT) (GlnAT) 
231 
 
Tb927.3.2960 inosine-adenosine-guanosine-nucleosidehydrolase, IAG-nucleoside 
hydrolase (IAGNH) 
Tb927.5.3830 dihydroorotate oxidase 
Tb927.6.2740 pyridoxal kinase (pdxK) 
232 
 
Tb927.11.6870 14-3-3 protein 
Tb927.11.9530 14-3-3-I protein 
233 
 
Tb927.10.14840 Mitochondrial ADP/ATP carrier protein 5a, putative (MCP5a) 
Tb927.2.2520 voltage-dependent anion-selective channel 2, Mitochondrial outer 
membrane protein porin 2 (VDAC2) 
234 
 
Tb927.10.11120 hypothetical protein, conserved 
Tb927.11.1600 tatD related deoxyribonuclease, putative 
Tb927.8.3550 mitogen-activated protein kinase 3, putative 
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Supplementary Table 3: List of suggested names for machine learning predicted protein 
complexes. Complex number matches those described in Table S2. Proportion of 
proteins within the complex annotated as ‘hypothetical’ or classed as ‘essential’ in any 
life-cycle stage (Alsford et al., 2011) are also displayed. The description highlights the 
proteins identified within the complex and denoting where there is orthogonal 
information for protein interaction. Complexes annotated as ‘Complex mixture’ contain 
more than two proteins with a number of different proposed functions or sub-cellular 
localisations. 
Com
plex 
no. 
Name Propor-
tion 
‘hypothe
-tical’ 
Propor-
tion 
'essen-
tial' 
Description 
1 Glycerophospho
lipid metabolism 
complex 
0/4 1/4 2 of 4 are components of glycerophospholipid 
metabolism - glycerophosphoryl diester 
phosphodiesterase; glycerol-3-phosphate 
dehydrogenase 
2 DNA 
topoisomerase 
IB and 
hypothetical 
1/2 1/2 Hypothetical described as localised to FAZ 
3 AMPK 1/5 1/5 AMPK beta and gamma (Clemmens et al., 2009), 
two predicted AMPK alpha subunits and a 
hypothetical protein 
4 Mitochondrial 
ribosome 
complex 1 
3/6 2/6 5 of 6 have been identified in multiple 
mitochondrial ribosome Ips, including MRPL13 
and KRIT2 (Zikova et al., 2008), and one 
remaining is a DEAD-box helicase, with 
homolofy to RRP3 
5 Complex 
mixture 1 
0/6 3/6 GAPDH, HSP70, quenine tRNA 
ribosyltransferase, METK1, NGG1 interacting 
factor 3-like protein and PCNA 
6 Membrane 
protein complex 
1/15 5/15 Membrane transporters of multiple categories 
including 3 multi-drug resistance transporters and 
two genes linked to pentamidine efficacy and 
resistance (Alsford et al., 2012) 
7 Complex 
mixture 2 
0/6 2/6 RNA binder, fructose-bisphosphate aldolase, 
ribonuclease, RHS, DUF2779 and tubulin 
tyrosine ligase 
8 Complex 
mixture 3 
2/6 0/6 Pex19, a dynein light chain, tryptophanyl tRNA 
synthetase, inosine-guanine hydrolase and two 
hypothetical proteins 
9 Deoxyhypusine 
synthase 
0/2 0/2 Interaction demonstrated in (Nguyen et al., 2013) 
10 RuvB helicase 
complex and 
mixture 1 
1/8 5/8 Two ruvB helicases with homology to RUVBL1 
and 2, thought to interact in a dodecamer. Other 
proteins sinclude a SET domain, glutamate 
dehydrogenase, carnitine O-acetyltransferase, 
hypotheitcal, cysteinyl tRNA synthase, hsIVU 
protease 
11 Threonyl tRNA 
synthase and 
2/4 1/4 Two hypothetical proteins (consistent co-elution), 
ARM domain protein and threonyl tRNA 
synthase 
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hypotheticals 
complex 
12 Heat shock 
protein 70/90 
complex 
1/5 1/5 HSP70 and HSP90, a S/T phosphatase 5 
(interacting with HSP90 in (Jones et al., 2008)) a 
WD domain and hypothetical protein 
13 Exon junction 
complex 
0/3 0/3 Y14 and mago-nashi protein, shown to interact in 
META domain (DUF1935) 
14 Hypothetical 
complex 1 
3/3 2/3 3 hypothetical proteins. 
15 tRNA 
synthetase 
complex 
2/5 2/5 3 putative tRNA synthetases (tyrosyl/methionyl, 
glutaminyl and prolyl), and two hypothetical 
proteins 
16 Pyruvate 
dehydrogenase 
complex 
0/4 3/4 PDH E1 alpha and beta, dihydrolipoamide 
acetyltransferase E2 and threonyl-tRNA 
transferase 
17 Nucelosome 
assembly 
complex 
0/4 0/4 2 nucleosome assembly proteins, ARM like and 
leucine-repeat protein 
18 E2 ubiquitin 
conjugating 
enzyme and CS 
domain complex 
0/2 1/2 E2 like enzyme (ATG3) + CS domain containing 
protein 
19 Major vault 
protein complex 
1/4 0/4 three major vault proteins + hypothetical 
20 Trafficking 
protein particle 
complex 
0/2 0/2 Transport protein particle complex putative 
subunits 5 and 2 
21 Proteasome 
activator and 
ankyrin repeat 
complex 
0/2 0/2 Proteasome activator and ankyrin repeat complex 
22 Ribosomal 
complex 1 
0/7 3/7 L35a, L7a, L7, L13 and L6 components of 60S + 
L14 of 40s and ribosomal protein S7 
23 SET domain 
protein and 60S 
ribosome 
complex 
0/2 1/2 SET domain protein and putative RPL10A 60S 
ribosome protein 
24 Heat shock 
protein and 
coronin 
(CRN12) 
complex 
0/2 1/2 HSP and CRN12 
25 Ribosomal 
complex 2 
0/13 6/13 S19, L18 ribo proteins and L34, L10, L19, L13a, 
RPL27a/L27a/L28, L21e, L23, L9 of 60S and 
S16, S4, S8 of 40S 
26 Vacuolar ATP 
synthase 
0/4 0/4 4 vacuolar type ATP synthases, all linked to 
isometamidum resistance (Baker et al., 2015) 
27 tRNA 
methyltransferas
e complex 
0/5 0/5 Gcd10p and conserved protein (putative tRNA 
adenine methyltransferases). NOL1/NOP2/sun 
family - methyltransferase BLAST + 2 RHS 
proteins 
28 Exosome 
complex 
2/12 5/12 EAP1, EAP2, RRP4, RRP45, RRP41A, RRP40, 
CSL4 (Estevez 2001 and 2003)+ hypothetical, 
HSP70, translation elongation factor, RNApolI 
subunit (RPA135), conserved ATP binding 
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29 Prefoldin 
complex 
0/4 0/4 4 prefoldin components 
30 Proteasome 
nonATPase 
regulatory 
complex 
0/14 11/14 RPT5, RPT4, RPN5, RPN6, RPN7, RPT2, RPT3, 
RPT6, RPN11, RPN9 + three more unnumbered 
+ CIFTA-4 transcription factor 
31 Proteasome core 
complex 
0/14 11/14 14 subunits including one termed unspecified 
product that BLASTs as core proteasome subunit 
32 Ribosomal 
complex 3 
0/2 1/2 L38 and L44 of 60S ribosome 
33 Ribosomal 
complex 4 
0/2 0/2 2 acidic ribosomal proteins 
34 Hypothetical 
complex 2 
2/2 0/2 2 hypothetical proteins 
35 Transportin and 
exosome protein 
0/2 1/2 Transportin and exosome (RRP44p) proteins 
36 Adenylyl 
cyclase 
associated and 
RNA binding 
protein 
0/2 0/2 Adenyly cyclase associated protein and RBP 
37 Tudor domain 
containing 
protein HSP84 
0/2 1/2 Tudor domain protein and HSP84 
38 2-oxoglutarate 
dehydrogenase 
complex 
0/3 2/3 2 E1 and 1 E2 2-oxoglutarate dehydrogenase 
components 
39 Dynein light 
chain and 
putative tRNA 
methyltransferas
e 
0/2 2/2 Dynein light chain and tRNA methyltransferase 
40 Mitochondrial 
processing 
peptidase 
complex 
0/2 0/2 alpha and beta subunits 
41 NOT5 and DUF 
protein 
0/2 0/2 NOT5 and DUF protein 
42 Radial spoke 
protein complex 
0/2 2/2 RSP4/6 and RSP10 
43 Hypothetical 
complex 3 
2/2 1/2 Two hypothetical proteins 
44 eIF3 complex 0/2 1/2 eIF3I and eIF3B 
45 Hypothetical 
complex 4 
2/2 1/2 Two hypothetical proteins 
46 Resolvase 
domain 
containing 
protein and 
cysteine 
peptidase 
0/2 2/2 Resolvase domain containing protein and 
cysteine peptidase 
47 SEC24.1 and 
hypothetical 
protein 
1/2 1/2 SEC24.1 and hypothetical protein 
48 TatD related 
DNase and 
pescadillo 
domain 
0/2 1/2 TatD related DNase and pescadillo domain 
containing protein 
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containing 
protein 
49 Mitochondrial 
elongation 
factor and 
HSP10 
0/2 1/2 Mitochondrial elongation factor and HSP10 
50 Paraflagellar rod 
protein and 
NADH fumarate 
reductase 
0/2 1/2 Paraflagellar rod protein and NADH fumarate 
reductase 
51 eIF4e and 
hypothetical 
protein 
1/2 1/2 eIF4e and hypothetical protein 
52 AMP deaminase 
and ZFP family 
member 
ZC3H10 
0/2 1/2 AMP deaminase and ZFP family member 
ZC3H10 
53 mitochondrial 
RNA binding 
protein and 
ATP-dependent 
DEAD/H RNA 
helicase 
0/2 1/2 mitochondrial RNA binding protein and ATP-
dependent DEAD/H RNA helicase 
54 polyA binding 
complex protein 
and zinc finger 
protein 
1/2 1/2 polyA binding complex protein and zinc finger 
protein 
55 Hypothetical 
and galactose 
oxidase domain 
1/2 0/2 Hypothetical and galactose oxidase domain 
56 Cysteine 
peptidase 
complex 
0/2 0/2 two C2 domain containing proteins complex 
57 GrpE and small 
glutamine 
tetratricopeptide 
repeat protein 
0/2 1/2 GrpE and small glutamine tetratricopeptide repeat 
protein 
58 Mitochondrial 
ribosome 
complex 2 
2/2 0/2 2 hypothetical proteins, both identified in (Zikova 
et al., 2008), one MRPL29, and other also 
annotated as MAPK5 
59 Hypothetical 
protein and ras 
like GTPase 
(NST) 
1/2 0/2 Hypothetical protein and ras like GTPase (NST) 
60 Putative 
transport protein 
complex 
1/2 1/2 Vta1 (similar to vacuolar protein sorting 
associated) and hypothetical (blast match to 
USX1, intracellular transport protein) 
61 NMD3 and 
regulator of 
chrosome 
condensation 
RCC1 
0/2 1/2 RCC1 (annotated as ISWI complex, E3 ligase or 
GTPase) and NMD3 is ribosomal export protein 
62 AcylCoA 
dehydrogenase 
and hypothetical 
mitochondrial 
import protein 
1/2 2/2 Hypothetical protein annotated as Tim62, a 
mitochondrial membrane transport complex 
involved in tRNA import. Both proteins 
identified in a pulldown of Tim17 (Singha et al., 
2012) 
63 Kinesin 
complex 
0/2 1/2 Two kinsesins, kin-C and kin-D, shown to 
interact in (Hu et al., 2012) 
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64 Hypothetical 
complex 5 
2/2 1/2 Both annotated with BLAST hit - trichohyalin. 
One also as myosin heavy chain and other also 
inner centromere protein 
65 DIGIT and 
NPAPL 
0/2 2/2 A polyA polymerase protein and flagellar protein 
66 Replication 
factor and 
glycosomal 
malate 
deydrogenase 
0/2 1/2 Replication factor and glycosomal malate 
deydrogenase 
67 ATG24 
phosphoinositid
e binding 
complex 
0/2 0/2 Both proteins contain PX domains and linked to 
suramin efficacy and resistance (Alsford et al., 
2012), both classed as SNX proteins previously 
with one classed as ATG24 (Brennand et al., 
2015) 
68 cAMP specific 
phosphodiestera
se complex 
0/2 1/2 PDEB1 and 2 
69 Hypothetical 
complex 6 
2/2 2/2 Both BLASTs match Rad50 ATPase 
70 Flagellar protein 
complex 
0/2 1/2 KH1 (flagellum targetting protein) and PFC7 
(paraflagellar protein) 
71 2-oxoisovalerate 
dehydrogenase 
complex 
0/2 0/2 alpha and beta subunits 
72 PUF10 complex 1/2 1/2 PUF10 and hypothetical protein 
73 Pyruvate 
dehydrogenase 
kinase complex 
0/2 0/2 One named developmental regulated phospho-
protein - BLASTs also as PDH kinase 
74 SRP68-72 
complex 
1/3 3/3 SRP72 and 68 and glutamine hydrolysing 
carbomoyl phosphate synthase. Interaction 
between SRPs are identified previously in (Lustig 
et al., 2005) 
75 Translation 
associated 
complex 
1/3 2/3 BFR (associated with yeast polysomal mRNP, 
also chromosome segregation), hypothetical 
protein (BLAST to Bromodomain chromosome 
ass./RNAPII deg factor/splicing factor) and 
MKT1 (translation elongation in yeast) 
76 H/ACA 
ribonucleoprotei
n complex 
0/3 0/3 Cbf5p, GAR1 and putative Nhp2 
77 Pseudouridine 
synthase 
complex 
0/3 0/3 2 pseudouridine synthases and a putative tRNA 
methyltransferase 
78 GRESAG 
complex 
0/3 0/3 Three receptor type adenylate cyclase 
79 N-
acetyltransferase 
complex 
0/3 2/3 Three N-acetyltransferase subunit 
80 Heat shock 
protein 70 
complex 
0/3 1/3 2 HSP70s and BiP (also with HSP70 homology) 
81 snRNP complex 0/3 2/3 SmD2, SmB, SmD3 
82 Vaculolar 
sorting, Ran 
binding and 
hypothetical 
protein 
1/3 1/3 Vaculolar sorting, Ran binding and hypothetical 
protein 
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83 Translation 
initiation factor, 
flagellar protein 
and hypothetical 
flagellar protein 
1/3 0/3 Translation initiation factor, flagellar protein and 
hypothetical flagellar protein 
84 ALBA complex 0/3 2/3 ALBA1, 3 and 4 
85 F1/F0 ATP 
synthase 
complex 1 
3/3 1/3 2 mitochondrial ATP synthase components 
identified in (Zikova et al., 2009) and a 
hypothetical protein 
86 U6 spliceosome 
complex 
0/3 0/3 LSm7p, LSm4p and PARN1. LSm proteins 
identified interacting in (Tkacz et al 2008) 
87 Histone 
complex 
0/3 0/3 H2A, H2B, H4 
88 Complex 
mixture 4 
0/3 2/3 Ribosome biogenesis, nucleolar RNA helicase 
and DNA topoisomerase proteins 
89 Hypothetical + 
DUF proteins 
1/2 1/2 Hypothetical + DUF proteins 
90 Complex 
mixture 5 
1/3 0/3 AMP binding protein thought to be part of 
NADH-ubiquinone oxidoreductase complex 
91 Hypothetical 
complex 7 
3/3 1/3 3 hypothetical proteins, one associated with 
cytoskeleton and one with ISWI domain 
homology. 
92 Mitochondrial 
ribosome 
complex 3 
2/3 0/3 All identified in (Zikova et al., 2008) 
93 Complex 
mixture 6 
1/3 0/3 Vesicular fusion protein SEC18, hypothetical 
protein and cold-shock DNA binding domain 
protein 
94 Complex 
mixture 7 
1/3 2/3 NUP-1 protein with CEP250 domain, 
hypothetical protein annotated as FAZ10 also 
with predicted CEP250 domain and SRP40 C-
terminal domain protein 
95 Complex 
mixture 8 
2/3 1/3 DNA directed RNA polymerase and two 
hypotheticals 
96 Complex 
mixture 9 
2/3 0/3 2 hypotheticals annotated as flagellar protein and 
POMP respectively and an endo-beta-N-
acetylglucosaminadase 
97 Complex 
mixture 10 
0/3 2/3 Lsm12 protein, cytoskeleton associated protein 
17 and RNA binding protein 20 
98 Mitochondrial 
inner membrane 
Tim10 and 
hypothetical 
protein 
1/2 0/2 Mitochondrial inner membrane Tim10 and 
hypothetical protein 
99 mRNA 
methytransferas
e cap and 
elongation 
factor complex 
1/5 1/5 3 elongation factors, cap methyltransferase and 
hypothetical shown to associate in (Zamudio et 
al., 2009) 
100 Complex 
mixture 11 
0/4 0/4 Twy3 homolog, tRNA methyltransferase, two 
pyrophosphorylases and a WD domain containing 
protein 
101 Complex 
mixture 12 
1/4 1/4 Pestivirus endopeptidase, a hypothetical protein, 
lysosmal alpha-mannosidase and leucine rich 
repeat protein 
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102 Complex 
mixture 13 
0/4 2/4 valsolin containing protein, WD40 ribosome 
biogensis protein, nucleolar GTP binding protein 
NOG1 and ribosome production factor protein 
103 Complex 
mixture 14 
2/4 0/4 2 hypothetical proteins, an oxidoreductase protein 
and leucine carboxymethyltransferase 
104 Hypothetical 
and transport 
protein 
1/2 0/2 Hypothetical protien and transport protein 
particle complex component 
105 Peptidase 
complex 
0/3 1/3 M76 and papain cysteine peptidase and DNL Zn 
finger type protein with Tim15 domain 
homology. M76 peptidase also has homology to 
ATP23 a mitochondrial inner membrane protein 
106 1,2-diOH-3-
keto-5-
methylthiopente
ne deoxygenase 
and hypothetical  
1/2 1/2 Hypothetical identified in (Zikova et al., 2008) as 
mitochondrial ribosome subunit 
107 Complex 
mixture 15 
0/3 2/3 RNA binding protein 17, mRNA export receptor 
Mtr2 and Zn finger containing protein 
108 U3 
ribonucleoprotei
n sub-complex 
0/4 1/4 Pwp2 yeast homolog and three proteins 
containing Utp21, Utp13 and Utp12 domains 
indicitative of U3 ribonucleoprotein complex 
109 Hypothetical 
protein and 
RNA binder 
(RBP29) 
1/2 0/2 Hypothetical protein and RNA binder (RBP29) 
110 Kinesin 
complex II 
2/4 2/4 One hypothetical with flagellar pocket 
localisation, two kinesins and another 
hypothetical protein 
111 Complex 
mixture 16 
0/4 1/4 GAPDH, cyclophilin,  glycerol-3-phosphate 
dehydrogenase and fructose 1-6-biphosphatase 
112 ARP2/3 
complex 
0/5 0/5 5 ARP2/3 components 
113 3-
methylcrotonyl-
coA carboxylase 
and 
dihydrolipoamid
e dehydrogenase 
complexes 
0/5 0/5 3-methylcrotonyl-coA carboxylase alpha and beta 
subunits and three dihydrolipoamide 
dehydrogenase subunits 
114 Complex 
mixture 17 
1/4 2/4 2 predicted 40S ribosomal components, a Zn 
finger protein and a hypothetical protein 
115 Hypothetical 
complex 8 
3/4 1/4 Intraflagellar transport hypothetical protein, a 
START domain protein and a hypothetical 
protein with motile cillium GO annotation 
116 Complex 
mixture 18 
1/5 0/5 Mak10 N-acetyltransferase, Cgm1 mRNA N-
methyltransferase, a third N-acetyltransferase, a 
hypothetical protein and a predicted heat shock 
protein 
117 Complex 
mixture 19 
1/5 3/5 Nup149, SEC31, RBP16, a hypothetical 
annotated as RBP8 and poly(A) export protein 
GLE2 
118 Complex 
mixture 20 
1/3 1/3 A hypothetical protein, a KRE33 ribosomal 
biogenesis protein, and UTP15 C-terminal 
domain putative U3 ribonucleoprotein component 
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119 eIF4G3 and 
ATP dependent 
DEAD/H 
helicase 
0/2 1/2 eIF4G3 and ATP dependent DEAD/H helicase 
120 eIF5 and 
hypothetical 
protein 
1/2 1/2 eIF5 and hypothetical protein 
121 Guide RNA 
associated 
complex  
1/5 2/5 MRB1 associated proteins - GAP1 and 2 
(Hashimi et al., 2009),  and HslU2 protease, 
eIF2a and hypothetical protein 
122 Complex 
mixture 21 
1/3 2/3 Pex7, hypothetical protein and phosphatase 
123 Complex 
mixture 22 
2/3 1/3 2 hypothetical proteins, one annotated as 
mitochondrial cytochrome bc1 component and a 
V-type ATPase 
124 Ankyrin repeat 
and alanine 
racemase 
protein 
0/2 1/2 Ankyrin repeat and alanine racemase protein 
125 Complex 
mixture 23 
1/3 1/3 RPB7 RNA polymerase subunit, succinate 
dehydrogenase and hypothetical protein 
126 Mitochondrial 
RNA binding 
complex 
1/7 3/7 GBP25, GBP21, MRB1590 + tRNA uracil 
methyltransferase, NOL1/NOP2/sun domain, an 
XRN exonuclease and a hypothetical protein 
127 Complex 
mixture 24 
1/6 0/6 Hypothetical and alpha/beta hydrolase were 
identified as mitochondrial ribosome components 
in (Zikova et al., 2008),XRN exoribonuclease, a 
unspecified product (cAMP response gene), a 
mitochondrial DNA polymerase subunit and a 
DNA topoisomerase 
128 Phosphoribosylt
ransferase 
complex 
0/8 3/7 3 PRS subunits and PRPS5 kinase, acetyl coA 
carboxylasem transitional ER ATPase (VCP) and 
phosphatidylinositol 4-phosphate 5-kinase 
129 T-complex 0/8 7/8 All 8 chaperonin T-complex subunits 
130 F1/F0 ATP 
synthase 
complex 2 
0/8 4/8 6 ATP synthase subunits identified in (Zikova et 
al., 2009) and aspartyl aminopeptidase and O-
phosphoryl-rRNA selenium transferase 
131 Protein 
phosphatase 
complex 
3/4 1/4 Protein phosphatase 1 and 3 hypothetical proteins 
(1 phosphatase inhibitor, 1 translating ribosome 
interactor, and 1 eIF3) 
132 Complex 
mixture 25 
1/4 2/4 A hypothetical protein, an adenylate kinase 
(ADKE), threonine dehydrogenase and 
deoxyuridine triphosphatase 
133 Complex 
mixture 26 
0/3 1/3 Peroxidoxin, tubulin-specific chaperone and an 
ATP-dependent RNA helicase 
134 Mitochondrial 
ribosome 4 
10/18 4/18 All proteins identified in (Zikova et al., 2008) 
135 Complex 
mixture 27 
0/4 2/4 seryl tRNA synthase, guanine deaminase, 
PFK/FBP and adenylosuccinate lyase 
136 Hypothetical 
protein and 
unspecified 
product 
1/2 0/2 RNA interference factor and iron sulfur cluster 
assembly protein 
137 Pyruvate 
dehydrogenase 
0/2 1/2 PDH E3 binding protien and adenoylsuccinate 
lyase 
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binding protein 
and 
adenylosuccinat
e lyase 
138 Complex 
mixture 28 
0/5 2/5 Paraflagellar rod component, proteasome 
activator 26, poly(A) ribonuclease 2 and 
dipthamide biosynthesis enzyme 
139 Hypothetical 
complex 9 
3/6 2/6 Glutamine synthase, polyadenylation factor, 3 
hypothetical proteins and an unspecified product 
140 Complex 
mixture 29 
2/4 0/4 2 hypothetical proteins, an HSP20 annotated as a 
putative tRNA import complex and agmatinase 
141 E2 ubiquitin 
conjugation 
enzyme and 
mago nashi 
protein 
0/2 1/2 Exon junction component and ATG autophagy 
associated E2 ubiquitin conjugation enzyme 
142 RuvB helicase 
complex and 
mixture 2 
1/6 4/6 2 ruvB like DNA helicase proteins, phenylalanyl 
tRNA synthetase, MORN1, a hypothetical protein 
and glutamate dehydrogenase 
143 Complex 
mixture 30 
0/6 2/6 amidohydrolase, pyruvate kinase, 
aminopeptidase, pseudouridine synthase, YjeF N-
terminal domain protein and calpain like cysteine 
peptidase 
144 Ribosome 
biogenesis 
complex 
1/16 9/16 CIFTA 1,3 and 6, PUF7, and mostly ribosomal 
biogenesis or rRNA associated proteins 
145 Complex 
mixture 31 
0/3 1/3 HSP110, leucine rich repeat protein and SET 
domain protein 
146 Complex 
mixture 32 
0/3 2/3 Kinetoplast associated protein 3, DRBD10 and 
mitochondrial polymerase subunit 
147 Complex 
mixture 33 
1/3 0/3 Bromodomain protein, glucose-6-phosphate 1-
dehydrogenase and hypothetical protein 
148 Complex 
mixture 34 
0/4 0/4 2 retrotransposon hotspot proteins, dipthamide 
biosynthesis enzyme and ankyrin repeat protein 
149 tRNA specific 
adenosine 
deaminase 
0/2 0/2 ADAT2 and 3 
150 Hypothetical 
complex 10 
3/3 3/3 3 hypothetical proteins 
151 Mitochondrial 
tRNA methylase 
and membrane 
bound acid 
phosphatase 
0/2 1/2 Mitochondrial tRNA methylase and membrane 
bound acid phosphatase 
152 Complex 
mixture 35 
0/6 1/6 RWD domain protein, ARF like 2 binding 
protein, radial spoke protein 11, WD domain 
protein, tRNA guanine methyltransferase and 
ribosome interacting GTPase 
153 UBA domain, 
diphthamide 
synthesis, 
phospanttocystei
ne decar, hypo 
1/4 0/4 Ubiquitin like protein dipthamide biosynthesis 
enzyme, phosphopantothenoylysteine 
decarboxylase and a hypothetical protein 
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154 Nuclear cap 
binding protein 
and peptidase 
0/2 0/2 CBP110 
155 Complex 
mixture 36 
0/3 2/3 SET domain (putative lysine metransferase), N6-
adenine methyltransferase and HSP70 
156 Queine tRNA 
ribosytransferas
e complex and 
mixture 
1/5 4/5 2 queine tRNA ribosyltransferase, a lysine 
decarboxylase, a hypothetical protein and PCNA 
157 Complex 
mixture 37 
1/3 0/3 A hypothetical protein, aldehyde dehdrogenase 
and a histidine phopsphatase 
158 eIF3 complex 1/2 1/2 eIF3C and hypothetical identified as eIF3A in 
(Rezende et al., 2014) 
159 tRNA 
dihydrouridine 
synthase 3 and 
METK1 
0/2 0/2 tRNA dihydrouridine synthase 3 and METK1 
160 Heat shock 
protein complex 
0/3 2/3 HSP110, HSP70 and RRP45(exosome) 
161 Phenylalanyl 
tRNA 
synthetase 
complex 
0/3 2/3 Phenylalanyl tRNA synthetse alpha and beta and 
hslVU peptidase component 
162 inositol-3-
phosphate 
synthase and 
glucosamine-6-
phosphate 
isomerase 
0/2 0/2 inositol-3-phosphate synthase and glucosamine-
6-phosphate isomerase 
163 Complex 
mixture 38 
0/5 1/5 calpain peptidase, Rab GAP, Ubiquitin E1 
enzyme, pyrophophatase and RHS4 
164 GPI associated 
complex and 
mixture 
0/9 4/9 GPI anchor transamidase (GPI8), signal 
peptidase, GPI transamidase (TTA1), 
dolicholphosphate-mannose synthase, Ankyrin 
repeat protein, ISWI, IFT57/55, 3-keto-
dihydrosphingosine reductase and hypothetical 
protein 
165 Nucleolar 
associated 
complex 
1/10 3/10 splicing factor (TSR1), RSBR1 RNA binding 
protein, 2 arginine methyltransferases (functional 
association from personal communication with 
Laurie Read), NOP1 (fibrillarin) NOP56, 
nucleolar RNA bind, cytosine tRNA 
metransferase,  fibrillarin, a hypothetical protein 
166 Complex 
mixture 39 
2/5 0/5 Serine peptidase, 2 hypothetical proteins, 
disulfide isomerase, and ALG9 
mannosyltransferase 
167 Putative 
Golgi/ER 
biogenesis 
complex 
0/2 0/2 NSF attachment protein (SNARE type) and SEP 
containing protein with NSFL1 cofactor Blast 
168 Trans-sialidase 
and ubiquitin 
like domain 
protein 
0/2 0/2 Trans-sialidase and ubiquitin like domain protein 
169 FE(II) 
oxygenase and 
1/2 0/2 Hypothetical protein annotate as FLA1BP 
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hypothetical 
protein 
170 NADH fumarate 
reductase and 
pyrroline-5-
carboxylate 
reductase 
0/2 1/2 NADH fumarate reductase and pyrroline-5-
carboxylate reductase 
171 Hypothetical 
complex 11 
2/2 1/2 2 hypothetical proteins 
172 Arginine N-
metrans 
(PRMT7) and 
nascent 
polypeptide 
associated 
complex protein 
0/2 1/2 PRMT7 and dubious annotation of nascent 
polypeptide associated complex protein 
173 Hypothetical 
protein and 
deoxyribose-
phosphate 
aldolase 
1/2 0/2 Hypothetical protein and deoxyribose-phosphate 
aldolase 
174 CNOT 10 and 
11  complex 
1/2 2/2 Hypothetical protein, human homolog CNOT11 
and CNOT11 protein. CNOT10 and 11 known to 
interact in human (Mauxion et al., 2013) 
175 Helicase and 
ubiquitin ligase 
0/2 0/2 Ubiquitin ligase also annotated as yeast TOM1 
homolog with role in nuclear mRNA export 
176 DRBD2 and 
RHS4 
0/2 0/2 DRBD2 and RHS4 
177 Unspecified 
product and 
fatty acyl CoA 
synthetase 2 
0/2 1/2 Unspecified product annotated as ribosomal 
protein 
178 Peroxisome 
biogenesis 
associated 
complex 
0/2 0/2 Peroxisome biogenesis protein and assembly 
protein PEX1 and 6 
179 eIF3L and 
COP9 
signalosome 
(eIF3K) and 
tatD 
deoxyribonuclea
se 
0/3 1/3 COP9 signalsome protein annotated as eIF3K 
(Rezende et al., 2014) 
180 U5 spliceosome 
complex 
0/3 2/3 U5 spliceosome protein, PRP8 and ATP 
dependent RNA helicase with hoology to U5 
spliceosome component. All identified in pull 
down experimetn of U5 spliceosome in (Silva et 
al., 2011) 
181 Complex 
mixture 40 
1/3 0/3 E2 ubiquitin conjugating enzyme, hypothetical 
protein and eIF1A 
182 Complex 
mixture 41 
1/4 3/4 hypo, MEX67 mRNA export, kinetoplastid 
phosphatase, SEC7 
183 Complex 
mixture 42 
1/4 0/4 hypothetical protein, 3-hydroxy-3methyl glutaryl 
coA reductase, endonuclease, enoyl CoA 
hydratase 
184 Complex 
mixture 43 
1/4 2/4 hypothetical protein, snoRNA binder, Dpy-30 
domain protein and SEC13 
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185 Importin alpha 
and M2 dsRNA 
replication 
associated 
protein 
0/2 2/2 Importin annotated as Kap60 and M2 dsRNA 
protein is annotated as putative splicing protein 
associated with nuclear speckles 
186 Cleavage and 
poly(A) 
specificity 
complex 
0/2 1/2 2 cleavage and poly(A) specficity factor proteins,  
CPSF2 and 3 
187 Paraflagellar rod 
complex 
0/2 0/2 PFC4 and 16 
188 DUF complex 0/2 0/2 two DUF proteins with same domain (DUF2009) 
189 Coatomer 
complex and 
mixture 
1/6 4/6 Coatomer beta and gamma, together with PFC5, 
SRP54, hypothetical protein and NUP93 
190 Complex 
mixture 44 
0/3 1/3 PGI, 6-phosphogluconate dehydrogenase, citrate 
synthase 
191 NOP86 and 
cytoskeleon 
associated 
protein 
0/2 2/2 NOP86 and cytoskeleon associated protein 
192 Complex 
mixture 45 
1/5 0/5 2 methyltranferase domain containing proteins, a 
hypothetical protein, monthiol glutaredoxin and a 
cysteine peptidase 
193 Acyl carrier 
protein and 
lipoic acid 
carrier protein 
0/2 0/2 ACP, member of NADHubiquinone 
oxidoreductase complex and lipoic acid carrier 
protein, GCVH 
194 Electron transfer 
flavoprotein 
complex 
0/2 0/2 2 electron transfer flavoproteins 
195 Hydroxy-
meglutaryl-coA 
lyase and NAD+ 
synthase 
0/2 1/2 Hydroxy-meglutaryl-coA lyase and NAD+ 
synthase 
196 D-alanine D-
alanine ligase 
and N2227 
protein 
0/2 1/2 D-alanine D-alanine ligase and N2227 protein 
197 Inositol-1 
monophosphatas
e complex 
0/2 0/2 2 IMPases 
198 Ubiquitin E2 
conjugation 
enzyme and 
hypothetical 
protein 
1/2 2/2 Ubiquitin E2 conjugation enzyme and 
hypothetical protein 
199 Hypothetical 
protein and S/T 
kinase NrkA 
1/2 1/2 Hypothetical protein and S/T kinase NrkA 
200 RGG domain 
protein and 
adenine 
phosphoribosyltr
ansferase 
0/2 1/2 RGG domain protein and adenine 
phosphoribosyltransferase 
201 maoC 
dehydratase and 
DJ-1 family 
protein 
0/2 1/2 maoC dehydratase and DJ-1 family protein 
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202 ras-like GTPase 
complex 
0/2 0/2 2 ras GTPases, GTR and GTP 
203 Ubiquitin 
conjugation 
complex 
0/2 0/2 2 E2 ubiqutin conjugation enzymes 
204 ADP 
ribosylation 
factor and 
tryparedoxin 1a 
0/2 1/2 ADP ribosylation factor and tryparedoxin 1a 
205 Farnesyltransfer
ase complex 
0/3 2/3 Farnesyltranfserase alpha and beta subunits and 
PARN2 
206 Glutathione 
synthetase and 
ankyrin repeat 
protein 
0/2 0/2 Glutathione synthetase and ankyrin repeat protein 
207 Nuclear pore 
complex 
0/3 2/3 NUP155, Nup93 and POMP1 a mitochondrial 
outer membrane protein 
208 N-
acetyltransferase 
complex 
0/3 1/3 N-acetyltransferases ARD1 and NatB and 
ribonucleoside-diphosphate reductase RNR1 
209 Tryparedoxin-
peroxidase 
complex 
0/2 1/2 TDPX1 and 2 
210 RAB11 and 
translation 
machinery 
associated 
protein 
0/2 1/2 RAB11 and translation machinery associated 
protein 
211 Glutamine 
amidotransferas
e and choline 
kinase 
0/2 1/2 Glutamine amidotransferase and choline kinase 
212 Fatty acid CoA 
ligase and enoyl 
CoA hydratase 
0/2 0/2 Fatty acid CoA ligase and enoyl CoA hydratase 
213 Complex 
mixture 46 
1/5 1/5 Hypothetical protein, SET domain protein, 
MAPK4, homocysteineSmethyltransferase and 
ornithine decarboxylase 
214 malic enzymes 0/2 0/2 2 malic enzyme proteins 
215 Complex 
mixture 47 
0/4 3/4 ribose 5-phosphate isomerase, spermidine 
synthase, uracil phosphoribosyltransferase, 
PGAM 
216 Valyl tRNA 
synthetase and 
METK1 
0/2 0/2 Valyl tRNA synthetase and METK1 
217 glyceraldehyde-
3-ph DH, 
NGG1, SET 
dom, serine 
peptidase and 
PLP G 
decarboxylase 
0/5 1/5 Glyceraldehyde-3-phosphate dehydrogenase, 
NGG1 interacting factor like protein, SET 
domain protein, serine peptidase and pyridoxal 
phosphate containing glycine decarboxylase 
218 Complex 
mixture 48 
0/3 1/3 Fatty acyl coA synthase (ACS1), proline 
dehydrogenase and sterol alpha demethylase 
219 Mitochondrial 
processing 
peptidase 
complex 
0/3 1/3 Mitochondrial processing peptidase alpha and 
beta subunits shown to interact in (Desy et al., 
2012) and an alpha beta hydrolase 
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220 Metallopeptidas
e and ubiquitin 
activating 
enzyme 
0/2 1/2 Metallopeptidase and E1 ubiqutin activating 
enzyme UBA1 
221 S/T protein 
phosase 2A and 
T complex like 
protein 
0/2 1/2 S/T protein phosase 2A and T complex like 
protein 
222 Complex 
mixture 49 
0/3 0/3 aminopeptidase, alanine aminotransferase and 
aspartate aminotransferase 
223 cytosolic malate 
dehydrogenase 
and uridine 
phosphorylase 
0/2 0/2 cytosolic malate dehydrogenase and uridine 
phosphorylase 
224 Complex 
mixture 50 
0/4 0/4 GMP synthase, branched chain amino acid 
aminotransferase, phosphoacetylglucosamine 
mutase, methylglutaconyl-coA hydratase 
225 Complex 
mixture 51 
0/3 1/3 UTP-glucose-1-phosphate uridyltransferase, 
nitrilase, MAPKKK 
226 Complex 
mixture 52 
0/3 2/3 adenosine kinase, transaldolase and enoyl CoA 
hydratase 
227 adenine 
phribosyltrans, 
diO2ase, iron 
superoxide 
dismutase 
0/3 0/3 adenine phosphoribosyltransferase, dioxygenase, 
iron superoxide dismutase 
228 Kynureninase 
and 
aminopeptidase 
0/2 1/2 Kynureninase and aminopeptidase 
229 Phosphatase and 
metalloprotease 
0/2 0/2 Phosphatase and metalloprotease 
230 Trypanothione 
reductase and 
glutamine 
aminotransferas
e 
0/2 0/2 Trypanothione reductase and glutamine 
aminotransferase 
231 Complex 
mixture 53 
0/3 0/3 Pyridoxal kinase, nucleosidehydrolase, 
dihydroorotate oxidase 
232 14-3-3 protein 
complex 
0/2 2/2 14-3-3 subunits I and II, identified in (Inoue et 
al., 2005) 
233 Mito ADP/ATP 
carrier protein 
and voltage-
dependent 
anion-selective 
channel 
0/2 0/2 MCP5a and VDAC2 
234 Complex 
mixture 54 
1/3 1/3 Hypothetical protein, tatD deoxyribonuclease and 
MAPK3 
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Supplementary Table 4: Proteins classified in cell-cycle regulated clusters. Table 
displays the cluster a protein was classified into along with the maximum fold change 
detected across the time-course of cell division. 
Gene ID Gene description Cluster Max
fc 
Tb927.10.6070  universal minicircle sequence binding protein (UMSBP), 
putative,predicted zinc finger protein  
G2&M 2.2 
Tb927.7.2160  hypothetical protein, conserved  G2&M 2.0 
Tb927.8.3220  exonuclease, putative  G2&M 2.0 
Tb927.11.12070  hypothetical protein, conserved  G2&M 2.0 
Tb927.10.12920  hypothetical protein, conserved  G2&M 2.0 
Tb927.7.4850  kinetoplastid kinetochore protein 5 (kkt5)  G2&M 1.9 
Tb927.10.13100  hypothetical protein, conserved  G2&M 1.9 
Tb927.10.15400  kinesin, putative  G2&M 1.9 
Tb927.5.440  trans-sialidase, putative  G2&M 1.9 
Tb927.10.4990  cell division related protein kinase 2, putative,CDC2-related 
protein kinase (CRK3)  
G2&M 1.9 
Tb927.6.570  hypothetical protein, conserved  G2&M 1.8 
Tb927.4.3430  hypothetical protein, conserved  G2&M 1.8 
Tb927.11.15800  hypothetical protein, conserved  G2&M 1.8 
Tb927.3.2140  transcription activator, putative  G2&M 1.8 
Tb927.4.4440  adenylyl cyclase (GRESAG 4.4)  G2&M 1.8 
Tb927.11.16390  cyclin dependent kinases regulatory subunit, putative 
(CKS1)  
G2&M 1.7 
Tb927.8.3560  DNA repair and recombination helicase protein PIF5 (PIF5)  G2&M 1.7 
Tb927.9.13140  hypothetical protein, conserved  G2&M 1.7 
Tb927.11.15780  hypothetical protein, conserved  G2&M 1.7 
Tb11.v5.0609  DNA-directed RNA polymerase III largest subunit, putative  G2&M 1.7 
Tb927.10.3380  60S acidic ribosomal protein P2, putative  G2&M 1.7 
Tb927.8.7120  squalene synthase, putative  G2&M 1.7 
Tb927.2.3720  ubiquitin-conjugating enzyme, putative  G2&M 1.7 
Tb927.6.3760  kinetoplastid kinetochore protein 15 (kkt15)  G2&M 1.6 
Tb927.11.7050  hypothetical protein, conserved  G2&M 1.6 
Tb927.9.14290  hypothetical protein, conserved  G2&M 1.6 
Tb927.11.11240  hypothetical protein, conserved  G2&M 1.6 
Tb927.9.13070  predicted heat shock factor binding protein  G2&M 1.6 
Tb927.8.960  hypothetical protein, conserved  G2&M 1.6 
Tb927.11.16380  hypothetical protein, conserved  G2&M 1.6 
Tb927.10.8710  centrin, putative  G2&M 1.6 
Tb927.6.1540  hypothetical protein, conserved  G2&M 1.6 
Tb927.3.860  acyl carrier protein,acyl carrier protein, mitochondrial 
precursor, putative (ACP)  
G2&M 1.6 
Tb927.9.9520  zinc finger protein family member, putative (ZC3H29)  G2&M 1.6 
Tb927.7.4680  hypothetical protein, conserved  G2&M 1.6 
Tb927.3.3240  hypothetical protein, conserved  G2&M 1.5 
Tb927.10.4050  serine palmitoyltransferase, putative  G2&M 1.5 
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Tb927.11.16820  hypothetical protein, conserved  G2&M 1.5 
Tb927.10.6060  universal minicircle sequence binding protein (UMSBP), 
putative,DNA-binding protein HEXBP, putative,zinc finger 
protein  
G2&M 1.5 
Tb927.10.6410  mismatch repair protein MSH8, putative,mismatch repair 
protein  
G2&M 1.5 
Tb927.11.13100  hypothetical protein, conserved  G2&M 1.5 
Tb927.10.890  kinesin, putative  G2&M 1.5 
Tb927.10.4750  hypothetical protein, conserved  G2&M 1.5 
Tb927.8.4190  hypothetical protein, conserved  G2&M 1.5 
Tb927.11.14410  hypothetical protein, conserved  G2&M 1.5 
Tb927.11.7600  hypothetical protein, conserved  G2&M 1.5 
Tb927.9.10250  small nuclear ribonucleoprotein Sm-F (Sm-F)  G2&M 1.5 
Tb927.8.3460  hypothetical protein, conserved  G2&M 1.5 
Tb927.5.3310  hypothetical protein, conserved  G2&M 1.5 
Tb927.11.12820  ribonucleoside-diphosphate reductase small chain (RNR2)  G2&M 1.5 
Tb927.11.4770  retrotransposon hot spot protein (RHS, pseudogene), 
putative  
G2&M 1.5 
Tb927.6.200  receptor-type adenylate cyclase GRESAG 4, putative  G2&M 1.5 
Tb927.10.11270  RNA-binding protein, putative (RBP23)  G2&M 1.5 
Tb927.10.14460  leucine-rich repeat protein (LRRP), putative  G2&M 1.5 
Tb927.10.8240  hypothetical protein, conserved  G2&M 1.5 
Tb927.8.3780  hypothetical protein, conserved  G2&M 1.5 
Tb927.7.2290  hypothetical protein, conserved  G2&M 1.5 
Tb927.11.640  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.13690.1  radial spoke protein RSP11, putative  G2&M 1.4 
Tb927.8.7340  trans-sialidase, putative,neuraminidase, putative  G2&M 1.4 
Tb927.11.3090  LisH domain-containing protein FOPNL, putative,FOP-
related protein of 20 kDa, putative (fopnl)  
G2&M 1.4 
Tb927.10.10000  hypothetical protein, conserved  G2&M 1.4 
Tb927.1.4700  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.13980  hypothetical protein, conserved  G2&M 1.4 
Tb927.9.12680  hypothetical protein, conserved  G2&M 1.4 
Tb927.10.10780  hypothetical protein, conserved  G2&M 1.4 
Tb927.8.6750  translationally controlled tumor protein (TCTP), putative  G2&M 1.4 
Tb927.5.1960  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.5260  SNF2 DNA repair protein, putative,SNF2 family protein  G2&M 1.4 
Tb927.10.11580  predicted WD40 repeat protein  G2&M 1.4 
Tb927.3.2330  kinetoplastid kinetochore protein 17 (kkt17)  G2&M 1.4 
Tb927.11.1300  hypothetical protein, conserved  G2&M 1.4 
Tb927.6.3360  hypothetical protein, conserved  G2&M 1.4 
Tb927.3.4950  hypothetical protein, conserved  G2&M 1.4 
Tb927.6.3290  intraflagellar transport protein 20, putative (IFT20)  G2&M 1.4 
Tb927.8.910  hypothetical protein, conserved  G2&M 1.4 
Tb927.10.3470  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.6340  hypothetical protein, conserved  G2&M 1.4 
Tb927.4.4620  cytochrome oxidase subunit VIII (COXVIII)  G2&M 1.4 
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Tb927.10.9080  pteridine transporter, putative  G2&M 1.4 
Tb927.7.1270  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.13150  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.14710  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.10520  kinetoplastid kinetochore protein 2,serine/threonine-protein 
kinase, putative,serine/threonine-protein kinase, putative 
(kkt2)  
G2&M 1.4 
Tb927.10.7430  GTP-binding protein, putative  G2&M 1.4 
Tb927.9.2760  hypothetical protein, conserved  G2&M 1.4 
Tb927.4.1750  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.13520  hypothetical protein, conserved  G2&M 1.4 
Tb927.9.11350  hypothetical protein, conserved  G2&M 1.4 
Tb11.v5.0971  mitochondrial DNA polymerase I protein A, putative  G2&M 1.4 
Tb927.5.3630  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.16750  hypothetical protein, conserved  G2&M 1.4 
Tb927.10.9230  adaptin complex 4 subunit, putative,beta-adaptin 4 protein, 
putative  
G2&M 1.4 
Tb927.4.2190  GTP-binding protein, putative  G2&M 1.4 
Tb927.11.9860  hypothetical protein, conserved  G2&M 1.4 
Tb927.10.3300  hypothetical protein, conserved  G2&M 1.4 
Tb927.11.10100  hypothetical protein, conserved  G2&M 1.3 
Tb927.7.4610  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.5750  hypothetical protein, conserved,protocatechuate 4,5-
dioxygenase-like protein  
G2&M 1.3 
Tb927.1.1270  homocysteine S-methyltransferase, putative  G2&M 1.3 
Tb927.8.2220  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.6560  hypothetical protein, conserved  G2&M 1.3 
Tb927.8.2150  hypothetical protein, conserved  G2&M 1.3 
Tb927.8.2690  hypothetical protein, conserved  G2&M 1.3 
Tb927.6.5130  60S acidic ribosomal protein P2, putative  G2&M 1.3 
Tb927.3.3950  hypothetical protein, conserved  G2&M 1.3 
Tb927.7.5730  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.14330  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.4620  peptidyl-prolyl cis-trans isomerase, putative (PPIase)  G2&M 1.3 
Tb927.10.5860  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.1240  hypothetical protein, conserved  G2&M 1.3 
Tb927.9.1850  60S ribosomal protein L35, putative  G2&M 1.3 
Tb927.4.3350  hypothetical protein, conserved  G2&M 1.3 
Tb927.9.7580  hypothetical protein, conserved  G2&M 1.3 
Tb927.5.4320  zinc finger protein family member, putative (FIP1)  G2&M 1.3 
Tb927.11.12520  hypothetical protein, conserved  G2&M 1.3 
Tb927.3.4270  hypothetical protein, conserved  G2&M 1.3 
Tb927.3.1890  cytochrome c oxidase assembly protein, putative  G2&M 1.3 
Tb927.8.2910  mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, 
putative  
G2&M 1.3 
Tb927.11.14950  zinc finger protein 2 (ZFP2)  G2&M 1.3 
Tb927.4.4970  myosin heavy chain kinase A, putative  G2&M 1.3 
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Tb927.11.7670  hypothetical protein  G2&M 1.3 
Tb927.2.4140  hypothetical protein, conserved  G2&M 1.3 
Tb927.7.1630  hypothetical protein, conserved  G2&M 1.3 
Tb927.1.4300  chaperone protein DNAj, putative  G2&M 1.3 
Tb927.10.11900  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.9160  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.7620  mitochondrial ATP-dependent zinc metallopeptidase, 
putative,metallo-peptidase, Clan MA(E) Family M41  
G2&M 1.3 
Tb927.10.4930  protein phosphatase 2C, putative  G2&M 1.3 
Tb927.11.20300  variant surface glycoprotein (VSG), putative  G2&M 1.3 
Tb927.7.5050  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.4970  predicted WD40 repeat protein  G2&M 1.3 
Tb927.10.7300  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.7930  RNA polymerase B subunit RPB8, putative (RPB8)  G2&M 1.3 
Tb11.1650  variant surface glycoprotein (VSG, pseudogene), 
putative,chrXI additional, unordered contigs  
G2&M 1.3 
Tb927.10.7780  mitogen-activated protein kinase 1, putative  G2&M 1.3 
Tb927.8.4170  RNA-binding protein, putative (MRD1)  G2&M 1.3 
Tb927.4.670  conserved protein, unknown function  G2&M 1.3 
Tb927.11.5850  RNA-binding protein, putative (RBP38)  G2&M 1.3 
Tb927.8.1750  hypothetical protein, conserved  G2&M 1.3 
Tb927.8.1130  protein phosphatase with EF-Hand domains, putative  G2&M 1.3 
Tb927.8.2870  conserved protein  G2&M 1.3 
Tb927.1.3450  hypothetical protein, conserved  G2&M 1.3 
Tb927.5.3200  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.6960  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.2350  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.8100  hypothetical protein, conserved  G2&M 1.3 
Tb927.6.3710  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.6440  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.9870  hypothetical protein, conserved  G2&M 1.3 
Tb927.1.1210  conserved protein, unknown function  G2&M 1.3 
Tb927.4.5180  tousled-like kinase I (TLK1)  G2&M 1.3 
Tb927.10.8580  ADP-ribosylation factor 3, putative,ADP-ribosylation factor-
like protein, putative (ARL3)  
G2&M 1.3 
Tb927.10.10710  hypothetical protein, conserved  G2&M 1.3 
Tb927.10.11730  zinc finger protein family member, putative (ZC3H33)  G2&M 1.3 
Tb927.11.650  hypothetical protein, conserved  G2&M 1.3 
Tb927.7.2060  DNA repair protein, putative  G2&M 1.3 
Tb927.11.7110  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.3080  vesicular protein trafficking mediator, putative  G2&M 1.3 
Tb927.6.300  receptor-type adenylate cyclase GRESAG 4, putative  G2&M 1.3 
Tb927.4.2910  hypothetical protein, conserved  G2&M 1.3 
Tb927.11.12930  DEAD-box helicase, putative  G2&M 1.3 
Tb927.11.14460  ADP-ribosylation factor GTPase activating protein 1, 
putative  
G2&M 1.3 
Tb927.9.7470  purine nucleoside transporter (NT10)  G2&M 1.3 
Supplementary Tables 
 
 
 
!
201 
Tb927.10.6540  kinetoplastid-specific phospho-protein phosphatase, putative  G2&M 1.3 
Tb927.10.12220  hypothetical protein, conserved  G2&M 1.3 
Tb927.1.990  Enkuring domain-containig protein  G2&M 1.3 
Tb927.9.11820  hypothetical protein, conserved  G2&M 1.3 
Tb927.9.15050  trypanin-related protein, putative  G2&M 1.3 
Tb927.8.4640  flagellar protofilament ribbon protein, putative  G2&M 1.3 
Tb927.4.4610  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.5270  mitogen-activated protein kinase kinase 5, putative (MKK5)  G2&M 1.2 
Tb927.10.1200  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.1450  hypothetical protein, conserved  G2&M 1.2 
Tb927.8.6910  cyclophilin, putative  G2&M 1.2 
Tb927.4.4370  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.14560  hypothetical protein, conserved  G2&M 1.2 
Tb927.2.5950  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.10330  hypothetical protein, conserved  G2&M 1.2 
Tb11.02.5105b  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.8610  hypothetical protein, conserved  G2&M 1.2 
Tb927.3.4230  subtilisin-like serine peptidase,serine peptidase, clan SB, 
family S8-like protein  
G2&M 1.2 
Tb927.2.6080  hypothetical protein, conserved  G2&M 1.2 
Tb927.9.5380  hypothetical protein, conserved  G2&M 1.2 
Tb927.4.720  hypothetical protein, conserved  G2&M 1.2 
Tb927.8.2800  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.13650  ARF-like 2-binding protein, putative,BART  G2&M 1.2 
Tb927.7.4780  hypothetical protein, conserved  G2&M 1.2 
Tb927.9.13350  hypothetical protein, conserved  G2&M 1.2 
Tb927.11.3930  hypothetical protein, conserved  G2&M 1.2 
Tb927.9.8260  rhomboid-like protein,serine peptidase, Clan S- , family S54, 
putative  
G2&M 1.2 
Tb927.4.1150  hypothetical protein, conserved  G2&M 1.2 
Tb927.11.7280  DNA-direcetd RNA polymerase II, subunit 9, putative 
(RPB9)  
G2&M 1.2 
Tb927.7.3000  kinesin, putative  G2&M 1.2 
Tb927.8.2590  hypothetical protein, conserved  G2&M 1.2 
Tb927.8.1370  hypothetical protein, conserved  G2&M 1.2 
Tb927.7.3740  hypothetical protein, conserved  G2&M 1.2 
Tb927.3.2040  kinesin, putative  G2&M 1.2 
Tb927.9.15020  hypothetical protein, conserved  G2&M 1.2 
Tb927.3.2370  hypothetical protein, conserved  G2&M 1.2 
Tb927.11.2020  hypothetical protein, conserved  G2&M 1.2 
Tb927.1.1630  transcription elongation factor 1 homolog (ELOF1)  G2&M 1.2 
Tb927.8.2300  hypothetical protein, conserved  G2&M 1.2 
Tb927.4.1170  ankyrin, putative  G2&M 1.2 
Tb927.4.3130  Spef1,flagellar component  G2&M 1.2 
Tb927.11.9750  hypothetical protein, conserved  G2&M 1.2 
Tb927.11.8890  DNA-dependent RNA polymerases, putative (RPC19)  G2&M 1.2 
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Tb927.1.690  hypothetical protein, conserved  G2&M 1.2 
Tb927.10.3160  hypothetical protein, conserved  G2&M 1.2 
Tb927.7.4630  hypothetical protein, conserved  G2&M 1.2 
Tb927.8.7540  hypothetical protein  G1/early 
S 
2.8 
Tb927.7.3410  centrin, putative  G1/early 
S 
2.3 
Tb927.2.5000  hypothetical protein, conserved  G1/early 
S 
2.0 
Tb927.10.12440  kinesin, putative  G1/early 
S 
1.9 
Tb927.9.15230  hypothetical protein, conserved  G1/early 
S 
1.9 
Tb927.11.4510  hypothetical protein, conserved  G1/early 
S 
1.8 
Tb927.10.11340  hypothetical protein, conserved  G1/early 
S 
1.8 
Tb927.7.6900  double-strand-break repair protein rad21 homolog, putative  G1/early 
S 
1.8 
Tb927.10.7730  hypothetical protein, conserved  G1/early 
S 
1.8 
Tb927.8.2120  hypothetical protein, conserved  G1/early 
S 
1.7 
Tb927.11.8780  hypothetical protein, conserved  G1/early 
S 
1.7 
Tb927.7.7360  cdc2-related kinase 2,cell division control protein 2 homolog 
2 (CRK2)  
G1/early 
S 
1.7 
Tb927.8.6000  fatty acid desaturase, putative  G1/early 
S 
1.7 
Tb927.6.3990  hypothetical protein, conserved  G1/early 
S 
1.6 
Tb927.4.1910  hypothetical protein, conserved  G1/early 
S 
1.6 
Tb927.9.5710  general transcription factor IIB (tf2b)  G1/early 
S 
1.6 
Tb927.10.6010  hypothetical protein, conserved  G1/early 
S 
1.6 
Tb927.2.4900  hypothetical protein, conserved  G1/early 
S 
1.6 
Tb927.7.1610  6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, 
putative  
G1/early 
S 
1.6 
Tb927.11.6420  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb11.v5.0452  GTPase activating protein, putative  G1/early 
S 
1.5 
Tb927.8.6530  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.8.7190  hypothetical protein  G1/early 
S 
1.5 
Tb927.10.11810  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.10.4280  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.10.5070  ribonuclease H, putative  G1/early 
S 
1.5 
Tb927.7.5330  hypothetical protein, conserved  G1/early 
S 
1.5 
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Tb927.7.1410  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.10.11990  RNA-binding protein  G1/early 
S 
1.5 
Tb927.11.14490  RNA polymerase subunit, putative (RPB7)  G1/early 
S 
1.5 
Tb927.3.4000  clathrin coat assembly protein ap19, putative  G1/early 
S 
1.5 
Tb927.1.1130  glycerol-3-phosphate dehydrogenase (FAD-dependent), 
putative  
G1/early 
S 
1.5 
Tb927.5.1620  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.9.10470  hypothetical protein, conserved  G1/early 
S 
1.5 
Tb927.11.5130  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.11.13740  receptor-type adenylate cyclase GRESAG 4, putative  G1/early 
S 
1.4 
Tb927.5.1600  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.10.910  DNA repair and recombination helicase protein PIF6 
(TbPIF6)  
G1/early 
S 
1.4 
Tb927.10.2680  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.3.4500  fumarate hydratase, class I (FHc)  G1/early 
S 
1.4 
Tb927.8.4920  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.9.13540  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.7.4440  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.7.6790  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.4.4400  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.7.5320  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.6.2900  dendritic cell-derived IFNG-induced protein,SAM domain 
and HD domain-containing protein 1  
G1/early 
S 
1.4 
Tb927.3.2820  TFIIF-stimulated CTD phosphatase, putative  G1/early 
S 
1.4 
Tb927.4.5120  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb11.1810b  retrotransposon hot spot protein (RHS, pseudogene), 
putative  
G1/early 
S 
1.4 
Tb927.7.7500  thymine-7-hydroxylase, putative (TLP7)  G1/early 
S 
1.4 
Tb927.10.2660  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.8.4240  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.11.7850  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.10.11840  hypothetical protein  G1/early 
S 
1.4 
Tb927.8.3530  glycerol-3-phosphate dehydrogenase [NAD+], glycosomal  G1/early 
S 
1.4 
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Tb927.11.7180  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.7.4390  threonine synthase, putative  G1/early 
S 
1.4 
Tb927.11.15240  Ras-related protein Rab2 (RAB2)  G1/early 
S 
1.4 
Tb927.9.5240  mismatch repair protein MSH3, putative,mismatch repair 
protein (MSH3)  
G1/early 
S 
1.4 
Tb927.11.12500  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.6.4180  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.11.14900  coatomer epsilon subunit, putative,cytosolic coat protein, 
putative  
G1/early 
S 
1.4 
Tb927.3.1970  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.11.11810  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.2.1820  protein kinase, putative  G1/early 
S 
1.4 
Tb927.11.3320  ras-like small GTPase, putative (TbGTR)  G1/early 
S 
1.4 
Tb927.7.1190  regulator of chromosome condensation, putative  G1/early 
S 
1.4 
Tb927.11.3540  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.8.840  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.10.11020  DNA mismatch repair protein MSH2, putative,MutS protein 
homolog 2, putative (MSH2)  
G1/early 
S 
1.4 
Tb927.11.2260  eukaryotic translation initiation factor 4e, putative (eIF4E)  G1/early 
S 
1.4 
Tb927.11.8920  hypothetical protein, conserved  G1/early 
S 
1.4 
Tb927.5.2690  inositol-1(or 4)-monophosphatase 1, putative (IMPase 1)  G1/early 
S 
1.4 
Tb927.10.2010  hexokinase (HK1)  G1/early 
S 
1.4 
Tb927.3.3270  ATP-dependent phosphofructokinase (PFK)  G1/early 
S 
1.4 
Tb927.10.7090  alternative oxidase (AOX)  G1/early 
S 
1.4 
Tb927.8.1780  protein kinase, putative  G1/early 
S 
1.3 
Tb927.6.3920  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.11.5520  triosephosphate isomerase (TIM)  G1/early 
S 
1.3 
Tb927.7.2980  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.11.12280  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.8.1420  acyl-CoA dehydrogenase, mitochondrial precursor, putative  G1/early 
S 
1.3 
Tb927.10.1800  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.10.13020  Vacuolar protein sorting-associated protein 16 homolog, 
putative  
G1/early 
S 
1.3 
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Tb927.7.4430  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.4.4950  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.6.3690  pre-mRNA cleavage complex II Clp1-like, conserved  G1/early 
S 
1.3 
Tb927.3.4710  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.4.2400  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.10.2000  actin-like protein, putative  G1/early 
S 
1.3 
Tb927.10.6710  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.8.2380  ABC transporter, putative  G1/early 
S 
1.3 
Tb927.6.3220  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.7.1790  Adenine phosphoribosyltransferase, putative  G1/early 
S 
1.3 
Tb927.7.7470  receptor-type adenylate cyclase GRESAG 4, putative  G1/early 
S 
1.3 
Tb927.8.5460  flagellar calcium-binding protein,44 kDa calflagin,44 kDa 
calcimedin (Tb-44)  
G1/early 
S 
1.3 
Tb927.10.4040  3-keto-dihydrosphingosine reductase  G1/early 
S 
1.3 
Tb927.1.4420  ABC transporter, putative  G1/early 
S 
1.3 
Tb927.11.11520  glycosomal membrane protein (PEX11)  G1/early 
S 
1.3 
Tb927.1.2260  calpain-like protein fragment, putative  G1/early 
S 
1.3 
Tb927.8.560  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.6.1910  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.9.4200  fatty acyl CoA synthetase 2 (ACS2)  G1/early 
S 
1.3 
Tb927.11.5580  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.10.5780  amino acid tansporter, putative  G1/early 
S 
1.3 
Tb927.8.3540  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.11.14820  hypothetical protein, conserved  G1/early 
S 
1.3 
Tb927.6.2760  hypothetical protein, conserved  G1/early 
S 
1.2 
Tb927.11.4840  hypothetical protein, conserved  G1/early 
S 
1.2 
Tb927.10.640  arginine N-methyltransferase, type II (PRMT5)  early G1 2.2 
Tb927.4.3920  hypothetical protein, conserved  early G1 2.0 
Tb927.7.2440  pyrroline-5-carboxylate reductase, putative (P5CR)  early G1 2.0 
Tb927.11.16790  mitogen-activated protein kinase (ECK1)  early G1 2.0 
Tb927.6.2540  DREV methyltransferase, putative  early G1 1.8 
Tb927.4.3800  hypothetical protein, conserved  early G1 1.8 
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Tb927.1.190  retrotransposon hot spot protein (RHS, pseudogene), 
putative  
early G1 1.7 
Tb927.10.14280  mitochondrial carrier protein (MCP20)  early G1 1.7 
Tb927.1.1390  hypothetical protein, conserved  early G1 1.7 
Tb927.10.3280  60S ribosomal proteins L38, putative  early G1 1.7 
Tb927.1.1640  hypothetical protein, conserved  early G1 1.7 
Tb927.6.4420  hypothetical protein, conserved  early G1 1.7 
Tb927.11.3620  nucleobase/nucleoside transporter 8.1 (NT8.1)  early G1 1.7 
Tb927.11.5590  hypothetical protein, conserved  early G1 1.7 
Tb927.2.5850  small nuclear ribonucleoprotein SmD2 (Sm-D2)  early G1 1.7 
Tb927.8.6490  protein kinase, putative  early G1 1.7 
Tb927.2.2670  histone H4 variant  early G1 1.7 
Tb927.7.4170  fatty acid elongase, putative  early G1 1.7 
Tb927.11.9620.1  hypothetical protein, conserved  early G1 1.7 
Tb927.4.3290  hypothetical protein, conserved  early G1 1.7 
Tb927.10.14360  U2 small nuclear ribonucleoprotein 40K (U2_40K)  early G1 1.7 
Tb927.11.6040  hypothetical protein, conserved  early G1 1.6 
Tb927.7.3520  mitochondrial pyruvate carrier protein 2, putative  early G1 1.6 
Tb927.11.9770  hypothetical protein, conserved  early G1 1.6 
Tb927.6.2940  phosphopantothenoylcysteine decarboxylase, putative 
(PPCDC)  
early G1 1.6 
Tb927.10.8410  hypothetical protein, conserved  early G1 1.6 
Tb927.11.16930  ABC transporter of the mitochondrion, putative,Iron-sulfur 
clusters transporter, putative (ABCB7)  
early G1 1.6 
Tb927.10.7740  protein transport protein SEC23 (SEC23.2)  early G1 1.6 
Tb927.3.3480  U2 small nuclear ribonucleoprotein B, putative (RBP36 
U2SNRNPB)  
early G1 1.6 
Tb927.7.7170  CYC2-like cyclin, putative (CYC4)  early G1 1.6 
Tb927.5.930  NADH-dependent fumarate reductase (FRDg)  early G1 1.6 
Tb927.11.7560  predicted WD40 repeat protein  early G1 1.6 
Tb927.10.15940  cation transporter, putative  early G1 1.6 
Tb927.11.7780  hypothetical protein, conserved  early G1 1.6 
Tb927.2.4930  esterase, putative  early G1 1.6 
Tb927.7.4050  hypothetical protein, conserved  early G1 1.6 
Tb927.8.7250  hypothetical protein, conserved  early G1 1.6 
Tb927.4.3560  protein phoshatase 1, putative  early G1 1.6 
Tb927.2.4540  Small nuclear ribonucleoprotein-associated protein B 
(snRNP-B) (Sm protein B) (Sm-B) (SmB), putative 
(TbSmB)  
early G1 1.5 
Tb927.7.6930  ATPase, putative  early G1 1.5 
Tb927.8.3270  hypothetical protein  early G1 1.5 
Tb927.11.4760  hypothetical protein  early G1 1.5 
Tb927.3.1840  3-oxo-5-alpha-steroid 4-dehydrogenase, putative,polyprenol 
reductase  
early G1 1.5 
Tb927.4.3500  hypothetical protein, conserved  early G1 1.5 
Tb927.4.5060  hypothetical protein  early G1 1.5 
Tb927.9.12630  glycerol kinase, glycosomal (glk1)  early G1 1.5 
Tb11.v5.0553  ubiquitin hydrolase, putative  early G1 1.4 
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Tb927.3.2280  vacuolar sorting protein 33 , putative  early G1 1.4 
Tb927.3.3120  hypothetical protein, conserved  early G1 1.4 
Tb927.11.11750  membrane-bound acid phosphatase, putative  early G1 1.4 
Tb927.4.1370  hypothetical protein, conserved  early G1 1.3 
Tb927.8.4770  small GTP-binding protein Rab18 (TbRAB18)  early G1 1.3 
Tb927.11.1030  kinetoplastid kinetochore protein 7 (kkt7)  high 
G2&M 
6.0 
Tb927.1.2600  pumilio/PUF RNA binding protein 9 (PUF9)  high 
G2&M 
5.3 
Tb927.9.6110  hypothetical protein, conserved  high 
G2&M 
4.7 
Tb927.9.1340  Myosin-like protein,Nucleoporin (TbMlp-2)  high 
G2&M 
4.7 
Tb927.6.4820  chromosomal passenger protein (CPC1)  high 
G2&M 
4.7 
Tb927.10.6330  kinetoplastid kinetochore protein 1 (kkt1)  high 
G2&M 
4.5 
Tb927.5.4520  hypothetical protein, conserved  high 
G2&M 
4.0 
Tb927.11.10940  hypothetical protein, conserved  high 
G2&M 
3.8 
Tb927.11.12410  kinetoplastid kinetochore protein 10 (kkt10)  high 
G2&M 
3.6 
Tb927.11.8370  hypothetical protein, conserved  high 
G2&M 
3.6 
Tb927.9.3650  kinesin (Kif-13-1)  high 
G2&M 
3.4 
Tb927.11.8220  aurora B kinase (AUK1)  high 
G2&M 
3.3 
Tb927.11.2880  kinesin, putative (KIN-A)  high 
G2&M 
3.2 
Tb927.3.2020  kinesin, putative  high 
G2&M 
3.2 
Tb927.6.1210  kinetoplastid kinetochore protein 6 (kkt6)  high 
G2&M 
3.2 
Tb927.10.870  hypothetical protein, conserved  high 
G2&M 
3.1 
Tb927.10.10990  predicted WD40 repeat protein  high 
G2&M 
2.7 
Tb927.9.13920  kinetoplastid membrane protein KMP-11 (KMP-11)  high 
G2&M 
2.2 
Tb927.7.6770  hypothetical protein, conserved  high 
G2&M 
1.9 
Tb927.11.1130  calpain-like cysteine peptidase, putative,antigen, putative  high 
G2&M 
1.9 
Tb927.6.2850  ESAG8-associated protein, putative (PIE8)  high S 4.3 
Tb927.3.4960  kinesin, putative  high S 4.2 
Tb927.11.14750  hypothetical protein, conserved  high S 4.1 
Tb927.10.8330  S. cerevisiae PSP1 homologue, putative  high S 3.5 
Tb927.11.1340  hypothetical protein, conserved  high S 3.4 
Tb927.6.4470  prozyme,S-adenosylmethionine decarboxylaseregulator  high S 2.8 
Tb927.11.13110  hypothetical protein, conserved  high S 2.7 
Tb927.10.3970  hypothetical protein, conserved  high S 2.6 
Tb927.4.530  hypothetical protein, conserved  high S 2.6 
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Tb927.10.880  thymidine kinase, putative  high S 2.5 
Tb927.11.5410  hypothetical protein, conserved  high S 2.3 
Tb927.1.4480  hypothetical protein, conserved  high S 2.2 
Tb927.1.4010  primase 2  high S 2.1 
Tb927.8.1900  hypothetical protein, conserved  high S 2.1 
Tb927.8.2550  mitochondrial DNA primase (PRI1)  high S 2.0 
Tb927.7.4370  hypothetical protein, conserved  high S 1.8 
Tb927.9.11580  Gim5A protein,glycosomal membrane protein (gim5A)  high 
early G1 
3.4 
Tb927.9.11600  unspecified product (gim5B)  high 
early G1 
3.2 
Tb927.5.320  receptor-type adenylate cyclase GRESAG 4, 
putative,adenylyl cyclase, putative  
high 
early G1 
3.1 
Tb927.6.3240  hypothetical protein, conserved  high 
early G1 
3.1 
Tb927.10.13230  hypothetical protein, conserved  high 
early G1 
3.0 
Tb927.9.2680  hypothetical protein, unlikely  high 
early G1 
2.9 
Tb927.6.820  pumilio RNA binding protein, putative (PUF4)  high 
early G1 
2.9 
Tb927.3.960  protein transport protein Sec61 gamma subunit, putative  high 
early G1 
2.8 
Tb927.7.2620  hypothetical protein, conserved  high 
early G1 
2.5 
Tb927.8.730  nucleolar RNA-binding protein, putative  high 
early G1 
2.4 
Tb927.1.570  Histone-lysine N-methyltransferase, H3 lysine-76 
specific,Histone H3-K76 methyltransferase (DOT1B)  
high 
early G1 
2.3 
Tb927.11.5940  receptor-type adenylate cyclase GRESAG 4, putative  high 
early G1 
2.1 
Tb927.10.12800  Zinc finger CCCH domain-containing protein 38 (ZC3H38)  high 
early G1 
2.0 
Tb927.10.15540  predicted VPS53-like domain protein  high G1 5.6 
Tb927.11.950  RNA-binding protein, putative (DRBD14)  high G1 4.5 
Tb927.11.14830  hypothetical protein, conserved  high 
early S 
3.5 
Tb927.11.6890  DNA repair and recombination helicase protein PIF1 (PIF1)  high 
early S 
3.5 
Tb927.11.4180  hypothetical protein, conserved  high 
early S 
3.3 
Tb927.6.5100  serine/threonine-protein kinase, putative  high 
early S 
2.4 
Tb927.8.710  RNA-binding protein, putative (DRBD17)  early 
G1/late 
G2&M 
2.8 
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Supplementary Table 5: List of proteins detected as cell-cycle regulated in both T. 
brucei proteomic and transcriptomic (Archer et al., 2011) analysis. 
Gene ID Product Description 
Tb927.1.1270 homocysteine S-methyltransferase, putative 
Tb927.1.2600 pumilio/PUF RNA binding protein 9 (PUF9) 
Tb927.1.3450 hypothetical protein, conserved 
Tb927.1.4480 WD repeat and HMG-box DNA-binding protein, putative 
Tb927.2.2670 histone H4 variant 
Tb927.2.5000 hypothetical protein, conserved 
Tb927.3.2020 kinesin, putative 
Tb927.3.4500 Fumarate hydratase class I, cytosolic (FHc) 
Tb927.3.4710 hypothetical protein, conserved 
Tb927.3.4960 kinesin, putative 
Tb927.4.1910 hypothetical protein, conserved 
Tb927.4.2400 hypothetical protein, conserved 
Tb927.4.4370 hypothetical protein, conserved 
Tb927.4.5120 hypothetical protein, conserved 
Tb927.5.4520 hypothetical protein, conserved 
Tb927.6.570 conserved protein 
Tb927.6.2850 ESAG8-associated protein, putative (PIE8) 
Tb927.6.2900 dendritic cell-derived IFNG-induced protein 
Tb927.6.3220 hypothetical protein, conserved 
Tb927.6.3240 hypothetical protein, conserved 
Tb927.6.4820 chromosomal passenger protein (CPC1) 
Tb927.6.5130 60S acidic ribosomal protein P2, putative 
Tb927.7.1410 hypothetical protein, conserved 
Tb927.7.2290 hypothetical protein, conserved 
Tb927.7.3410 centrin-4 (Centrin4) 
Tb927.7.4390 threonine synthase, putative 
Tb927.7.5320 hypothetical protein, conserved 
Tb927.7.5730 hypothetical protein, conserved 
Tb927.7.6900 double-strand-break repair protein rad21 homolog, putative 
Tb927.7.7470 procyclic-enriched flagellar receptor adenylate cyclase 3 (ACP3) 
Tb927.8.710 RNA-binding protein, putative (DRBD17) 
Tb927.8.960 hypothetical protein, conserved 
Tb927.8.1900 hypothetical protein, conserved 
Tb927.8.2550 mitochondrial DNA primase (PRI1) 
Tb927.8.3540 hypothetical protein, conserved 
Tb927.8.3560 DNA repair and recombination helicase protein PIF5 (PIF5) 
Tb927.8.4240 hypothetical protein, conserved 
Tb927.8.7340 trans-sialidase, putative 
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Tb927.8.7540 hypothetical protein 
Tb927.9.1340 Myosin-like protein (TbMlp-2) 
Tb927.9.5240 mismatch repair protein MSH3, putative (MSH3) 
Tb927.9.6110 hypothetical protein, conserved 
Tb927.9.13140 hypothetical protein, conserved 
Tb927.9.14290 hypothetical protein, conserved 
Tb927.9.15050 trypanin-related protein, putative 
Tb927.9.15230 hypothetical protein, conserved 
Tb927.10.870 hypothetical protein, conserved 
Tb927.10.880 thymidine kinase, putative 
Tb927.10.890 kinesin, putative 
Tb927.10.2660 hypothetical protein, conserved 
Tb927.10.3970 hypothetical protein, conserved 
Tb927.10.4990 cdc2-related kinase 3, putative (CRK3) 
Tb927.10.5070 ribonuclease H, putative 
Tb927.10.6010 STAG domain containing protein, putative 
Tb927.10.6330 kinetoplastid kinetochore protein 1 (kkt1) 
Tb927.10.7730 Domain of unknown function (DUF4496), putative 
Tb927.10.8330 S. cerevisiae PSP1 homologue, putative 
Tb927.10.9870 Protein of unknown function (DUF2870), putative 
Tb927.10.11020 DNA mismatch repair protein MSH2, putative (MSH2) 
Tb927.10.11340 hypothetical protein, conserved 
Tb927.10.11990 RNA-binding protein 
Tb927.10.12920 hypothetical protein, conserved 
Tb927.10.13100 hypothetical protein, conserved 
Tb927.10.15400 kinesin, putative 
Tb927.11.950 RNA-binding protein, putative (DRBD14) 
Tb927.11.1030 kinetoplastid kinetochore protein 7 (kkt7) 
Tb927.11.1130 calpain-like cysteine peptidase, putative 
Tb927.11.1340 hypothetical protein, conserved 
Tb927.11.4180 PSP1 C-terminal conserved region, putative 
Tb927.11.4510 Sister chromatid cohesion C-terminus, putative 
Tb927.11.4840 hypothetical protein, conserved 
Tb927.11.5410 hypothetical protein, conserved 
Tb927.11.6040 Nodulin-like, putative 
Tb927.11.6560 hypothetical protein, conserved 
Tb927.11.7600 hypothetical protein, conserved 
Tb927.11.7930 RNA polymerase B subunit RPB8, putative (RPB8) 
Tb927.11.8220 aurora B kinase (AUK1) 
Tb927.11.8920 hypothetical protein, conserved 
Tb927.11.10520 kinetoplastid kinetochore protein 2 (kkt2) 
Tb927.11.10940 hypothetical protein, conserved 
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Tb927.11.13110 hypothetical protein, conserved 
Tb927.11.14750 PSP1 C-terminal conserved region, putative 
Tb927.11.14830 hypothetical protein, conserved 
Tb927.11.15800 hypothetical protein, conserved 
Tb927.11.16390 cyclin dependent kinases regulatory subunit, putative (CKS1) 
 
Supplementary Table 6: List of proteins identified in both transcriptomic and proteomic 
analysis of the cell-cycle, and only classified as regulated from proteomic data. 
Gene ID Product Description 
Tb927.1.1130 glycerol-3-phosphate dehydrogenase (FAD-dependent), putative 
Tb927.1.1210 conserved protein, unknown function 
Tb927.1.1390 hypothetical protein, conserved 
Tb927.1.1630 transcription elongation factor 1 homolog (ELOF1) 
Tb927.1.1640 hypothetical protein, conserved 
Tb927.1.190 retrotransposon hot spot protein (RHS, pseudogene), putative 
Tb927.1.2260 calpain-like protein fragment, putative 
Tb927.1.4010 primase 2 
Tb927.1.4300 chaperone protein DNAj, putative 
Tb927.1.4420 ABC transporter, putative 
Tb927.1.4700 hypothetical protein, conserved 
Tb927.1.570 Histone-lysine N-methyltransferase, H3 lysine-76 specific (DOT1B) 
Tb927.1.690 hypothetical protein, conserved 
Tb927.1.990 Enkuring domain-containig protein 
Tb927.10.10000 hypothetical protein, conserved 
Tb927.10.10330 Anaphase-promoting complex, cyclosome, subunit 3/TPR repeat, putative 
Tb927.10.10710 hypothetical protein, conserved 
Tb927.10.10780 hypothetical protein, conserved 
Tb927.10.10990 predicted WD40 repeat protein 
Tb927.10.11270 RNA-binding protein, putative (RBP23) 
Tb927.10.11580 predicted WD40 repeat protein 
Tb927.10.11730 zinc finger protein family member, putative (ZC3H33) 
Tb927.10.11810 hypothetical protein, conserved 
Tb927.10.11900 thioredoxin, putative 
Tb927.10.1200 Programmed cell death protein 2, C-terminal putative domain containing protein, 
putative 
Tb927.10.12220 hypothetical protein, conserved 
Tb927.10.12440 kinesin, putative 
Tb927.10.13020 Vacuolar protein sorting-associated protein 16 homolog, putative 
Tb927.10.13230 hypothetical protein, conserved 
Tb927.10.14280 mitochondrial carrier protein (MCP20) 
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Tb927.10.14330 Utp14 protein, putative 
Tb927.10.14360 U2 small nuclear ribonucleoprotein 40K (U2_40K) 
Tb927.10.14460 leucine-rich repeat protein (LRRP), putative 
Tb927.10.1450 plectin, putative 
Tb927.10.14560 TPR repeat, putative 
Tb927.10.15540 predicted VPS53-like domain protein 
Tb927.10.15940 cation transporter, putative 
Tb927.10.1800 methyltransferase domain containing protein, putative 
Tb927.10.2000 actin-like protein, putative 
Tb927.10.2680 pyridine nucleotide-disulphide oxidoreductase, putative 
Tb927.10.3160 hypothetical protein, conserved 
Tb927.10.3280 60S ribosomal proteins L38, putative 
Tb927.10.3300 Domain of unknown function (DUF4206), putative 
Tb927.10.3380 60S acidic ribosomal protein P2, putative 
Tb927.10.3470 Ankyrin repeats (3 copies), putative 
Tb927.10.4040 3-keto-dihydrosphingosine reductase 
Tb927.10.4050 serine palmitoyltransferase, putative 
Tb927.10.4280 ubiquinol-cytochrome c reductase complex 14kD subunit, putative 
Tb927.10.4620 peptidyl-prolyl cis-trans isomerase, putative (PPIase) 
Tb927.10.4750 hypothetical protein, conserved 
Tb927.10.4930 protein phosphatase 2C, putative 
Tb927.10.5270 mitogen-activated protein kinase kinase 5, putative (MKK5) 
Tb927.10.5750 Extradiol ring-cleavage dioxygenase, putative 
Tb927.10.5780 amino acid tansporter, putative 
Tb927.10.5860 hypothetical protein, conserved 
Tb927.10.6060 universal minicircle sequence binding protein 2 (UMSBP2) 
Tb927.10.6070 universal minicircle sequence binding protein 1 (UMSBP1) 
Tb927.10.640 arginine N-methyltransferase, type II (PRMT5) 
Tb927.10.6410 DNA mismatch repair protein MSH6, putative (MSH6) 
Tb927.10.6540 kinetoplastid-specific phospho-protein phosphatase, putative 
Tb927.10.6710 hypothetical protein, conserved 
Tb927.10.6960 hypothetical protein, conserved 
Tb927.10.7090 Alternative oxidase, mitochondrial (AOX) 
Tb927.10.7430 GTP-binding protein, putative 
Tb927.10.7620 mitochondrial ATP-dependent zinc metallopeptidase, putative 
Tb927.10.7740 protein transport protein SEC23 (SEC23.2) 
Tb927.10.7780 mitogen-activated protein kinase 1, putative 
Tb927.10.8240 hypothetical protein, conserved 
Tb927.10.8410 hypothetical protein, conserved 
Tb927.10.8580 ADP-ribosylation factor-like protein 
Tb927.10.8610 hypothetical protein, conserved 
Tb927.10.8710 centrin, putative 
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Tb927.10.9080 pteridine transporter, putative 
Tb927.10.910 DNA repair and recombination helicase protein PIF6 (TbPIF6) 
Tb927.10.9160 hypothetical protein, conserved 
Tb927.10.9230 beta adaptin, putative 
Tb927.11.10100 hypothetical protein, conserved 
Tb927.11.11240 hypothetical protein, conserved 
Tb927.11.11520 glycosomal membrane protein (PEX11) 
Tb927.11.11810 hypothetical protein, conserved 
Tb927.11.12280 hypothetical protein, conserved 
Tb927.11.1240 hypothetical protein, conserved 
Tb927.11.12410 kinetoplastid kinetochore protein 10 (kkt10) 
Tb927.11.12500 hypothetical protein, conserved 
Tb927.11.12520 hypothetical protein, conserved 
Tb927.11.12930 DEAD-box helicase, putative 
Tb927.11.1300 UBA/TS-N domain containing protein, putative 
Tb927.11.13100 hypothetical protein, conserved 
Tb927.11.13150 UEV domain/Zinc finger, C3HC4 type (RING finger), putative 
Tb927.11.13520 hypothetical protein, conserved 
Tb927.11.13740 procyclic-enriched flagellar receptor adenylate cyclase 5 (ACP5) 
Tb927.11.13980 Outer row dynein-assembly protein 7 (ODA7) 
Tb927.11.14410 Ankyrin repeats (3 copies), putative 
Tb927.11.14460 ADP-ribosylation factor GTPase activating protein 1, putative 
Tb927.11.14490 RNA polymerase subunit, putative (RPB7) 
Tb927.11.14710 rRNA processing, putative 
Tb927.11.14820 hypothetical protein, conserved 
Tb927.11.14900 coatomer subunit epsilon (COPE) 
Tb927.11.14950 zinc finger protein 2 (ZFP2) 
Tb927.11.15240 Ras-related protein RAB2B, putative (RAB2B) 
Tb927.11.15780 hypothetical protein, conserved 
Tb927.11.16380 TPR repeat, putative 
Tb927.11.16750 hypothetical protein, conserved 
Tb927.11.16820 hypothetical protein, conserved 
Tb927.11.16930 ABC transporter of the mitochondrion, putative (ABCB7) 
Tb927.11.2020 hypothetical protein, conserved 
Tb927.11.2260 eukaryotic translation initiation factor 4E, putative (eIF4E) 
Tb927.11.2880 kinesin, putative (KIN-A) 
Tb927.11.3080 vesicular protein trafficking mediator, putative 
Tb927.11.3090 LisH domain-containing protein FOPNL, putative (fopnl) 
Tb927.11.3320 ras-like small GTPase, putative (TbGTR) 
Tb927.11.3540 hypothetical protein, conserved 
Tb927.11.3930 hypothetical protein, conserved 
Tb927.11.4760 hypothetical protein 
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Tb927.11.4770 retrotransposon hot spot protein (RHS, pseudogene), putative 
Tb927.11.4970 predicted WD40 repeat protein 
Tb927.11.5130 hypothetical protein, conserved 
Tb927.11.5260 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 
subfamily A-like protein, putative 
Tb927.11.5520 triosephosphate isomerase (TIM) 
Tb927.11.5580 hypothetical protein, conserved 
Tb927.11.5590 hypothetical protein, conserved 
Tb927.11.5850 RNA-binding protein 38, putative (RBP38) 
Tb927.11.5940 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.11.6340 PUB domain containing protein, putative 
Tb927.11.640 pentatricopeptide repeat domain containing protein, putative 
Tb927.11.6420 hypothetical protein, conserved 
Tb927.11.6440 hypothetical protein, conserved 
Tb927.11.650 hypothetical protein, conserved 
Tb927.11.6890 DNA repair and recombination helicase protein PIF1 (PIF1) 
Tb927.11.7050 PA domain containing protein, putative (ESP7) 
Tb927.11.7110 myotubularin-associated protein, putative 
Tb927.11.7180 MORN repeat, putative 
Tb927.11.7280 DNA-direcetd RNA polymerase II, subunit 9, putative (RPB9) 
Tb927.11.7560 predicted WD40 repeat protein 
Tb927.11.7780 Mitochondrial import receptor subunit ATOM46 (ATOM46) 
Tb927.11.7850 hypothetical protein, conserved 
Tb927.11.8100 Ankyrin repeats (3 copies), putative 
Tb927.11.8370 hypothetical protein, conserved 
Tb927.11.8780 hypothetical protein, conserved 
Tb927.11.8890 DNA-dependent RNA polymerases, putative (RPC19) 
Tb927.11.9750 Protein of unknown function (DUF498/DUF598), putative 
Tb927.11.9770 hypothetical protein, conserved 
Tb927.11.9860 EF-hand domain pair, putative 
Tb927.2.4140 hypothetical protein, conserved 
Tb927.2.4540 Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (Sm protein B) 
(Sm-B) (SmB), putative (TbSmB) 
Tb927.2.4930 esterase, putative 
Tb927.2.5850 small nuclear ribonucleoprotein SmD2 (Sm-D2) 
Tb927.2.5950 hypothetical protein, conserved 
Tb927.2.6080 hypothetical protein, conserved 
Tb927.3.1840 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 
Tb927.3.1890 cytochrome c oxidase assembly protein, putative 
Tb927.3.1970 DNA / pantothenate metabolism flavoprotein, putative 
Tb927.3.2040 kinesin, putative 
Tb927.3.2140 transcription activator, putative 
Tb927.3.2280 vacuolar sorting protein 33 , putative 
Supplementary Tables 
 
 
 
!
215 
Tb927.3.2330 kinetoplastid kinetochore protein 17 (kkt17) 
Tb927.3.2370 hypothetical protein, conserved 
Tb927.3.2820 TFIIF-stimulated CTD phosphatase, putative 
Tb927.3.3120 hypothetical protein, conserved 
Tb927.3.3240 hypothetical protein, conserved 
Tb927.3.3270 ATP-dependent 6-phosphofructokinase, glycosomal (PFK) 
Tb927.3.3480 U2 small nuclear ribonucleoprotein B, putative (RBP36 U2SNRNPB) 
Tb927.3.3950 hypothetical protein, conserved 
Tb927.3.4000 clathrin coat assembly protein ap19, putative 
Tb927.3.4230 subtilisin-like serine peptidase (CMF33) 
Tb927.3.4270 hypothetical protein, conserved 
Tb927.3.4950 hypothetical protein, conserved 
Tb927.3.860 Acyl carrier protein, mitochondrial (ACP) 
Tb927.3.960 protein transport protein Sec61 gamma subunit, putative 
Tb927.4.1150 hypothetical protein, conserved 
Tb927.4.1170 ankyrin, putative 
Tb927.4.1370 hypothetical protein, conserved 
Tb927.4.1750 hypothetical protein, conserved 
Tb927.4.2190 GTP-binding protein, putative 
Tb927.4.2910 hypothetical protein, conserved 
Tb927.4.3130 Spef1 
Tb927.4.3350 N2227-like protein, putative 
Tb927.4.3430 hypothetical protein, conserved 
Tb927.4.3500 Amastin surface glycoprotein, putative 
Tb927.4.3560 protein phoshatase 1, putative 
Tb927.4.3800 hypothetical protein, conserved 
Tb927.4.3920 CRAL/TRIO domain containing protein, putative 
Tb927.4.4440 adenylyl cyclase (GRESAG 4.4) 
Tb927.4.4610 hypothetical protein, conserved 
Tb927.4.4620 cytochrome oxidase subunit VIII (COXVIII) 
Tb927.4.4970 myosin heavy chain kinase A, putative 
Tb927.4.5060 hypothetical protein 
Tb927.4.5180 tousled-like kinase I (TLK1) 
Tb927.4.530 hypothetical protein, conserved 
Tb927.4.670 conserved protein, unknown function 
Tb927.4.720 hypothetical protein, conserved 
Tb927.5.1600 hypothetical protein, conserved 
Tb927.5.1620 hypothetical protein, conserved 
Tb927.5.1960 hypothetical protein, conserved 
Tb927.5.2690 inositol-1(or 4)-monophosphatase 1, putative (IMPase 1) 
Tb927.5.320 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.5.3200 hypothetical protein, conserved 
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Tb927.5.3310 hypothetical protein, conserved 
Tb927.5.3630 hypothetical protein, conserved 
Tb927.5.4320 zinc finger protein family member, putative (FIP1) 
Tb927.5.440 trans-sialidase, putative 
Tb927.5.930 NADH-dependent fumarate reductase (FRDg) 
Tb927.6.1210 kinetoplastid kinetochore protein 6 (kkt6) 
Tb927.6.1540 Yip1 domain containing protein, putative 
Tb927.6.1910 hypothetical protein, conserved 
Tb927.6.200 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.6.2540 DREV methyltransferase, putative 
Tb927.6.2760 hypothetical protein, conserved 
Tb927.6.2940 phosphopantothenoylcysteine decarboxylase, putative (PPCDC) 
Tb927.6.3290 intraflagellar transport protein 20 (IFT20) 
Tb927.6.3690 pre-mRNA cleavage complex II Clp1-like, conserved 
Tb927.6.3710 hypothetical protein, conserved 
Tb927.6.3760 kinetoplastid kinetochore protein 15 (kkt15) 
Tb927.6.3920 hypothetical protein, conserved 
Tb927.6.3990 hypothetical protein, conserved 
Tb927.6.4180 FUN14 family, putative (POMP32) 
Tb927.6.4420 tRNA (Guanine-1)-methyltransferase, putative 
Tb927.6.4470 prozyme 
Tb927.6.5100 serine/threonine-protein kinase, putative 
Tb927.7.1190 regulator of chromosome condensation, putative 
Tb927.7.1610 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 
Tb927.7.1790 Adenine phosphoribosyltransferase, putative 
Tb927.7.2060 DNA repair protein, putative 
Tb927.7.2160 hypothetical protein, conserved 
Tb927.7.2440 pyrroline-5-carboxylate reductase, putative (P5CR) 
Tb927.7.2620 hypothetical protein, conserved 
Tb927.7.2980 Nitroreductase family, putative 
Tb927.7.3000 kinesin, putative 
Tb927.7.3520 mitochondrial pyruvate carrier protein 2, putative 
Tb927.7.3740 hypothetical protein, conserved 
Tb927.7.4050 hypothetical protein, conserved 
Tb927.7.4170 fatty acid elongase, putative 
Tb927.7.4370 hypothetical protein, conserved 
Tb927.7.4430 hypothetical protein, conserved 
Tb927.7.4440 NAD dependent epimerase/dehydratase family, putative 
Tb927.7.4610 hypothetical protein, conserved 
Tb927.7.4630 Miro-like protein, putative 
Tb927.7.4680 hypothetical protein, conserved 
Tb927.7.4780 conserved hypothetical protein, putative 
Supplementary Tables 
 
 
 
!
217 
Tb927.7.4850 kinetoplastid kinetochore protein 5 (kkt5) 
Tb927.7.5050 hypothetical protein, conserved 
Tb927.7.5330 hypothetical protein, conserved 
Tb927.7.6770 Acyl CoA binding protein, putative 
Tb927.7.6790 hypothetical protein, conserved 
Tb927.7.6930 ATPase, putative 
Tb927.7.7170 CYC2-like cyclin, putative (CYC4) 
Tb927.7.7360 cdc2-related kinase 2 (CRK2) 
Tb927.7.7500 thymine-7-hydroxylase, putative (TLP7) 
Tb927.8.1130 protein phosphatase with EF-Hand domains, putative 
Tb927.8.1420 acyl-CoA dehydrogenase, mitochondrial precursor, putative 
Tb927.8.1750 Cytokine-induced anti-apoptosis inhibitor 1, Fe-S biogenesis, putative 
Tb927.8.1780 protein kinase, putative 
Tb927.8.2120 hypothetical protein, conserved 
Tb927.8.2150 hypothetical protein, conserved 
Tb927.8.2220 hypothetical protein, conserved 
Tb927.8.2300 hypothetical protein, conserved 
Tb927.8.2380 ABC transporter, putative 
Tb927.8.2590 hypothetical protein, conserved 
Tb927.8.2690 SET domain containing protein, putative 
Tb927.8.2800 hypothetical protein, conserved 
Tb927.8.2870 conserved protein 
Tb927.8.2910 mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, putative 
Tb927.8.3220 exonuclease, putative 
Tb927.8.3270 hypothetical protein 
Tb927.8.3460 Ring finger domain containing protein, putative 
Tb927.8.3530 glycerol-3-phosphate dehydrogenase [NAD+], glycosomal 
Tb927.8.3780 MORN repeat, putative 
Tb927.8.4170 RNA-binding protein, putative (MRD1) 
Tb927.8.4190 hypothetical protein, conserved 
Tb927.8.4640 flagellar protofilament ribbon protein, putative 
Tb927.8.4920 hypothetical protein, conserved 
Tb927.8.5460 Flagellar calcium-binding protein 44 (Tb-44) 
Tb927.8.560 hypothetical protein, conserved 
Tb927.8.6000 fatty acid desaturase, putative 
Tb927.8.6490 protein kinase, putative 
Tb927.8.6530 SET domain containing protein, putative 
Tb927.8.6750 translationally controlled tumor protein (TCTP), putative 
Tb927.8.7120 squalene synthase, putative 
Tb927.8.7190 hypothetical protein 
Tb927.8.7250 Maf1 regulator, putative 
Tb927.8.730 nucleolar RNA-binding protein, putative 
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Tb927.8.840 hypothetical protein, conserved 
Tb927.9.10250 small nuclear ribonucleoprotein Sm-F (Sm-F) 
Tb927.9.10470 hypothetical protein, conserved 
Tb927.9.11350 hypothetical protein, conserved 
Tb927.9.11580 Gim5A protein (gim5A) 
Tb927.9.11600 Gim5B protein (gim5B) 
Tb927.9.11820 CRAL/TRIO domain containing protein, putative 
Tb927.9.12680 hypothetical protein, conserved 
Tb927.9.13070 predicted heat shock factor binding protein 
Tb927.9.13350 hypothetical protein, conserved 
Tb927.9.13540 hypothetical protein, conserved 
Tb927.9.15020 hypothetical protein, conserved 
Tb927.9.2760 EB1-like C-terminal motif containing protein, putative 
Tb927.9.3650 Kinesin-13 1 (KIN13-1) 
Tb927.9.4200 fatty acyl CoA synthetase 2 (ACS2) 
Tb927.9.5380 Rab-GTPase-TBC domain containing protein, putative 
Tb927.9.5710 general transcription factor IIB (tf2b) 
Tb927.9.7470 purine nucleoside transporter (NT10) 
Tb927.9.7580 hypothetical protein, conserved 
Tb927.9.8260 rhomboid-like protein 
Tb927.9.9520 zinc finger protein family member, putative (ZC3H29) 
Supplementary Table 7: List of proteins identified in both transcriptomic and proteomic 
analysis of the cell-cycle, and only classified as regulated from transcriptomic data. 
Gene ID Product Description 
Tb927.1.1890 Replication Factor C Subunit 1-related protein 
Tb927.1.2670 paralyzed flagella 16 (PF16) 
Tb927.1.2730 hypothetical protein, conserved 
Tb927.1.3310 hypothetical protein, conserved 
Tb927.1.3390 Eukaryotic protein of unknown function (DUF866), putative 
Tb927.1.4180 leucine-rich repeat protein (LRRP), putative 
Tb927.1.4310 hypothetical protein, conserved 
Tb927.1.5030 leucine-rich repeat protein (LRRP), putative 
Tb927.1.880 Midasin, putative (MDN1) 
Tb927.10.10150 hypothetical protein, conserved 
Tb927.10.10370 hypothetical protein, conserved 
Tb927.10.1140 epsilon tubulin (TUBE1) 
Tb927.10.11780 hypothetical protein, conserved 
Tb927.10.11850 WD domain, G-beta repeat, putative 
Tb927.10.12030 hypothetical protein, conserved 
Tb927.10.12130 Ubiquitin family, putative 
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Tb927.10.12180 hypothetical protein, conserved 
Tb927.10.12860 pre-RNA processing PIH1/Nop17, putative 
Tb927.10.13290 ethanolamine phosphotransferase (EPT) 
Tb927.10.13430 citrate synthase, putative 
Tb927.10.13970 uracil-DNA glycosylase, putative 
Tb927.10.14000 aconitase (ACO) 
Tb927.10.14010 tubulin cofactor C domain-containing protein RP2 (rp2) 
Tb927.10.14390 Histone chaperone Rttp106-like, putative 
Tb927.10.14490 hypothetical protein, conserved 
Tb927.10.14500 hypothetical protein, conserved 
Tb927.10.14550 ATP-dependent DEAD/H RNA helicase, putative 
Tb927.10.14710 40S ribosomal protein S2, putative (RPS2) 
Tb927.10.15330 CYTH domain containing protein, putative 
Tb927.10.15660 hypothetical protein, conserved 
Tb927.10.15730 SPRY domain/Ankyrin repeats (3 copies), putative 
Tb927.10.1900 DNA topoisomerase IA, putative 
Tb927.10.2020 hexokinase (HK2) 
Tb927.10.2200 hypothetical protein, conserved 
Tb927.10.3110 DNA primase large subunit, putative (pril) 
Tb927.10.350 protein kinase, putative 
Tb927.10.3920 hypothetical protein, conserved 
Tb927.10.4220 hypothetical protein, conserved 
Tb927.10.4450 stress-inducible protein STI1-like, putative 
Tb927.10.4740 nucleolar RNA-binding protein, putative 
Tb927.10.5020 Eukaryotic translation initiation factor 4E type 5 (eif4e5) 
Tb927.10.5260 C2 domain containing protein, putative 
Tb927.10.5370 40S ribosomal protein S10, putative 
Tb927.10.5400 hypothetical protein, conserved 
Tb927.10.5540 hypothetical protein, conserved 
Tb927.10.5620 fructose-bisphosphate aldolase, glycosomal (ALD) 
Tb927.10.5880 Proteophosphoglycan, putative 
Tb927.10.5890 Galactose oxidase, central domain containing protein, putative 
Tb927.10.6110 hypothetical protein, conserved 
Tb927.10.700 hypothetical protein, conserved 
Tb927.10.7120 hypothetical protein, conserved 
Tb927.10.7230 Flagellar Member 1 (FLAM1) 
Tb927.10.7270 hypothetical protein, conserved 
Tb927.10.8290 eukaryotic translation initiation factor 3 subunit 8, putative 
Tb927.10.830 adenylate kinase, putative 
Tb927.10.8820 bilobe protein, conserved 
Tb927.10.8930 paraflagellar rod component, putative (PFC18) 
Tb927.10.8980 hypothetical protein, conserved 
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Tb927.10.9000 hypothetical protein, conserved 
Tb927.10.9240 Tir chaperone protein (CesT) family, putative 
Tb927.10.9570 paraflagellar rod component, putative (PFC14) 
Tb927.10.9840 chaperone protein DNAj, putative 
Tb927.11.10300 hypothetical protein, conserved 
Tb927.11.10540 hypothetical protein, conserved 
Tb927.11.10660 hypothetical protein, conserved 
Tb927.11.1090 calpain-like protein, putative 
Tb927.11.10930 tubulin delta chain (TUBD1) 
Tb927.11.11010 hypothetical protein, conserved 
Tb927.11.11210 paraflagellar rod component, putative (PFC17) 
Tb927.11.11220 dynein heavy chain, putative 
Tb927.11.11580 hypothetical protein, conserved 
Tb927.11.12030 hypothetical protein, conserved 
Tb927.11.12150 flagellar protein essential for flagellar pocket biogenesis (BILBO1) 
Tb927.11.1220 hypothetical protein, conserved 
Tb927.11.12210 Domain of unknown function (DUF4586), putative 
Tb927.11.12840 Domain of unknown function (DUF4486), putative 
Tb927.11.13270 hypothetical protein, conserved 
Tb927.11.13500 par1 
Tb927.11.13650 cytochrome b5, putative (CYB5) 
Tb927.11.13700 hypothetical protein, conserved 
Tb927.11.13780 profilin 
Tb927.11.13930 U3 small nucleolar ribonucleoprotein protein IMP3, putative 
Tb927.11.14300 dynein intermediate chain IC70, putative 
Tb927.11.14650 hypothetical protein, conserved 
Tb927.11.14690 Microtubule-binding protein MIP-T3, putative 
Tb927.11.14880 Paraflagellar Rod Proteome Component 9, putative (PFC9) 
Tb927.11.14890 DNA polymerase alpha/epsilon subunit B, putative 
Tb927.11.15070 hypothetical protein, conserved 
Tb927.11.15100 Tb5.20 
Tb927.11.15650 poly(A) polymerase, putative 
Tb927.11.16120 hypothetical protein, conserved 
Tb927.11.16400 kinetoplast-associated protein 3, putative (KAP3) 
Tb927.11.16640 Uncharacterised protein family UPF0564, putative 
Tb927.11.2060 60S acidic ribosomal protein P0, putative 
Tb927.11.20730 glycerophosphoryl diester phosphodiesterase, putative 
Tb927.11.2500 metallo-peptidase, Clan MA(E) Family M32 
Tb927.11.2540 hypothetical protein, conserved 
Tb927.11.2570 hypothetical protein, conserved 
Tb927.11.270 mitochondrial carrier protein (MCP10) 
Tb927.11.3250 dynein heavy chain, putative 
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Tb927.11.3260 mitochondrial DNA polymerase I protein D, putative (POLID) 
Tb927.11.3290 hypothetical protein, conserved (p166) 
Tb927.11.350 RNA-binding protein, putative 
Tb927.11.3660 dynein light chain Tctex-type, putative 
Tb927.11.3990 hypothetical protein, conserved 
Tb927.11.4210 U-box domain containing protein, putative 
Tb927.11.4690 mitochondrial DNA polymerase I protein B (POLIB) 
Tb927.11.5030 hypothetical protein, conserved 
Tb927.11.5570 DNA replication licensing factor MCM5, putative 
Tb927.11.5640 hypothetical protein, conserved 
Tb927.11.6050 Flagellar-associated PapD-like, putative 
Tb927.11.6530 hypothetical protein, conserved 
Tb927.11.6710 predicted tetratricopeptide repeat (TPR) protein 
Tb927.11.6780 regulator of chromatin condensation, putative 
Tb927.11.7130 hypothetical protein, conserved 
Tb927.11.7840 ribonucleoside-diphosphate reductase large chain (RNR1) 
Tb927.11.7860 DNA replication licensing factor MCM2, putative 
Tb927.11.8060 SNARE associated Golgi protein, putative 
Tb927.11.8210 RAD50 DNA repair-like protein 
Tb927.11.8230 hypothetical protein, conserved 
Tb927.11.8390 hypothetical protein, conserved 
Tb927.11.8810 hypothetical protein, conserved 
Tb927.11.8950 leucine rich repeat (TbLRRP1) 
Tb927.11.900 isocitrate dehydrogenase, putative (IDH) 
Tb927.11.9100 Domain of unknown function (DUF4586), putative 
Tb927.11.9540 hypothetical protein, conserved 
Tb927.2.4810 hypothetical protein, conserved 
Tb927.2.5270 dynein heavy chain, putative 
Tb927.2.5280 Enriched in surface-labeled proteome protein 1 (ESP1) 
Tb927.2.5660 adenylate kinase, putative (ADKA) 
Tb927.2.5760 Flagellar Member 8 (FLAM8) 
Tb927.2.5970 hypothetical protein, conserved 
Tb927.2.5980 heat shock protein, putative 
Tb927.2.6100 hypothetical protein, conserved 
Tb927.3.1040 unspecified product 
Tb927.3.1060 cAMP response protein, putative (CARP4) 
Tb927.3.1700 diacylglycerol acyltransferase, putative 
Tb927.3.1900 hypothetical protein, conserved 
Tb927.3.2050 hypothetical protein, conserved 
Tb927.3.2310 PACRGA 
Tb927.3.2670 hypothetical protein, conserved 
Tb927.3.2810 hypothetical protein, conserved 
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Tb927.3.2880 hypothetical protein, conserved 
Tb927.3.2890 radial spoke protein RSP10, putative 
Tb927.3.3200 Domain of unknown function (DUF4586), putative 
Tb927.3.3440 phytanoyl-CoA dioxygenase (PhyH), putative 
Tb927.3.3490 high mobility group protein, putative (TDP1) 
Tb927.3.3790 hypothetical protein, conserved 
Tb927.3.3940 RNA-binding protein, putative (DRBD11) 
Tb927.3.5350 hypothetical protein, conserved 
Tb927.3.5370 hypothetical protein, conserved 
Tb927.3.5430 hypothetical protein, conserved 
Tb927.3.5620 Metallopeptidase family M24/FACT complex subunit (SPT16/CDC68)/Histone 
chaperone Rttp106-like, putative 
Tb927.3.690 protein kinase, putative 
Tb927.3.700 hypothetical protein, conserved 
Tb927.3.930 dynein heavy chain, putative 
Tb927.3.950 2OG-Fe(II) oxygenase superfamily, putative 
Tb927.3.990 hypothetical protein, conserved 
Tb927.4.1330 DNA topoisomerase IB, large subunit 
Tb927.4.2450 thioredoxin, putative 
Tb927.4.2600 hypothetical protein, conserved 
Tb927.4.310 SPRY domain/HECT-domain (ubiquitin-transferase), putative 
Tb927.4.3120 bilobe protein, conserved 
Tb927.4.3320 uracil phosphoribosyltransferase, putative 
Tb927.4.3700 hypothetical protein, conserved 
Tb927.4.4690 hypothetical protein, conserved 
Tb927.4.4700 hypothetical protein, conserved 
Tb927.4.4940 hypothetical protein, conserved 
Tb927.4.870 dynein heavy chain, putative 
Tb927.5.1120 Phage tail fibre repeat, putative 
Tb927.5.1180 hypothetical protein, conserved 
Tb927.5.1270 hypothetical protein, conserved 
Tb927.5.1360 nucleoside 2-deoxyribosyltransferase (NDRT) 
Tb927.5.1490 Eukaryotic translation initiation factor 4 gamma type 1 (eif4g1) 
Tb927.5.1700 replication Factor A 28 kDa subunit, putative 
Tb927.5.1880 inhibitor of serine peptidase (ISP), putative (ISP2) 
Tb927.5.1900 hypothetical protein, conserved 
Tb927.5.1940 hypothetical protein, conserved 
Tb927.5.2780 mitochondrial DNA polymerase beta 
Tb927.5.2790 mitochondrial DNA polymerase beta-PAK (Pol beta-PAK) 
Tb927.5.2950 Repeat of unknown function (DUF1126), putative 
Tb927.5.3260 WD domain, G-beta repeat, putative 
Tb927.5.3510 structural maintenance of chromosome 3 , putative (SMC3) 
Tb927.5.3730 hypothetical protein, conserved 
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Tb927.5.4160 hypothetical protein, conserved 
Tb927.5.4390 hypothetical protein, conserved 
Tb927.5.4440 dynein light chain, putative 
Tb927.5.4470 hypothetical protein, conserved 
Tb927.5.4480 paraflagellar rod component par4, putative 
Tb927.5.570 hypothetical protein, conserved 
Tb927.5.580 prefoldin subunit, putative 
Tb927.5.760 cell cycle sequence binding phosphoprotein (RBP33), putative 
Tb927.5.830 hypothetical protein, conserved 
Tb927.6.1180 hypothetical protein, conserved 
Tb927.6.3040 small GTP-binding protein Rab28, putative 
Tb927.6.3150 Hydin 
Tb927.6.3330 hypothetical protein, conserved 
Tb927.6.3580 ATP-dependent DEAD/H DNA helicase recQ, putative 
Tb927.6.4100 hypothetical protein, conserved 
Tb927.6.4300 glyceraldehyde 3-phosphate dehydrogenase, glycosomal (GAPDH) 
Tb927.6.4670 MORN repeat-containing protein 1 (MORN1) 
Tb927.6.4710 calmodulin, putative 
Tb927.6.4780 DNA ligase I, putative 
Tb927.6.5090 hypothetical protein, conserved 
Tb927.6.860 hypothetical protein 
Tb927.7.1050 40S ribosomal protein S16, putative 
Tb927.7.1860 hypothetical protein, conserved 
Tb927.7.190 thimet oligopeptidase, putative (THOP1) 
Tb927.7.1920 paraflagellar rod component, putative (PFC5) 
Tb927.7.2390 hypothetical protein, conserved 
Tb927.7.3160 Cytoplasmic dynein 1 heavy chain (DYNC1H1), putative 
Tb927.7.3330 hypothetical protein, conserved 
Tb927.7.3590 hypothetical protein, conserved 
Tb927.7.3990 mitochondrial DNA polymerase I protein C (POL1C) 
Tb927.7.4810 HD domain containing protein, putative 
Tb927.7.4870 hypothetical protein, conserved 
Tb927.7.4910 hypothetical protein, conserved 
Tb927.7.5020 60S ribosomal protein L19, putative 
Tb927.7.5480 dihydrofolate reductase-thymidylate synthase (DHFR-TS) 
Tb927.7.5660 hypothetical protein, conserved 
Tb927.7.570 prefoldin, putative 
Tb927.7.5920 mercaptopyruvate sulfurtransferase, putative (MST) 
Tb927.7.6230 ADP-ribosylation factor, putative (ARF3) 
Tb927.7.630 hypothetical protein, conserved 
Tb927.7.920 dynein heavy chain, putative 
Tb927.8.1550 paraflagellar rod component, putative (PFC3) 
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Tb927.8.1630 MSP-B, putative 
Tb927.8.3050 Chitobiase/beta-hexosaminidase C-terminal domain containing protein, putative 
Tb927.8.3060 cytosolic leucyl aminopeptidase, putative 
Tb927.8.3250 dynein heavy chain, putative 
Tb927.8.3410 Inositol hexakisphosphate, putative 
Tb927.8.3790 paraflagellar rod component, putative (PFC2) 
Tb927.8.4230 hypothetical protein, conserved 
Tb927.8.4880 DNA polymerase alpha catalytic subunit 
Tb927.8.4950 kinesin, putative 
Tb927.8.5400 hypothetical protein, conserved 
Tb927.8.550 peptide methionine sulfoxide reductase, putative 
Tb927.8.5600 transaldolase, putative 
Tb927.8.6060 2-amino-3-ketobutyrate coenzyme A ligase, putative 
Tb927.8.6070 Trypanosome basal body component protein (TBBC) 
Tb927.8.610 hypothetical protein, conserved 
Tb927.8.6240 STOP axonemal protein 
Tb927.8.6420 beta-ketoacyl-ACP reductase 2 (KAR2) 
Tb927.8.6580 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (SDH1) 
Tb927.8.6660 paraflagellar rod component, putative (PFC1) 
Tb927.8.6980 hypothetical protein, conserved 
Tb927.8.7950 Flagellar Member 4 (FLAM4) 
Tb927.8.7970 hypothetical protein 
Tb927.8.810 radial spoke protein RSP9, putative 
Tb927.9.10010 chaperone protein DNAj, putative 
Tb927.9.10440 DNA polymerase epsilon catalytic subunit, putative 
Tb927.9.11230 calmodulin-like protein, putative 
Tb927.9.11850 structural maintenance of chromosome 1, putative (SMC1) 
Tb927.9.12390 hypothetical protein, conserved 
Tb927.9.13440 Flagellar Member 5 (FLAM5) 
Tb927.9.1510 D-ala D-ala ligase C-terminus/SET domain containing protein, putative 
Tb927.9.15450 Domain of unknown function (DUF4205), putative 
Tb927.9.1700 btb/poz domain containing protein, putative 
Tb927.9.1750 Fibronectin type III domain containing protein, putative 
Tb927.9.2310 hypothetical protein, conserved 
Tb927.9.2940 hypothetical protein, conserved 
Tb927.9.4420 hypothetical protein, conserved 
Tb927.9.5190 proliferative cell nuclear antigen (PCNA), putative 
Tb927.9.5590 DNA topoisomerase ii (TOP2) 
Tb927.9.6100 TFIIF-stimulated CTD phosphatase, putative 
Tb927.9.6130 calmodulin, putative 
Tb927.9.6760 hypothetical protein, conserved 
Tb927.9.7180 adenosine monophosphate deaminase, putative 
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Tb927.9.7550 adenylosuccinate lyase, putative (ADSL) 
Tb927.9.8760 hypothetical protein, conserved 
Tb927.9.8990 Ankyrin repeats (3 copies), putative 
Tb927.9.9230 hypothetical protein, conserved 
Tb927.9.9730 hypothetical protein, conserved 
Tb927.9.9810 hypothetical protein, conserved 
Supplementary Table 8: Proteins classified as cell-cycle regulated that are not identified 
in transcriptomic data. 
Gene ID Product Description 
Tb927.2.1820 protein kinase, putative 
Tb927.2.3720 ubiquitin-conjugating enzyme, putative 
Tb927.2.4900 hypothetical protein, conserved 
Tb927.4.3290 Trypanosomal VSG domain containing protein, putative 
Tb927.4.4400 hypothetical protein, conserved 
Tb927.4.4950 hypothetical protein, conserved 
Tb927.6.300 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.6.820 pumilio RNA binding protein, putative (PUF4) 
Tb927.6.3360 hypothetical protein, conserved 
Tb927.7.1270 hypothetical protein, conserved 
Tb927.7.1630 hypothetical protein, conserved 
Tb927.8.910 hypothetical protein, conserved 
Tb927.8.1370 hypothetical protein, conserved 
Tb927.8.4770 small GTP-binding protein Rab18 (TbRAB18) 
Tb927.8.6910 cyclophilin, putative 
Tb927.9.1850 60S ribosomal protein L35, putative 
Tb927.9.2680 hypothetical protein, unlikely 
Tb927.9.12630 glycerol kinase, glycosomal (glk1) 
Tb927.9.13920 kinetoplastid membrane protein KMP-11 (KMP-11) 
Tb927.10.2010 hexokinase (HK1) 
Tb927.10.7300 hypothetical protein, conserved 
Tb927.10.11840 WD domain, G-beta repeat, putative 
Tb927.10.12800 Zinc finger CCCH domain-containing protein 38 (ZC3H38) 
Tb927.10.13650 ARF-like 2-binding protein, putative 
Tb11.02.5105b hypothetical protein, conserved 
Tb11.1810b retrotransposon hot spot protein (RHS, pseudogene), putative 
Tb11.v5.0452 GTPase activating protein, putative 
Tb11.v5.0553 ubiquitin hydrolase, putative 
Tb11.v5.0609 DNA-directed RNA polymerase III largest subunit, putative 
Tb11.v5.0971 mitochondrial DNA polymerase I protein A, putative 
Tb927.11.20300 variant surface glycoprotein (VSG), putative 
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Tb927.11.2350 hypothetical protein, conserved 
Tb927.11.3620 nucleobase/nucleoside transporter 8.1 (NT8.1) 
Tb927.11.7670 Cornifin (SPRR) family, putative 
Tb927.11.9620.1 hypothetical protein, conserved 
Tb927.11.11750 membrane-bound acid phosphatase, putative 
Tb927.11.12070 hypothetical protein, conserved 
Tb927.11.12820 ribonucleoside-diphosphate reductase small chain (RNR2) 
Tb927.11.13690.1 radial spoke protein RSP11, putative 
Tb927.11.16790 mitogen-activated protein kinase (ECK1) 
Tb11.1650 variant surface glycoprotein (VSG, pseudogene), putative 
Supplementary Table 9: Transcripts classified as cell-cycle regulated that are not 
identified in proteomic data. 
Gene ID Product Description 
Tb927.1.1350 kinesin heavy chain, putative 
Tb927.1.1360 hypothetical protein, unlikely 
Tb927.1.1740 hypothetical protein 
Tb927.1.1920 conserved protein, unknown function 
Tb927.1.2290 hypothetical protein, unlikely 
Tb927.1.2310 hypothetical protein 
Tb927.1.2320 hypothetical protein, conserved 
Tb927.1.2370 beta tubulin 
Tb927.1.2510 histone H3, putative 
Tb927.1.2560 hypothetical protein, unlikely 
Tb927.1.2620 hypothetical protein, unlikely 
Tb927.1.3150 hypothetical protein, conserved 
Tb927.1.3440 hypothetical protein, unlikely 
Tb927.1.3560 WW domain containing protein, putative 
Tb927.1.4190 hypothetical protein, unlikely 
Tb927.1.4500 SNARE associated Golgi protein, putative 
Tb927.1.4510 hypothetical protein, unlikely 
Tb927.1.4800 hypothetical protein, conserved 
Tb927.10.10210 procyclin-associated gene 4 (PAG4) protein (PAG4) 
Tb927.10.10220 procyclin-associated gene 2 (PAG2) protein (PAG2) 
Tb927.10.10240 procyclin-associated gene 1 (PAG1) protein (PAG1) 
Tb927.10.10250 EP2 procyclin (EP2) 
Tb927.10.10550 histone H2B, putative 
Tb927.10.11710 hypothetical protein 
Tb927.10.12670 hypothetical protein, conserved 
Tb927.10.12950 hypothetical protein, conserved 
Tb927.10.1330 hypothetical protein, conserved 
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Tb927.10.13380 hypothetical protein, conserved 
Tb927.10.1350 hypothetical protein, conserved 
Tb927.10.14900 hypothetical protein, conserved 
Tb927.10.15250 paraflagellar rod component, putative (PFC15) 
Tb927.10.16070 eukaryotic translation initiation factor 4E, putative 
Tb927.10.1940 serine/threonine-protein kinase, putative 
Tb927.10.3130 myotubularin-associated protein, putative 
Tb927.10.4600 predicted SET domain protein 
Tb927.10.4730 ribonuclease HII, putative 
Tb927.10.5360 40S ribosomal protein S10, putative 
Tb927.10.550 hypothetical protein, conserved 
Tb927.10.5650 hypothetical protein, conserved 
Tb927.10.5960 engulfment and cell motility domain 2, putative 
Tb927.10.6500 amino acid transporter, putative 
Tb927.10.6520 hypothetical protein, conserved 
Tb927.10.7000 hypothetical protein, conserved 
Tb927.10.7890 hypothetical protein, conserved 
Tb927.10.8450 glucose transporter 1E (THT1E) 
Tb927.10.9060 hypothetical protein, conserved 
Tb927.10.9730 hypothetical protein, conserved 
Tb927.11.10310 hypothetical protein, unlikely 
Tb927.11.10610 hypothetical protein, conserved 
Tb927.11.10800 Domain of unknown function (DUF4496), putative 
Tb927.11.1100 cysteine peptidase, Clan CA, family C2, putative 
Tb927.11.11540 unspecified product 
Tb927.11.11740 membrane-bound acid phosphatase, putative 
Tb927.11.11920 molybdenum cofactor biosynthesis protein, putative 
Tb927.11.12980 hypothetical protein, conserved 
Tb927.11.13030 calmodulin 
Tb927.11.14370 hypothetical protein, conserved 
Tb927.11.1470 65 kDa invariant surface glycoprotein-like protein 
Tb927.11.14800 hypothetical protein, conserved 
Tb927.11.14840 chromosomal passenger protein (CTC2) 
Tb927.11.14860 hypothetical protein, conserved 
Tb927.11.14930 hypothetical protein, conserved 
Tb927.11.15090 hypothetical protein, conserved 
Tb927.11.16140 DNA replication licensing factor MCM7, putative 
Tb927.11.2310 hypothetical protein, conserved 
Tb927.11.2700 hypothetical protein, conserved 
Tb927.11.2710 cell division cycle 45 (CDC45), putative 
Tb927.11.3000 60S ribosomal protein L37, putative 
Tb927.11.340 hypothetical protein, conserved 
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Tb927.11.4590 hypothetical protein, conserved 
Tb927.11.4600 unspecified product 
Tb927.11.5010 TFIIF-stimulated CTD phosphatase, putative 
Tb927.11.5340 Cell division protein kinase, putative 
Tb927.11.5670 Mnd1 family, putative 
Tb927.11.5980 conserved protein 
Tb927.11.6180 60S ribosomal protein L28, putative 
Tb927.11.6550 PUF nine target 1 (PNT1) 
Tb927.11.780 hypothetical protein, conserved 
Tb927.11.7800 hypothetical protein, conserved 
Tb927.11.8750 hypothetical protein, conserved 
Tb927.11.890 hypothetical protein, conserved 
Tb927.11.9030 cation transporter, putative 
Tb927.11.9330 helicase-like protein 
Tb927.2.4480 hypothetical protein, conserved 
Tb927.2.5040 MORN repeat, putative 
Tb927.3.1420 hypothetical protein, conserved 
Tb927.3.1860 ATP-grasp domain containing protein, putative 
Tb927.3.2760 hypothetical protein, conserved 
Tb927.3.2790 leucine-rich repeat protein (LRRP), putative 
Tb927.3.3310 60S ribosomal protein L13, putative 
Tb927.3.3920 serine/threonine-protein kinase, putative 
Tb927.3.4310 Paraflagellar rod protein 1-3 (PFR1-3) 
Tb927.3.4670 cdc2-related kinase 10, putative (CRK10) 
Tb927.3.5200 hypothetical protein, conserved 
Tb927.3.5260 hypothetical protein, conserved 
Tb927.3.590 adenosine transporter, putative 
Tb927.3.870 Histone RNA hairpin-binding protein RNA-binding domain containing protein, 
putative 
Tb927.4.1290 hypothetical protein, conserved 
Tb927.4.2270 Histone-like transcription factor (CBF/NF-Y) and archaeal histone, putative 
Tb927.4.2490 hypothetical protein, conserved 
Tb927.4.2780 hypothetical protein, conserved 
Tb927.4.3440 hypothetical protein, conserved 
Tb927.4.4080 C-5 sterol desaturase, putative 
Tb927.4.4130 hypothetical protein, conserved 
Tb927.4.4180 hypothetical protein, conserved 
Tb927.4.4480 hypothetical protein, conserved 
Tb927.4.4900 hypothetical protein 
Tb927.4.5110 kinetoplastid kinetochore protein 8 (kkt8) 
Tb927.4.5330 hypothetical protein 
Tb927.5.1550 mitochondrial carrier protein (MCP23) 
Tb927.5.2390 hypothetical protein, conserved 
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Tb927.5.2970 suppressive immunomodulating factor (TSIF) 
Tb927.5.3460 hypothetical protein, conserved 
Tb927.5.3680 GPI-GlcNAc transferase complex, PIG-H component, putative 
Tb927.5.4240 histone H4, putative 
Tb927.5.4530 fatty acid elongase, putative 
Tb927.5.470 monocarboxylate transporter-like protein 
Tb927.5.850 hypothetical protein, conserved 
Tb927.6.1220 hypothetical protein, conserved 
Tb927.6.1710 hypothetical protein, conserved 
Tb927.6.3180 hypothetical protein, conserved 
Tb927.6.3430 protein kinase, putative 
Tb927.6.3880 hypothetical protein, conserved 
Tb927.6.900 hypothetical protein, conserved 
Tb927.7.1590 mitotic cyclin (CYC8) 
Tb927.7.1750 60S ribosomal protein L7, putative 
Tb927.7.2110 kinetoplastid kinetochore protein 11 (kkt11) 
Tb927.7.2580 zinc finger protein family member, putative (ZC3H19) 
Tb927.7.2650 hypothetical protein, conserved 
Tb927.7.2870 histone H2A, putative 
Tb927.7.3970 hypothetical protein, conserved 
Tb927.7.4580 Cornifin (SPRR) family, putative 
Tb927.7.4860 kinetoplastid kinetochore protein 13 (kkt13) 
Tb927.7.490 hypothetical protein, conserved 
Tb927.7.5040 kinesin, putative (KIN-B) 
Tb927.7.5220 protein kinase, putative 
Tb927.7.5370 hypothetical protein, conserved 
Tb927.7.5650 kinesin, putative 
Tb927.7.5740 conserved protein 
Tb927.7.6050 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.7.6060 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.7.6070 receptor-type adenylate cyclase GRESAG 4, putative 
Tb927.7.610 mitochondrial DNA ligase homolog, LIG k-alpha 
Tb927.7.6310 polo-like protein kinase (PLK) 
Tb927.7.6590 hypothetical protein, conserved 
Tb927.7.6630 hypothetical protein, conserved 
Tb927.7.6730 hypothetical protein, conserved 
Tb927.7.6840 Centrosomal spindle body, CEP44, putative 
Tb927.7.7150 hypothetical protein, conserved 
Tb927.7.720 conserved protein 
Tb927.7.7270 hypothetical protein, conserved 
Tb927.7.7320 hypothetical protein, conserved 
Tb927.7.750 hypothetical protein, conserved 
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Tb927.8.1150 kinetoplastid kinetochore protein 9 (kkt9) 
Tb927.8.1920 histone-lysine n-methyltransferase (DOT1A) 
Tb927.8.3850 PSP1 C-terminal conserved region, putative 
Tb927.8.3990 hypothetical protein, conserved 
Tb927.8.4060 flagellum-adhesion glycoprotein, putative 
Tb927.8.4350 hypothetical protein, conserved 
Tb927.8.4730 amino acid transporter, putative 
Tb927.8.490 hypothetical protein 
Tb927.8.4900 hypothetical protein, conserved 
Tb927.8.4990 Paraflagellar rod protein 2-3 (PFR2-3) 
Tb927.8.5570 transporter, putative 
Tb927.8.6120 hypothetical protein, conserved 
Tb927.8.6300 hypothetical protein, conserved 
Tb927.8.7070 hypothetical protein, conserved 
Tb927.9.10480 hypothetical protein, unlikely 
Tb927.9.10540 hypothetical protein, unlikely 
Tb927.9.11690 hypothetical protein, conserved 
Tb927.9.12310 hypothetical protein, conserved 
Tb927.9.12590 glycerol kinase, glycosomal (glk1) 
Tb927.9.14300 hypothetical protein, conserved 
Tb927.9.14400 leucine-rich repeat protein (LRRP), putative 
Tb927.9.15520 BARP protein (BARP) 
Tb927.9.15580 BARP protein (BARP) 
Tb927.9.15600 BARP protein (BARP) 
Tb927.9.1580 hypothetical protein, unlikely 
Tb927.9.1670 protein kinase, putative 
Tb927.9.4550 hypothetical protein, conserved 
Tb927.9.4580 hypothetical protein, unlikely 
Tb927.9.5920 hypothetical protein, unlikely 
Tb927.9.6090 PTP1-interacting protein, 39 kDa 
Tb927.9.6140 hypothetical protein, unlikely 
Tb927.9.8620 hypothetical protein, conserved 
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Appendix: Optimisation of TMT 
quantitation 
7.1 Extension of data from Chapter 4 
The data presented in this Appendix is an extension of the data produced in Chapter 4. 
A mixture of TMT labelled peptides was produced in the manner described in section 
4.3.3, mixing human peptides, labelled in ratios of 10:4:1:1:4:10 with six-plex TMT 
reagents that generate reporter ions at m/z 126, 127, 128, 129, 130 and 131, and 
trypanosome peptides labelled at a 10:10:10 ratio in the m/z 126, 127 and 129 TMT 
reporter ion channels. The addition of trypanosome TMT labelled peptides mimics the 
effect of compression when quantifying human peptides in the first three reporter ion 
channels (126, 127 and 128), while the latter three (129, 130, 131) act as a control, 
demonstrating the accuracy and precision of quantitation of the expected 10-fold, 4-fold 
and 2.5-fold ratios of intensity between each TMT reporter. 
 Supplementary Figure 1 shows an extended range of the precursor ion mass 
isolation widths tested on a QExactive+ mass spectrometer, compared to Figure 4.8. 
The general trend for more accurate quantitation of the three compressed ratios with 
narrower isolation widths holds for this extended set of data including 0.4, 0.7, 1.0, 1.5, 
2.0, 3.0 and 4.0 m/z. In Chapter 4 we also saw an increase in the number of identified 
psms as we decreased the isolation window. With the extended range of isolation widths 
tested we see an increase in the number of psms identified from 2,754 to 3,544 as we go 
from 4.0 m/z to 1.0 m/z. A further decrease of the isolation window leads to a lower 
number of psms identified, to 3,493 at 0.7 m/z and 3,422 at 0.4 m/z. 
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Supplementary Figure 1: Effect on TMT quantitation of modifying the isolation 
window on a QExactive+ MS. N shows the number of psms quantified, together with 
the percentage of psms identified that pass the quality control criteria for quantification. 
!
Supplementary Figure 2: Effect on TMT quantitation of modifying the isolation 
window on a Fusion MS. N shows the number of psms quantified, together with the 
percentage of psms identified that pass the quality control criteria for quantification. 
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Supplementary Figure 3: Effect on psm identification and quantification of isolation 
window on a Fusion MS. N shows the number of psms quantified, together with the 
percentage of psms identified that pass the quality control criteria for quantification. 
In Supplementary Figures 2 and 3 we tested the effect of modifying the isolation 
width for precursor ion selection on a Fusion MS. Supplementary Figure 2 shows that a 
narrower isolation width produces more accurate quantitation of compressed ratios, 
though more variability in the quantitation of the uncompressed ratios is also observed. 
Supplementary Figure 3 also shows that although all three isolation widths tested 
produced similar numbers of psms identified, narrowing the isolation width to 0.8 m/z 
resulted in a large drop in the number of psms both identified and quantified to 1,591 
(61.8% of those identified), from 2,081 at 1.6 m/z (81.1% of those identified). 
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Supplementary Figure 4: Effect on TMT quantitation of peptide load on a Fusion MS. 
N shows the number of psms quantified, together with the percentage of psms identified 
that pass the quality control criteria for quantification. 
!
Supplementary Figure 5: Effect on psm identification and quantification of peptide load 
on as Fusion MS. N shows the number of psms quantified, together with the percentage 
of psms identified that pass the quality control criteria for quantification. 
Appendix: Optimisation of TMT quantitation 
!
!
 
!
235 
Supplementary Figures 4 and 5 demonstrate the effect on TMT quantitation of 
modifying the peptide load in a mass spectrometry run. In this set of experiments there 
appears to be little difference in the quantitation of either the compressed or 
uncompressed ratios when loading anything from 0.5 to 3.0 µg of peptide, with similar 
accuracy and precision. However, as shown in Supplementary Figure 5, there are 
significant differences between the number of psms identified and quantified between 
these samples. At 0.5 µg peptide loads only 60.2% of psms identified pass our quality 
control for quantitation, described in Chapter 4, producing data for 1,402 psms. This 
increases to 2,025 psms at 1.0 µg, 2,321 at 2.0 µg, and 2,434 at 3.0 µg. At a peptide 
load of 3.0 µg we see that over 90% of psms identified are also being quantified. 
7.2 Preparation of second batch of TMT peptide mixture 
The experiments that follow utilise a second preparation of TMT-modified peptides 
produced by mixing mouse and trypanosome peptides in a similar manner to that 
described in Section 4.3.3. Instead of using human peptides to assess effects on 
compression we are now using mouse peptides, mixed in the ratios of 10:4:1:1:4:10 
with six-plex TMT reagents that generate reporter ions at m/z 126, 127, 128, 129, 130 
and 131. Trypanosome peptides were again used to mimic interfering peptides, and 
labelled in the m/z 126, 127 and 128 TMT reporter ion channels. A number of 
experiments are displayed which are described in the caption of Supplementary Figure 
6, a subset of which are discussed in more detail in later figures. 
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Supplementary Figure 6: Contour plots of compressed (red) and uncompressed (blue) 
psms with an expected 10-fold ratio with a range of methods tested on QExactive, 
QExactive+ and Fusion with mouse and trypanosome TMT-peptide mix. Facet titles 
indicate the experiment performed. ‘Pt’ indicates experiments performed on a 
QExactive instrument with numbers indicating isolation widths tested. Similarly, ‘Cs’ 
indicates experiments performed on a QExactive+ instrument. All other experiments 
were performed on a Fusion. 10N or 2N 1.0e4, 2.5e4, 7.5e4 and 1.0e5 shows the effect 
of modifying the AGC target for the MS3 scan at either 10 SPS-notches or 2 SPS-
notches. HCD40, 50, 55, 60 and 70 show the effect of modifying the collision energy 
used for reporter ion fragmentation. IT 050ms, 100ms, 150ms, 200ms, 250ms and 
300ms show the effect of modifying the MS3 injection time. MS 0.8 and 1.5 show the 
effect of modifying isolation width. N02, 03, 04, 06, 08 and 10 show the effect of 
modifying the number of SPS-notches used for the quantitative MS3 scan. The res120k 
experiment shows the effect of acquiring data at a higher Orbitrap resolution. 
TMTcomp uses methods reported in another publication. Top10, 15, 20 and Speed 
show the effect of different ion selection methods. 
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7.3 Differential effects of increasing the MS3 scan maximum injection time 
!
Supplementary Figure 7: Effect on TMT quantitation of modifying the MS3 scan 
maximum injection time on a Fusion MS with mouse and trypanosome TMT-peptide 
mix. N shows the number of psms quantified, together with the percentage of psms 
identified that pass the quality control criteria for quantification. 
The maximum injection time for MS3 scans does not appear to modify the 
accuracy or precision of quantitation of compressed or uncompressed ratios when using 
the mouse and trypanosome peptide mixture. There is also no effect on the number of 
psms identified that pass quantification criteria, with all experiments quantifying >99% 
of the psms identified. This is in contrast to the data presented in Figures 4.10 and 4.11 
in Chapter 4, where we observed an increased precision in quantification of the 
uncompressed ratios, and an increase in the number of peptides passing quantification 
criteria as we increased the MS3 maximum injection time from 105 ms to 300 ms. We 
believe this is likely due to inaccuracies in peptide quantitation which meant that, 
inadvertently, more peptide was loaded in the mouse and trypanosome peptide mix 
compared to the human and trypanosome peptide mix described in Chapter 4. This can 
also be observed from the scatterplots of the 10-fold ratios and total TMT reporter ion 
intensity for each identified psm in Supplementary Figure 6 and Figure 4.9. In the 
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experiment in Figure 4.9, there are many psms with a total TMT reporter ion intensity 
below 100,000 units. However, in the experiments where maximum ion injection time 
was modified, displayed in Supplementary Figure 6 (IT 050ms, IT 100ms, IT 150ms, 
IT200ms, IT250ms, IT300ms), there are few psms that are detected below a total TMT 
reporter ion intensity of 100,000. It may therefore be the case that due to a higher load 
of peptide in these experiments, the maximum injection time was not being met for any 
of the peptides quantified, even at a maximum injection time of 50 ms. 
7.4 Optimising the number of SPS notches 
!
Supplementary Figure 8: Effect on TMT quantitation of decreasing the number of SPS-
notches used on a Fusion MS with mouse and trypanosome TMT-peptide mix. N shows 
the number of psms quantified, together with the percentage of psms identified that pass 
the quality control criteria for quantification. 
The original method published for synchronous precursor selection (SPS) MS3 for 
isobaric tag quantitation utilised 10 ‘notches’ to select fragment ions for higher energy 
collision dissociation for fragmentation of reporter ions for the quantitative MS3 scan. 
This means that 10 fragment ions produced from fragmentation of the precursor ion 
were re-isolated for this second round of high energy fragmentation. In Supplementary 
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Figure 8 we investigated the effect on quantiation of TMT by reducing the number of 
fragment ions (or ‘notches’) that were re-isolated for fragmentation for the quantitative 
MS3 scan. Reducing the number of notches increases the accuracy of quantitation of 
compressed ratios. This may be due to reduced effects of co-isolation of contaminant 
peptide ions. By using a higher number of notches you increase the chance that any one 
of the notches selected may contain a fragment ion of a contaminating peptide, therefore 
leading to the effect of compression as shown in Figure 4.7. Reducing the number of 
notches reduces the likelihood of this occurring, especially as fragment ions from the 
ion of interest are likely to be higher intensity, and therefore selected first. However, we 
also see in the uncompressed ratios an increased imprecision in quantitation. This likely 
occurs due to a decrease in the amount of TMT reporter ion available for quantitation, 
which leads to increased variability in quantitation too. This can be observed in 
Supplementary Figure 6 (N02, N03, N04, N06, N08, N10), where the contour plots of 
data acquired with a higher number of notches shows a higher total TMT reporter ion 
intensity, though a wider deviation in the compressed and uncompressed ratios. 
 
 
 
 
 
Appendix: Optimisation of TMT quantitation 
!
!
 
!
240 
7.4 Modification of MS3 AGC target at 10 and 2 SPS notches 
!
Supplementary Figure 9: Effect on TMT quantitation of decreasing the automatic gain 
control target using 10 SPS-notches on a Fusion MS with mouse and trypanosome 
TMT-peptide mix. N shows the number of psms quantified, together with the 
percentage of psms identified that pass the quality control criteria for quantification. 
Decreasing the automatic gain control target of ions to be used for the quantitative MS3 
scan from 1x105 down to 1x104 shows a trend towards more accurate quantitation of 
compressed ratios. For low abundance peptides in particular, it may be that a lower 
AGC target limits the amount of co-isolated contaminant ions that can also be 
accumulated prior to the quantitative MS3 scan. Unfortunately, although we see an 
increase in accuracy of compressed ratio quantitation, we also see an increased 
imprecision in quantitation of the uncompressed ratios as we decrease the AGC target. 
We also observe the effect of a decreased number of identified ions passing quality 
control criteria to be utilised for quantitation. At an AGC target of 2.5x104, 3,314 psms 
are quantified (91% of those identified). This drops to 2,390 psms at an AGC target of 
1x104 (65.4% of those identified). This effect is much more marked when the number of 
SPS-notches used is decreased from 10 to 2. 
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Supplementary Figure 10: Effect on TMT quantitation of decreasing the automatic gain 
control target using 2 SPS-notches on a Fusion MS with mouse and trypanosome TMT-
peptide mix. N shows the number of psms quantified, together with the percentage of 
psms identified that pass the quality control criteria for quantification. 
At 2 notches we again see an improvement of the compressed ratio accuracy and 
the variability of the uncompressed ratio is similar across all AGC targets tested. 
However, we see a large drop in number of psms quantified as we reduce the AGC at 2 
notches. Starting from 2,961 psms (85.3% of those identified) at an AGC target of 
1x105, we see a drop to 2,509 psms (70.4% of those identified) at an AGC target of 
5x104, further dropping to 864 psms (23.8% of those identified) at an AGC target of 
1x104. These results again highlight the balance between achieving accurate 
quantitation of compressed ratios and precise quantitation of the uncompressed ratios. 
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7.5 Identification of compression through analysis of trypanosome peptides 
!
Supplementary Figure 11: Percentage of mouse and trypanosome peptide spectral 
matches identified in all 6 TMT reporter ions channels. Nomenclature for experiments 
plotted are identical to Supplementary Figure 6.  
Another method to assess the effects of compression is to determine how many psms 
identified as trypanosome peptides are quantified in all 6 TMT channels. As these 
peptides have only been labelled using the 126, 127 and 128 m/z TMT reporter ions, 
they should only be detected in 3 channels. Identification in 6 channels indicates the 
co-isolation of mouse peptides, which have been labelled with all 6 TMT reporter ions. 
Therefore, in the ideal scenario in Supplementary Figure 11 we would expect to see 
experiments plotted in the right hand corner, with 0% of trypanosome peptides and 
100% of mouse peptides detected in all 6 TMT reporter ion channels. 
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 We see that for all QExactive and QExactive+ methods tested, where we varied 
the isolation width, almost all trypanosome and mouse peptides were identified with an 
intensity from all 6 TMT reporter ions (Supplementary Figure 11). For data acquired on 
a Fusion MS, using the SPS-MS3 methodology, we see the bulk of experiments 
identifying a signal for all 6 TMT reporter ions in >65% of trypanosome peptides and 
almost 100% of mouse peptides. This group includes experiments where the HCD 
collision energy, the maximum injection time for MS3 scan, or the ion selection method 
was modified. We also observe experiments where 10 or 8 SPS notches were utilised. A 
further reduction in trypanosome peptides identified in all 6 TMT reporter ions is 
detected by: decreasing the number of SPS notches used (N08, N06, N04, N03 and 
N02); decreasing the isolation width for precursor ion selection to 0.8 m/z for the MS3 
scan (MS 0.8); and decreasing the AGC target at 10 notches (10N 5e4 and 2.5e4) or 
2 notches. However, we also observe that as we decrease the number of trypanosome 
peptides with reliably identified signal for all TMT reporter ions, we also begin to see a 
large drop this category of mouse peptides too. Just under 25% of mouse peptides are 
detected in all 6 TMT reporter channels for instance. This result highlights that there is 
a fine balance to be struck between producing accurate quantification of measured ratios 
using TMT (by trying to reduce the effect of compression), and producing precise and 
reliable quantification of measured ratios (by increasing the amount of material or 
signal reaching the Orbitrap mass analyser). 
In summary, we envision two situations for the quantitation of proteomic 
samples using isobaric tag based quantitation. The first, where sample material is 
plentiful and the amount of peptide available for analysis is not limiting, it would be 
worthwhile to reduce the effects of compression by decreasing the number of SPS-
notches utilised and decreasing the isolation width for selecting the precursor ion for the 
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MS3 quantitative scan, while increasing the amount of sample loaded per run. These 
parameters would allow for a reduction of the effect of compression with high sample 
loads. We would not recommend reducing the AGC target below 1x105 as this would 
consistently reduce the amount of sample analysed on the Orbitrap mass analyser, 
resulting in inaccurate quantification. In the second situation, where the amount of 
sample and peptide available is limiting, it would be worthwhile to maximise the 
number of SPS-notches used, increase the isolation width for the precursor ion selection 
for the quantitative MS3 scan, and increase the maximum injection time for the MS3 
scan. In this case we are looking to increase the amount of sample that reaches the 
Orbitrap mass analyser to allow for more precise quantitation of the material which is 
available. 
